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Abstract 
Laura Jane PARRY 
An Asymmetric Horner-Wittig reaction: Synthesis of Phytosterols and 
unravelling their role in disease 
Keywords: Phytosterol, Horner-Wittig reaction 
Phytosterols are major components of food and are structurally related to 
cholesterol, but differ from it by virtue of a carbon substituent at the C-24 
position and in some cases, a double bond between C-22 and C-23 (Figure i). 
Furthermore, phytosterols are shown to have protective actions against colon, 
breast, and prostate cancer1; further investigation is required as their mode of 
action is unknown. Thus, reported herein is the design and synthetic 
implementation required to construct these naturally occurring compounds. 
 
Figure i : Cholesterol  
Construction towards a double bond flanked by two asymmetric carbon atoms, 
observed in the phytosterol side chain, will be synthesised using an asymmetric 
Horner-Wittig (H-W) reaction, involving a chiral α-substituted aldehyde and a 
chiral β-substituted phosphine oxide. In addition to the synthesis, the 
stereochemical outcomes of these H-W reactions were probed. The results 
demonstrated, that by varying the steric bulk, electronic nature, and aromatic 
ii 
 
properties of the groups β to the phosphorus and α to the aldehyde can control 
the cis/trans selectivity in alkene formation.  
Finally, to display the utility of this methodology, the phytosterol compounds will 
be synthesised and tested in MD-MBA-231 cancer cell lines, allowing further 
investigation into the phytosterol mechanism of action. 
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1.0 CHAPTER 1 - Phytosterols and their role in biology 
1.1 Structure of Phytosterols 
Phytosterols, as the name suggests, are sterol molecules found in plants. 
Within plant physiology, they play a similar role to that played in animals by 
cholesterol 1 (5-cholesten-3-ol) 2 with which they are structurally related. 
There are over 200 phytosterols found in plants, the most abundant being -
sitosterol 2 (3-stigmast-5-en-3-ol), campesterol 3 (3-stigmasta-5,22-dien-3-
ol), stigmasterol 4 (3-ergost-5-en-3-ol), and brassicasterol 5 (ergosta-5,22-
dien-3β-ol) (Figure 1) 1,3.  
 
Figure 1 : Structures of phytosterols 4 
The plant sterols structurally belong to the 27-carbon cholestane family and 
share its tetracyclic-[]-phenanthrene (sterol) ring structure. However, they 
differ from it by the presence of carbon substitution at the C-24 position of the 
lateral side chain and in some cases a double bond between the C-22 and C-23 
positions. (Figure 1 and Figure 2) 1,5-7.  
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Figure 2 : Numbering and positional nomenclature of phytosterol molecules 4. 
1.2 Origins of phytosterols 
 1.2.1 Dietary Intake 
The cholesterol 1 in humans is acquired via two sources: 70 % of 1 is 
biosynthesized within the liver and the remainder is obtained through the dietary 
intake of foods high in saturated fat, mainly animal products, such as eggs, milk, 
cheese, and meat5. In contrast, phytosterols cannot be synthesized within the 
mammalian body and are introduced into human biology solely through dietary 
intake. Phytosterols are found naturally in high concentrations within oils, 
spreads, nuts and seeds, and to a lesser extent within cereals, fruits, and 
vegetables. Some examples of high phytosterol food sources can be found in 
Table 1 1,5. A typical daily consumption of plant sterols in Europe is 
approximately 200-300 mg/day whereas a vegetarian’s intake is considerably 
higher at 300-450 mg/day8. A study with 35 healthy volunteers showed that the 
diet affects the circulating phytosterol levels. The results showed that the 
plasma concentrations were elevated by 20 % while on a 2-week diet which 
consisted of food sources rich in -sitosterol 2 and campesterol 31. 
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Table 1 : Concentration (mg/100g) of major phytosterols in food sources 1 (Note: ND = 
not detected). 
Over the recent years, phytosterols have been added to certain manufactured 
foods, mainly for their cholesterol lowering abilities (section 1.4). Some of these 
foods include: low-fat or non-fat foods, bakery products and margarine 9. 
Margarine is a major source of phytosterols that have been marketed to help 
lower serum cholesterol and reduce risk of heart disease; for example 
Benecol spread has 850 mg of plant sterol esters and 500 mg of free sterols 
per serving1. 
 1.2.2 Biosynthesis 
Phytosterols are biosynthesised from 1, but only in algae, fungi, and plants. 
Therefore, the biogenesis of 1 is firstly considered.  
In circumstances where there is a low dietary intake of 1, higher organisms 
including humans are able to adapt by an upregulation in cholesterol 
biosynthesis10. The SREBP-cleaving-activating protein (SCAP) is a sensor of 
sterols and an activator of sterol regulatory element-binding protein-2 
(SREBP2). SCAP detects the depletion in 1 and upregulates SREBP2 release 
from the membrane, which results in an increased expression of HMG-CoA 
reductase, a major enzyme in the mevalonate pathway 11,12. The mevalonate 
Food 
-Sitosterol 
2 
Campesterol 
3 
Stigmasterol 
4 
Total 
Phytosterol 
content 
Olive oil 117 5 ND 145 
Peanuts * 47-133 6-18 7-10 64-161 
Sesame 
seeds 
231 53 22 306 
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pathway is an important metabolic pathway present in all higher eukaryotes, as 
it is critical for the formation of isopentenyl pyrophosphate (IPP). The synthesis 
of all steroids starts with the formation of IPP, which is then converted into an 
intermediate known as farnesyl pyrophosphate (FPP) via FPP synthase. Two 
molecules of FPP condense with reduction by nicotinamide adenine 
dinucleotide phosphate (NADPH) to give the biosynthetic precursor squalene. 
Oxidation at one of the terminal double bonds of squalene, by squalene 
synthase, yields oxidoaqualene13. From this point on the biosynthesis pathway 
to phytosterols is fundamentally different to that of 1. The enzyme-catalysed 
cyclisation that occurs in higher animals mainly affords lanosterol 6, whereas 
plants afford cycloartenol 7 (with some exceptions) (Scheme 1)10,14,15. 
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Scheme 1 : Cholesterol and phytosterol biosynthesis pathway (Note: PP pyrophosphate). 
Diagram modified from Liao et al. 16. 
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Furthermore, a group of enzymes that are collectively known as sterol 
methyltransferases (SMT’s) catalyse the introduction of the carbon atoms at the 
C-24 position, of the phytosterol side chain, along with a co-substrate known as 
S-adenosyl-L-methionine (SAM) 8. There are three families of 
methyltransferases; the first are C-24 methyltransferase (SMT1), they are 
responsible for the first methylation step towards the formation of compounds 3 
and 5. The other two families are SMT2 and SMT3 they are responsible for the 
second methylation step and the formation of C-24 ethyl groups present in β-
sitosterol 2 and stigmasterol 4 (Scheme 2) 15. 
 
 
Scheme 2 : Synthesis to show the methylation steps on the lateral side chains of 
phytosterols. Scheme adapted from 15. 
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1.3 Absorption and metabolism of sterols 
 1.3.1 Micelle formation of cholesterol prior to entering cell  
Molecules like cholesterol 1 that have both polar and non-polar regions form 
aggregates that are referred to as micelles. The polar region or the ionic heads 
are in contact with the aqueous region creating an outer shell, whilst the non 
polar tails sequester in a disorganised fashion towards the interior of micelle 
creating a circular shape (Figure 3) 17,18.  
 
 
 
Figure 3 : Micelle formation - the polar heads remain on the outer of the micelle, whereas 
non-polar tails elongate towards the inside. Micelle formation of this nature occurs in 
aqueous solutions 19. 
The size of the micelle is dependent upon various factors such as the pH of the 
solution and temperature. Micelles are seen to form only when the 
concentration of the amphiphilic molecule has reached a given concentration 
referred to as critical micelle concentration (cmc) 19. This concentration is 
monitored by the sudden change in the chemical and physical properties of the 
solution. Furthermore, below the cmc micelles are completely absent (Figure 
4). 
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Figure 4 : Critical micelle concentration (cmc): Left to right: Increasing concentration of 
surfactant in water slowly forming a layer on the surface and eventually forming micelles 
at or above the cmc 18. 
 1.3.2 Absorption and metabolism 
In normal western diets, the absorption of dietary cholesterol 1 from the lower 
intestine is high, around 60 %. In contrast, phytosterols are much less efficiently 
absorbed which results in phytosterols accumulating within the tissues and 
plasma, in concentrations up to 1000 times lower than that of 1 9. Sterols can 
exist in the body in the free or esterified form. The existence of the free form is 
associated mainly with the cell membranes, whereas the esterified form is found 
in intercellular and extracellular lipid stores throughout the body. The overall 
distribution of the plant sterols in the lipid stores correlates to that of 1, with high 
concentrations in the adrenal cortex, ovaries, and epithelia and at low 
concentrations in the spleen, bone marrow, and testes 1. After ingestion from 
the diet, 1 is emulsified by bile salts and incorporated into micelles. This is a 
necessary process in order to aid sterol absorption 6. Following this, the uptake 
of micelles into the enterocytes is a process carried out by the NPC1L1 
(Neimann-Pick C1 Like 1; Lipid micelle transporter 5,20), using passive transport 
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of proteins located on the brush border membranes 21. Following immediate 
absorption into the enterocytes, the free sterols can be subsequently secreted 
back into the intestinal lumen through an active transport mechanism, via the 
enterocytes efflux transporters ABCG5 and ABCG8. Both ABC transporters 
have an ability to discriminate between 1 and phytosterols. This reinforces a low 
net absorption of phytosterols and high net absorption of 1 22. Thus, ABCG5 
and ABCG8 limit the absorption of phytosterols and promote their excretion 
from the liver and into the bile, by effluxing the sterols back into the intestinal 
lumen 22-24. A study by Plosch et al.25, showed that ABCG5-null mice had 
significantly elevated levels (37-fold) of circulating -sitosterol 2, compared to 
wild-type controls, which possessed both transporters25. These transporters 
differentiate between the phytosterol and 1 structures, based on the differences 
on the lateral side chain mainly occurring at the C-24 position1,22,24,26. 
Campesterol 3 is absorbed at higher concentrations than that of -sitosterol 2 
and stigmasterol 4. This is potentially due to the lack of the C-22 double bond 
and only a Me- group present (CH3) at the C-24 position of the lateral side chain 
27.  
Alternatively, rather than being secreted back into the intestinal lumen, free 
sterols (normally 90% of 1 and less than 20 % of plant sterols) within the 
enterocytes can become esterified 15,21. The esterification takes place by an 
enzyme known as ACAT (acyl-CoA cholesterol acyltransferases), this enzyme 
has a relatively low affinity for phytosterols 11. In the enterocytes, the esterified 
sterols form chylomicrons, which are large lipoproteins used for long distance 
transport between cells10. The chylomicrons are then secreted into the lymph 
and blood stream, where they are converted to chylomicron-remnants, by 
lipoprotein lipase 11 and transported to the liver where they are taken up by 
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hepatocytes 1,3. Once in the liver 1 is incorporated into very low-density 
lipoproteins (VLDL) 10 and become further modified within the circulation to low-
density lipoproteins (LDL). LDL is termed the “bad” cholesterol, its role is to 
deliver lipids to the body’s cells via LDL receptor-mediated endocytosis 5,15,26. 
The LDL particles are incorporated into the cell membrane along with the free 
sterols and here the LDL’s become oxidised creating a risk for the development 
of cardiovascular disease 28. Another transporter in the enterocytes belongs to 
the ABC-Transporter family and is termed the ABCA1 transporter, the free 
sterols are transported back to the intestinal tract where the sterols can become 
esterified once again 11. Some are then converted into high-density lipoproteins 
(HDL) in the plasma by a enzyme known as lecithin-cholesterol acyltransferase 
(LCAT) these are termed “good” cholesterol and have an inverse relationship 
with cardiovascular disease development 26. The HDL particles circulate 
through the capillaries and collect excess lipids from peripheral tissues, 
including 1, cholesterol esters and phytosterols.  
The HDL returns these lipids to the liver via the plasma, this is a process known 
as reverse cholesterol transport, monitored by the Liver X receptor (LXR) 3,5. 
From the liver the excess lipids are excreted from the body as secondary bile 
acids or they are removed from the body as unchanged sterols 3,5,10,29 (Figure 
5). 
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Figure 5 : Sterol and phyotsterol absorption, esterification and incorporation into 
chylomicrons. Abbreviations: NPC1L1 - lipid micelle transporter; ABC - ATP-Binding 
Cassette transporters; ACAT - Acyl-coA Cholesterol Acyl Transferase; TG - 
Triglycerides; MPT - Microsomal TG transfer protein; QM - Chylomicrons; HDL - High 
Density Lipoprotein; SR-B1 - Scavenger Receptor type B. Diagram taken from 5. 
1.4 High phytosterol content causes a reduction in 
cholesterol 
There are several mechanisms by which a high phytosterol diet reduces the 
serum cholesterol 1 within humans, and validates that plant sterols in the diet 
are negatively correlated with cholesterol absorption and total/LDL cholesterol 
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levels 15. The first mechanism prevents cholesterol absorption. Phytosterols are 
more hydrophobic and have a higher affinity for the micelles and at high 
concentrations; phytosterol uptake into the micelles is preferential over 1, thus 
preventing cholesterol absorption 9. A study was completed 26 in vivo, which 
revealed that cholesterol absorption declined during -sitosterol 2 infusion by 
almost 50-85 %. This results in a decreased level of total cholesterol 1 and LDL 
within the body 26. Also Weststrate et al. 30 showed that the intake of 2 g/day of 
phytosterols for 4 weeks resulted in a 14 % reduction in total and LDL 
cholesterol 1 in mildly hypercholestemic patients 30. Another study reported the 
same results in individuals with normal cholesterol levels 31. This reduction in 1 
is particularly important in coronary heart disease 27.  
The second mechanism causing a reduction in LDL particles is the reduction of 
the esterified cholesterol. The mechanism occurs with inhibition of ACAT, 
(section 1.3) by phytosterols at high concentrations. This then allows 
cholesterol to be replaced in chylomicrons by phytosterols, thus reducing serum 
cholesterol and circulating LDL 5.  
The third mechanism occurs because phytosterols are slight agonists of LXR, 
with EC50 levels at 30-150 nM, which causes an increase in the removal of 
cholesterol from the body 5,32,33. A high level of 1 in the body is positively 
correlated with cancer growth 34. Therefore, the inhibition of cholesterol 1 
absorption is thought to produce a state of 'cholesterol deficiency', which is 
particularly important in the prevention of cancer 9. 
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1.5 Role of Phytosterols in Cancer 
 1.5.1 Cancer Overview 
Cancer is one of many life-threatening diseases. Cancer is a multi-step process 
involving the conversion of normal cells to malignant tumours. This progression 
is defined by a number of characteristics (hallmarks), including; uncontrollable 
cell growth, insensitivity to antigrowth signals, inhibition of apoptotic pathways, 
alteration to the body’s immune system, acceleration of passage of cells 
through cell check points in the cell cycle, overproduction of growth signals and 
hormones, enhanced angiogenesis. The ability to metastasize to various 
locations in the body is one of many main hallmarks of malignancy 3,35. 
Malignant growth is dependent on a balance between cell proliferation and 
apoptosis, if cell proliferation is greater than apoptosis then the growth of the 
cancer is usually faster. Therefore, the potential to regulate these two functions 
has become the determinants of effective anticancer therapy and has become 
the subject for in vivo and in vitro studies 29.  
 1.5.2 Dietary Phytosterols and Cancer: Epidemiological 
 studies 
Epidemiological studies have long suggested that a diet rich in phytosterols 
contributes to a decreased risk of various chronic ailments particularly 
cardiovascular disease and cancer. People from Western societies consume 
around 200-300 mg/day of plant sterols 1,9, whereas Asians and vegetarians 
consume a larger quantity. The epidemiological studies discussed in this 
section show that there are strong correlations between individual cancer types 
and population, even though the mechanism for the protective role of 
phytosterol action is not yet completely understood 9,36. These studies can 
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confirm that people who consume predominantly plant-based, phytosterol-
enriched diets have lower incidences of colon, lung, stomach and breast cancer 
37.  De Stefani et al. 38 showed that the Uruguayan population consume a diet 
that is rich in meat and low in fruits and vegetables. Several case controlled 
studies have been carried out in hospitals in Uruguay, in which the risk of 
specific cancers are investigated in relation to the subject’s diet 34,38,39. Due to a 
poor diet, stomach cancer is the third most frequently occurring cancer in the 
Uruguayan population. The patients were interviewed using food frequency 
questionnaires based upon 64 food items, which are considered to represent 
their local diet. Published food composition data 40 was used to assess the 
specific intake of certain phytosterols; -sitosterol 2, campesterol 3, stigmasterol 
4 and total phytosterols. The results showed that plant sterols were inversely 
associated with risk of stomach cancer. In conclusion, this effect of plant sterols 
could have a major public health impact, not only in Uruguay but also in a 
disease such as gastric cancer, which has a poor prognosis and has a high 
incidence. Mendilaharsu34 and Normén6, reported that there was a protective 
effect of phytosterols on colon cancer, due to a decreased cholesterol 1 
absorption in the small intestine, which is achieved by a rich phytosterol diet, 
showed a negative association towards the risk of colon cancer. 
As well as their effect on cancer, phytosterols also have a cholesterol 1 lowering 
effect on humans. Escurriol and co workers 41 have completed a number of 
studies. Their first aimed to show whether increasing phytosterol intake was 
associated with a cholesterol-lowering effect for primary cardiovascular 
prevention, a trial was carried out with nutritional intervention of a population 
that consumes Mediterranean diets. The results showed that enhancing the 
Mediterranean diets with a 158 mg/day increase in phytosterol intake, gave the 
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most beneficial effects on cholesterol lowering, when compared with a second 
population on low-fat diets after 1 year. The study concluded that there was a 
larger reduction in plasma concentration of cholesterol 1 by the consumption of 
phytosterols, rather than the reduced intake of cholesterol itself. When in 2010, 
Escurriol et al. 42 also showed that participants in the Spanish cohort of 
European Prospective Investigation into Cancer and Nutrition (EPIC) have a 
larger consumption of plant sterol rich diets than most European countries and 
the US, which resulted from their adherence to the Mediterranean diet. The 
results speculate that the increased plasma concentrations of phytosterols, 
mainly -sitosterol 2 and campesterol 3, are associated with a decreased risk of 
coronary heart disease.  
In conclusion, the epidemiological studies demonstrate a slight discrepancy 
regarding the effects of phytosterols within the body. This discrepancy can be 
due to the type of cancer, lifestyle, and diets that different populations consume. 
Although, most of the epidemiological studies clearly show a protective effect 
cancer and all favour the cholesterol-lowering effect shown by a high 
phytosterol diet. Nevertheless, support towards a protective role of phytosterols 
for cancer can be strengthened by animal experimentation studies, which are 
discussed below. 
 1.5.3 Dietary Phytosterols and Cancer: In vivo studies 
  1.5.3.1 Models on Colon Cancer 
Colon cancer is responsible for 9-11 % of all cancer related deaths and 
according to the World Health Organisation (WHO), it is the third leading cancer 
worldwide 33,43. Animal studies have been developed to assess the effect of 
defined dietary intakes of phytosterols on the incidence of colon cancer, 
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induced either by chemical carcinogens or indirectly due to any changes in an 
associated risk factor for the development of colon cancer.  
Carcinogenesis is promoted when cell DNA undergoes oxidative stress and is 
damaged. Therefore, to replicate cell DNA damage in animal studies, 
carcinogens are directly administered to animal models in order to promote 
tumour growth 3. A study completed by Raicht et al. 44, showed that the rats fed 
with 0.2% -sitosterol 2 , along with administration of a direct acting carcinogen 
N-methyl-N-nitrosourea (MNU) had a lower incidence of tumours after 28 weeks 
compared to the controls, MNU alone. The results showed that there was 0.4 
tumours/animal in the 2 dietary group compared with 1.3 tumours/animal in the 
control group 26,44.  
A risk factor associated with the development of colon cancer is an increased 
cell proliferation of colonic mucosa 29. High cholesterol diets cause an increase 
in cholesterol metabolites, such as cholic acid. Cholic acid is a known stimulator 
of cell proliferation and sterol absorption. Janezic et al. 45 studied the effects of 
dietary phytosterols on colonic epithelium proliferation in mice. Feeding mice 
diets supplemented with 0.3-2 % of phytosterols along with 0.1 % of cholic acid 
showed that there was a dose dependent reduction in cell proliferation. Also, to 
confirm Janezic’s findings on mice, Awad et al. 46 showed that in rats, after 22 
days of treatment with 0.2 % of cholic acid and a 2 % phytosterol diet (made up 
of 56 % -sitosterol 2, 28 % campesterol 3, 10 % stigmasterol 4 and 6 % 
dihydrobrassicasterol by weight) a normalisation of the cholic-acid induced 
proliferation of colon epithelial cells was observed. These studies demonstrate 
that dietary phytosterols can protect from colon cancer development by a 
reduction in cell proliferation 3.  
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  1.5.3.2 Models on Breast cancer  
The most common cancer in women is breast cancer and the metastasis of the 
primary tumour to secondary tumours is the most threatening aspect. There are 
many environmental factors that can contribute to the development of the 
cancer 47, but the focus here is the diet. A study completed in rodent hosts by 
Awad et al. 37, centres on the dietary intake of phytosterols and their ability to 
decrease proliferation and metastasis of breast cancer cells to the lymph nodes 
and lungs. The SCID mice, both B and T cell deficient, were separated into two 
different groups and fed for 15 days before the MDA-MB-321 oestrogen-
negative tumour cells were added; the first was fed a 0.2 % cholic acid and 2 % 
phytosterol diet, while the other was fed 2 % 1. After 8 weeks there was a 33 % 
reduction in tumour size and there were 20 %, fewer metastases in the mice fed 
the phytosterol diet. In the cholesterol-fed mice, the pathological studies 
showed the tumour cells had metastasized 71 %, compared to only 57 % in 
phytosterol-fed mice. High intake and blood concentrations of 1 have been 
identified as a risk factor for breast cancer. A study completed by Chang et al. 48 
observed that women with breast cancer have an elevated blood cholesterol 
levels and lower HDL-cholesterol levels compared with normal women. It can 
be concluded from these studies that dietary phytosterols retard the growth and 
spread of breast cancer cells in vivo, through an action independent of 
oestrogen. Although due to structural similarity, phytosterols could also compete 
for the oestrogen receptor and this could affect endogenous oestrogen levels in 
the body 1,49,50,51. The oestrogen receptor-α is over expressed in transformed 
cells, and is required for the proliferative effects of estradiol in breast cancer 
cells 52. Research by Gutendorf and Westendorf  53 shows that -sitosterol 2 is 
a weak agonist for oestrogen receptors and has been demonstrated that 2 
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binds with equivalent affinity to both α- and -isoforms of the oestrogen receptor 
53. Moreover, 2 has been shown to moderately stimulate the growth of an 
oestrogen receptor-positive breast cancer cell line 54.Despite their potential to 
exert some oestrogenic effects, phytosterols may have beneficial effects on 
breast cancer, but may also have an indirect effect on the oestrogenic activity of 
cells, attenuating de novo steroid synthesis through the reduction in cholesterol 
levels 52. 
  1.5.3.3 Models on Prostate cancer 
Animal studies have been designed in order to determine if dietary phytosterols 
provide protection against prostate cancer. High cholesterol intake within the 
diet causes high levels of androgens in the body and this itself aids progression 
of this disease 55. It has been suggested by several groups 55-57 that prostate 
tumour cells are capable of de novo androgen synthesis; from cholesterol 
acquired from the systemic circulation, thus also promoting cancer progression 
29,58. Within these studies, it is reported that without this cholesterol 
supplementation there is a reduction in the growth of prostate cancer 55. Awad 
et al. 59, previously mentioned in section 1.5.3.1 37, to reveal results about the 
positive effects of high phytosterol intake against the growth and metastasis of 
PC-3 human prostate cancer cells in male SCID mice. After the 8 week feeding 
period, there was a 40-43 % decrease in tumour size in phytosterol fed animals 
verses the cholesterol fed control. Alongside this result, there was also a 
reduction in rate of tumour metastasis to the lung, liver, and lymph nodes by 50 
% compared to the control.  
In summary, it is thought that a high intake of phytosterols may cause a 
reduction in prostate metabolism and growth of cancer cells 29. 
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 1.5.4 Dietary phytosterols and Cancer: Mechanisms of 
 action and in vitro studies 
Phytosterols encourage anti-tumour responses within the body that effect the 
normal cellular processes, some of these potential mechanisms include; 
slowing the cell cycle, inducing apoptosis, reducing tumour growth and 
influencing hormones of tumours dependent on oestrogen and androgen 
(Figure 6) 1. 
 
Figure 6 : Dietary phytosterols act as anticancer compounds through various 
mechanisms shown. Effects on tumours include: slowing of cell cycle progression; 
induction of apoptosis; inhibition of tumour metastasis; altered signal transduction; and 
induction or activation of endogenous antiangiogenic factors. Diagram taken from 
Woyengo et al. 3. 
In this section, using in vitro studies, the hypothesised mechanisms of action, by 
which plant sterols carry out their roles will be discussed. The in vitro 
experiments use established cell lines of human; colon (i.e. HT-29) 45, prostate 
(i.e. LNCaP) 60 and breast (i.e. MDA-MB-231) 3. Most cancers are becoming 
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resistant to single target chemotherapeutic agents and cancers may require 
drugs that will act on several different pathways at the same time. Therefore, 
the low specificity towards a single target makes phytosterols an ideal agent for 
the next generation cancer drugs 61. 
  1.5.4.1 Effects on signal transduction 
   1.5.4.1.1 Membrane Phases  
Cholesterol 1 induced cell growth may be due to the formation of liquid-ordered 
(LO) lipid rafts, (Figure 7), within cell membranes (Figure 8), with phospholipids 
known as sphingomyelin 58,62. 1 is abundant in the mammalian cell plasma 
membrane and is essential for its structural and functional properties 63. The 
presence of 1 in the bilayer is reported to regulate lipid order (Figure 7) 64. 
 
Figure 7 : Membrane phases - Structures of lipid bilayer are shown in their different 
phases 65.  
Furthermore, many biochemical and biophysical studies have demonstrated 
that 1 can laterally organise the bilayer components into specialised 
microdomains such as lipid rafts 66.  
   1.5.4.1.2 Incorporation and effect 
Cholesterol 1 is incorporated into the membranes at the hydroxyl group found at 
the C-3 position. It interacts with the polar head groups of the membrane 
22 
 
phospholipids, to anchor the steroid backbone and lateral side chain into the 
membrane (Figure 8).  
 
 
Figure 8 : Cell membrane containing a lipid raft. Abbreviations: A - Intracellular space 
(Cytosol); B - Extracellular space; 1 - Non-raft membrane; 2 - lipid raft; 3 - lipid-raft 
associated membrane protein; 4 - non-raft membrane protein; 5 - Glycoproteins and 
Glycolipids; 6 - GPI-anchored protein; 7 - cholesterol; 8 - glycolipid 57. 
The cholesterol 1 molecules are embedded within the membrane and parallel to 
the fatty acid acyl chains, maintaining the structure 15,67. The high cholesterol 
content within the cell membrane is particularly important for cell signalling as 
well as cell structure. The lipid rafts can signal to the proteins, which are in 
close proximity and will result inevitably in an increased cell growth and 
reduction in apoptosis 55. Alternatively, if 1 content decreases within the lipid 
rafts, there is a sudden increase in apoptosis as a result 56,3. Thus, when 
phytosterols in the diet are high, this causes them to incorporate into the cell 
membranes, reducing the cholesterol rich environment 29. Without this 
cholesterol rich environment the structure and signalling capabilities of the lipid 
rafts become reduced, as phytosterols diminish the capacity to mimic 
cholesterol functions. This may potentially disorder raft associated signal 
transduction pathways, which previously favoured cell growth, but instead may 
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begin to favour apoptosis 55. In addition, there is a reduction in membrane 
fluidity, as the phytosterols have weaker interactions with the membrane 
phospholipids, due to the larger groups present on the lateral side chain. This 
causes the phospholipids to remain further apart, reducing the cohesion of the 
cell membrane, thus weakening it 62,68. A study was completed by Awad et al. 43 
showed when there was supplementation of 16 M concentrations of -
sitosterol 2 to HT-29 colon cancer cells, there was a 54 % increase of plant 
sterol incorporation, which caused a reduction in 1 content by 26 % when 
compared with the untreated cells. The most interesting changes to the cellular 
signal transduction reported from this study, were the activation of the 
sphingomyelin cycle, -sitosterol 2 incorporation into cell membranes causes a 
reduction in sphingomyelin by 50 % 43,60. This in turn caused an increased 
production in ceramide, which is a cellular inducer of cell cycle arrest and 
apoptosis 29,43. The upregulation of ceramide inhibits the activation of protein 
kinase C (PKC), which is a target enzyme in the regulation of proliferation. 
These changes resulting from the activation of this pathway, causes inhibition of 
growth and an increase in apoptosis, indirectly via the sphingomyelin cycle, in 
tumour cells 43,60,69. To validate this a study completed by von Holtz et al. 60 
observed a similar result. After 16 M of -sitosterol 2, there was a 4-fold 
increased in apoptosis after 2 days of treatment, whereas after 5 days there 
was a 50-55 % increase in ceramide compared with the untreated groups 60.   
From these studies, it seems that lowering blood cholesterol levels, by 
increasing phytosterols intake in the diet, could reduce the amount of 
cholesterol 1 in the lipid rafts, thus hindering the signals towards proliferation 
and allowing an increase in apoptosis. It appears that phytosterol influence on 
24 
 
membrane signal transduction is strongly desirable for the prevention of 
carcinogenesis 3,70. 
  1.5.4.2 Effects on Apoptosis. 
Apoptosis is essential in the body for elimination of unwanted or damaged cells; 
they have several distinct features that distinguish them from normal cells. The 
first change is membrane blebbing. Membrane blebbing is characterised by 
distinct irregular bulges in the plasma membrane. This is followed by cell 
shrinkage, chromatin condensation and finally nuclear and DNA fragmentation 
2. Apoptosis is the most effective anti-cancer mechanism, thus, it is important to 
discover new compounds that are capable of inducing apoptosis specifically in 
cancer cells 2. 
Activation of apoptosis occurs via the intrinsic mitochondrial pathway and is 
dependent on an imbalance between BAX, a pro-apoptotic regulator and BCL-
2, an anti-apoptotic protein; this imbalance decides whether the cell favours cell 
growth or programmed cell death. Direct activation occurs in cellular stress or 
damage, BAX is activated and BCL-2 is inhibited, resulting in cytochrome c 
leakage from the mitochondria. Cytochrome c then activates downstream 
caspase-7 and -3, promoting apoptosis 3. The results from a study completed 
by Park et al. 2, show that after 72 hrs of 20 M -sitosterol 2  treatment, there 
was a dose dependent increase in the BAX/BCL-2 ratio, favouring apoptosis 
and resulting in a reduction in cell viability of human leukemic U937 cells, when 
compared to the control. Apoptosis was induced through the down-regulation of 
BCL-2, resulting in a 3-fold increase in the cleavage of caspase-3 2. This down 
regulation was proven when BCL-2 was over-expressed in the phytosterol 
treated cell lines and there was a reduction in caspase-3 activation 3.  
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Apoptosis can be triggered via activation of the sphingomyelin cycle, previously 
reported in section 1.5.4.1.2, which causes an increase in ceramide levels. 
Ceramide is a strong inducer of apoptosis and proceeds with the indirect 
activation of the intrinisic pathway, via activation of protein phosphatases (i.e. 
PP2A), which mediate the dephosphorylation of BCL-2 3,20,29 (Figure 9). A study 
completed by Awad et al. showed that by treating MDA-MD-231 cell lines with a 
combination of -sitosterol 2 and Tamoxifen stimulated ceramide production in 
vitro. -Sitosterol 2 activates an enzyme known as serine C 
palmitoyltransferase, which in turn increases the ceramide concentration. This 
enzyme is involved in the biosynthesis of sphingosine, resulting in the activation 
of the sphingomyelin cycle. Therefore, because of this activation there is an 
increase in apoptosis and inhibition of cell proliferation by 62 %. Therapeutic 
implications of this study suggest that diets rich in phytosterols may offer 
protection against the development of breast cancer and may potentiate the 
antitumor activity of Tamoxifen during breast cancer therapy 1,71,72. It has been 
shown that both of these processes play causative roles in phytosterol-
mediated apoptosis in tumour cells 29. 
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Figure 9 : Proposed mechanisms by which phytosterols inhibit tumour growth and 
stimulate apoptosis. Abbreviations: SIT - β-sitosterol/phytosterols; SPh - sphingomyelin; 
PP2A - protein phosphatase 2A - SPh-ase/sphingomyelinase; SPh-synthase- 
sphingomyelin synthase 29.  
  1.5.4.3 Effects on the Cell cycle 
During the cell cycle in healthy cells, there are various time points at which the 
cells are checked, allowing the repair of damaged DNA, before continuing to the 
division stage of the cell cycle, better known as mitosis. In the development of 
cancer, it is noted that during the cell cycle there is loss of normal checkpoint 
control therefore allowing damaged DNA to divide and replicate. In addition, 
there is a reduction in the number of cells in the G0 phase, which is the phase 
where the cell is neither dividing nor preparing to divide 1. A study by Awad et 
al. 47 showed that phytosterols interfere with cell cycle kinetics in MDA-MB-231 
breast cancer cell lines. Phytosterols induce cell cycle arrest at the G2 phase, 
preventing the progression to the mitosis part of the cell cycle. Cholesterol 1 is 
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required to promote the cells in G2 to divide, by moving into the mitosis phase. 
In cholesterol 1 treated cells 12-24% of the cells where in G2 compared to 43% 
that where treated with -sitosterol 2 47. This study is further proof that there is a 
longer interphase in phytosterol treated cells, thus inhibiting cell division. The 
most important point to take from these studies is that a relatively long S-phase 
is ideal. This is because DNA-replication occurs in the S-phase. A longer time 
spent at this point in the cell cycle may prevent the damaged DNA from 
progressing into the G2 phase without being repaired, therefore allowing a more 
precise and accurate DNA replication and preventing abnormal cells, which may 
often lead to cancer 45.  
  1.5.4.4 Effects on Metastasis  
Metastasis plays a major role in morbidity and mortality for several forms of 
cancer, and it is thought that phytosterols may prevent or protect from 
metastasis occurring. Metastasis is the ability of primary tumour cells to leave 
their site of origin and spread to various parts of the body using the blood and 
lymphatic system. In some cases, they even evade the host’s immune system, 
developing secondary tumours at a new site where they continue to develop 
and proliferate 1,47. A study was completed in vitro, in order to assess whether 
phytosterols have an effect on tumour metastasis by measuring the cell 
invasion, migration and adhesion of phytosterol treated MDA-MB-231 cancer 
cell. A number of events relating to cancer begin with the initial attachment of 
the cancer cells to the basement membrane, followed by subsequent migration 
across the membrane. It is important to note that Matrigel is acting as a 
membrane for the cancer cell lines in this study. The cell lines were treated with 
16 M of -sitosterol 2 and the control cell line was treated with cholesterol 1 for 
3 days. The results showed that the -sitosterol 2 treated cells showed the best 
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effects towards diminishing metastasis. -sitosterol 2 decreased the ability of 
the cells to adhere to Matrigel-coated plates by 31% when compared with 
cholesterol 1 treated cells. This reduced adhesion caused the invasiveness of 
the breast cancer to also reduce, therefore this may be sufficient enough to 
block the metastatic process 47. It has not been reported whether phytosterols 
have any effect on angiogenesis and more work within this area is required to 
investigate this.  
1.6 Cytotoxicity  
In vitro studies treating cancer cells with cholesterol 1 have shown that 1 does 
not exert a cytotoxic effect 73. However, many in vitro studies have 
demonstrated cytotoxicity of phytosterols towards cancer cells 2,47,74. Awad et 
al.47,59 reported that -sitosterol 2 treatment at a concentration of 16mM 
inhibited growth of MDA-MB-231 cells by 70 % compared to controls.  
 
Figure 10 : General phytostanol structure - Cholestanol 10 andStigmastanol 11  
Additionally, as well as the sterols (containing either 1 or 2 double bonds), 
within this thesis interest is also in the testing of the stanol compounds (which 
contain no double bonds). There is little evidence in the literature about the 
testing and cytotoxicity of these stanols, i.e. cholestanol 10 and stigmastanol 11 
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(Figure 10). There is little evidence in the literature providing evidence for 
cytotoxicity of 10 and 11 75. 
1.7 Conclusion 
Although the mechanisms of actions of phytosterols on carcinogenesis are not 
understood, it is known that dietary factors are thought to contribute to as much 
as one-third of the factors influencing the development of cancer 1. Therefore, 
there is now considerable evidence from in vitro and in vivo studies to suggest a 
protective role of plant based diets on cancer progression. Phytosterols have 
been shown to act on various stages of the tumour development, including cell 
division, apoptosis and metastasis. Anti-proliferative effects on cancer cells 
were associated with the activation of the sphingomyelin cycle, cell cycle arrest, 
and stimulation of apoptotic death. It will be only through continued 
experimentation in areas of human epidemiology, animal systems and in 
cellular biochemistry that the cancer preventative actions of dietary phytosterols 
can be affirmed and understood.  
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2.0 CHAPTER 2 - The Wittig reaction and its variants 
2.1 Introduction  
The reactions between carbonyl functions and phosphorus-stabilised 
carbanions constitute some of the most powerful double bond forming reactions 
in organic synthesis. These reactions have evolved over time into three main 
types: namely the "classic" Wittig reaction of phosphonium ylides, the Horner-
Wittig (H-W) reaction of phosphine oxide anions, and the Horner Wadsworth 
Emmons (HWE) reaction of stabilised phosphonate esters.  
2.2 The Wittig Reaction 
This reaction is the most general of the three types and provides a range of 
alkenes under good stereocontrol 76. Wittig and Geissler first reported the Wittig 
reaction in 1953 77 and since then, it has been studied in great detail. It is 
perhaps the most commonly used method for synthesising alkenes, due to its 
reliability and efficiency. The reaction occurs between a carbonyl compound 
(aldehyde or ketone) and a phosphonium ylide (section 2.2.1) and it allows the 
conversion of C=O bond into a C=C bond, with concurrent formation of a P=O 
bond 76,78. 
 2.2.1  Mechanism and Stereoselectivity 
The earliest proposed mechanism for the Wittig reaction involves the formation 
of two intermediate species from the first step: the betaine 12 and the 
oxaphosphetane ring 13. In this proposed Wittig reaction, the initial step is the 
nucleophilic addition of the ylide to the carbonyl moiety forming 12 followed by 
ring closure to afford the oxaphosphetane ring intermediate 13. In the final step, 
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the breakdown of the four member ring intermediate 13 produces gives the 
alkene and the phosphine oxide by-product (Scheme 3) 78.  
 
Scheme 3 : Proposed Wittig reaction mechanism involving a betaine 12 78. 
There has been much debate over this mechanism 78, particularly about which 
species (the betaine 12 or the oxaphosphetane ring 13) is of lower energy and 
about how the existence of each species can rationalise the stereochemical 
outcome, under different reaction conditions 79. For many years, 12 was known 
as the lower energy species, because an alkoxide is an extremely stable 
species. However, low temperature 31P NMR studies, have revealed that 13 is 
the lower energy intermediate 80,81. Therefore, the current accepted mechanism 
of the Wittig reaction does not include the betaine intermediate 12 82 suggesting 
that the reaction proceeds directly to the four membered ring transition state 13 
(Scheme 3) 83.  
The stereoselectivity of the Wittig reaction can be influenced by many factors 
including the type of ylide, the type of carbonyl compound, the nature of solvent, 
and the counterion involved in the ylide formation.  
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The phosphonium ylide can be synthesised by an in situ deprotonation of the 
parent phosphonium salt, which is obtained directly from the SN2 reaction of 
triphenyl phosphine and an alkyl halide (Scheme 4) 84. Often, primary alkyl 
iodides and benzyl bromides are converted into the corresponding 
phosphonium salts by heating with triphenylphosphine at 50 °C in THF 79. 
 
Scheme 4 : Formation of a ylide 84 
Phosphorus ylides have been classified into three groups according to their 
general reactivity and stability. Stabilised ylides have conjugating or anion 
stabilising substituents (such as carbonyl groups) adjacent to the negative 
charge therefore they are stabilised not only by the phosphorus atom but also 
by the adjacent functional group 78. These ylides usually favour the production 
of trans-(E) alkenes. Non-stabilised or unstabilised ylides are without such 
functionalities and usually favour the formation of cis-(Z) alkenes 76. Semi-
stabilised ylides contain an aryl group and usually favour a mixture of cis and 
trans alkenes (Figure 11) 83. 
 
Figure 11 : Stabilised, semi-stabilised and unstabilised ylides 
There have been different rationalisations for the E-selectivity of stabilised 
ylides. In much of the early literature, the selectivity was attributed to 
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thermodynamic vs. kinetic control. In particular, due to the difference in the 
relative rate of formation of the oxaphosphetane ring 13 vs. the elimination of 
the oxaphosphetane ring 13 to the desired alkenes. In this model the selectivity 
is governed by the first step (the rate determining step) 79. Hence, the E-
selectivity of stabilised ylides has been attributed to the fact that these ylides 
are additionally stabilised, allowing the reaction to be reversible, and therefore 
affording the most stable trans-oxaphosphetane 13a under thermodynamic 
control. This rationalisation is supported by reaction rate studies82,85. The 
starting ylide is stable, as well as the newly formed oxaphosphetane ring 13, 
and this stability allows time for the less crowded and more stable trans-
oxaphosphetane intermediate 13a to be formed over the cis-oxaphosphetane 
13b 86 (Figure 12). 
 
Figure 12 : Stabilised ylide  79,86. 
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Furthermore, it has been proposed that equilibrium may arise between the two 
oxaphosphetanes, favouring the accumulation of the more thermodynamically 
stable, trans-oxaphosphetane 13a. Thus, trans alkenes are formed 
predominantly. In addition to the C=C bond being formed, a P=O bond is also 
formed which is again a thermodynamic driving force for the reaction.  
The Z-selectivity of the semi/ unstabilised ylides, is due to the kinetic control of 
the reaction, via the less favoured cis-oxaphosphetane ring or puckered 
transition state 13c (Figure 13) 82,83, 79. The carbonyl and the ylide approach 
each other at right angles and form the puckered four membered 
oxaphosphetane ring 13c in the transition state, in one-step, allowing the large 
substituents point away from each other. Due to the instability of the starting 
ylide, the reaction is irreversible and the Z-alkene is formed (Figure 13) 83. To 
form the unstabilised ylides, usually a strong base, such as BuLi, is required 
under inert reaction conditions; while stabilised ylides require a weak base such 
as an alkali metal hydroxide and the reaction can proceed in aqueous solution 
79. In general, good Z-selectivity can be expected when unstabilised ylides react 
with aldehydes under salt-free conditions in a dipolar aprotic solvent 87.  
 
Figure 13 : Semi-stabilised and unstabilised ylides 79,86. 
36 
 
However, further investigations have provided evidence against the reversible 
mechanism for the Wittig reaction of stabilized ylides. The model, that accounts 
for the best range of experimental observations, was postulated by Vedejs et al. 
88
. In this model Vedejs, proposes the irreversible addition of the ylide to the 
aldehyde producing the four-membered oxaphosphetane transition state, yet 
the formation of this transition state intermediate is not explained by 
thermodynamic control, but by the interplay between 1,2 and 1,3 steric 
interactions (Figure 14) 82.  
 
Figure 14 : Transition state structures for the reaction of non-stabilised ylides and semi-
stabilised ylides 83 
Vedejs proposed that the reactions of unstabilised ylides proceeds through an 
early puckered cis transition state 14a approaching in such manner that the 
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large substituents are kept away from each other. Thus, preventing the 1,2 
interaction, between the ylide substituent and the aldehyde, and the 1,3 
interaction, between the aldehyde and the phosphorous side chain, as 
observed in 14b (Figure 14). This balancing of steric effects, avoiding all 
possible interactions, favours the cis transition state 14a, which is formed 
selectively under conditions of kinetic control and further produces the Z-alkene 
78,83.  
For semi-stabilised ylides, the cis transition state 14c is less puckered than the 
corresponding one of an unstabilised ylide 14a, thereby making it harder to 
differentiate between the puckered and planar conformations (14c and 14d) for 
semi-stabilised ylides. Hence, the cis transition state 14c is more favourable in 
terms of 1,3 interactions but less favourable in terms of 1,2 interactions, 
therefore accounting for the relatively equal amounts of E and Z alkenes 83 
(Figure 14). 
Additionally, for stabilised ylides, the transition states are late and further 
advanced (Figure 15) 82,83 89.  
 
Figure 15 : Transition state structures for stabilised ylides 83 
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Experimental work alongside computational modelling carried out by Aggarwal 
et al. 83 ruled out the betaine mechanism and provided unequivocal support for 
the generally accepted oxaphosphetane mechanism by Vedejs 88, with one 
exception. Vedejs proposed that the late transition state associated with 
reactions of stabilised ylides would prevent puckering and both transition states 
would be closer to resembling four membered oxaphosphetane rings88,89. 
However, this was not supported by Aggarwal et al. and the computational 
modelling carried out (Figure 15, 14e and 14f) 82,88. Therefore, Aggarwal's 
rationale for the E-selectivity observed in stabilised ylides is through the 
emergence of a dipole-dipole interaction, between the two reactants, in the 
transition state. This strong, opposing dipole interaction occurs along the 
carbonyl bond of the aldehyde and the anion-stabilising group or the ylide, 
resulting in a favourable semi-puckered trans transition state 14f. Furthermore, 
the unfavourable orientation of the dipoles occurs in the planar cis transition 
state 14e, revealing an unfavourable 1,2 interaction. Hence, forming the highly 
favoured 14f transition state, which is formed selectively under kinetic control 
and yielding the E-alkene predominantly (Figure 15) 83,90. 
2.3 Horner-Wittig reaction 
In 1958, Horner published a modified Wittig-type reaction describing the use of 
phosphine oxides. Horner showed that the carbanion stabilised by a phosphine 
oxide reacted with aldehydes and ketones to give alkenes, along with a water-
soluble dialkylphosphate side product, which provides an advantage in terms of 
ease of separation79,87.  
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 2.3.1 Mechanism and Stereoselectivity 
When a potassium base (i.e. KOtBu) was used to form the phosphine oxide 
anion, the reaction with a carbonyl would proceed to give the alkene, in one-
step, as in the Wittig reaction (Scheme 5) 77,79. 
 
Scheme 5 : One step H-W 
But if a lithium base (i.e. LDA) was used, the reaction did not produce the 
alkene directly, but stopped at a β-hydroxyphosphine oxide intermediate (either 
15a or 15b), which in fact could be isolated, and later transformed into the 
alkene in a subsequent step  (Scheme 6) 77 76. Thus, allowing the reaction to 
become a two step process, the first step being the addition of the lithiated 
phosphine oxide to an aldehyde or ketone, producing β-hydroxyphosphine 
oxide intermediates, 15a and 15b, isolation following aqueous work up. The 
second step is the elimination of the phosphinic acid by addition of base, 
usually KHMDS, to afford the cis and trans alkenes (Scheme 6). 
Careful manipulation of each step then allows control of the overall reaction and 
being able to stop the Wittig reaction “half-way” allows isolation and separation 
of the β-hydroxyphosphine oxide intermediates. These intermediates are 
generally quite stable at room temperature. Once isolated, each 
diastereoisomer can be reacted separately to allow full control over the double 
bond geometry obtained 77,79. Another strategy for controlling the double bond 
geometry results from manipulating the groups that are present at the α or even 
β position to the phosphorus atom (section 4.1.3). 
40 
 
Scheme 6 : General H-W Reaction (Note: the 2,3 numbering system is used for 
consistency and will become apparent later on in the thesis) 
As mentioned previously, if R1 is an anion stabilizing group (i.e. CO2Me, COMe, 
CN, SO2R, SOR, vinyl or phenyl), the first step becomes reversible resulting in 
the accumulation of 15a and favouring the formation of the trans isomer. 
However, if R1 is not an anion stabilizing group, the reaction affords a mixture of 
adducts 15a and 15b and a mixture of cis and trans alkenes. 
2.4 Horner-Wadsworth-Emmons reaction 
In 1961, William Wadsworth and William Emmons further extended the scope of 
the reaction, to phosphonate-stabilised carbanions. In these reactions, the 
nucleophilic carbon bears a strong anion-stabilising group (i.e. CO2Me, COMe, 
CN, SO2R, SOR, vinyl or phenyl) 78,79. Likewise, the phosphonate-stabilised 
carbanions can also be alkylated (Scheme 7), and the dialkylphosphate salt by-
product is easily removed by aqueous extraction. These phosphonate-stabilised 
carbanions have the advantages of higher nucleophilicity and increased 
reactivity, due to the neighbouring carbonyl group present, therefore allowing 
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the elimination step to be very rapid, unlike the standard alkyl ylides used in the 
Wittig reaction 78. 
 
 
Scheme 7 : HWE reaction to give α-β unsaturated esters and ketones (Note: R2 = large 
groups) 
Like the analogous Wittig reagents, the dialkylphosphonates normally produce 
trans alkenes. Likewise, greater E-selectivity can be achieved by increasing the 
steric bulk of the aldehyde, using lithium counterions and increasing the 
temperature results in higher E-selectivity 78, whereas if non-coordinating 
cations are used (i.e. potassium), the reaction becomes cis-selective.  
2.5 Conclusion 
The geometry of the carbon-carbon double bond products in Wittig and H-W 
reactions can be controlled in a number of ways. In Wittig reactions, control can 
be achieved by choosing the type of ylide, which will direct the reaction to give 
the desired geometry of the double bond. In the H-W reaction, it can be 
achieved by isolation of the β-hydroxyphosphine oxide intermediates (2,3-syn 
15a and 2,3-anti 15b, Scheme 6) from the reaction. Regardless of the change 
in ylide, counterion, or intermediate isolation, all strategies for control 
concentrate on the first step (addition step) where the stereoselectivity of the 
reaction arises. Within this thesis, the isolation of the β-hydroxyphosphine oxide 
intermediates are explored further, to investigate if the ratio of these 
intermediates can control the cis/trans ratio of the alkene product. 
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3.0 CHAPTER 3 - Aims 
Many naturally occurring phytosterols are difficult to isolate with high purity 91 
they also present a very limited range of substitution at the C-24 position 
(Figure 1). This lack of diversity severely restricts the ability to investigate the 
potential for biological activity of these compounds. The objective of the 
research presented in this thesis is to utilise an asymmetric H-W reaction with 
the aim to expand the range of substituents present at the C-24 position of the 
phytosterol skeleton.  
The construction of the double bond flanked by two asymmetric carbon atoms, 
observed in the phytosterol side chain (e.g. 16, Scheme 8), represents an 
interesting synthetic challenge. The asymmetric H-W reaction involves a chiral 
α-substituted aldehyde e.g. 17, and a chiral β-substituted phosphonyl 
compound e.g. 18, to afford a double bond (Scheme 8). 
 
 
Scheme 8 : Retrosynthetic analysis of phytosterols (Note: sp3-sp2-sp3 motif highlighted 
in structure 16) 
Research completed by Clayden et  al. 76 has contributed to the rationalisation 
of why substitution α to the phosphorus atom may influence the stereochemical 
outcome of the H-W reactions. Clayden's model proposes a transition state 
model that can help to understand the stereoselectivity observed over a range 
of phosphine oxides shown in Table 2 76,92-94. The phosphine oxides have 
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limited substitution pattern at the R1 and R2 positions; nevertheless, the use of 
the transition state model clearly justifies the results obtained. 
 
Scheme 9 : General H-W reaction.  
Table 2 : H-W additions 76,94  
Table 2 indicates that the H-W addition step preferentially produces the 2,3-anti 
diastereoisomer 15b of the β-hydroxyphosphine oxide intermediate (Scheme 
9). Therefore, it can be postulated that the 2,3-anti selectivity: is fairly 
independent of R2 (entries 1-5), but reduced slightly if R2 is very large (entry 6) 
or very small (entries 7, 8) and reduced significantly if R1 is very large (entries 
9-12) 76,79,94. Clayden et al. 76,94 suggested that the reaction passes through a 
Entry R1 R2 Yield (%) anti/syn ratio 
1 Me Ph 88 88 : 12 
2 Et Ph 86 85 : 15 
3 Bu Ph 84 84 : 16 
4 iBu Ph 81 80 : 20 
5 Ph Ph 88 83 : 17 
6 Me C6H11 * 86 79 : 21 
7 Me Me 93 75 : 25 
8 Ph Me 97 72 : 28 
9 iPr nPr 84 57 : 43 
10 iPr Ph 79 67 : 33 
11 C6H11  nPr 100 53 : 47 
12 C6H11  Ph 80 80 : 20 
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“butterfly-shaped” transition state structure 95 (Figure 16), and justifies the 
these observations for the H-W additions, in Table 2. 
Both R1 and R2 occupy the less sterically demanding exo positions (TS-1), 
hence they adopt the 2,3-anti transition state 15b and therefore have 2,3-anti 
selectivity. Whereas an increase in the steric bulkiness of the phosphine oxide 
side chain (R1), causes an increase in the steric clash between R1 and R2, 
which leads to the observed drop in the 2,3-anti selectivity (Figure 16). 
 
 
Figure 16 : Transition state model, adapted from Clayden et al.76,94 (Note: the 2,3 
numbering system is used for consistency and will become apparent later on in the 
thesis) 
Starting from these fundamental observations published by Clayden and 
Warren 76,94 in this thesis, a level of complexity will be introduced to these 
systems. Investigations into how changes in the substituents at the position β to 
the phosphorus (R3), on the phosphorus (Ph) and the group present α to the 
aldehyde (R1) can influence the stereoselectivity of these reactions (Scheme 
10). Furthermore, it is possible to demonstrate the influence of each group on 
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the potential outcome of the cis/trans selectivity within the H-W reaction. It is 
already known that the cis/trans selectivity in the formation of alkenes 19 results 
from the relative configuration of the carbon atoms bearing the phosphonyl and 
hydroxyl functions in the initial β-hydroxyl phosphine oxide 20 (H-W adduct) 
obtained during the reaction between 21 and 22 (Scheme 10). Finally, to 
rationalise the results obtained from the H-W reactions carried out, a 
modification to Clayden and Warren’s transition state is proposed (see section 
4.1.2, Figure 24). 
 
 
Scheme 10 : A method for the synthesis of contiguous stereocenters (Note: the 2,3 
numbering system is used for consistency and will become apparent later on in the 
thesis) 
To illustrate the utility of this methodology, phytosterol compounds will be 
synthesised to give, ideally, a trans only lateral side chain, which is common 
amongst many natural products (Figure 17). Aside from the mechanistic studies 
and preparation of phytosterols. The synthesised phytosterols will then be 
tested in MD-MBA-231 cancer cell line, to assess their effect on proliferation in 
an attempt to clarify the mechanisms of action of these phytosterols. 
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         Okadaic acid 23 
 
      
 Ergocalciferol 24         (-) exiguolide 25 
 
 
 Macbecin 26 
Figure 17 : Okadaic acid (23) 96, ergocalciferol (24)  97, (-)-exiguolide (25)  98, macbecin 
(26) 99 (Note: sp3-sp2-sp3 motif highlighted in the dotted boxes) 
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4.0 CHAPTER 4 - Results and Discussion 
4.1 Horner- Wittig Methodology  
The diphenylphosphinoyl (Ph2PO) group has been established as a remarkably 
powerful directing group, shown in section 2.3, and many methods have been  
explored for controlling relative stereochemistry using phosphine oxides 100. 
Furthermore the exploration of the 1,4-related stereogenic centres across a 
double bond requires further work, allowing for selective configuration of either 
cis or trans. This can be completed by investigating the H-W reaction and 
understanding how it works as a two-step process.  
It is important to note throughout this chapter, each individual reaction was 
completed twice and an average was taken to validate the observed results. All 
reactions completed and reactions not mentioned in this section are shown 
within Appendix A.  
 4.1.1 The Horner-Wittig reaction and its unselective nature 
As a starting point for the synthetic studies, an example of how unselective H-W 
reactions are was demonstrated. In this model study, a one pot reaction was 
carried out between racemic diphenyl(2-phenylpropyl)phosphine oxide 27 101, 
which contains a chiral centre at the position β to the phosphorus atom, and 1-
naphthaldehyde 28. TLC monitored the first step and on completion, additional 
reagents were added, in situ, to proceed to the second step of the reaction, 
these reactions were completed as a one-pot synthesis and there were no work 
ups between steps. Proposed intermediates are shown in Scheme 11, these 
intermediates can be isolated if required, but in this case, they were not. 
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Scheme 11 : H-W reaction as a one-pot reaction 
Table 3 : Unselective H-W reactions (Note: reactions completed as a one-pot synthesis, 
thus, no aqueous work-up between steps) 
Under the first set of conditions (i, Table 3); both the addition and elimination 
step were completed using lithium diisopropylamide (LDA). A second equivalent 
of LDA was added once the first step was completed and the reaction gave a 
15 % yield. The reason for this modest yield, was that the lithium counterion 
binds strongly to the oxyanion formed in the reaction and prevents it from 
Reaction set Addition step Elimination Step Yield Ratio (Z/E) 
i 
LDA 
-72°C 
LDA 
55°C 
Aq. Workup 
15 1 : 1 
ii 
LDA 
-72°C 
KHMDS 
RT / 55°C 
Aq. Workup 
72 1 : 1 
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attacking the electrophilic Ph2PO group 76. As described in Chapter 2 (section 
2.3), the use of non-coordinating cations improves the efficiency of the 
elimination step, by generating a more "naked" oxyanion 76. Indeed using 
potassium hexamethyldisilazide (KHMDS) for the elimination step on the 
second attempt (ii, Table 3) proved this correct and resulted in improvement of 
the yield to72 %. However, under both sets of conditions no change was 
observed in the cis/trans ratio (Scheme 11, Table 3).  
From these results, it is important to understand the reason for this 
unselectively, to ensure the product is enriched with either a cis or a trans 
alkene. Therefore, is the lack of selectivity in the formation of cis and trans 
because of a lack of selectivity in the formation of the intermediate β-hydroxy 
phosphine oxide adduct? To answer this question, all four diastereomeric β-
hydroxy phosphine oxide adducts were isolated and further investigations into 
their individual elimination were assessed. To identify if under individual 
elimination they formed mixtures of cis and trans alkenes, or just give their 
desired olefin. 
 4.1.2 Isolation and Identification of the H-W Intermediates 
Herein, isolation of the intermediates from the model reaction of diphenyl (2-
phenylpropy) phosphine oxide 27 (Scheme 12) was attempted. The selected 
phosphine oxide was treated with an organolithium base (i.e. LDA) in 
tetrahydrofuran (THF) at -72 °C, followed by the addition of 1-naphthaldehyde 
28 to the resulting anion. Under these conditions, after aqueous work up, the H-
W β-hydroxyphosphine oxide intermediates are obtained exclusively and 
without the further addition of base, no elimination to afford the alkene products 
was observed, as mentioned previously in section 2.3. The reaction afforded 
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four diastereomeric adducts, in the ratio of  29a : 29c : 29b : 29d   = 1.0 : 1.1 : 
4.7 : 3.2, as determined from the 31P NMR.  
After separation and purification of the single diastereoisomers, X-ray 
crystallography allowed us to identify the relative configurations of all four 
diastereoisomers beyond doubt (Scheme 12). 
 
Scheme 12 : Reaction of Diphenyl (2-phenylpropyl) phosphine oxide 27 with 28 to afford 
H-W adducts 29. 
The relative configurations of the major diastereoisomers 29b and 29d, were 
confirmed as (1R*, 2R*, 3S*) and (1R*, 2S*, 3R*) (2,3-anti) configuration and 
the minor diastereoisomers 29a and 29c, were confirmed as (1R*, 2R*, 3R*) 
and (1R*, 2S*, 3S*) (2,3-syn) configuration (Figure 18). The two 2,3-anti 
adducts, compounds 29b and 29d  were in excess of the 2,3-syn adducts 29a 
and 29c, which was consistent with the predominant 2,3-anti selectivity of the 
H-W addition, previously reported by Clayden and Warren et al. 76 (Chapter 3). 
It is important to note for later in this thesis, that in the X-ray crystal structures 
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(Figure 18), there are several types of π-π stacking which can be observed, 
and this will be explored in more detail in section 4.1.4. 
 
Figure 18 : X-ray crystallography 
Since determination of 2,3-anti and 2,3-syn configuration by X-ray 
crystallography, in every case is not practical, an NMR-based correlation to 
determine the configuration of the adducts was established. This NMR based 
identification was created using several H-W reactions, which were prepared 
later on in Chapter 4, and comparing them to the results obtained by X-ray 
crystallography. At first using a combination of both methods it was determined 
that the JH3-P coupling for the 2,3-syn isomers was always larger than the JH3-P 
coupling for the 2,3-anti isomer (Figure 19), eventually not requiring the 
crystallography data, and relying solely on the 1H-NMR coupling constants. For 
example, in this series, 2,3-anti configuration gave JH3-P = 8.6 Hz, for (1R*, 2R*, 
B D 
A C 
 29a  29c 
29b 29d 
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3S*) diastereoisomer 29b and JH3-P = 8.4 Hz for (1R*, 2S*, 3R*) 
diastereoisomer 29d. For the 2,3-syn configuration, JH3-P = 26.2 Hz for (1R*, 
2R*, 3R*) diastereoisomer 29a and JH3-P = 23.2 Hz for (1R*, 2S*, 3S*) 
diastereoisomer 29c coupling, following the rule described in Figure 19. 
 
Figure 19 : Coupling constants  
Treatment of the 2,3-syn adducts, 29a and 29c, with KHMDS to effect 
elimination. The reaction was facile at room temperature and afforded the 
corresponding trans alkene 30a in high yield, 85-96 %, thus confirming the 
assignment of the adduct (Figure 20). 
 
 
Figure 20 : H-W Elimination; 2,3-syn i) KHMDS, RT, 21 hrs 
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In contrast, elimination of the more sterically congested 2,3-anti diastereomers 
29b and 29d, to the corresponding cis alkene 30b was sluggish at room 
temperature and required heating to 55 °C, to acquire the desired alkene at a 
relatively lower yield of 50 % (Figure 21).  
 
 
Figure 21 : H-W Elimination; 2,3-anti i) KHMDS, RT - 55°C, 21hrs 
It has been shown previously 79,82,102,  that the 2,3-anti-adduct is more likely to 
undergo the retro-Wittig decomposition much faster than the 2,3-syn, due to a 
overcrowded transition state, at the β-group to the phosphorus, compared to 
Clayden and Warren's α group, (Chapter 3). As a result of the lower yield, the 
reaction was purified by flash chromatography and analysed. Along with the cis 
alkene 30b, both the aldehyde 28 and starting phosphine oxide 27 were also 
isolated, indicating that the retro-Wittig reaction had occurred. This could be 
easily rationalised in terms of the significant steric repulsion between the 1-
naphthyl and α-phenylethyl substituents in the transition state leading to the 
elimination of phenylphosphinic acid (Figure 22). This steric repulsion means 
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that the molecule cannot easily adopt the required conformation for the 
elimination to the cis isomer and instead fragments to 1-naphthaldehyde 28 and 
starting material 27 (Figure 22). 
 
Figure 22 : Transition states for H-W elimination 
In conclusion, there is still a preference for 2,3-anti, 29b and 29d, over the 2,3-
syn, 29a and 29c, regardless of the configuration at the C1 position, even with 
this sterically hindered transition state. The anti isomer also eliminates at 
significantly lower rate than the syn isomer and results in significantly more retro 
fragmentation. This fragmentation is due to a sterically congested transition 
state. It also seems that there is a preference for opposing configurations 
between 1,2 and 2,3 orientations. The reaction afforded four diastereomeric 
adducts, in the ratio of 29a : 29c : 29b : 29d   = 1.0 : 1.1 : 4.7 : 3.2. Therefore, 
there is a preference for 2,3-anti : 1,2-syn 29b, over 2,3-anti : 1,2-anti 29d, and 
a preference for 2,3-syn : 1,2-anti 29c, over 2,3-syn : 1,2-syn 29a, this is 
presumably due to steric congestion also.  
Clayden et al. 76,95,100describes a transition state model based on a series of H-
W reactions carried out, previously mentioned in Chapter 3 76 (Figure 16). This 
transition state model rationalises when there is a steric interaction between R1 
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and R2, where R1 is the position α to the phosphine oxide (Figure 23, 
compound 31) and R2 is the group on the aldehyde. Clayden also mention that 
the reason for high 2,3-anti selectivities observed, are due to the less sterically 
demanding exo positions, within the TS-1 transition state. Whereas, the 
phosphine oxides used within this thesis have an additional β substituent 
(Figure 23, compound 32). As a consequence of this change, Clayden and 
Warren's transition state model can no longer be utilised (Figure 14), thus a 
slight modification has been proposed, focusing on the steric interactions 
between R and R2, where R is the position β to the phosphine oxide, rather than 
α. From using the Afarinkia transition state model it can justified why 
diastereoisomer 29b, was in abundance compared to the other three 
diastereoisomers (29a : 29c : 29b : 29d   = 1.0 : 1.1 : 4.7 : 3.2). 
 
Figure 23 : Clayden vs. Afarinkia phosphine oxide models 
In the Afarinkia model, Figure 24, it is important to note, that the transition 
states exemplify a stage further in the reaction, where the Li can no longer bond 
to the central carbon because it has now bonded to the aldehyde. Clayden's 
TS-1 and TS-2 have simply been shown as a reference when comparing to the 
modified transition states. Figure 24 shows the transition states leading to the 
2,3-anti adduct are drawn as TS-1a and TS-1b, with the latter being disfavoured 
due to the steric repulsion between R and the diphenyl phosphonyl group. This 
is consistent with Warren’s model (TS-1, Figure 16), in which the steric 
interaction between the phosphine oxide side chain and aldehyde is not 
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significant. On the other hand, the transition states leading to the 2,3-syn 
adduct are drawn as TS-2a and TS-2b, with the latter being disfavoured due to 
the steric repulsion between R and the aldehyde group. This is consistent with 
Warren’s model (TS-2, Figure 16), in which the steric interaction between the 
phosphine oxide side chain and aldehyde is significant. In conclusion, there is a 
preference for the 2,3-anti over the 2,3-syn, due to the instability of the TS-2 
transition state. Hence explaining why the 2,3-anti : 1,2-syn,diastereoisomer 
29b has the TS-1a transition state and is in abundance compared with the other 
three diastereoisomers, as the transition state it acquires is favoured over the 
others. To conclude, the modified transition state model is ideal for observing 
the effects the group at the β-position has on the overall ratio of the H-W 
adducts and this model will be used throughout this thesis. 
 
 
Figure 24: Afarinkia and Parry transition state model 
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 4.1.3 Role of the β substituent to the phosphorus 
In pursuit of the objectives, a series of phosphine oxides with varying 
substituents at the β positions were synthesised, to observe the affect of steric 
bulk and electronic nature at this position. The H-W reactions were studies with 
a series of different aldehydes, to investigate the influence that the β-
hydroxyphosphine oxide intermediates had on the alkene products formed, and 
whether certain substituents at the β position to the phosphorus can control the 
outcome and selectivity to give either a cis or trans alkene.  
  4.1.3.1 Preparation of the phosphine oxides  
Phosphine oxides of the general type 33 (Figure 25), were synthesised 103,104 
with varying steric bulk and electronic nature (Table 4).  
 
 
33 
Figure 25 : General phosphine oxide type 33 
Phosphine 
oxide 
R1 R2 
34 H H 
35 Me Me 
36 H Ph 
27 Me Ph 
37 Et Ph 
38 iPr 4-C6H4(Cl) 
39 tBu Ph 
40 H C6H11 
41 C5H9 Ph 
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42 H 3,5-C6H3(F)2 
43 H 3,5-C6H3(CH3O)2 
Table 4 : R1 and R2 groups of phosphine oxide 33  
The phosphine oxides were prepared in several different ways; 27, 37, 38, and 
41 were synthesised by treating the commercially available carboxylic acids 
(44-47) with lithium aluminium hydride, to gain the desired alcohol, in excellent 
yields 90-100%. The alcohols (48-51) were then treated with p-toluene sulfonyl 
chloride and pyridine, to give an intermediate tosylate compound (52-55). 
These intermediates (52-55) were then treated with lithium bromide, in the dark, 
for 20 hours to give 56-59. Finally, the resulting bromo- compounds were 
exposed to 0.5 M potassium diphenyl phosphide, in THF, followed by treatment 
with 30 % H2O2 to give the desired phosphine oxides (Scheme 13). All steps 
proceeded without any problems. Phosphine oxides 35 and 40, were 
synthesised as in Scheme 13, starting from commercially available 1-bromo-2-
methylpropane 60 in the case of 35 and (2-bromoethyl)cyclohexane 61 in the 
case of 40, isolated yield of the desired phosphine oxides were around 80-93 
%.  
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Scheme 13 : a LiAlH4, THF, 5 hrs, reflux, 90-100 %; b TsCl, pyridine, 0 °C 30 min, -5 °C, 6 
days; 60-90 %; c LiBr, reflux, dark, 20 hrs; d potassium diphenyl phosphide, -78 °C, 1 hr, 
RT, 1 hr H2O2, 30 min 60-90 %.  
For the synthesis of structurally more complex (3,3-dimethyl-2-phenylbutyl) 
diphenylphosphine oxide, 39, it was decided to start from commercially 
available 2,2-dimethyl-1-phenylpropan-1-one, 62. Lodge et al. 104, reported that 
the phenyl tert-butylketone 62 reacted with dimethylsulfonium methylide, to give 
an epoxide 63, then exposed to hydrogen would give the corresponding alcohol 
65, shown in Scheme 14, allowing synthesis to continue using the route 
provided in Scheme 13.  
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Scheme 14 : Synthesis towards 65; a 50% sodium hydride, dry Me2SO, 70 °C, 1 hr, 
followed by dry Me2SO, trimethylsulfonium iodide, THF and ketone; b ethyl acetate, 10 % 
Pd/C, acetic acid; method adapted from 104. 
However, after several attempts to form the epoxide 63 (Scheme 14), it was 
decided to change routes. Firstly, a Wittig reaction was performed to give the 
corresponding alkene 64, continuing to form the epoxide, 63, via a reaction with 
m-CPBA (Scheme 15).  
 
Scheme 15 : Alternative route to that described by Lodge et al. 104; a tBuOK, methyl 
triphenylphosphonium bromide, 18 hrs, RT; b m-CPBA, DCM, 0 °C-RT, 3 days; c ethyl 
acetate, 10 % Pd/C,H2,  acetic acid; method adapted from 
104; d BH3-THF complex, 1 hr, 
RT, 14 hrs, reflux, 18 hrs, RT. 
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However, due to relatively low yields of 63, this route was aborted and a simple 
hydroboration reaction of 64 was carried out. The hydroboration proceeded in 
excellent yields > 95%, to give the required alcohol 65, allowing the synthesis to 
continue, towards the desired phosphine oxide 39, using the route described in 
Scheme 13. Phosphine oxides (36, 42 and 43) were prepared by an alternative 
procedure, developed by Miss Fanny Dulon 105, using a HWE type reaction 
(Scheme 16).  
 
Scheme 16 : HWE type reaction; a hydrogen peroxide, DCM, 20 mins, 99 %; b aldehyde, t-
BuOK, toluene, (36) 2 hrs, (42) 24 hrs, (43) 24 hrs, RT 78-92 %; c 10 % Pd/C, H2, ethanol, 
24 hrs, 90-99 %. 
These phosphine oxides were synthesised by deprotonation of bis(diphenyl 
phosphonyl)methane 69, generated from the corresponding 
bis(diphenylphosphino)methane 68, forming a carbanion which then undergoes 
nucleophilic addition to the aldehyde: for 36 benzaldehyde was used; for 42 3,5-
difluorobenzaldhyde and for 43 3,5-dimethoxybenzaldehyde. Hydrogenation of 
compounds 70-72, gave the desired phosphine oxides 36, 42 and 43, in 
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excellent yields, > 95 %. Commercially available ethyldiphenyl phosphine oxide, 
34, was also used in the investigation; it was purchased from Sigma Aldrich, 
UK. 
4.1.3.2 Horner-Wittig reactions 
   4.1.3.2.1 1-Naphthaldehyde  
Phosphine oxides 27, 34, 36, 37, 38 and 39, were treated with an organolithium 
base in tetrahydrofuran (THF) at -72 °C. The resulting anion was then treated 
with the 1-naphthaldehyde 28, under these conditions, the H-W adducts were 
obtained exclusively and no elimination, to afford alkene products were 
observed (Scheme 17, Table 5).  
Scheme 17 : General H-W reaction to give desired adducts  
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Diastereomeric ratio * 
2,3-syn : 2,3-anti 
2,3-anti : 
2,3-syn 
1,2-anti : 1,2-
syn 
(in the 2,3-syn 
adduct)** 
1,2-syn : 1,2-
anti 
(in the 2,3-anti 
adduct)** 
34 73a : 73b 
0.16 : 0.84 
5.3 - - 
36 74a : 74b 
0.11 : 0.89 
8.1 - - 
27 29a : 29c : 29b : 29d 
0.10 : 0.11 : 0.47 : 0.32 
3.8 1.1  1.5 
37 76a : 76c : 76b : 76d 
0.09 : 0.11 : 0.52 : 0.28 
4.4 1.2  1.9 
38 77a : 77c : 77b : 77d 
0.06 : 0.12 : 0.77 : 0.05 
4.5 2  15.4 
39 - - - - 
Table 5 : Diastereomeric ratios in the formation of HW adducts; using a variety of 
phosphine oxides and 28. (Note: * in all cases, the reactions were completed twice to 
validate results. ** 1,2-syn and 1,2-anti are mentioned only in the case of the 1-
naphthaldehyde series. 1,2-syn and 1,2-anti can only be characterised using X-ray 
crystallography and cannot be characterised using the NMR based method). 
The first reaction of 34, using 1-naphthaldehyde 28, affords 2,3-syn and 2,3-anti 
diastereomeric adducts, 73a and 73b, in a ratio of 1.6 : 8.4 (Table 5). The 
second reaction of 36, affords 2,3-syn and 2,3-anti diastereomeric adducts, 74a 
and 74b, in a ratio of 1.1 : 8.9 (Table 5). The relative configuration of the major 
diastereomer 74b was confirmed as (2S*,3R*) or 2,3-anti, using a combination 
of NMR (section 4.1.2, Figure 19) and X-ray crystallography (Figure 26).  
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Figure 26 : Major diastereoisomer (2S*, 3R*), 74b 
Furthermore, isolation of 74b by flash chromatography, followed by treatment 
with potassium hexamethyl disilazide (KHMDS) to effect elimination,  afforded 
the corresponding cis alkene, along with recovery of the starting phosphine 
oxide (Scheme 18).  
 
 
Scheme 18 : Formation of the cis alkene during the H-W elimination reaction; a KHMDS, 
65 °C 3 days  
Thus confirming the assignment of the adduct, although due to small quantities, 
it could not be isolated in high purity. The chemical shifts relating to the double 
bond protons could be observed at δ 5.97 and 6.15 ppm, with the JH coupling of 
11.1 Hz and 10.9 Hz, to confirm the cis alkene 75b only to be present and no 
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corresponding trans alkene 75a was observed. Due to small quantities of 74a, it 
could not be treated with KHMDS to give only the trans alkene 75a (Scheme 
18).  
In the case of phosphine oxide 27, this reaction has been explained in great 
detail in section 4.1.2, were it was used as a model system in the reaction with 
1-naphthaldehyde 28, the final ratio of the adducts were  29a : 29c : 29b : 29d 
as  1.0 : 1.1 : 4.7 : 3.2 (Table 5). 
In the case of phosphine oxides 37and 38 the reactions with 1-naphthaldehyde 
28 proceeded to completion, giving four 2,3-syn and 2,3-anti diastereomeric 
adducts in each case. 76a : 76c : 76b : 76d in a ratio of 0.9 :1.1 : 5.2 : 2.8 for 37 
and 77a : 77c : 77b : 77d, ratio of 0.6 : 1.2 : 7.7 : 0.5 for phosphine oxide 38 
(Table 5). The reaction with phosphine oxide, 39 did not proceed, presumably 
due to the increased steric hindrance at the β position, preventing formation of 
the adducts, therefore after several attempts this route was aborted.  
The first observation from Table 5 was that, the ratio of 2,3-anti : 2,3-syn 
adducts when a substituent  to the phosphine oxide, be it Me, Et or iPr, varies 
from about 3.8-4.5, favouring the 2,3-anti transition state. The ratio was 
considerably greater when there was no  substituent present (between 5 and 
8) and this observation can be explained using the model proposed by Warren 
(Chapter 3, Figure 16) 76,95,106. In this model, an increase in the steric bulkiness 
of the phosphine oxide side chain, favours the formation of the 2,3-anti adduct. 
This is due to a decrease in the stability of the TS-2, resulting from a smaller 
repulsion between the phosphorus side chain and the aldehyde groups, 
compared with that between the phosphorus side chain and the phosphonyl 
groups, therefore the TS-1 was favoured in this case (Figure 16). It is possible 
that the 2,3-anti transition state was favoured, because there was a favourable 
68 
 
π-π stacking between the aldehyde and the aromatic group on the phosphorus 
side chain, which was preferred, over the π-π stacking between the aldehyde 
and the phenyl rings on Ph2PO group. Hence, the change in the R1 group, from 
Me to iPr, has no observed effect on the transition state and does not pose any 
steric factors in the 2,3-anti transition state. This therefore indicates that the R2 
group (aromatic group on the phosphorus side chain) and the R3 group 
(aldehyde), are the only groups that influence the transition state, and a bulkier 
side chain at the R1 position has no affect on the formation of the transition 
state. Is it possible the aldehyde actually provides a more stable conformation 
and aids the stacking, to the phosphorus side chain? 
It should be noted that the modest increase in the anti selectivity as the steric 
bulk of the R1 substituent increases from Me towards iPr (β to the phosphorus), 
cannot be rationalised by this model, but can be explained later using the 
rational of the Afarinkia modified version of Warren’s model (Figure 27).  
The second observation is that as the steric bulk of the R1 substituent increases 
from Me to iPr, there is a preference for the opposing configurations, for 
example 2,3-syn : 1,2-anti is favoured over 2,3-syn : 1,2-syn and 2,3 anti : 1,2-
syn diastereomer is preferred over the 2,3-anti : 1,2-anti diastereomer. This was 
observed in both the 2,3-syn and the 2,3-anti diastereomeric pairs, but it 
appears more enhanced in the latter pair than the former. As the induction of 
stereoselectivity is relatively modest in the 2,3-syn series only doubling as R1 
changes from Me to iPr. However, the effect is more pronounced in the 2,3-anti 
series, increasing 10-fold as R1 changes from Me to iPr. 
Taking together these two observations indicates that as the steric bulk of the  
substituent (R1) increases, a larger portion of the 2,3-anti : 1,2-syn adduct is 
observed and presumably a larger amount of the cis alkene, if the reaction was 
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to go to completion (explained later in Scheme 20). As the 2,3-anti : 1,2-syn 
adduct  begins to dominate, the modified transition state model described in 
section 4.1.2, Figure 24, can be used to rationalise this observation. In all 
cases, 29b, 76b and 77b, are of larger proportion and are all in fact the 2,3-anti 
: 1,2-syn adduct, this is because they adopt the most stable transition state 
(Figure 27). 
 
Figure 27 : Transition state TS-1a; (2,3-anti : 1,2-syn)  
The moderate increase in the 2,3-anti : 2,3-syn ratio in the formation of the 
adducts, also reflects in the cis : trans ratio for the outcome of the H-W reaction. 
Inevitably, the cis/trans selectivity of the one-pot reactions were influenced by 
the reaction conditions employed during the elimination step. 27, 37, and 38 
were treated with LDA and 28, the reactions were allowed to continue without 
isolation of the intermediates. KHMDS was added to each reaction and they 
were heated to optimal temperature (65 °C) for 3 days. The reactions afforded 
mixtures of alkenes in each case and the ratios show better selectivity towards 
the cis alkenes, as the size of R1 increases, from Me to iPr (Scheme 19).  
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Scheme 19 : Formation of alkenes during the H-W reaction; a LDA, - 72 °C, 1-
naphthaldehyde, 5 hours; b KHMDS, 65 °C 3 days  
In the case of 27, the trans 78a : cis  78b ratio was 1 : 1, indicating that no 
selectivity was observed. However, as the size of R1 increases from the ethyl 
group to the isopropyl group, the ratio in favour of the cis alkene in both cases 
increased from 2 to 4. Hence, indicating that the ratio of the adducts being in 
favour of the 2,3-anti has an effect on the overall outcome of the alkenes.  
In conclusion, the results show that in the H-W reactions of several  
substituted phosphine oxides, as the steric bulk of the substituent increases, the 
2,3-anti : 1,2-syn diastereomer begins to dominate. It has also been shown that 
this increase results in larger cis selectivity in the reactions, although that was 
significantly influenced by the conditions employed for the elimination step.  
   4.1.3.2.2 Benzaldehyde  
The study was extended using the same phosphine oxides 27, 34, 36, 37, 38, 
and 39 but rather than using 28, benzaldehyde 81 was used (Scheme 20, 
Table 6). The method used was the same as described in the start of this 
second. The reason for completing these reactions was to compare the 
observations with the results published by Warren et al. 76,95,101 and to further 
validate the study, with a change in only the aldehyde, over a series of 
phosphine oxides with varying steric bulk.  
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Phosphine oxide, 34, proceeded with benzaldehyde 81, giving two 2,3-anti and 
2,3-syn diastereomeric adducts, 82a and 82b in a ratio of 1 : 2 (Table 6).   
The ratio is comparable with that reported by Warren, who observed 1 : 5, 
which was slightly different and more selective than the result here. The 2,3-anti 
transition state was preferred, 82b, as determined by NMR and this was later 
confirmed by Warren et  al. 95,101.   
The products for phosphine oxides 27, 37 and 38, observed gave four 2,3-anti 
and 2,3-syn diastereomeric adducts, quantified and analysed using the NMR 
method described in (section 4.1.2, Figure 19), the results found were reported 
in Table 6. Unfortunately, phosphine oxide 39 was again unreactive after 
several attempts and the 1,2-syn and 1,2-anti diastereoisomers could not be 
determined for this series, as the NMR method is not valid for this assignment. 
 
 
Scheme 20 : General H-W reaction to give adducts  
 Diastereomeric ratio * 
2,3-syn : 2,3-anti 
2,3-anti : 2,3-syn 
34 82a : 82b 
0.33 : 0.67 
2.0 
36 83a : 83b 
0.2 : 0.8 
4.0 
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27 84a : 84b  
0.12 : 0.14 : 0.41 : 0.33 
2.8 
37 85a : 85b 
0.17 : 0.12 : 0.46 : 0.25 
2.4 
38 86a : 86b 
0.08 : 0.49 : 0.28 : 0.15 
0.8 
39 - - 
Table 6 : Diastereomeric ratios in the formation of H-W adducts; using a variety of 
phosphine oxides and 81; (Note: * in all cases, the reactions were completed twice to 
validate results). 
It is important to note that the selectivities within Table 6 are in reverse of what 
was observed in the 1-naphthyl series (Table 5). There seems to be clearly 
more of the 2,3-syn adduct formed than in the latter series. The reaction seems 
to be less selective towards 2,3-anti transition state, as there was an increase in 
steric bulk, from Me to iPr, of the group present at the β position, as predicted 
by Warren (Chapter 3, Figure 16). Warren observed a drop in the 2,3-anti 
selectivity when the steric bulk at the phosphorus side chain was increased (2.8 
to 0.8). This increase in steric bulk, favours the formation of the 2,3-syn adduct, 
due to a decrease in the stability of the TS-1, resulting from a larger repulsion 
between the side chain and aldehyde groups, compared with that between the 
side chain and the phosphonyl groups, therefore the TS-2 was favoured. 
Presumably, there could be a π-π stacking effect that contributes to the 
transition state formed, these results shows that the stacking was preferred 
between the phenyl rings on the phosphorus and the aldehyde rather than 
between the phosphorus side chain and the aldehyde. This change in selectivity 
could be because there is now a single aromatic group present at the aldehyde 
position, rather than a bicyclic group, which would have stronger π stacking 
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capabilities, with the phosphorus side chain, hence observing more 2,3-anti in 
the latter series.  
Another important observation from this table is the increase in the 2,3-anti 
transition state when there is a change from a methyl group at the α position, in 
phosphine oxide 34, to a phenyl group in phosphine oxide 36. It seems in this 
case the large phenyl ring is somewhat preferred. Warren et al. continually 
mentions this role of steric bulk being significant to these reactions 101, but is it 
possible that steric bulk is not the only factor allowing for this large increase in 
the 2,3-anti transition state. Is it possible that it is actually a combination of 
effects accounting for this change, another being the possible π-π stacking 
interaction between the added phenyl group and either the benzaldehyde 
moiety or the phenyl rings on the phosphorus. This stacking effect also 
accounts for this change, replacing the methyl group α to the phosphorus that is 
unable to stack, with a phenyl ring that can, could explain this increase in 2,3-
anti  transition state.  
   4.1.3.2.3 Cyclohexanecarboxaldehyde 
To rationalise the theory of the steric vs. stacking effect, it was decided to 
complete the same set of reactions, with a non-aromatic aldehyde, 
cyclohexanecarboxaldehyde 87 (Scheme 21, Table 7). Phosphine oxide 34, 
proceeded with 87, giving two 2,3-anti and 2,3-syn diastereomeric adducts, 88a 
and 88b in a ratio of 1 : 2 (Table 7). The products observed for phosphine 
oxides 27, 37 and 38, gave four 2,3-anti and 2,3-syn diastereomeric adducts, 
quantified and analysed using the NMR method described in (section 4.1.2, 
Figure 19), the results found were reported in Table 7. 
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Scheme 21 : General H-W reaction to give adducts  
 Diastereomeric ratio * 
2,3-syn : 2,3-anti 
2,3-anti : 2,3-syn 
34 88a : 88b 
0.40 : 0.60 
1.5 
36 89a : 89b 
0.45 : 0.55 
1.2 
27 90a : 90b 
0.17 : 0.20 : 0.29 : 0.34 
1.7 
37  91a : 91b 
0.16 : 0.21 : 0.22 : 0.40 
1.7 
38 92a : 92b 
0.16 : 0.19 : 0.20 : 0.44 
1.8 
39 - - 
Table 7 : Diastereomeric ratios in the formation of HW adducts; using a variety of 
phosphine oxides and 87; (Note: * in all cases, the reactions were completed twice to 
validate results) 
Shown in Table 7, there is no selectivity observed regardless of the steric bulk. 
Furthermore, it is interesting to note that if the aldehyde was changed to a non-
aromatic group, incapable of π-π stacking the selectivity is reduced rather 
significantly. 
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The results obtained from 87 are encouraging. For the first time, selectivities 
dropped indicating that there is a possible effect allowing this to happen, 
however, further research is required within this area. In order to achieve the 
goal, further investigation into π-π stacking is necessary and exploring how 
these groups, cause changes to the anti : syn ratio.  
4.1.4 Role of the π-π stacking  
After observing the various π-π stacking geometries in the X-ray crystal 
structures (previously mentioned in section 4.1.2, Figure 18), and within the 
reactions observed in section 4.1.3, it was thought that the stacking of groups 
had a large effect on the selectivity of the H-W reaction, therefore it was 
decided to compile enough evidence to consolidate this theory. It is possible 
that the stacking can occur between groups present on the phosphorus, as well 
as the groups on the aldehyde and at the β position.  
π stacking is a general term used to describe the attractive, non-bonding 
interactions observed between two aromatic systems or π-systems. These 
inter- or intramolecular associations display a diverse array of geometries, 
ranging from parallel face-to-face, parallel offset and edge-to-face stacking, 
general examples of such are shown in Figure 28.  
 
Figure 28 : A range of pi-pi stacking geometries 107 
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Below in Figure 29 are the X-ray crystal structures first introduced in section 
4.1.2, Figure 18.  
 
Figure 29 : X-ray crystal structures of diphenyl (2-phenyl-propyl) phosphine oxide with 1-
naphthaldehyde. (Note: TOP parallel offset stacking; BOTTOM edge to face). 
The top two arrangements (Figure 29) show parallel offset stacking, between 
the naphthyl ring and the phenyl ring on the phosphorus. Whereas the bottom 
arrangement (Figure 29) shows an example of an edge-to-face stacking 
geometry between the phenyl ring, β to the phosphorus and the naphthyl 
proton, shown with the dashed line. Edge-to-face stacking, is the most 
favourable interaction and the explained reason for this is based on 
electrostatics (Figure 30). 
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Figure 30 : π-π stacking geometries, favoured and unfavoured 107 
In essence, there is an interaction between the negatively charged benzene 
face and the positively charged proton based at the ring edge, on the interacting 
aromatic ring, thus the preference for edge-to-face interactions. Actually, the 
edge-to-face stacking, shown in Figure 29, affected the proton shift in the 1H-
NMR of two of diastereomeric adducts 29a and 29d (Figure 31). 
The proton responsible for this stacking geometry, on the naphthyl ring, 
indicated in Figure 31 by an *, moved out of the aromatic region and was 
observed with a lower chemical shift than all the other aromatic protons present 
within this molecule, one example is shown in Figure 32.  
 
Figure 31 : (1-hydroxy-1-(naphthalen-1-yl)-3-phenylbutan-2-yl)diphenylphosphine oxide 
29. (Note: * indicates proton responsible for the favourable edge-to-face stacking) 
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 Both diastereomeric adducts have edge-to-face stacking present in the X-ray 
crystal structures (section 4.1.2, Figure 18) 
 
Figure 32 : HMQC coupling to show the shift in the proton responsible for this stacking 
geometry, highlighted with a grey circle (X axis 1H-NMR and Y axis DEPT135); 5.91 (2H, d,  
JH = 7.8 Hz, naph aromatic-H), 6.14 (1H, d,  JH = 8.4  Hz, CHOH). (Note: Diastereoisomer D 
29d) 
Edge-to-face stacking, is the most favourable interaction and occurs between 
the proton on the naphthyl ring (Figure 31, proton *) and the centre of any 
phenyl ring that is aligned. This interaction could be responsible for greater 
selectivity in the 2,3-anti transition state, observed only in the 1-naphthyl series. 
To support this conclusion, this interaction cannot occur without a naphthyl 
group being present, thus giving reason to the observed drop in the 2,3-anti 
transition state, and increase in the 2,3-syn. Hence, with this being said, in 
pursuit of the objectives, a series of phosphine oxides with varying groups 
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present on the phosphorus moiety are studied, with a series of different 
aldehydes.  
  4.1.4.1 Preparation of the phosphine oxides  
The new compounds synthesised herein with have varying groups present on 
the phosphorus moiety of the molecule and in most cases contain a standard 
benzyl side chain. Phosphine oxides of the general type 93 (Figure 33), were 
synthesised via three different routes and the methods for the preparation of 
these phosphine oxides were adapted from those previously published in the 
literature 108-111. The types of groups present on the phosphorus should have an 
influential effect on the outcome of the β-hydroxyphosphine oxide 
intermediates, therefore several groups were specifically selected for synthesis 
(Table 8). 
 
93 
Figure 33: General type phosphine oxide 93 
Phosphine 
oxide 
X R1 R2 
94 3-C6H4(CH3O) H Ph 
95 4-C6H4(F) H Ph 
96 4-C6H4(CH3O) H Ph 
97 C6H11 H Ph 
98 C6H2(CH3)3 Me Me 
Table 8 : R1 and R2 groups of the general type 93 of phosphine oxide  
Preparation of phosphine oxides 94, 95 and 96, occurred with the reaction of 
diethyl phosphonate 99, with the required Grignard reagent, 3-
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methoxyphenylmagnesium bromide giving 100 in the case of 94, 4-
fluorophenylmagnesium bromide giving 101 in the case of 95 and 4-
methoxyphenylmagnesium bromide 102 in the case of 96, to generate the 
symmetric secondary phosphine oxides (Scheme 22).  
 
 
Scheme 22 : Formation of secondary phosphine oxides 108; a MgBrX (X shown in Table 
8), HCl; b KOH, TABI, 2-bromoethylbenzene, 70 °C, 1 hr 30 mins, (94) 59 %, (95) 47 %, (96) 
23 %. 
The reaction of the phosphonate and three equivalents of the grignard reagent 
was overall quite exothermic, therefore an ice bath was required to maintain the 
temperature of 25-30 °C. The reaction was vigorous and only required 2 hours 
to go to completion in all cases 112. Conversion of the secondary phosphine 
oxides to the tertiary 94, 95 and 96, occurred via the treatment with 2-
bromoethylbenzene 103, potassium hydroxide and a phase transfer catalyst, 
tetra (n-butyl) ammonium iodide in toluene, which was used to solubilise salt, 
allowing them to move into the organic layer, in order to react. The reactions 
were successful and gave moderate yields, 23-50 % 108 (Scheme 22).  
Our attempts to synthesise dicyclohexyl (phenethyl) phosphine oxide 97 were 
not so successful. Our initial endeavours attempted to produce the secondary 
phosphine oxide, dicyclohexyl phosphine oxide 104, using the route described 
in Step a, Scheme 22. However even though 104 could in fact be synthesised, 
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the conversion to the final compound 97 (Step b, Scheme 22) failed to give any 
of the desired product and so this route was abandoned 108. An alternative route 
was pursued using the air sensitive dicyclohexyl phosphine 105 and styrene 
106, in an attempt to oxidise 105, to the required phosphine oxide using DMSO 
110 (Scheme 23), but this was unsuccessful and this route was also abandoned. 
 
Scheme 23 : Formation of 97,110; a DMSO, tBuOK (20 mol%), RT-40 °C, 1 hr-2 days. 
Finally, the third synthetic route undertaken 111 was attempted by Dr. Victoria 
Vinader, using chloro dicyclohexyl phosphine oxide 107 and treatment with 
phenylethylmagnesium chloride. This reaction gave dicyclohexyl 
(phenethyl)phosphine 108, which was not isolated and  oxidised using 
hydrogen peroxide, to the desired compound 97 113. The yield was poor 
therefore rendering insufficient for obtaining the large quantities required, 
because of this compound 97 was not used (Scheme 24). 
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Scheme 24 : Route to desired compound 97 111; a phenylethylmagnesium chloride (1 M), -
78 °C, THF, RT, 24 hrs; b 0 °C, 30 % H2O2, 30 mins. 
Dimesityl(phenethyl)phosphine oxide 98, was synthesised by modifying the 
procedure by Pérez et al. 114 using an allylic alcohol, 1-bromo-2-methylpropane 
60 and bis(2,4,6 trimethylphenyl)phosphine 109 with the addition of hydrogen 
peroxide. It was found by changing the base, from BuLi 114, to non-nucleophilic 
base KHMDS, gave a reduction in the contaminants within the reaction and as 
a result a higher yield of 95 % was observed (Scheme 25). 
 
  
Scheme 25 : Formation of 98; mes = (2, 4, 6 trimethylphenyl/ C6H2(CH3)3); a KHMDS, 40 
mins, 60, 2 hrs, 30 % H2O2, 30 mins 95 %. 
Commercially available diethyl phenethyl phosphonate 110 was also used 
within the investigation. 
  4.1.4.2 Aldehydes  
Aldehydes of a general type 111 (Figure 34) were chosen for the H-W reactions 
(Table 9). 
 
 
 
Figure 34 : Aldehyde of the general type 111 
 Aldehyde R1 
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28 1-naphthaldehyde C10H8 
81 Benzaldehyde Ph 
87 cyclohexanecarboxaldehyde C6H11 
112 propionaldehyde Et 
113 2-naphthaldehyde C10H8 
114 mesitaldehyde C6H2(CH3)3 
115 pivaldehyde tBu 
116 3,5-dimethoxybenzaldehyde C6H3(CH3O)2 
117 3,5-difluorobenzaldehyde C6H3(F)2 
118 3-nitrobenzaldehyde C6H4NO2 
119 4-methoxybenzaldehyde C6H4(CH3O) 
120 4-fluorobenzaldehyde C6H4(F) 
121 3,5-dinitrobenzaldehyde C6H3(NO2)2 
Table 9: Aldehydes 
Aldehydes 28-120 were commercially available from Sigma Aldrich, UK. 121 
was not commercially available, therefore a synthetic route was undertaken, 
starting from 3-(3,5-dinitrophenyl)methanol 122. 122 was treated with oxalyl 
chloride in DMSO in DCM, to give 121 in 95 % yield after purification (Scheme 
26).  
 
Scheme 26 : Formation of 3,5-dinitrobenzaldehyde 121; a DMSO, oxalyl chloride, DCM, 
NEt3, - 72 °C – RT, 1 hr. 
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Some aldehydes gave little or no influence on the selectivity of the β-
hydroxyphosphine oxides therefore these will not be discussed in the next 
section. 
  4.1.4.3 Horner-Wittig reactions 
The analysis was started using three aldehydes; 28, 81 and 87; two being 
adequate for π-stacking and one being incapable. Phosphine oxides were used 
with a varying groups present, β to the phosphorus, (34, 36 and 40) again some 
with π-stacking capabilities and others without. These reactions proceeded to 
give two 2,3-syn and 2,3-anti products, using the method described in section 
4.1.2 (Scheme 27, Table 10).  
 
 
Scheme 27 : General H-W reaction  
Phosphine 
oxides 
 
Aldehydes; 2,3-anti ratio * (R2 = (87), (81), (28)) 
C6H11 (87) Ph (81) C10H8 (28) (87) : (81) : (28) 
34 
88b 
1.5 
82b 
2 
73b 
5 
1 : 1.3 : 3.5 
40 
125b 
1.2 
124b 
2.3 
123b 
3 
1 : 1.9 : 2.5 
36 
89b 
1.0** 
83b 
4 
74b 
8.1 
1 : 4 : 8.1 
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Table 10 : Diastereomeric ratios of reactions between π-π stacking capable moieties and 
non-π-π stacking capable substituents (Note: *in all cases, the reactions were completed 
twice to validate results and 2,3-syn = 1; except for ** where it is 1.1) 
The first observation from Table 10, was that the 2,3-anti diastereomeric 
adducts dominated in all cases, apart from the reaction between phosphine 
oxide 36 and 87. The reaction was very unselective in this instance (1.1 : 1) but 
slightly favoured the 2,3 syn transition state (assigned using the NMR technique 
observed in section 4.1.2 Figure 19). This observation was concordant with the 
results shown in Chapter 3 by Warren et al. 76,95. Warren states that there will 
be a reduction in the 2,3-anti transition state as the aldehyde substituent 
becomes very large (i.e. from 81 to 87), therefore favouring the 2,3-syn 
transition state. This is a result of the decreases stability of the TS-1, resulting 
from a larger repulsion between the R1 and R2 groups compared with that 
between R1 and phosphonyl groups.  
Table 10 shows that if there is an increase in the amount of π-π stacking 
capable groups present on the phosphine oxide, from two phenyl rings in 
compound 34 to three in compounds 36, the selectivity of the 2,3-anti adduct 
increases, when reacting with a π-π stacking, aromatic aldehyde (i.e. 81,  Table 
10). The formation of the 2,3-anti transition state, can again be rationalised by 
the Warren’s model (section 4.1.2, Figure 16), because as there was little 
steric repulsion between R1 and R2, due to π-π stacking, the TS-1 transition 
state was in fact favoured, with regards to 81.  
However, when the same phosphine oxides, were reacted with an aldehyde 
incapable of π-π stacking (i.e. 87, Table 10), the reactions proved rather 
unselective and a steady decrease in selectivity was observed, down the series, 
ultimately favouring the 2,3-syn diastereoisomer. Presumably, due to the fact 
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the transition states can no longer rely on electronic interactions (i.e. π-π 
stacking between substituents), and the steric effects begin dominate. 
Therefore as the substituents on the phosphine oxide increase in steric bulk, 
down the series (from a small methyl group to a large naphthyl group), the 
selectivity drops, due to an increasing steric interaction between the R1 and R2 
substituents. This again is in concordance with the effects observed by Warren 
et al. 76,95 in the results shown in Chapter 3. 
In addition to the reactions with 81 and 87, 1-naphthaldehyde 28 was also 
investigated to see if the addition of an aromatic bicyclic group, would again 
increase the selectivities. Table 10 shows that there was an increase in 
selectivity as predicated, indicating again as you increase the number of 
aromatic groups present on the phosphorus moiety, from two phenyl rings in 
compound 34  to three in compound 36, there is a larger amount of the 2,3-anti 
adduct formed. It should be noted that the bicyclic aromatic group 28 had a 
greater effect on selectivity, when in comparison with benzaldehyde 81, 
presumably due to the favourable edge-to-face π-π stacking geometry which 
can only occur through the * proton on the naphthyl ring (Figure 31, proton *).  
However, interestingly, having a cyclohexyl group β to the phosphorus 40, 
rather than a methyl 34, with 1-naphthaldehyde 28, seems to reduce selectivity, 
presumably because the reaction was more sterically hindered with the 
cyclohexyl than with the smaller methyl present.  
To extend the study further, it was decided to replace the phenyl rings on the 
diphenylphosphinoyl group (Ph2PO) with varying groups capable and incapable 
of π-π stacking. Electron-withdrawing (EWG) and electron-donating groups 
(EDG) were added and the changes were observed (Scheme 28, Table 11).   
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Scheme 28 : General H-W reaction 
 Aldehydes; 2,3-anti ratio * (R2 = (81), (116), (117), (121), (87)) 
 
Ph 
(81) 
3,5-
C6H3(CH3O)2 
(116) 
3,5- C6H3(F)2  
(117) 
3,5- C6H3(NO2)2 
(121) 
C6H11 (87) 
110 
126b 
1.5 
127b 
1.2 
128b 
1.5 
129b 
1.0** 
130b 
0.5** 
36 
83b 
4 
131b 
5.5 
132b 
6 
133b 
1.5 
89b 
1.0** 
94 
134b 
6 
135b 
4 
136b 
4 
137b 
2.4 
138b 
1.5 
Table 11 : Diastereomeric ratios of reactions between π-π stacking capable and non-π-π 
stacking capable substituents (Note: *in all cases, the reactions were completed twice to 
validate results and 2,3-syn = 1, except for ** when the reaction was 2,3-syn selective). 
Table 11 confirms what was observed in Table 10 that by replacing the phenyl 
rings in the diphenylphosphinoyl group (Ph2PO), with groups that have no π-π 
stacking capability (i.e. OEt, 110), there was little selectivity observed 
regardless of the aldehyde used, across the series within these H-W reactions. 
Again, in some cases even the 2,3-anti transition states do not dominate, this 
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can be observed when using 87 and electron-withdrawing 121. It is possible 
that when there is a reduction in the π-stacking, the stability of the carbanion is 
reduced and the steric effects begin to control the transition state formation, 
giving unselective diastereoisomers in the process. From these results using 
110, very little selectivity was observed, which indicates the formation of  
diastereoisomers is very fast and even. At this point, the reaction is irreversible, 
regardless of the nature of R1 and R2, therefore if the aromaticity of the groups 
on the phosphorus was to be removed, cis and trans alkenes should be 
acquired in an even ratio. Thus, proving that the nature of the groups on the 
phosphorus is extremely important for the selectivity of the diastereoisomers 
and the alkenes. 
Phosphine oxide 36 has been shown previously within this report but several 
aspects of the data are new, in particular regarding aldehydes 116, 117 and 
121. The results observed here were unexpected, as the selectivities increased 
in the reaction with 3,5-difluorobenzaldehyde 117. When compared directly with 
the results from Table 10, using 81 alone,  the selectivity is a modest, 4 : 1 
favouring the 2,3-anti diastereoisomer 83b, whereas with the reaction with 3,5-
difluorobenzaldehyde 117 the selectivity increases to 6 : 1, also favouring the 
2,3-anti diastereoisomer 132b. To rationalise these results, Sherrill et al. 115,116 
completed a study to decipher the changes in π-stacking between substituted 
and unsubstituted benzene rings. The results showed that with the addition of  a 
EWG group, to one of the benzene rings, caused changes in the configuration 
of the π-stacking, from face-to-face to the parallel-offset. Additionally, it was 
found that adding these substituents, regardless of their electronic nature 
actually increased the binding energy between the two rings and these two 
rings began to adjust depending on the groups present. For example, a 
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benzene ring with a fluorine atom attached would stack with a normal benzene 
ring, but as the number of fluorine's increased, there would be more parallel 
offset interactions than face-to-face, as it would favour the opposing dipole 
moments shown in Figure 35.  
 
Figure 35 : Stacking with EWG substituents  
Therefore, because of these opposing dipole moments being favoured, the 
EWG increases the binding energy of the π-stacking, allowing more varied type 
of stacking to occur. Thus, this could be responsible for the increase in the 2,3-
anti selectivity with 117 that is observed, when compared with 81. Sherrill et al. 
116 also mentions the same effects are observed with electron donating 
substituents, but at a slightly weaker binding energy. Hence, why a slightly 
higher selectivity for the 2,3-anti transition state when using 116 is observed 
(5.5 : 1) but it is still slightly lower than when using an electron withdrawing 
group 117.  
When replacing the phenyl rings in the diphenylphosphinoyl group (Ph2PO), 
with groups that are electron rich (i.e. 94), it was thought that huge changes in 
the selectivity would be observed, when reacting with the opposing, electron 
deficient moiety, 117. However, what was actually observed was very different; 
there were only modest changes in the selectivities. Unexpectedly the reactions 
between 117 and 116, with phosphine oxide 94, actually gave very similar and 
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results. In theory, within a σ environment fluorine is very electron-withdrawing 
and would normally remove electron density from a conjugated system, making 
it less nucleophilic and more electrophilic. However, it may not have the same 
effect in a π-system and the fluorine could behave like the electron donating, 
OMe group and it could increase electron density in to the π system 117. This 
increase in electron density arises by donating its electrons to make the 
aldehyde more nucleophilic and less electrophilic, which is unfavourable for the 
aldehyde, hence observing the same selectivity as 116 (Table 11). From 
several obscure results using 3,5-difluorobenzaldehyde 117 it was decided to 
replace the EWG model with 3,5-dinitrobenzaldehyde 121, but the selectivities 
drop unexpectedly (Table 11). The electron-withdrawing group present on the 
aldehyde should in fact increase the electrophilic nature of the aldehyde, 
withdrawing electrons from the aldehyde making it more open to nucleophilic 
attack, by the electron rich phosphine oxide, 94.  
The unselective nature of 121 seems apparent throughout regardless of the 
phosphine oxide used. The reason for this could also bring us back to the point 
mentioned earlier, regarding the stability of the carbanion (Chapter 2). 
Therefore, with a view to investigate the rate of reaction further, several 
reactions were observed with varying electron-donating and withdrawing 
substituents, with a view to understand the reason for these selectivities.  
Consequently, phosphine oxide 36, was reacted with 4-methoxybenzaldehyde 
119 and 4-fluorobenzaldehyde 120, the results are shown in Table 12. The 
reactions using the para-fluoro 120 and para-methoxy 119 aldehydes have an 
observed affect on the rate of reaction and the electronic effects from the 
specific location of the EWG and EDG groups (C-4) causes an overall effect on 
the observed selectivities. This further confirms that the selectivities are caused 
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by the effects of π-π stacking between aromatics, but also due to the electronic 
nature of the groups present on the aromatic substituents.  
 
 Aldehydes 2,3-anti ratio * (R2 = (116), (81), (119), (120)) 
Phosphine 
oxide 
3,5-
C6H3(CH3O)2 
(116) 
Ph (81) 
4-C6H4(CH3O) 
(119) 
4-C6H4(F) 
(120) 
36 
131b 
5.5 
83b 
4 
139b 
1** 
140b 
1** 
Table 12 : Diastereomeric ratios to show electronic effects (Note: *in all cases the 
reactions were completed twice to validate results and 2,3-syn = 1; except for ** when the 
reaction was 2,3-syn selective). 
For the final investigation, it was decided to introduce the electron-withdrawing 
and donating groups, β to the phosphine oxide, to observe the effects on 
selectivity. Therefore phosphine oxides 42 and 43 were synthesised and the 
effects of the electron-withdrawing and electron-donating nature was analysed 
in comparison to other phosphine oxides shown previously (Scheme 29, Table 
13).  
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Scheme 29 : General H-W reaction 
 Aldehydes 2,3-anti ratio * (R2 = (116), (81), (117), (87), (121), (118)) 
 3,5-
C6H3(CH3O)2 
(116) 
Ph 
(81) 
3,5-
C6H3(F)2 
(117) 
C6H11 
(87) 
3,5-
C6H3(NO2)2 
(121) 
3-
C6H4(NO2) 
(118) 
42 
141b 
20 
142b 
19 
143b 
3.3 
144b 
2 
145b 
1 
146b 
1.8 
43 
147b 
8 
148b 
6 
149b 
1.6 
150b 
1.8 
151b 
2.6 
152b 
3.3 
36 
131b 
5.5 
83b 
4 
132b 
6 
89b 
1** 
133b 
1.5 
153b 
2.2 
40 
154b 
5 
124b 
2.3 
155b 
4 
125b 
1.2 
156b 
2.5 
157b 
4 
Table 13 : Diastereomeric ratios to show electronic effects (Note: *in all cases these 
reactions were completed twice to validate results and 2,3-syn = 1, except for ** when the 
reaction was 2,3-syn selective). 
Armstrong et al. 95 stated that if R1 (Scheme 30) contains either a nitrogen or a 
oxygen (i.e. OMe), then there would be an observed reduction in the 
stereoselectivity95.  
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After the addition of LDA during the first step of the H-W reaction, a lithiated 
phosphine species is formed and if there is either an oxygen or nitrogen 
substituent present at the R1 position, then this coordinating group could bond 
to the lithium atom during the formation of the TS-1 transition state (Scheme 
30, A). Hence stabilising the transition state and thus reducing the selectivity of 
the dominant 2,3-anti diastereoisomer, due to its now unfavourable stability. It is 
important to note that this bonding interaction between the R1 and the Li cannot 
occur in the TS-2, as the R1 group is now equatorial and too far away from the 
Li to chelate (Scheme 30, B). 
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Scheme 30 : A: Formation of the TS-1 transition state with the effect of the coordinating 
Li to the R1 group which is either oxygen or nitrogen based, giving 2,3-anti; B: Formation 
of the TS-2 transition state without the coordinating effect of the R1 group to the Li, 
giving 2,3-syn 95. 
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As proved by Armstrong et al.95 this was in fact what was observed in Table 13. 
If a coordinating group is present at the R1 position (i.e. 43) and aldehydes 81, 
87, 116, and 117 are used, there were lower 2,3-anti selectivities when 
compared to the non-coordinating fluorine group in 42. It is important to note 
that when reacting phosphine oxide 43, with aldehydes 118 and 121, the 
selectivities modestly improved in comparison with phosphine oxide 42. 
Armstrong et al. observed that chelating groups present on the aldehyde side 
chain (R2 position) do not lead to reduced selectivity from the 2,3-anti transition 
state, and this was observed in Table 13.  
In conclusion, from the results obtained it is clear that there is a π-π stacking 
effect observed between the aldehyde moiety, phosphine oxide side chain and 
the groups present β to the phosphorus. The removal of aromatic groups from 
these systems causes a reduction in the 2,3-anti transition state and in some 
cases a preference for the 2,3-syn. Once EWG and EDG groups are added to 
these systems they became more complex. Thus, these groups give reason to 
prove that the effects of the 2,3-anti and 2,3-syn outcome cannot be pin-pointed 
to π-π stacking alone. Any factor that changes the stability of the carbanion, 
can change the 2,3-anti : 2,3-syn ratio of diastereoisomers, and furthermore the 
cis and trans alkenes.  
To display this methodology, aldehydes with phytosterol backbones are now 
required in order to synthesise the required phytosterols. The phytosterol 
aldehyde moiety will be used in the final H-W reactions and it contains a methyl 
group α to the aldehyde. Therefore, it is required to investigate further, what 
would happen if a change in steric bulk occurred at the substituent α to the 
aldehyde.  
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4.1.5 Role of the α-substituted aldehyde  
H-W  reactions, between a phosphine oxide, with a racemic centre present at 
the β position and an aldehyde, have been widely researched and studied 
78,79,100,101,118 (Scheme 31).  
Scheme 31 : General H-W with β-phosphine oxide 
However, little has been published on the H-W reactions between a phosphine 
oxide and an aldehyde, containing a racemic centre α to the carbonyl (Scheme 
32, compound 162). 
 
Scheme 32 : General H-W reaction with a α-substituted aldehyde 162 
Therefore, phenethyl diphenylphosphine oxide 36 with be reacted with several 
aldehydes and the results are reported herein, for the synthesis of 36 (Figure 
36) see section 4.1.3.1, Scheme 16. 
 
 
Figure 36: phenethyl diphenylphosphine oxide 36 
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  4.1.5.1 Preparation of the α-substituted aldehydes 
The synthesis of several α-substituted aldehydes 163, with varying steric bulk at 
the R1 position are required (Figure 37, Table 14).  
 
Figure 37 : α-substituted aldehyde of the general type 163 
 R1 R2 
164 Me Ph 
165 Et Ph 
166 iPr 4-C6H4(Cl) 
167 tBu Ph 
Table 14 : R1 and R2 groups of the general type 163 
2-(4-chlorophenyl)-3-methylbutanoic acid 46 was used as a suitable accessible 
starting material for the initial investigation into the synthesis of the 166. The 
carboxylic acid was treated with acetyl chloride in methanol, which gave the 
desired ester in 94 % yield. Conversion of 168 to 166 with diisobutylaluminium 
hydride (DIBAL-H), in toluene at -72 °C, failed therefore this synthetic route was 
aborted (Scheme 33).  
 
Scheme 33 : a Acetyl chloride, MeOH, 65 °C, 20 hrs, 94 %; b DIBAL-H, Toluene, -72 °C. 
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In a second attempt to obtain the required aldehyde 166, 2-(4-chlorophenyl)-3-
methylbutanoic acid 46, was treated with LiAlH4, to give the corresponding 
alcohol 50, following the procedures described in section 4.1.3.1, (Scheme 13, 
step a). 2-(4-chlorophenyl)-3-methylbutan-1-ol 50 was exposed to the Swern 
conditions, oxalyl chloride, DMSO and triethylamine. The crude product was 
purified and the desired aldehyde 166 was isolated in 68 % yield (Scheme 34). 
 
Scheme 34 : Swern Oxidation, a DMSO, oxalyl chloride, NEt3, DCM, -72 °C – RT, 1 hr; 
119.  
Aldehydes 165 and 167 were synthesised from the Swern reaction and 164 was 
commercially available from Sigma Aldrich, UK. 
  4.1.5.2 Horner-Wittig reactions  
The analysis started using phenethyl diphenylphosphine oxide 36, with the 
addition of aldehydes; 2-phenylpropanal 164; 2-phenylbutanal 165 and 2-(4-
chlorophenyl)-3-methylbutanal 166 (Scheme 35, Table 15). Phosphine oxide 
36 was treated with an organolithium base in tetrahydrofuran (THF). The 
resulting anion was then treated with the aldehyde of choice at -72 °C. Under 
these conditions, the H-W adducts were obtained exclusively and no 
elimination, to afford alkene products was observed.  
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Scheme 35 : General H-W reaction, using an α-substituted aldehyde 
Aldehyde 
Diastereomeric ratio * 
2,3-syn : 2,3-anti 
2,3-anti : 2,3-syn** 
164 
170a : 170b  
1 : 6: 20 : 50 
10 
165 
171a: 171b  
1 : 2 : 5 : 9 
4.6 
166 
172a : 172b  
1 : 2.9 : 2.6 : 3.2 
1.5 
167 
173a : 173b 
1.4 : 1.1 : 1 : 1 
0.8 
Table 15 : Diastereomeric ratios in the formation of HW adducts, using a variety of 
aldehydes and phenethyl diphenylphosphine oxide 36; (Note: *in all cases, the reactions 
were completed twice to validate results; **2,3 syn = 1) 
The reactions using aldehydes 164, 165 and 166, proceeded to give four 2,3-
syn and 2,3-anti products, whereas aldehyde 167 proved a little more difficult, 
after 5 hours, no reaction was observed. The reaction with 167 was completed 
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again and left in the freezer for 6 weeks, after work up, the reaction has in fact 
gone to completion, and the results are shown in Table 15. 
Table 15 shows that as the steric bulk increases in α position to the aldehyde, 
from Me to tBu, the selectivity of these reactions decreases. The formation of 
the 2,3-anti transition state drops greater than a fact of 10, when increasing 
steric bulk. This indicates that in the 2,3-anti transition state, there was strong 
π-π stacking between the β substituent on the phosphine oxide and the 
aldehyde as indicated by Warren et al. 76,95. It also implies that there was little 
steric hindrance with the small methyl group present α to the aldehyde. Warren 
states, if the repulsion between the side chain and the aldehyde was less than 
that between the side chain and the phenyl ring on the Ph2PO group, then the 
2,3-anti transition state was favoured. This is what is observe here, as the steric 
bulk α to the aldehyde is increased it causes a greater steric hindrance and 
reduces the π-π stacking between the aldehyde and phosphorus side chain, 
therefore the reactions begin to favour the 2,3-syn transition state.  
In pursuit of the objectives the reaction between phenethyl diphenylphosphine 
oxide, 36 (Scheme 36), was treated with an organolithium base in 
tetrahydrofuran (THF) at -72 °C and the resulting anion was then treated with 
164. Under these conditions, after a sample was withdrawn, the 
diastereoisomer ratio obtained was shown in Table 15. The reaction was then 
continued and treated with potassium hexamethyl disilazide (KHMDS), at room 
temperature and left for a further 3 days. After this time, it was shown, in the 1H-
NMR that no alkene product was observed. 
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Scheme 36 : H-W addition and elimination between phenethyl diphenylphosphine oxide, 
36, and 2-phenylpropanal 164 
A different approach was taken and the reaction was attempted again, but 
isolation of H-W adducts by chromatography was carried out, followed by 
treatment with potassium hexamethyl disilazide (KHMDS) to effect elimination, 
in a two-step process. However, this reaction also afforded no trace of the 
alkene, indicating that this phosphine oxide was not suitable for the H-W 
reactions with the phytosterol. In an attempt to further the investigations using 
α-substituted aldehydes, it was decided to attempt the H-W elimination step 
using diphenyl (2-phenylpropyl) phosphine oxide 27, with aldehydes 164 and 
166 (Scheme 37, Table 16).  
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Scheme 37 : H-W addition and elimination between 27 and aldehydes 164 and 166  
Aldehyde 
Diastereomeric ratio * 
2,3-syn : 2,3-anti 
164 
175a : 175b 
1 : 2.1 : 1.8 : 2.3 
166 - 
Table 16: Diastereomeric ratios in the formation of HW adducts; using a variety of 
aldehydes and diphenyl (2-phenylpropyl) phosphine oxide (Note: * in all cases, the 
reactions were completed twice to validate results). 
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A test reaction was set up were 27 was treated with an organolithium base in 
tetrahydrofuran (THF) at -72 °C, the resulting anion was then treated with 164. 
Under these conditions, a sample was withdrawn and the diastereomeric ratio 
obtained without isolation and can be found in Table 16. The reaction then 
continued and was treated with potassium hexamethyl disilazide (KHMDS), at 
room temperature and left for a further 3 days. After this time, a 1H-NMR was 
taken and small peaks that correlated to the trans 177a and cis 177b double 
bonds could be seen. Nevertheless, due to the small reaction scale, these 
products could not be isolated and fully characterised; therefore, it could not be 
confirmed if 177 a and b were formed. 
Aldehyde, 166, on the other hand, was reacted in exactly the same way, but 
after the sample had been analysed there were no adducts observed. Following 
this discovery, the reaction was then left in the freezer for 6 weeks, but still after 
this time no adducts were observed after analysis. This reaction indicated that 
this phosphine oxide was too sterically hindered to form any stable adducts, it 
was decided that this aldehyde would not be suitable for the addition to the 
phytosterol moiety. 
In conclusion, the reaction between 27 and 164 was a great success as the α-
substituted phytosterol aldehyde, therefore the initial H-W reaction will contain a 
methyl group present at the α-position. Scheme 38 shows the next step in this 
investigation and it is predicted that this reaction in particular will give the best 
selectivity, concerning alkene formation.  
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Scheme 38 : H-W reaction predicted to observe the best selectivity concerning the 
formation of the alkenes.  
With this idea in mind, preparation of the α- substituted aldehyde components 
required for the H-W reactions are explained in the next section.  
4.2 Preparation of the aldehyde components 
The desired phytosterol compounds fall into four groups A. B, C, D shown in 
Figure 38. Group A are those that have both 5-6 and 22-23; Group B are those 
that have only 5-6 but no 22-23; Group C are those that have neither 5-6 nor 
22-23 and Group D are those that have no 5-6 but do have 22-23.  
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Figure 38 : Phytosterol analogues 
The H-W reaction, couples the aldehyde and the phosphine oxide (183 and 
184), to generate a double bond between C-22 and C-23 182. This double bond 
can be subsequently reduced, to afford lateral side chains lacking this alkene. 
However, the synthetic design must take the potential for groups sensitive to 
hydrogenation into account, in particular, the double bond between C-5 and C-
6. Nevertheless, the double bond at C-5/C-6 can be masked, 185 (Scheme 39), 
allowing the alkene at C-22/C-23 to be reduced, following the removal of the 
protecting group thereafter. 
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Scheme 39: Disconnection of the phytosterol: with the double bond that requires 
protection shown in the dotted box 
Therefore, there needs to be two different types of starting aldehydes: one in 
which 5-6 is masked and one in which it is already hydrogenated, starting from 
commercially available pregnenolone (Scheme 40)  
 
 
Scheme 40: The synthesis of the desired α-substituted aldehyde from, commercially 
available, pregnenolone 188 (Note: masked double bond option shown in box). 
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 4.2.1 Preparation of the aldehyde: analogues in classes A 
 and B 
Aldehyde precursors to analogues in classes A and B are prepared by masking 
the double bond between the C-5 and C-6 with a cyclopropane ring, resulting in 
compounds either containing both double bonds (C-5/C-6 and C-22/C-23) or 
only the double bond present between C-5 and C-6 (Figure 38). 
The route to α-substituted aldehyde compounds uses commercially available 
pregnenolone as a starting point. Pregnenolone 188 was treated with p-
toluenesulfonyl chloride, pyridine, and 4-(dimethylamino) pyridine (DMAP), 
which was used as a nucleophilic catalyst to afford the corresponding tosylate. 
The reaction proceeded in good yield, 72% and was purified by recrystallization, 
giving 189 (Scheme 41).  
 
Scheme 41: Formation towards analogues A and B; a TsCl, DMAP, Pyridine, RT 29 hrs, 
72%; b Potassium acetate, MeOH, reflux, 1 hr, 79%; 
The next step was the treatment of the tosylate 189 with basic methanol. Under 
these conditions, a methoxide anion is generated which attacks at the C-6 
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position, and kicks out the tosylate group, forming a cyclopropane ring, e.g. 
190. The reaction is under stereoelectronic control leading to a single 
enantiopure diastereoisomer (Figure 39).  
 
Figure 39 : Antibonding and bonding orbitals leading to a single enantiopure 
diastereoisomer 
Whilst carrying this reaction out, it was observed that under certain conditions, 
for example long reaction times or use of weak bases such as pyridine, the 
desired product was contaminated. The contamination was identified as 
compound 191 and results when double substitution occurs. The excess 
methoxide anion attacks from the top face, breaking the cyclopropane ring, 
forming 191 which was inseparable by column chromatography from the major 
product 190 (Scheme 42). Since C-3 has undergone two consecutive 
substitutions, each resulting in inversion of its configuration, the overall effect is 
retention of the configuration of the C-3-O bond therefore; this product was also 
obtained as a single enantiomer. The reaction gave a mixture of products in a 
4:1 ratio, in favour of the desired compound 190. 
 
Scheme 42: Double isomerisation occurs with excess MeO: i pyridine, methanol, 4 days 
RT 
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Indeed, if compound 189 was treated with potassium acetate and methanol at 
reflux for 1 hour, the formation of the “double-substituted” product did not occur, 
giving only the desired product 190, in an acceptable 79% after recrystallization 
(Scheme 41). Once the double bond was masked a Wittig reaction was carried 
out, forming an alkene at the C-20 position giving compound 192, with an 
excellent yield of 100% (Scheme 43). A hydroboration reaction, followed by 
oxidation of the boron-carbon bond was completed forming a 1.4:1 ratio of 
diastereoisomeric alcohols 193a and 193b in a combined yield of 78%. These 
diastereoisomers are separable by column chromatography (Scheme 43). 
 
Scheme 43: c CH3P(C6H5)3Br, (CH3)3COK, THF, RT, 2hrs, 100%; d BH3 1 M in THF, 2 M 
NaOH, 30% H2O2, Et2O, reflux to RT, 13 hrs then 16 hrs, diastereomeric mixture 78% 
(46%/32%); (R1 = Me, H; R2 = Me, H) 
This reaction could be carried out using a chiral hydroborating agent in order to 
afford only the alcohol with the required stereochemistry. However, since 
access to both diastereoisomers of the aldehyde is desirable, it is then possible 
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to study the role of chirality in the formation of the H-W product, therefore it was 
decided that a non-stereoselective reduction was preferable. The next step was 
the formation of the -substituted aldehydes 194a and 194b, which are required 
for the H-W reaction, but due to a potential for the loss of chirality over time, this 
step would only be completed immediately prior to the H-W reaction (Scheme 
44).  
Scheme 44: e DMSO, CH2Cl2, oxalyl chloride, 1 hr  RT, f phosphine oxide, THF. LDA, 5 
hrs, followed by KHMDS. 60 °C, 3 days. 
This potential loss of chirality can be lost over time due to the acidic nature of 
the proton at the C-20 position. The proton can conjugate into the system, 
increasing the stability, then can reprotonate on either face giving a scrambled 
or racemic centre at the C-20 position (Figure 40). Therefore when required, 
each diastereoisomeric alcohol (193a and 193b) will be reacted separately, in 
order to obtain the desired aldehyde in each case (194a and 194b). 
 
 
Figure 40 : Acidic Proton 
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When the aldehydes are required the Swern oxidation will be used, this reaction 
achieves high yields of 98-100 % for both diastereoisomeric aldehydes 194a 
and 194b. Each aldehyde cannot be stored at room temperature and should be 
stored in the freezer, if not required immediately (-18 °C), for no greater than 3 
months (Scheme 44). 
 4.2.2 Preparation of the aldehyde: analogues in classes C 
 and D 
The aldehyde precursor to analogues in classes C and D are prepared by 
removing the double bond between C-5 and C-6. This results in compounds 
either containing one double bond between C-22 and C-23 or no double bonds 
present within the analogue (Figure 38).  
 
Scheme 45: a Imidazole,TBDMSCl, DMF, RT, 20 hrs, 66%, b 10% Pd/C, H2, Ethanol, RT, 2 
days, diastereomeric mixture 74% (45%/29%);  
First, pregnenolone 188 was protected as a TBDMS ether 195. Unexpectedly 
however, the attempted hydrogenation of this TBDMS ether resulted also in a 
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reduction of the ketone function forming the undesired diastereomeric mixture of 
196a and 196b in a 1.4:1 ratio (Scheme 45).  
To avoid this problem, pregnenolone 188 was first treated with hydrogen and 
10% Pd on carbon, as a catalyst, for 24 hours to reduce the double bond 
between C-5 and C-6. The desired compound 197 was obtained in 99% yield. 
Treatment of this alcohol with tert-butyldimethylsilylchloride then afforded the 
TBDMS ether 198. The Wittig reaction was then attempted on the resulting 
saturated TBDMS ether but it was unsuccessful after 4 days (Scheme 46). The 
reasons for this were unclear.  
 
 
Scheme 46: Progression from pregnenolone; a 10% Pd/C, Ethanol, RT, 24 hrs, 99%, b 
Imidazole, TBDMSCl, DMF, RT, 20 hrs, 66%, c CH3P(C6H5)3Br, (CH3)3COK, THF, RT, 4 days, 
no reaction 
Nevertheless, a Wittig reaction on compound 197 was carried out using excess 
methyl triphenyl phosphonium bromide, to give a 97% yield of the desired 
alkene 200 (Scheme 47).  
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Scheme 47: Formation towards analogues C and D; a 10% Pd/C, Ethanol, RT, 24 hrs, 
99%, b CH3P(C6H5)3Br, (CH3)3COK, THF, RT, 2 hrs, 97% 
Compound 200 was then taken forward and treated with tert-
butyldimethylsilylchloride, in order to protect the OH group at the C-3 position, 
to give compound 199. After the protection with TBDMS, compound 199 was 
then treated with borane to give separable diastereoisomers in a 1.8:1 ratio and 
a combined yield of 87%, 201a, and 201b (Scheme 48).  
Scheme 48: c Imidazole,TBDMSCl, DMF, RT, 20 hrs, 92% d BH3 1M  in THF, 2 M NaOH, 
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30% H2O2, Et2O, reflux to RT, 13 hrs then 16 hrs, diastereomeric mixture 87% (56%/31%); 
(R1 = Me, H; R2 = Me, H) 
On continuing the synthesis from compound 201a and 201b (Scheme 49), the 
final step is the formation of the -substituted aldehyde 202, which is required 
for the H-W reaction (Scheme 49). 
 
 
Scheme 49: e DMSO, CH2Cl2, oxalyl chloride, 1 hour RT, f phosphine oxide, THF. LDA 5 
hours, followed by KHMDS. 60 °C, 3 days.  
The attempted oxidation of both alcohols 201a and 201b using the Swern 
conditions, gave great success, with yields ranging from 60-98 %. Each 
aldehyde 202a and 202b cannot be stored at room temperature and should be 
stored in the freezer, if not required immediately (-18 °C), for no greater than 3 
months. 
The overall synthetic route is shown in Scheme 50. 
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Scheme 50: a 10% Pd/C, H2, Ethanol, RT, 24 hrs, 99%, b CH3P(C6H5)3Br, (CH3)3COK, THF, RT, 2 hrs, 97% ; c TsCl, DMAP, Pyridine, RT 29 hrs, 72%; d 
Potassium acetate, MeOH, reflux, 1 hr, 77%;  e Imidazole,TBDMSCl, DMF, RT, 20 hrs, 92%; f CH3P(C6H5)3Br, (CH3)3COK, THF, RT, 2 hrs, 100%; g BH3 1 M  
in THF, 2 M NaOH, 30% H2O2, Et2O, reflux to RT, 13 hrs then 16 hrs, h DMSO, CH2Cl2, oxalyl chloride, 1 hour RT; i phosphine oxide, THF. LDA 5 hrs, 
followed by KHMDS. 60 °C, 3 days. 
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4.2.3 Chirality at the C-20 position 
After separation of the desired aldehydes, in route A and B (section 4.2.1 and 
4.2.2), it was required to know the configuration of the chiral centre present, on 
each of the diastereoisomers, at the C-20 position (Figure 41).  
 
Figure 41 : Aldehydes required for the synthesis of classes A, B, C and D (C-20 is shown) 
This information will be useful for future reference when forming the lateral side 
chain, via the asymmetric H-W reaction. The classification of the C-20 position 
on the aldehyde precursors are identified by using commercially available 
Stigmasterol 4 (Sigma Aldrich, UK). Stigmasterol 4 was used because of the 
known R-configuration at this C-20 position, which will be known herein as the 
natural configuration, when referring to the double bond compound (Figure 42). 
The double bond between the C-5 and C-6 position, present on Stigmasterol 4, 
was masked with a cyclopropane ring 204, followed by an ozonolysis reaction 
on the C-22 and C-23 double bond to the alcohol and a reduction to give the 
alcohol, with known configuration.  
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Figure 42 : Stigmasterol or (3S,8S,9S,10R,13R,14S,17R)-17-((2R,5S,E)-5-ethyl-6-
methylhept-3-en-2-yl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-
1H-cyclopenta[a]phenanthren-3-ol 4 
Initially stigmasterol 4 was treated with p-toluenesulfonyl chloride, pyridine and 
4-(dimethylamino)pyridine (DMAP), which was used as a nucleophilic catalyst to 
afford the corresponding tosylate 203. The reaction proceeded in good yield, 
72% and was purified by recrystallization, giving 203 (Scheme 51).  
 
Scheme 51 : Formation of the cyclopropane ring using stigmasterol; a TsCl, DMAP, 
Pyridine, RT 29 hrs, 70%; b Potassium acetate, MeOH, reflux, 1 hr, 63%; 
The next step was the treatment of the tosylate 203 with basic methanol. Under 
these conditions, a methoxide anion is generated which attacks at the C-6 
position, and kicks out the tosylate group, forming a cyclopropane ring, e.g. 
204. The reaction is under stereoelectronic control leading to a single 
118 
 
enantiopure diastereoisomer, refer to section 4.2.1; Figure 39, for a more 
detailed explanation. 
Once the double bond was masked, an ozonolysis reaction was carried out, 
breaking the alkene between the C-22 and C-23 position, directly followed by a 
reduction using NaBH4 to give the alcohol at the C-22 position, in 54 % yield. It 
was decided to reduce the compound to the more stable alcohol, due to the 
potential loss of chirality over time, with regards to the aldehyde. The final 
compound 193a has a known S-configuration at the C-20 position, which will be 
known from herein as the natural configuration, when referring to either the 
alcohol or aldehyde compound (Scheme 52).  
 
Scheme 52 : Formation of the alcohol; c Ozone, DCM : Methanol (1 : 1 vv), NaBH4, 54% 
After completing the reactions using stigmasterol 4, the final compound (2S)-2-
((1aR,3aR,5aS,6R,10R,10aR)-10-methoxy-3a,5a-
dimethylhexadecahydrocyclopenta[a]cyclopropa[2,3]cyclopenta[1,2-
f]naphthalen-6-yl)propan-1-ol 193a was isolated by column chromatography 
and the NMR was characterised, giving two distinctive peaks. The C-22eq 
proton was observed at 3.57 ppm and the C-22ax proton was observed at the 
3.29 ppm (Figure 43).  
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Figure 43 : Spectra of alcohol 193a, synthesised from stigmasterol 4  
It is important to note, stigmasterol 4 has an R-configuration at C-20 but when 
converted to the alcohol, C-20 is S-configuration, these are the natural 
configurations. The NMR’s of the corresponding alcohols in both series were 
overlaid with the NMR of compound 193a and the configuration at the C-20 
position for each diastereoisomer was determined.  
Starting with the alcohols required to form classes A and B (Figure 44).  
 
 
 
Figure 44 : Two diastereoisomers of the alcohol 
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The mixture of diastereoisomers was separated via column chromatography, to 
give 193b, which eluted the column first and 193a, which eluted the column 
last. 193b was shown to have 2 peaks between 3.7 and 3.3 ppm, which 
correspond to the C-22 protons. The C-22eq proton was observed at 3.66 ppm 
and the C-22ax proton was observed at the 3.37 ppm (Figure 45).  
 
 
Figure 45 : C-22 protons for 193b  
When overlaid with alcohol 193a derived from stigmasterol 4, they did not 
match the peaks observed in Figure 43, therefore 193b, has an unnatural 
configuration, which is the R-configuration, with regards to the alcohol and 
aldehyde compounds (Figure 46). 
 
 
Figure 46 : 193b with R-configuration at C-20 
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The other diastereoisomer was shown to have 2 peaks between 3.6 and 3.3 
ppm that correspond to the C-22 protons. The C-22eq proton was observed at 
3.56 ppm and the C-22ax proton was observed at the 3.29 ppm (Figure 47).  
 
 
Figure 47 : C-22 protons for 193a 
When overlaid with alcohol 193a derived from stigmasterol 4, they did match 
the peaks observed in Figure 43, therefore 193a, has a natural configuration, 
the same as that of alcohol from stigmasterol 4, which is the S-configuration, 
with regards to the alcohol and aldehyde compounds (Figure 48). 
 
 
 
Figure 48 : 193a; with S-configuration at the C-20 position 
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The same process was completed for the alcohols, in the TBDMS series, 
required to form classes C and D (Figure 49). 
 
 
Figure 49 : Two diastereoisomers of the alcohol 
The mixture of diastereoisomers was separated via column chromatography, to 
give 201b, which eluted the column first and 201a, which eluted the column 
last. 201b, was shown to have 2 peaks between 3.7 and 3.4 ppm that 
correspond to the C-22 protons. The C-22eq proton was observed at 3.67 ppm 
and the C-22ax proton was observed at the 3.42 ppm (Figure 50). The peak 
present at 3.49 ppm refers to the C-3 proton. 
 
  
Figure 50 : C-22 protons for 201b  
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When overlaid with alcohol 193a, they did not match the peaks observed in 
Figure 43, therefore 201b, has an unnatural configuration, which is the R-
configuration, with regards to the alcohol and aldehyde compounds (Figure 51). 
 
Figure 51 : 201b; with R-configuration at the C-20 position 
The other diastereoisomer was shown to have 2 peaks between 3.5 and 3.3 
ppm that correspond to the C-22 protons. The C-22eq proton was observed at 
3.57 ppm and the C-22ax proton was observed at the 3.31 ppm (Figure 52). 
 
 
Figure 52 : C-22 protons for 201a 
When overlaid with alcohol 193a, they did match the peaks observed in Figure 
43, therefore 201a, has a natural configuration, the same as that of alcohol 
193a, which is the S-configuration, with regards to the alcohol and aldehyde 
compounds (Figure 53). The peak present at 3.49 ppm refers to the C-3 proton. 
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Figure 53 : 201a; with S-configuration at the C-20 position 
Therefore in both cases, the diastereoisomers which eluted the column last  
193a and 201a, are the ones found to have the same conformation at the C-20 
position as the diastereoisomer, found in nature,  synthesised from stigmasterol 
4. The other diastereoisomers that eluted the column first, 193b and 201b are 
found to have the unnatural configuration that is not found in nature. From this 
the asymmetric H-W reactions can be completed with known chirality at all the 
chiral positions.  
4.4 Synthesis of Phytosterols via the asymmetric 
Horner-Wittig reaction 
The idea in this section is to couple both motifs together, the β-substituted 
phosphine oxides with the phytosterol aldehydes, were one must be 
enantiomerically pure.  
The main objective being the synthesis of these phytosterol compounds via the 
asymmetric Horner-Wittig reaction, to see if the absolute configuration at the sp3 
centre β to the phosphorus, (or the sp3 centre  α to the aldehyde) can in fact 
control the absolute configuration at the adjacent sp2. In order to carry out the 
aim it was important to set up three different types of reactions, were the 
position: 
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1. α to the aldehyde is enantiopure, reacting with a racemic phosphorus 
compound 
2. β to the phosphorus is enantiopure , reacting with a racemic aldehyde 
compound 
3. β to the phosphorus and α to the aldehyde, are both enantiopure. 
To help analysis, the results obtained from reaction 3, whereby the aldehyde 
and the phosphonate are both enantiomerically pure, will be used as a 
reference to depict the purity of the other two reactions, using the same NMR 
technique observed within section 4.1.2, Figure 19. This section will 
concentrate on the preparation of the starting materials required for the H-W 
reactions, and the analysis of the diastereomeric mixtures obtained.  
 
4.4.1 Preparation of both the aldehydes and phosphine 
oxides 
As already discussed earlier in this chapter, the preparation of the aldehydes, 
based on the phytosterol backbone, are synthesised from the alcohol precursor 
using the Swern oxidation (Scheme 53). 
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Scheme 53 : Formation of the aldehyde; TOP - cyclopropane series; BOTTOM - TBDMS 
series. h DMSO, CH2Cl2, oxalyl chloride, 1 hr RT; i phosphine oxide, THF. LDA 5 hrs, 
followed by KHMDS. 60 °C, 3 days. 
The C-20R 202b and C-20S 202a aldehydes in the TBDMS series (Scheme 
53; BOTTOM) were easier to obtain and separate,  when compared to the C-
20R 194b and C-20S 194a aldehydes in the cyclopropane series (Scheme 53; 
TOP), for this reason they were carried forward and used in this part of the 
methodology. Previously synthesised phosphine oxides will be used in these 
reactions (section 4.1.3.1). The racemic phosphine oxide chosen for this H-W 
reaction was diphenyl (2-phenyl-propyl) phosphine oxide 27 (Figure 54). This 
was selected to in order to give the highest selectivity in these H-W reactions, 
with the aim to expand the substituents at the C-24, as part of future work. 
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Figure 54 : Racemic diphenyl(2-phenylpropyl)phosphine oxide 27 
Along with the racemic phosphine oxide a further two enantiopure phosphine 
oxides, each bearing complementary chirality at the β-position, (Figure 55) 
were also required. Enantiopure diphenyl (2-phenylpropyl) phosphine oxide 27a 
and 27b, were chosen. The preparation of these phosphine oxides has been 
reported in section 4.1.3.1, using either racemic, R- or S- 2-phenylpropionic 
acid 44 in each case.  
 
 
Figure 55 : S- and R- diphenyl (2-phenylpropyl) phosphine oxide 27a and 27b 
 4.4.2 Enantiopure aldehyde 202b with racemic and 
 enantiopure phosphine oxides 
The R- and S- phosphine oxides (27a and 27b) will be used as reference 
compounds for the racemic phosphine oxide reaction 27. Once the NMR's for 
the enantiopure compounds have been characterised, the racemic NMR's can 
be overlaid and the results can be interpreted. 
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4.4.2.1 Racemic diphenyl (2-phenylpropyl)phosphine oxide  
As the diastereomeric aldehydes, 202b and 202a, have all known 
stereocenters, (explained in detail in section 4.2.3), it was important to see if 
some selectivity on the adjacent sp2 stereocenter could be induced, by reacting 
each aldehyde with racemic diphenyl (2-phenyl-propyl) phosphine oxide 27 
(Scheme 54). The theoretical outcome of this reaction, using an 
enantiomerically pure aldehyde and racemic phosphorus, is a mixture of four 
different products. These products will have a combination of cis and trans 
double bonds and R- and S- stereocenters at the C-24 position of the lateral 
side chain and fixed chirality at the C-20 position, depending on which starting 
aldehyde was used (Scheme 54).  
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Scheme 54 : Outcome of H-W reaction; A and B are trans and C and D are cis, with 
varying chirality at the C-24 position and fixed chirality at the C-20 position  
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The first system enantiopure aldehyde, 202b and racemic diphenyl (2-phenyl-
propyl) phosphine oxide 27 was investigated, the question being how many 
products will be observed, out of the four possibilities 205a-d (Scheme 55)? 
 
Scheme 55 : H-W reaction; a LDA, - 72 °C, 5 hours; b KHMDS, 55-60 °C, 3 days; 205 A and 
B are trans, 205 C and D are cis, with varying chirality (R and S) at the C-24 position and 
fixed chirality at the C-20R position. R3 shown in Scheme 85 
Firstly, 27 in THF, was treated with lithium diisopropylamide (LDA) at -78 °C for 
2 hours, after this time the desired aldehyde, 202b, was added, and a colour 
change was observed from red/orange to yellow. The reaction was left at this 
temperature for a further 4 hours. After the stated time the reaction was allowed 
to warm to room temperature were, potassium bis(trimethylsilyl)amide (KHMDS) 
was added and the reaction was left at 55-60 °C for a further 3 days. Following  
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this, the reaction was purified. At first glance the 1H-NMR showed two signals 
(ddd, δ 5.39 ppm and 5.20 ppm), corresponding to the double bond protons, 
present on the lateral side chain. After interpreting the coupling constants of 
these two signals (approx. 15.2 Hz), this product was identified as a potential 
trans compound with possible stereoselection at the adjacent sp2 position, 
induced by the enantiopure aldehyde (Figure 56).  
 
Figure 56 : 1H-NMR; racemic phosphine oxide 27 and 202b 
Furthermore, it was observed that the enantiopure aldehyde did not racemise at 
-78 °C but did at 55-60 °C. It was thought unlikely that the β-hydroxyphosphine 
oxide intermediate would break up on heating and form a mixture, therefore the 
only likely racemic centre would be at the C-24, from the phosphine oxide 
moiety. Hence, it was required to independently prepare, the reaction between 
the enantiopure aldehyde, 202b and enantiopure phosphine oxides, bearing 
either R- or S- chirality β to the phosphorus 27a and 27b. Resulting in, 
reference compounds, which can be used to aid the analysis of the 
diastereoisomers using NMR. Thus, several enantiopure reactions were 
132 
 
completed, in order to distinguish whether this product was 205a or 205b or a 
mixture of the two. 
4.4.2.2 (S)- and (R)- diphenyl(2-phenyl-propyl)phosphine 
oxide 27a and 27b 
The attention was turned towards the reference compounds. The theoretical 
outcome of these reactions, using an enantiomerically pure aldehyde and an 
enantiomerically pure phosphorous, would be a mixture of two different 
products. A combination of cis and trans double bonds only, as the C-24 and C-
20 position’s are fixed from the starting phosphine oxide and aldehyde (Figure 
57). This method was repeated using exactly the same conditions, as described 
in section 4.4.1, but instead of using (R/S)-diphenyl(2-phenyl-propyl)phosphine 
oxide 27, S-diphenyl(2-phenyl-propyl)phosphine oxide 27a was used when 
reacting with 202b. The possible products expected in this reaction are 205a 
and 205c, one being cis and one being trans. 
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Figure 57 : Outcome of H-W reaction; trans and cis only, with fixed chirality at the C-24 
position and fixed chirality at the C-20 position.  
The results observed were rather surprising, again 1H-NMR showed two signals 
(δ 5.38 ppm and 5.20 ppm), corresponding to the double bond protons, present 
on the lateral side chain (Figure 58), but rather than the more complex ddd 
observed in the previous NMR, the more simple dd was present. Indicating, that 
this was in fact a single diastereoisomer, rather than a mixture of the two 
products, 205a and 205c, expected (Figure 58).   
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Figure 58 : 1H-NMR; (S)-phosphine oxide 27a and aldehyde, 202b. 
After interpreting the coupling constants of these two signals (approx. 15.2 Hz), 
it was revealed to have only produced a single diastereoisomer of the trans 
alkene, 205a. The cis alkene, 205c, was not observed (Scheme 56).  
 
 
Scheme 56 : H-W reaction; a LDA, - 72 °C, 5 hours; b KHMDS, 55-60 °C, 3 days; 205 a 
product is observed, trans with fixed chirality at the C-24 position and fixed chirality at 
the C-20 position. 
To investigate the racemic reaction further, both NMR's were overlaid, the 
racemic reaction proton NMR (Figure 56) and the single diastereoisomer 205a 
(Figure 58). On closer inspection of the overlaid NMR’s (Figure 59), it became 
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apparent that Figure 56, did in fact contain a mixture of two diastereoisomers, 
identified by the coupling constants, 15.2 ppm. This coupling constant indicated 
that the two products contained trans alkenes and were identified as 205a and 
205b (Scheme 57). 
 
Figure 59 : Overlay of 1H-NMR; red; (R/S)- phosphine oxide 27, with 202b; blue; (S)-
phosphine oxide 27a, with 202b. 
Hence, showing that out of a possible four products (205 a-d) only two were 
observed (205a  and 205b), demonstrating that the α-substituted aldehyde had 
in fact controlled the adjacent sp2 centre.  
 
Scheme 57 : H-W reaction; a LDA, - 72 °C, 5 hours; b KHMDS, 55-60 °C, 3 days; 205a and 
b are trans with varying chirality at the C-24 position and fixed chirality at the C-20S 
position.  
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To prove this interpretation further, 13C-NMR spectroscopy was also used to 
confirm the result. The 13C-NMR spectra, of the reaction with the racemic 
phosphine oxide 27, also showed this pattern of “doubling up of signals”, but 
only for the carbon atoms that were located close by the racemic centre, C-24. 
For example; in the reaction with the racemic phosphorus compound 27, it can 
been seen in the 13C-NMR spectra that there are two peaks present at δ 136.10 
ppm and 135.94 ppm, which relate to C-22. The same is apparent for C-23 at δ 
132.03 ppm and 131.85 ppm, indicating that the reaction mixture contains two 
products (Figure 60; TOP). Whereas, in the reaction for S-phosphine oxide 
27a, it can be seen in the 13C-NMR spectra (Figure 60; BOTTOM) that only 
one peak is present with regards to C-22, δ 136.10 ppm, and one peak is 
present for C-23, δ 132.03 ppm, corresponding to 205a. 
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Figure 60 : 13C-NMR's showing the carbon shifts for C-22 and C-23; TOP : (R/S)- 
phosphine oxide 27, with 202b; BOTTOM : (S)-phosphine oxide 27a, with 202b. 
By repeating the procedure from section 4.4.1, using exactly the same 
conditions described, but instead of using (R/S)-diphenyl(2-phenyl-
propyl)phosphine oxide 27, R-diphenyl(2-phenyl-propyl)phosphine oxide 27b 
will be used when reacting with 202b. The possible products expected in this 
reaction are 205b and 205d, one being cis and one being trans. The results 
observed, showed repeatedly, that rather than a mixture of two products, only 
one diastereoisomer was observed in the crude NMR. Followed by purification, 
it was revealed to have only produced a single diastereoisomer of the trans 
alkene 205b and the cis alkene 205d, was not observed (Scheme 58).  
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Scheme 58 : H-W reaction; a LDA, - 72 °C, 5 hours; b KHMDS, 55-60 °C, 3 days; 205b 
product is observed, trans with fixed chirality at the C-24 position and fixed chirality at 
the C-20 position. 
Once overlaid with Figure 56, the racemic phosphine oxide 27, it can clearly be 
observed that racemic phosphine oxide is 100 % a mixture of both 205a and 
205b, both trans alkenes with opposing chirality at the C-24 position (Figure 
61).  
 
Figure 61 : Overlay of 1H-NMR; red; (R/S)- phosphine oxide 27, with 202b; blue; (R)-
phosphine oxide 27b, with 202b. 
4.4.3 Enantiopure aldehyde 202a with racemic and 
enantiopure phosphine oxides 
4.4.3.1 Racemic diphenyl(2-phenyl-propyl)phosphine oxide 27 
The same approach was taken using enantiopure aldehyde 202a, the reaction 
proceeded with the 27, as described in section 4.4.1 (Scheme 59).  
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Scheme 59 : H-W reaction; a LDA, - 72 °C, 5 hours; b KHMDS, 55-60 °C, 3 days; 206a and 
b are trans, 206c and d are cis, with varying chirality (R and S) at the C-24 position and 
fixed chirality at the C-20R position. 
Attention was again turned to the proton NMR, concentrating on the peaks 
observed at around δ 5.48 ppm and 5.28 ppm, the double bond protons on the 
lateral side chain. These again were shown as multiplets, relating to presumably 
a mixture of diastereoisomers. The coupling constants were repeatedly around 
15.3 ppm, which indicated that the trans isomers were formed (Figure 62). This 
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again confirmed that the α-substituted aldehyde had in fact controlled the 
adjacent sp2 centre. To prove this theory the reference compound was again 
synthesised, using R-diphenyl(2-phenyl-propyl)phosphine oxide 27b. 
 
 
Figure 62 : 1H-NMR of racemic phosphine oxide 27 and 202a 
4.4.3.2 R-diphenyl(2-phenyl-propyl)phosphine oxide 27b 
This procedure was repeated using the conditions described in section 4.4.1, 
but instead of using 27, R-diphenyl (2-phenyl-propyl) phosphine oxide 27b was 
used. The reaction produced a single trans diastereoisomer 206b and the cis 
isomer 206d was not observed (Scheme 60). 
 
Scheme 60 : H-W reaction; a LDA, - 72 °C, 5 hours; b KHMDS, 55-60 °C, 3 days; 206b 
product is observed only, trans with fixed chirality at the C-24 position and fixed chirality 
at the C-20 position. 
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The results obtained, once overlaid with the 1H-NMR, shown in Figure 62, 
proved once again that the mixture (Figure 63) was in fact two 
diastereoisomers with varying chirality at the C-24 position.  
 
 
Figure 63 : Overlay of 1H-NMR; red; (R/S)- phosphine oxide 42, with 211a; blue; (R)-
phosphine oxide 42b, with 211a. 
This confirmed that the mixture of diastereoisomers present within the reaction 
of 27, to be 206a and 206b (Scheme 61).  
 
 
Scheme 61 : H-W reaction; a LDA, - 72 °C, 5 hours; b KHMDS, 55-60 °C, 3 days; 206a and 
206b are trans with varying chirality at the C-24 position and fixed chirality at the C-20 
position. 
Unfortunately, as a result of limiting starting material phosphine oxide 27a could 
not be reacted with 202a. However, with the results confirmed for enantiopure 
aldehyde 202b, it is predicted that the reaction between 202a and 27a would 
give 206a only.  
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In conclusion, it has been shown that when reacting an enantiopure aldehyde 
with a racemic phosphine oxide, the stereocenters present α to the aldehyde 
can in fact control the outcome of the adjacent sp2 centre, by selectively 
choosing trans over cis alkenes. 
4.4.4 Identification of C-22, C-23 and C-24 within the NMR 
Using the reactions with 202b as an example, both the proton and carbon 
NMR’s were analysed and the groups of interest, C-22, 23 and 24, were 
assigned (Figure 64). Many examples of similar sp3-sp2-sp3 motifs exist in the 
literature and these examples will be used to guide the assignments120,121.  
 
Figure 64 : C-3, 22, 23 and 24 shown on 205a and 205b 
The first system investigated was the reaction of S-diphenyl(2-phenyl-
propyl)phosphine oxide 27a and 202b, using the reaction with 27 for additional 
guidance. The 1H-NMR of the C-22 and C-23 protons, have previously been 
mentioned in Figure 58.  
With the guidance of Breit et al. 120 coupling constants for the observed dd at δ 
5.38 ppm, were 3J couplings of 15.3 Hz and 6.8 Hz (Figure 58). 15.3 Hz, which 
indicated the trans coupling and the 6.8 Hz, indicated the coupling between 
itself and the proton on C-24 (Figure 65).  
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Figure 65 : Coupling constants relating to the lateral side chain 
There were some finer 4J = 0.6-1.2 Hz which indicated the coupling between 
the C-23 trans proton and the C-20 proton. As you move further from the 
stereocenter, the C-20 position, the ppm shift between diastereoisomers 
increases, in this case the difference was 0.02 ppm, shown in (Figure 66), 
which was rather large, suggesting that this peak at δ 5.38 ppm,  was in fact 
assigned to the C-23 proton.  
 
Figure 66 : 0.02 ppm shift, identified by black circle, between  the R- and S- 
diastereoisomers, indicating this peak if further from the stereocenter of C-20; Racemic 
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reaction mixture overlaid with (S)-diphenyl(2-phenyl-propyl)phosphine oxide 27a and 
202b aldehyde product. 
Whereas the coupling constants for the dd observed at δ 5.20 ppm, were both 
3J couplings of 15.4, 9.04 Hz couplings. 15.4 Hz being the trans coupling and 
the 9.04 Hz coupling being between itself and the proton at the C-20 position 
(Figure 65). There were also some finer 4J coupling present at 0.6-1.2 Hz which 
indicated the coupling between C-22 trans protons and the C-24 proton. Further 
evidence relates to the 0.01 ppm shift, associated between the two different 
diastereoisomers, indicating it is in fact closer to the stereocenter at the C-20 
position (Figure 67). This suggests that this peak at δ 5.20 ppm, is assigned to 
the C-22 proton.  
 
Figure 67 : 0.01 ppm shift, identified by black circle, between the R- and S- 
diastereoisomers, indicating this peak if closer to the stereocentre of C-20; Racemic 
reaction mixture overlayed with (R)-diphenyl(2-phenyl-propyl)phosphine oxide 27b and 
202b aldehyde product. 
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Further evidence is supplied later on in the section, when referring to the 
quintet, assigned to the C-24 proton. According to Breit et al., 120 the C-24 
proton should have a chemical shift of approx. δ 3.00 ppm. Within the 1H-NMR, 
there are two peaks observed around this ppm shift (Figure 68), the first being 
a multiplet at around δ 3.45 ppm and the second being a quintet at δ 3.30 ppm. 
 
 
Figure 68 : 1H-NMR; multiplet at δ 3.45 ppm to be C-3; quintet at δ 3.30 ppm to be C-24 
The first peak at δ 3.45 ppm, corresponds to the proton at the C-3 position 
(Figure 64), due to the fact this is a recurring feature throughout the phytosterol 
series, evident by the associated carbon at δ 72.23 ppm in the 13C-NMR 
(Figure 69).  
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Figure 69 : 13C-NMR; showing peak in relation to the C-3 position (δ 72.23 ppm). Peak 
associated with the C-3 position 
Therefore allowing assignment of the peak at δ 3.30 ppm to the C-24 proton. 
Further evidence, suggests that the quintet observed at δ 3.30 ppm (Figure 
68), relates to the C-24 proton, due to a “doubling of peaks” in the carbon NMR 
(shown with the racemic overlay), which is a common feature when in close 
proximity to the racemic centre (Figure 70).  
 
Figure 70 : 13C-NMR, to show the “doubling of peaks” in relation to the C-24 (δ 42.23 
ppm). 
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Furthermore, C-24 has a coupling in the 1H-NMR of 3J = 6.8 Hz, associating the 
coupling constant to that observed at δ 5.38 ppm, which was the C-23 proton. 
This further confirms the assignment that δ 5.38 ppm was the C-23 proton and 
δ 5.20 ppm was the C-22 proton. 
4.4.5 Preparation of the phytosterols using enantiopure 
phosphine oxides and racemic aldehydes 
The study was extended briefly, to see if an enantiopure phosphorus had any 
observed effect on a racemic aldehyde mixture (Scheme 62). The same 
approach was taken using racemic aldehyde, 202, the reaction proceeded with 
the R-diphenyl (2-phenyl-propyl)phosphine oxide 27b, as described in section 
4.4.1. The results showed, that unfortunately there was no stereoselectivity 
observed within the reaction, the crude NMR showed that there was a mixture 
of all four possible products expected 205b, 205d, 206b and 206d, indicating 
no stereocontrol over the adjacent sp2, by the enantiopure phosphine oxide.  
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Scheme 62 : H-W reaction; a LDA, - 72 °C, 5 hours; b KHMDS, 55-60 °C, 3 days; 205b and 
206b are trans, 205d and 206d are cis, with varying chirality (R and S) at the C-20 position 
and fixed chirality at the C-24S position. 
In conclusion, the reactions using enantiopure aldehydes over enantiopure 
phosphine oxides acquires more stereoselectivity in the products. These 
reactions have controlled the formation of the adjacent sp2 centre. 
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4.4.6 Cyclopropane series 
Using the information obtained from the latter, it was decided to attempt the H-
W reactions with the more precious cyclopropane series (Scheme 63; TOP).   
 
Scheme 63 : Formation of the aldehyde; TOP - cyclopropane series; BOTTOM - TBDMS 
series. h DMSO, CH2Cl2, oxalyl chloride, 1 hr RT; i phosphine oxide, THF. LDA 5 hrs, 
followed by KHMDS. 60 °C, 3 days. 
These reactions where only attempted with the racemic phosphine oxides and 
the enantiopure aldehydes, 194a and 194b due to time constrains towards the 
end of the PhD (Scheme 64).  
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Scheme 64 : General H-W reaction 
First, the reaction of racemic aldehyde and enantiopure aldehyde, 194b, was 
carried out, this procedure was repeated using exactly the same conditions as 
described in section 4.4.1, giving a mixture of diastereoisomers (Scheme 65). 
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Scheme 65 : H-W reaction; a LDA, - 72 °C, 5 hours; b KHMDS, 55-60 °C, 3 days; 207a and 
b  are trans, 207c and d are cis, with varying chirality (R and S) at the C-24 position and 
fixed chirality at the C-20R position. 
Attention again was turned to the proton NMR, concentrating on the peaks 
observed at around δ 5.37 ppm and 5.17 ppm, the double bond protons on the 
lateral side chain. These again were multiplets, relating to presumably a mixture 
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of diastereoisomers. The coupling constants were repeatedly around 15.6 ppm, 
which indicated that the trans isomers 207a and 207b were formed (Figure 71, 
Figure 72). Implying in this reaction also, the α-substituted aldehyde had in fact 
controlled the adjacent sp2 centre. 
 
 
Figure 71 : 1H-NMR; (R/S)-phosphine oxide 27 and aldehyde, 194b. 
This observation was confirmed by the “doubling up of peaks” presented in the 
13C-NMR, which relate to the double bond carbon signals. 
 
 
Figure 72 : 13C-NMR's showing the carbon shifts for C-22 and C-23 with (R/S)-diphenyl(2-
phenyl-propyl)phosphine oxide 27 
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The reaction with aldehyde, 194a and racemic phosphine oxide 27 was 
completed, under the same conditions as described in section 4.4.1, giving 
again a mixture of both trans compounds, 208a and 208b, using the evidence 
(as described in the latter), from the 1H-NMR and 13C-NMR (Scheme 66). 
 
 
Scheme 66 : H-W reaction; a LDA, - 72 °C, 5 hours; b KHMDS, 55-60 °C, 3 days; 254a and 
254b are trans, with varying chirality (R and S) at the C-24 position and fixed chirality at 
the C-20 position. 
It was even attempted to overlay the reactions of 194 with the enantiopure 
reactions from the TBDMS series, but unfortunately these could not be used. 
Therefore, future work would involve, completing the reactions with the 
enantiopure β-substituted phosphine oxides 27a and 27b and investigating the 
enantioselection using NMR. 
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5.0 CHAPTER 5 - Biology 
There are potentially three hypotheses about the cellular localisation and 
activity of these phytosterol compounds that contribute to their anticancer 
activity. It is possible that phytosterols will incorporate within the lipid rafts of the 
plasma membrane, altering the membrane structure and composition. This 
alteration may interfere with the downstream processes involved in cell 
proliferation, thus decreasing or inhibiting the rate of cell proliferation. Secondly, 
phytosterols may interact with the nucleus within the cell, and may disrupt 
machinery within the ribosomes required to transcribe DNA. Finally, 
phytosterols could interfere with the metabolism of growth hormones such as 
oestrogen thereby perturbing cell growth and activity. In pursuance of the 
possible sites of aggregation of these phytosterols and in order to investigate 
their mechanism of action, the cellular incorporation of cholesterol 1, 
cholestanol 10 and stigmastanol 11 were investigated using MDA-MB-231 
cancer cell lines122, only the results from cholesterol 1 and stigmastanol 11 are 
reported herein.  
The molecular probes used consist of the sterol linked by a fluorescent tag. 
These compounds were prepared by Miss Emilie Sellier 123,121,122. 6-((7-
nitrobenzo[c][1,2,5]oxadiazol-4-yl)amino) hexanoic acid  (NBD) was used as the 
fluorescent tag within this investigation 124,125 and was coupled to the 
phytosterol compounds (Figure 73). 
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Figure 73 : Phytosterol structures and structures of the NDB fluorescent probe 123,126 
After synthesis, Asam et al. 122 carried out preliminary experiments to determine 
the highest non-cytotoxic concentration of pure and fluorescently tagged 
phytosterols, towards MDA-MB-231 cells, by use of cellular viability assays. The 
results are reported within Table 17. 
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Compound 
Maximum 
Compound 
Concentration 
(M) 
Incubation 
Time 
(Days) 
Cell Survival at 
Maximum 
Concentration 
(%) 
Cholesterol 1 ** 
5.2 x 10-5 
 
4 95±5 
NBD cholesterol 209 
** 
4.4 x 10-5 
 
4 85±5 
Stigmastanol 11* 
1.6 x 10-4 
 
4 72±7 
NBD Stigmastanol 
210 * 
1.0 x 10-5 
 
2 99±5 
Table 17 : Cell survival following incubation of MDA-MB-231 cells with various 
compounds. The cells were treated with the indicated compound concentration for the 
specified time periods. The cell survival at the maximum concentration represents the 
survival of cells in comparison to the compound free control 122 
Following this initial investigation, these verified concentrations of labelled 
phytosterols, shown in Table 17, were supplemented to the non-oestrogen 
dependant MDA-MB-231 cells. Using fluorescence microscopy, the 
incorporation, and cellular distribution of these labelled phytosterols could be 
monitored.   
 5.1 Incorporation of cholesterol and stigmastanol 
into the MDA-MB-231 cell membrane  
In order to determine the cellular localisation of cholesterol 1, MDA-MD-231 
cells were treated with NBD cholesterol 209 for ten minutes. At compound 
concentrations of 50 μM, 5 μM and 0.5 μM, a concentration-dependent 
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incorporation of NBD cholesterol 209 into the cell membrane was observed 
(Figure 74).  
 
(a) 
 
 
(b) 
 
 
10 min 10 min 
10 min 
10 min 
10 min 
10 min 
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(c) 
 
 
Figure 74 : Incorporation of NBD Cholesterol 209 into MDA-MB-231 cells. The cells were 
incubated with 2ml of (a) 50 μM, (b) 5 μM or (c) 0.5 μM 209 in complete RPMI medium for 
10 minutes. Fluorescence microscopy of the cells revealed compound incorporation into 
the cell membrane. 209 is displayed in green. The blue represents the cell nucleus as 
stained by DAPI 122 
Furthermore, it appears upon fluorescence microscopy of the cells, formation of 
what appears to be liposome was observed (Figure 75). 
 
10 min 
10 min 
10 min 
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Figure 75 : The view of a liposome obtained when 209 is dissolved in an aqueous 
solution. NBD cholesterol was dissolved in complete RPMI to a concentration of 50 μM 
and incubated with MDA-MB-231 cells for 10 minutes. The image taken displays the 
formation of a liposome. NBD fluorescent tag is displayed in green and the liposome is 
NBD cholesterol 122 
In order to determine the cellular localisation of NBD stigmastanol 210, MDA-
MD-231 cells were treated with 10 μM and 0.1 μM of compound dissolved in 
complete RPMI. After 10 minutes, 2 hours and 48 hours both a time- and 
concentration-dependent incorporation of NBD stigmastanol 210 into the cell 
membrane was observed (Figure 76).  
 
= 
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Figure 76 :  Incorporation of NBD stigmastanol 210 into MDA-MB-231 cells. The cells 
were incubated with 2ml of 10 μM or 0.1 μM of NBD stigmastanol in complete RPMI 
medium for 10 minutes, 2 hours or 48 hours. Fluorescence microscopy of the cells 
revealed compound incorporation into the cell membrane. 210  is displayed in green. The 
blue represents the cell nucleus as stained by DAPI 122 
5.2 Discussion 
As previously mentioned, cholesterol-rich microdomains or better known as lipid 
rafts, have a significantly more ‘rigid’ environment compared to their cholesterol 
poor counterparts. Huang et al. 127 demonstrated that exogenous cholesterol 
incorporates into a model membrane system with an orientation similar to that 
of cholesterol present in the membrane bilayer127. However, it should be noted, 
that it is unknown whether the orientation and affinity to which fluorescently 
labelled cholesterol binds to intracellular proteins is similar to that of pure 
10 min 10 min 
0.1 M 
48 h 2 h 10 min 
10 M 
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cholesterol, but it can be observed from the studies that the fluorescent tag, 
without the sterol attached, does not incorporate into the cell membrane 128.  
It has been previously reported in the literature129 that cholesterol and 
phytosterol supplementation can alter the composition of the MDA-MB-231 cell 
membrane and the authors concluded that the sterols may become 
incorporated into lipid rafts of the breast cancer cell membranes and exert an 
effect on the cell membrane. The purpose of this present study was to 
determine the cellular site of aggregation of sterols in MDA-MB-231 cells, using 
fluorescent microscopy. The MDA-MB-231 cell line is an oestrogen receptor-
negative model of late or advanced stage breast cancer, meaning the cells do 
not rely upon oestrogen-dependent downstream pathways to promote cell 
proliferation. Therefore, any effects the sterols have on the cancer cells will 
exclude the original hypothesis that the sterols interfere with the metabolism of 
the growth hormone alone to perturb cellular activity. This cell line was selected 
due to previous reports in the literature of the cells being affected by treatment 
with sterols 47,73,129. Incorporation of the sterols under investigation into these 
cells has not yet been studied visually by fluorescence microscopy, therefore it 
was hoped that the results would have some contribution to the science behind 
these sterols.  
In the investigation, cholesterol and stigmastanol and their fluorescent 
analogues displayed no significant cytotoxicity towards MDA-MB-231 breast 
cancer cells. However, upon fluorescence microscopy, a time- and 
concentration-dependent incorporation of the compounds into the cell plasma 
membrane was observed. A novel mechanism is proposed for the incorporation 
of exogenous sterols into the plasma membrane; when the MDA-MB-231 cells 
are treated with a maximum tolerable dose of NBD cholesterol and NBD 
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stigmasterol, fluorescence microscopy revealed that the sterols may form 
micelles in solution which dissolve upon contact with the cell plasma membrane 
and subsequently diffuse into the cell. The results obtained in this research 
project provide novel insights into the potential mechanism of action of 
phytosterols.
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6.0 CHAPTER 6 - Experimental 
6.1 Experimental Techniques, materials and 
Instrumentation 
Commercially available reagents were purchased from Sigma-Aldrich®, Tokyo 
Chemistry Industry (TCI®), Alfa Aesar® and Merck®, and were used as received 
without additional purification unless otherwise stated. The dry solvents were 
also obtained from Sigma-Aldrich®, VWR®, and Merck®. All other solvents were 
of reagent grade. Petroleum ether refers to the fraction of petroleum spirit 
boiling in the range of 60 to 80 °C. Where stated, mixtures of solvents are 
referred to as percentage volume-to-volume (v/v) ratios. 
Products were typically purified by column chromatography using Merck 9385 
silica gel 60 (40-63 μm). Analytical thin layer chromatography (TLC) was 
conducted on Merck silica gel 60 F254 glass backed plates. Visualisation of the 
reaction components was accomplished by illumination under short wavelength 
(254 nm) ultraviolet light or using basic potassium permanganate (KMnO4) stain 
and where stated, the use of vanillin was required. 
Routine infrared (IR) spectra were recorded on a Perkin-Elmer FTIR 
spectrometer using sodium chloride plates or made using KBr discs. Spectra 
are reported in wavenumbers (cm-1). 
Proton Nuclear Magnetic Resonance (1H NMR) spectra were recorded using 
Bruker AMX400 (400 MHz) spectrometer. Carbon and phosphorus Nuclear 
Magnetic Resonance (13C and 31P NMR) were performed on the same 
machines operating at 101 and 162 MHz respectively. Deuterated chloroform 
(CDCl3) was used as the NMR solvent unless otherwise stated. Chemical shifts 
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are reported in parts per million (δ, ppm). 1H NMR chemical shifts are reported 
relative to an internal reference (tetramethylsilane) or residual proton signals of 
the solvent. Coupling constants (J) are expressed in Hertz (Hz). Coupling 
constant due to splitting by a phosphorus nucleus are reported as JP. The 
splitting patters in NMR spectra are reported with the following abbreviations: 
singlet (s), doublet (d), triplet (t), quartet (q), quintet (quint.), multiplet (m) and 
broad (br). 13C NMR chemical shifts are reported relative to the signal of the 
solvent. 31P NMR chemical shifts are reported relative to the signal of an 
external reference (85 % H3PO4). Where necessary, phosphorus decoupled 
proton NMR, correlation spectroscopy (COSY), nuclear Overhauser enhanced 
spectroscopy (NOESY), heteronuclear multiple quantum correlation 
spectroscopy (HMQC) for both 13C/1H and 31P/1H nuclei (short range for JP > 6 
Hz and long range for JP < 6 Hz), and distortionless enhancement by 
polarization transfer (DEPT) technique were employed to confirm the 
assignment of NMR spectra.  
Routine mass spectra was carried out by Andrew Healey and were run on a 
Micromass Quattro Ultima spectrometer in the electron impact (EI), chemical 
ionisation (CI) or positive (+ve) electrospray mode as stated. All high resolution 
mass spectrometry (HRMS) was carried out at the ESPRC National mass 
spectrometry service centre located in Swansea University. Optical rotations 
where carried out on a Perkin Elmer polarimeter, model 341. The HPLC 
analysis was completed by Dr Richard Telford and Andrew Healey in the 
University of Bradford Analytical Centre on a Waters 2690/5 Separation module, 
a Waters 2487 Dual λ Absorbance Detector and a Micromass ZMD. The 
analysis was carried out with a Daicel Chiracel OD, 0.46 cm Φ x 25 cm and the 
eluent used for diphenylphosphine oxide compounds was 2.5% IPA/ 97.5% 
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Hexane, run time 100 minutes and for diethylphosphine oxides 0.5% IPA/99.5% 
Hexane, run time 180 minutes.  
Glassware was dried approximately >2 hours prior to the experiment in a dry 
oven at 140 °C. All moisture sensitive reactions were carried out under an inert 
atmosphere using dry argon and nitrogen. Heating was completed using an oil 
bath, containing silicon oil, placed on top of a hot plate stirrer. Cooling baths 
were prepared as described below for a range of various temperatures: 
0 °C  Ice 
-10 °C  Ice and sodium chloride/ Ethylene glycol and dry ice 
-45 °C  Acetonitrile and dry ice 
-78 °C  Ethanol and dry ice 
Mass Directed Auto Preparative HPLC (MDAP) was performed on either a 
Sunfire (formic modifier) or XBridge (ammonium bicarbonate modifier) C18 
columns (150 mm x 30 mm, 5 µm packing diameter) at ambient temperature 
and 40 mL/min flow rate. The gradient employed was selected from 5 pre-set 
methods (A, B, C, D, or E) with the following solvents: A = 0.1% v/v solution of 
modifier in Water: B = 0.1% v/v solution of modifier in Acetonitrile. 
 
Time 
(min 
Method A Method B Method C Method D Method E 
A% B% A% B% A% B% A% B% A% B% 
0 95 5 85 15 70 30 50 50 30 70 
1 95 5 85 15 70 30 50 50 30 70 
20 70 30 45 55 15 85 1 99 85 15 
20.5 1 99 1 99 1 99 1 99 1 99 
25 1 99 1 99 1 99 1 99 1 99 
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Please note: 
Each H-W reaction has been completed twice and the best yield has been 
stated. In the event of inseparable diastereoisomeric mixtures, the hydrogen 
and carbon have been given values referring to their equivalent number of 
atoms, therefore the word eqv. has been stated at the beginning of the NMR's 
were this is apparent. All NMR's have been completed in CDCl3 otherwise 
stated. 
X-ray crystallography has not been completed in all cases, therefore without X-
ray crystallography the configuration of the C1 and C4 positions cannot be 
determined, here only 2,3-syn and 2,3-anti configuration is mentioned. The 2,3 
syn and 2,3-anti configuration has been determined using the NMR techniques 
described in section 4.1.2, Figure 19.   
Compounds: 27 130,101; 36 103; 49 131; 52 132; 56 132,133; 167 104; 190 134; 195 135; 
197 136; 198 137; 203 4; 204 138, were made according to  the literature procedure 
and spectroscopic data was in accordance. 
Compound 97 was synthesised by Dr Victoria Vinader 113, see unpublished 
results for detailed experimental and characterisation. 
Compounds: 209 and 210 were synthesised by Miss Emilie Sellier 123, see 
unpublished results for detailed experimental and characterisation. 
Compounds: 69 139; 70; 71 and 72 103, were synthesised by Miss Fanny Dulon 
105, see unpublished results for detailed experimental and characterisation.  
Compounds: 34; 44; 45; 46; 47; 60; 61; 62; 99; 103; 105-110; 112-120; 122; 
164 were purchased from Sigma Aldrich UK 
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6.2 Experimental procedures  
6.2.1  (1R*, 2R*, 3R*) and (1R*, 2R*, 3S*)-(1-hydroxy-1-
(naphthalen-1-yl)-3-phenylbutan-2-yl)diphenylphosphine oxide  
LDA (2 M solution in THF, 14 mL, 28 mmol) was added drop wise to a stirred 
solution of phosphine oxide 27 (3 g, 9 
mmol) in THF (70 mL) at -72 °C, under an 
argon atmosphere. The resulting red 
solution was stirred for 3 hours at this 
temperature. After this time 1-
naphthaldehyde 28 (4.01 mL, 4.39 g, 28 
mmol), was added drop wise and was left 
to stir at this temperature for a further 4 
hours. After the stated time, saturated 
ammonium chloride (30 mL) was added, 
the solution turned clear, here it was 
allowed to warm up to room temperature. THF was removed in situ and the 
residue was dissolved in dichloromethane and water (1 : 1 v/v, 50 mL). The 
organic layer was combined, dried and filtered to yield a orange oil (5 g), which 
was purified by column chromatography (70 : 30 v/v, petroleum ether : ethyl 
acetate) collecting all relevant fractions, to afford a mixture of all four 
diastereomers  as a yellow solid (4.3 g, 98 %). The diastereomers were 
separated by column or preparative thin layer chromatography (100 v/v, 
petroleum ether). The first eluted was 29a (0.1338 g, 3 %),  Rf 0.8, along with 
29d (0.892 g, 20 %),  Rf 0.8, followed by 29c (0.7582g, 17 %), Rf 0.5, and 29b 
(1.248 g, 28 %),  Rf 0.4. 29b and 29c were further purified by recrystalisation 
2,3-syn : 1,2-syn 29a; 
2,3-anti : 1,2-syn 29b; 
2,3-syn : 1,2-anti 29c; 
2,3-anti : 2,3-anti 29d 
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(1:1 v/v, toluene : hexane). 29a and 29d were purified by trituration with 
petroleum ether, and filtered hot, to give 29d in the filtrate and 29a as the white 
solid 140. 
 
(1R*, 2R*, 3R*)-1-hydroxy-1-(naphthalen-1-yl)-3-phenylbutan-2-
yl)diphenylphosphine oxide; 29a; m.p. 192-193 °C; Vmax(CHCl3)/cm-1 3319 
(OH), 2946 (C-H), 1622 (C=C arom.), 1321 (P=O), 1123 (C-O), 847 (C-H 
arom.); δH ppm (400 MHz.) 1.90 (3H, d, JH = 7.3 Hz, CH3), 3.11 (1H, dt, JH = 
1.6, 3.3,  JP = 10.7  Hz, PCH), 3.29 (1H, dquin, JH = 3.3,  JP = 15.9 Hz, 
CHPhMe), 5.92 (1H, dd, JH = 9.4, 1.6 Hz, JP = 26.2 Hz  CHOH), 6.21 (1H, d, JH 
= 9.6 Hz, Naphth aromatic-H), 6.64 (1H, d, JH = 9.5 Hz, OH), 6.84 (1H, d, JH = 
9.9, 5.5 Hz, Naphth aromatic-H), 7.03-7.07 (3H, m, Naphth aromatic-H), 7.08 
(1H, t, JH = 6.9 Hz, aromatic-H), 7.23 (1H, s, Naphth aromatic-H), 7.30-7.34 
(1H, m, Naphth aromatic-H), 7.40-7.52 (8H, m, aromatic-H), 7.57 (1H, d, JH = 
7.3 Hz, aromatic-H), 7.65 (1H, d, JH = 8.0 Hz, aromatic-H), 7.71 (1H, dd, JH = 
10.5, 7.1 Hz, aromatic-H); δP ppm (400 MHz.) 39.83; δC ppm (125 MHz.) 15.4 
(d, JP = 3.3 Hz, CH3), 39.3 (CHPhMe), 45.7 (d, JP = 63.7 Hz, PCH), 70.3 (d, JP 
= 5.3 Hz, CHOH), 121.7-144.9 (aromatic C and CH); m/z (EI) 321.2 (MH+-OH,1-
Naph), 477.3 (MH+); HRMS (ES); calc. for C32H30O2P (MH+) 477.1969; Found 
477.1978; 
 
 (1R*, 2R*, 3S*)-(1-hydroxy-1-(naphthalen-1-yl)-3-phenylbutan-2-
yl)diphenylphosphine oxide; 29b; m.p. 185.2-185.8 °C; Vmax(CHCl3)/cm-1 
3319(OH), 2946 (C-H), 1622 (C=C arom.), 1321 (P=O), 1213 (C-O), 847(C-H 
arom.); δH ppm (400 MHz.) 1.15 (3H, d, JH = 7.5 Hz, CH3), 3.27 (1H, dt, JH = 
5.8, 2.5, JP = 9.05  Hz, PCH), 3.54 (1H, ddq, JH = 2.9, 6.9, JP = 10.2 Hz, 
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CHPhMe), 5.41 (1H,  s, OH), 6.11 (1H, d, JP = 8.6 Hz, CHOH), 6.64-6.72 (5H, 
m, Naphth aromatic-H), 7.01 (1H, d, JH = 8.5 Hz, Naphth aromatic-H), 7.12-7.19 
(1H, m, Naphth aromatic-H), 7.23-7.37 (5H, m, aromatic-H), 7.43-7.51 (4H, m, 
aromatic-H), 7.53-7.68 (3H, m, aromatic-H), 7.84 (1H, t, JH = 11.5 Hz, Naphth 
aromatic-H), 7.99 (2H, ddd, JH = 9.9, 6.7, 3.0 Hz, aromatic-H); δP ppm (400 
MHz.) 37.66; δC ppm (125 MHz.) 19.3 (d, JP = 3.3 Hz, CH3), 34.9 (CHPhMe), 
48.9 (d, JP = 65.9 Hz, PCH), 69.0 (CHOH), 122.0-142.6 (aromatic C and CH); 
m/z (EI) 321.2 (MH+-OH,1-Naph), 477.3 (MH+); HRMS (ES); calc. for C32H30O2P 
(MH+) 477.1969; Found 477.1978; 
 
(1R*, 2S*, 3S*)-(1-hydroxy-1-(naphthalen-1-yl)-3-phenylbutan-2-
yl)diphenylphosphine oxide; 29c; m.p. 237.2-238.8 °C; Vmax(CHCl3)/cm-1 
3319(OH), 2946(C-H), 1622 (C=C arom.), 1321(P=O), 1289 (C-O), 847 (C-H 
arom.); δH ppm (400 MHz.) 1.31 (3H, d, JH = 7.2 Hz, CH3), 3.48 (1H, dt, JH = 
3.3, 1.5, JP = 14.21 Hz, PCH), 3.74 (1H, dquin, JH = 1.5, 7.1, JP = 17.8 Hz, 
CHPhMe), 5.73 (1H, ddd, JH = 8.8, 3.1, JP = 23.2  Hz, CHOH), 5.89 (1H,  d, JH = 
8.8 Hz OH), 6.82 (2H, td, JH = 7.7, 2.9 Hz, aromatic-H), 6.91 (1H, t, JH = 7.7 Hz, 
aromatic-H), 7.02 (3H, dd, JH = 12.1, 7.5 Hz, aromatic-H), 7.06-7.13 (1H, m, 
aromatic-H), 7.13-7.18 (5H, m, aromatic-H), 7.22-7.30 (2H, m, aromatic-H), 
7.33-7.50 (6H, m, aromatic-H), 7.62 (2H, dd, JH = 7.8, 4.6 Hz, aromatic-H); δP 
ppm (400 MHz.) 36.97; δC ppm (125 MHz.) 19.8 (CH3), 39.6 (CHPhMe), 48.4 (d, 
JP = 65.8 Hz, PCH), 73.7 (d, JP = 5.3 Hz, CHOH), 122.4-144.6 (aromatic C and 
CH); m/z (EI) 321.2 (MH+-OH,1-Naph), 477.3 (MH+); HRMS (ES); calc. for 
C32H30O2P (MH+) 477.1969; Found 477.1978; 
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(1R*, 2S*, 3R*)-(1-hydroxy-1-(naphthalen-1-yl)-3-phenylbutan-2-
yl)diphenylphosphine oxide; 29d  
m.p. 256-257 °C; Vmax(CHCl3)/cm-1 3319 (OH), 2946 (C-H), 1622 (C=C arom.), 
1321 (P=O), 1345 (C-O), 847(C-H arom.); δH ppm (400 MHz.) 1.71 (3H, d, JH = 
7.4 Hz, CH3), 3.03 (1H, d, JH = 1.4, 2.9, JP = 8.1 Hz, PCH), 3.42 (1H, dq, JH = 
1.5, 6.9, JP = 25.3 Hz, CHPhMe), 5.54 (1H,  s, OH),  5.91 (2H, d,  JH = 7.8 Hz, 
aromatic-H), 6.14 (1H, d,  JH = 8.4  Hz, CHOH), 6.76 (2H, t, JH = 7.7 Hz, 
aromatic-H), 6.86-7.11 (2H, m, aromatic-H), 7.18-7.24 (2H, m, aromatic-H), 7.26 
(1H, dd, JH = 7.0, 1.4 Hz, aromatic-H), 7.37-7.49 (4H, m, aromatic-H), 7.53-7.55 
(1H, m, aromatic-H), 7.62-7.81 (3H, m, aromatic-H), 7.82 (1H, d, JH = 8.2 Hz, 
aromatic-H), 7.92 (1H, d, JH = 8.0 Hz, aromatic-H), 8.01-8.13 (3H, m, aromatic-
H); δP ppm (400 MHz.) 36.34; δC ppm (125 MHz.) 16.9 (d, JP = 3.3,  CH3), 33.6 
(CHPhMe), 49.9 (d, JP = 65.8 Hz, PCH), 70.0 (d, JP = 2.1 Hz, CHOH), 121.9-
145.1 (aromatic C and CH); m/z (EI) 321.2 (MH+-OH,1-Naph), 477.3 (MH+); 
HRMS (ES); calc. for C32H30O2P (MH+) 477.1969; Found 477.1978; 
 
6.2.2 (E)-1-(3-phenylbut-1-en-1-yl)naphthalene 30a 
Potassium bis(trimethylsilyl)amide solution (0.5 
M solution in THF, 0.251 mL, 0.12 mmol) was 
added to a solution of (1R*, 2R*, 3R*)-(1-
hydroxy-1-(naphthalen-1-yl)-3-phenylbutan-2-
yl)diphenylphosphine oxide 29a (0.05 g, 0.1 
mmol) in THF (5 mL) under argon conditions, 
upon which the reaction turned peach in 
colour. After stirring for 24 hours at RT, the 
reaction was complete (monitored by TLC). The mixture was partitioned 
30a 
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between dichloromethane and brine (1 : 1 v/v). The organic layer was then 
dried over MgSO4, filtered and the solvent was removed in vacuo to give a 
residue (0.028 g, 100 %). Further purification via column chromatography (90 : 
10 v/v, petroleum ether : ethyl acetate) gave the title compound as a colourless 
gum 30a (0.026 g, 96 %) 140. 
Vmax(CHCl3)/cm-1 2958 (C-H), 1623 (C=C), 1604 (C=C arom.), 850(C-H arom.); 
δH ppm (400 MHz.) 1.48 (3H, d, JH = 7 Hz, CH3), 3.56 (1H, q, JH = 15.7, 7 Hz, 
Ph(CH3)CH), 6.33 (1H, dd, JH = 15.6, 6.9 Hz, CH=CH(Naph)), 7.07 (1H,  d, JH = 
15.6 Hz, CH=CH(Naph)),  7.12-7.19 (1H, m, aromatic-H), 7.26 (4H, d, JH = 4.8 
Hz, aromatic-H), 7.30-7.35 (1H, m, aromatic-H), 7.36-7.46 (2H, m, aromatic-H), 
7.48 (1H, d, JH = 7.1 Hz, aromatic-H), 7.66 (1H, d, JH = 8.1 Hz, aromatic-H), 
7.70-7.79 (1H, m, aromatic-H), 8.01 (1H, d, JH = 7.7 Hz, aromatic-H); δC ppm 
(125 MHz.) 20.4 (CH3), 41.9 (Ph(CH3)CH), 122.6-125.2 (aromatic C and CH), 
126.3 (CH=CH(Naph)), 126.4-134.4 (aromatic C and CH), 137.5 
(CH=CH(Naph)), 144.6 (aromatic-C); m/z (EI) 259 (MH+); HRMS (ES); calc. for 
C20H19 (MH+)  259.1477; Found 259.1481; 
 
6.2.3 (Z)-1-(3-phenylbut-1-en-1-yl)naphthalene 30b 
Using the method described in section 6.2.2;  
(1R*, 2S*, 3R*)-(1-hydroxy-1-(naphthalen-1-
yl)-3-phenylbutan-2-yl)diphenylphosphine 
oxide 29d (0.05 g, 0.1 mmol) was used. The 
reaction was stirred for 8 hours at RT, and 
then at 50 °C overnight, yielding a residue 30b 
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(0.025 g, 92%). After further purification, the reaction gave 1-naphthaldhyde 28 
(0.006g, 22 %) as well as the title compound as a yellow gum 30b (0.014 g, 50 
%) 140.  
Vmax(CHCl3)/cm-1 2962 (C-H), 1693 (C=C), 1602 (C=C arom.) 798 (C-H arom.); 
δH ppm (400 MHz.) 1.28 (3H, d, JH = 6.9 Hz, CH3), 3.68 (1H, td, JH = 13.7, 6.8 
Hz, Ph(CH3)CH), 6.02 (1H, t, JH = 10.8 Hz, CH=CH(Naph)), 6.81 (1H,  d, JH = 
11.3 Hz, CH=CH(Naph)),  7.05-7.14 (3H, m, aromatic-H), 7.17-7.30 (3H, m, 
aromatic-H), 7.40 (3H, ddd, JH = 18.2, 12.8, 7.2 Hz, aromatic-H), 7.72 (1H, d, JH 
= 8.2 Hz, aromatic-H), 7.75-7.85 (1H, m, aromatic-H), 7.88-7.99 (1H, m, 
aromatic-H); δC ppm (125 MHz.) 22.4 (CH3), 38.2 (Ph(CH3)CH), 125.2-126.0 
(aromatic C and CH), 126.2 (CH=CH(Naph)), 126.9-134.5 (aromatic C and CH); 
138.8 (CH=CH(Naph)), 145.9 (aromatic-C); m/z (EI) 259 (MH+); HRMS (ES); 
calc. for C20H19 (MH+) 259.1467; Found 259.1489; 
 
6.2.4  isobutyldiphenylphosphine oxide 35 
THF (200 mL) was added to 1-bromo-2-methylpropane 
60 (8 g, 58 mmol) under argon and the remaining 
solution was then cooled to -72 °C (ethanol/dry ice). 
After 10 minutes, potassium diphenyl phosphide (0.5 M 
solution, 140 mL, 70 mmol) was added generating a 
deep red solution. The reaction was slowly allowed to 
warm to 0 °C, this was left for approximately 1 hour, followed by 1 hour at room 
temperature resulting in a yellow solution. After the reaction was complete 
(monitored by TLC), H2O2 30%w/w (90 mL) was added at 0 °C and left for 10 
minutes, followed by the addition of sat.aq. NH4Cl (60 mL), and the solution 
turned colourless almost immediately. The THF was then removed and the 
35 
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residue was partitioned between dichloromethane and distilled water (1:1 v/v), 
the aqueous layer was washed with dichloromethane (3 x 100 mL) and the 
combined organic extracts where washed with sat. brine (3 x 100 mL), dried 
with MgSO4, filtered and the solvent was removed in vacuo to yield a  crude 
compound as a white solid 35 (7.45 g), which was triturated (aided by heat) in 
hexane to give a pure white solid (7 g, 93 %), or purified by column 
chromatography (95 : 5 v/v, petroleum ether : ethyl acetate) 141. 
m.p. 136-138.2 °C; m.p. lit. 138-139 °C; Vmax(CHCl3)/cm-1 2962 (C-H), 1637 
(C=C arom.), 1363 (P=O), 799 (C-H arom.); δH ppm (400 MHz.) 0.94 (6H, d, JH 
= 6.5 Hz, (CH3)3), 2.02 (1H, ddp, JH = 15.4, 8.7, JP = 27.3 Hz, CH(CH3)3), 2.12-
2.24 (2H, m, JH = 9.6, 5.5 Hz, PCH2), 7.31-7.49 (6H, m, aromatic-H), 7.58-7.72 
(4H, m, aromatic-H); δP ppm (400 MHz.) 30.21;  δC ppm (125 MHz.) 23.6 (d, JP 
= 2.8 Hz, PCH2CH), 24.7 (d, JP = 69.7 Hz, (CH3)3), 38.4 (d, JP = 77.4 Hz, 
PCH2), 128.6-134.5 (aromatic C and CH);  m/z (EI) 259.2 (MH+);  
 
6.2.5 diphenyl(2-phenylbutyl)phosphine oxide 37 
THF (75 mL) was added to (1-bromobutan-2-
yl)benzene 57 (3.4 g, 16.1 mmol) under argon 
and the remaining solution was then cooled to 
-72 °C (ethanol/dry ice). After 10 minutes, 
potassium diphenyl phosphide (0.5M solution, 
38.4 mL, 19.2 mmol) was added and the 
reaction was slowly allowed to warm to 0 °C, this was left for approximately 1 
hour, followed by 1 hour at room temperature resulting in a orange solution. 
After the reaction was complete (monitored by TLC), H2O2 30 % w/w (38.4 mL) 
was added along with the addition of sat.aq. ammonium chloride (30 mL), and 
37 
 
176 
 
the solution turned colourless almost immediately. The THF was then removed 
and the residue was partitioned between dichloromethane and distilled water 
(1:1), the aqueous layer was washed with dichloromethane (3 x 10 mL) and the 
combined organic extracts where washed with sat. brine (3 x 10 mL), dried with 
MgSO4, filtered and the solvent was removed in vacuo to yield a  crude 
compound as a white solid (6 g), which was triturated (aided by heat) in hexane 
to give a pure white solid 37 (4.5 g, 84%).  
m.p. 187.6-189.6 °C; Vmax(CHCl3)/cm-1 2782 (C-H), 1637 (C=C arom.), 1234 
(P=O), 794 (C-H arom.); δH ppm (400 MHz.) 0.60 (3H, t, JH = 7.3 Hz, CH2CH3), 
1.58 (1H, ddq, JH = 14.5, 10.3, 7.3 Hz, CH2CH3), 1.88 (1H, dqd, JH = 14.6, 7.4, 
4.8 Hz, CH2CH3),  2.55 (2H, ddd, JH = 7.8, 5.9, JP = 9.0 Hz, CH2), 2.98 (1H, dq, 
JH = 11.4, 6.7, JP = 6.7 Hz, CH), 6.91-7.01 (3H, m, aromatic-H), 7.04-7.21 (2H, 
m, aromatic-H), 7.24 (2H, ddd, JH = 7.2, 5.3, 2.3 Hz, aromatic-H), 7.36 (4H, 
dddd, JH = 10.9, 9.0, 6.4 Hz, aromatic-H), 7.47-7.59 (2H, m, aromatic-H), 7.61-
7.78 (2H, m, aromatic-H); δP ppm (400 MHz.) 31.34;  
δC ppm (125 MHz.) 11.9 (CH2CH3), 30.7 (CH2CH3), 37.2 (d, JH = 69.9 Hz, CH2), 
41.3 (d, JH = 3.1 Hz, CH), 126.3-144.2 (aromatic C and CH); m/z (EI) 335.15 
(MH+); HRMS (ES); calc. for C22H24OP (MH+) 335.1557 ; Found 335.1559; 
 
6.2.6 (2-(4-chlorophenyl)-3methylbutyl) diphenylphosphine 
oxide 38 
Using the method described in section 
6.2.5; THF (35 mL) was added to 1-(1-
bromo-3-methylbutan-2-yl)-4-
chlorobenzene 58 (1.45 g, 5.6 mmol). 
                         38 
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Followed by potassium diphenyl phosphide (0.5M solution, 13.4 mL, 6.7 mmol), 
H2O2 30 % w/w (14 mL) was added along with the addition of sat.aq. 
ammonium chloride (20 mL), yielding a  crude compound as a white solid (4 g), 
which was purified by column chromatography  (50 : 50 v/v, petroleum ether : 
ethyl acetate) to yield a pure white solid 38 (2 g, 95%).  
m.p. 162.9-165.4 °C; Vmax(CHCl3)/cm-1 3002 (C-H), 1592 (C=C arom.), 1292 
(P=O), 873 (C-H arom.), 704 (C-Cl); δH ppm (400 MHz.) 0.67 (3H, d, JH = 6.7 
Hz, CH(CH3)2), 0.89 (3H, d, JH = 6.7  Hz, CH(CH3)2), 1.87 (1H, dq, JH = 13.6, 
6.8 Hz, CH(CH3)2), 2.51  (1H, ddd, JH = 15.0, 10.0, JP = 7.5 Hz, CH2), 2.73 (1H, 
td, JH = 15.2, 3.7, JP = 3.8 Hz, CH2), 2.96 (1H, tdd, JH = 13.8, 3.8, JP = 7.4 Hz, 
CH), 6.79-6.87 (2H, m, aromatic-H), 6.88-7.12 (2H, m, aromatic-H), 7.17 (2H, 
td, JH = 7.6, 3.0 Hz, aromatic-H), 7.28-7.56 (6H, m, aromatic-H), 7.63-7.82 (2H, 
m, aromatic-H); δP ppm (400 MHz.) 29.78; δC ppm (125 MHz.) 19.5 (CH3), 20.9 
(CH3), 33.8 (CH(CH3)2), 34.2 (CH2), 45.4 (CH), 127.9-134.6 (aromatic C and 
CH); m/z (EI) 383.3 (MH+); HRMS (ES); calc. for C23H25ClOP (MH+) 383.1235; 
Found 383.1326; 
 
6.2.7 (3,3-dimethyl-2-phenylbutyl)diphenylphosphine  oxide 39 
Using the method described in section 6.2.5; 
THF (10 mL) was added to 3,3-dimethyl-2-
phenylbutyl 4-methylbenzenesulfonate 67 (0.27 
g, 0.81 mmol). Followed by potassium diphenyl 
phosphide (0.5 M solution, 1.95 mL, 0.98 mmol), 
H2O2 30 % w/w (4 mL) was added along with the 
addition of sat.aq. ammonium chloride (30 mL). 
Which was filtered and the solvent was removed in vacuo to yield a  crude 
39 
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compound as a white solid (0.5 g), which was triturated (aided by heat) in 
hexane to give a pure white solid 39 (0.21 g, 72%).  
m.p. 151.3-152.2 °C; Vmax(CHCl3)/cm-1 2961 (C-H), 1538 (C=C arom.), 1130 
(P=O), 842 (C-H arom.); δH ppm (400 MHz.) 0.81 (9H, s, (CH3)3), 2.79 (1H, dd, 
JH = 10.5, 4.5 Hz, PCH2CH), 4.24 (1H, td, JP = 18.9, JH = 4.8 Hz, PCH2), 4.47 
(1H, dt, JP = 9.3, JH = 4.6 Hz, PCH2), 6.98-7.16 (2H, m, aromatic-H), 7.13-7.48 
(11H, m, aromatic-H), 7.50 (2H, ddd, JH = 29.8, 15.6, 14.2 Hz, aromatic-H); δP 
ppm (400 MHz.) 31.78; δC ppm (125 MHz.) 28.5 ((CH3)3), 33.2 (C(CH3)3), 56.8 
(PCH2CH), 65.1 (d, JP = 6.0 Hz, PCH2), 126.5-140.3 (aromatic C and CH); m/z 
(EI) 380 (MH2O+); HRMS (ES); calc. for C24H28O2P (MHO+) 379.1818; Found 
379.1821; 
 
6.2.8 (2-cyclohexylethyl)diphenylphosphine oxide 40 
Using the method described in section 6.2.5; 
THF (40 mL) was added to (2-
bromoethyl)cyclohexane 61 (1 g, 5.6 mmol). 
Followed by potassium diphenyl phosphide 
(0.5 M in THF solution, 12.6 mL, 6.3 mmol), 
H2O2 30 % w/w (40 mL) was added along with 
sat.aq. ammonium chloride (20 mL). The solvent was removed in vacuo to yield 
a crude compound as a white solid (1.7 g), which was purified by column 
chromatography  (20 : 80 v/v, petroleum ether : ethyl acetate) to yield a pure 
white solid 40 (1.4 g, 86 %). 
m.p 93.2-94.2 °C; Vmax(CHCl3)/cm-1 2921(C-H), 1437 (C=C arom.), 1119 (P=O), 
756 (C-H arom.); δH ppm (400 MHz.) 0.73-0.91 (2H, m, cyclo-CH2), 1.01-1.20 
(3H, m, cyclo-CH2), 1.23 (1H, ddd, JH = 14.1, 6.8, 3.3 Hz, cyclo-CH), 1.44-1.51 
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(2H, m, PCH2), 1.56-1.62 (1H, m, cyclo-CH2), 1.66 (4H, m, cyclo-CH2), 2.19-
2.29 (2H, m, PCH2CH2), 7.41-7.51 (6H, m, aromatic-H), 7.68-7.74 (4H, m, 
aromatic-H); δP ppm (400 MHz.) 33.96; δC ppm (125 MHz.) 26.2 (cyclo-CH2), 
26.5 (cyclo-CH2), 26.8 (PCH2CH2), 27.5 (PCH2CH2), 28.5 (cyclo-CH2), 32.8 
(cyclo-CH2), 38.7 (cyclo-CH), 128.6-133.7 (aromatic C and CH);  m/z (EI) 313.2 
(MH+); HRMS (ES); calc. for C20H26OP (MH+) 313.1717; Found 313.1716; 
 
6.2.9 (2-cyclopentyl-2-phenylethyl)diphenylphosphine oxide 41 
Using the method described in section 6.2.5; 
THF (25 mL) was added to (2-bromo-1-
cyclopentylethyl)benzene 59 (1 g, 3.9 mmol). 
Followed by potassium diphenyl phosphide 
(0.5M solution, 9.5 mL, 4.7 mmol), H2O2 30 % 
w/w (9.5 mL) was added along with the 
addition of sat.aq. ammonium chloride (20 
mL). The solvent was removed in vacuo to yield a crude compound as a white 
solid (1.7 g), which was purified by column chromatography  (50 : 50 v/v, 
petroleum ether : ethyl acetate) to yield a pure white solid 41 (1.2 g, 81 %).  
m.p. 193.0-194.2 °C; Vmax(CHCl3)/cm-1 2940 (C-H), 1636 (C=C arom.), 1178 
(P=O), 799 (C-H arom.); δH ppm (400 MHz.) 0.93-1.01 (1H, m, cyclo-CH2), 1.23-
1.32 (3H, m, cyclo-CH2), 1.46-1.49 (3H, m, cyclo-CH2), 1.88-1.91 (1H, m, cyclo-
CH2), 2.18-2.22 (1H, m, cyclo-CH), 2.68 (1H, ddd, JH = 15.1, 9.9, 7.3 cyclo-
CH2), 2.68 (1H, ddd, JH = 15.1, 9.9, JP = 7.3 Hz, CH2), 2.78 (1H, dtd, JH = 15.2, 
3.2, JP = 9.0 Hz, CH2), 3.05 (1H, dtd, JH = 9.8, 3.2, JP = 12.7 Hz, CH), 6.93-7.12 
(5H, m, aromatic-H), 7.13-7.24 (2H, m, aromatic-H), 7.21-7.25 (1H, m, aromatic-
H), 7.26-7.49 (5H, m, aromatic-H), 7.66-7.81 (2H, m, aromatic-H); δP ppm (400 
41 
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MHz.) 29.71; δC ppm (125 MHz.) 25.1 (d, JH = 10.0 Hz, cyclo-CH2), 31.2 (d, JH = 
18.0 Hz, cyclo-CH2), 35.9 (d, JP = 71.2 Hz, CH2), 44.8 (d, JP = 3.6 Hz, CH), 47.6 
(d, JH = 11.5 Hz, cyclo-CH), 126.1-143.8 (aromatic C and CH); m/z (EI) 375.4 
(MH+); HRMS (ES); calc. for C25H28OP (MH+) 375.1868; Found 375.1872 
 
6.2.10 (3,5-difluorophenethyl)diphenylphosphine oxide 42 
A flask was charged with (E)-(3,5-
difluorostyryl)diphenylphosphine oxide 
71 (1 g, 2.94 mmol) and 5% Pd/C (0.2 g, 
0.094 mmol) the flask was evacuated 
and flushed with argon. Anhydrous 
ethanol (100 mL) was added and the 
flask was evacuated and flushed with 
hydrogen. The reaction was stirred for 24 hours at room temperature. On 
completion, monitored by NMR, the mixture was filtered through Celite® and 
washed with dichloromethane (100 mL), the solvent was removed in vacuo to 
yield the title product as an off white solid 42 (0.97 g, 97%). No further 
purification was required.   
m.p. 109.2-110.3 °C; Vmax (CHCl3)/cm-1 2973 (C-H), 1594 (C=C arom.), 1115 
(P=O), 783 (C-H arom.), 703 (C-F); δH ppm (400 MHz.) 2.56-2.67 (2H, m, 
PCH2), 2.94-3.02 (2H, m, PCH2CH2), 6.65-6.78 (3H, m, aromatic-H), 7.52-7.62 
(6H, m, aromatic-H), 7.78-7.89 (4H, m, aromatic-H); δP ppm (400 MHz.) 30.95; 
δF ppm (400 MHz.) 109.92; δC ppm (125 MHz.) 27.5 (d, JP = 2.5 Hz, PCH2CH2), 
31.3 (d, JP = 70.1 Hz, PCH2), 101.8 (t, JP = 25.3 Hz, aromatic-CH), 110.9 (d, JP 
= 11.5 Hz, aromatic-CH), 110.9-164.3 (aromatic C and CH); m/z (EI) 343.4 
(MH+);  HRMS (ES); calc. for C20H1819F2OP (MH+) 343.1058; Found 343.1058; 
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6.2.11 (3,5-dimethoxyphenethyl)diphenylphosphine oxide  43 
Using the method described in 
section 6.2.10; (E)-(3,5-
dimethoxystyryl)diphenylphosphine 
oxide 72 (0.67 g, 1.84 mmol) and 5% 
Pd/C (0.12 g, 0.056 mmol) and 
anhydrous ethanol (100 mL) was 
added.  The solvent was removed in 
vacuo to yield the title product as an 
off white solid 43 (0.67 g, 99 %). No further purification was required.   
m.p. 109.1-110.0 °C; Vmax (CHCl3)/cm-1 2933 (C-H), 1589 (C=C arom.), 1175 
(P=O), 1057 (C-O), 854  (C-H arom.); δH ppm (400 MHz.) 2.50-2.68 (2H, m, 
PCH2), 2.82-2.95 (2H, m, PCH2CH2), 3.77 (6H, s, CH3), 6.32-6.37 (3H, m, 
aromatic-H), 7.52-7.79 (6H, m, aromatic-H), 7.79-7.92 (4H, m, aromatic-H); δP 
ppm (400 MHz.) 31.59; δC ppm (125 MHz.) 27.8 (d, JP = 2.9 Hz, PCH2), 31.8 
(PCH2CH2), 55.3 (CH3), 98.2-160.9 (aromatic C and CH); m/z (EI) 367.4 (MH+); 
HRMS (ES); calc. for C22H24O3P (MH+) 367.1459; Found 367.1458; 
 
6.2.12 2-phenylpropan-1-ol 48 
6.2.12.1 (R)-2-phenylpropan-1-ol  
Lithium aluminium hydride (1 g, 26.6 mmol) was added 
in small portions to THF (100 mL) at 0 °C. Followed 
shortly after by (R)(-)(2)phenylpropionic acid 44 (2 g, 
13.3 mmol) in THF (20 mL), which was added over a 20 minute period. After the 
effervescing had ended, the reaction was refluxed for approximately 4 hours at 
43 
 
48 
 
182 
 
65 °C. After the reaction was completed (monitored by TLC), the grey reaction 
mixture was allowed to cool to room temperature and 15 % w/w NaOH solution 
(1 mL) and H2O (1 mL) was added dropwise. The reaction was allowed to 
continue at room temperature for a further 1 hour, H2O (1 mL) was again added 
dropwise. Once the reaction had turned white, the solution was filtered through 
Celite®, to give a clear filtrate. The filtrate was dried over MgSO4 and the 
solvent was removed in vacuo to yield a crude clear oil 62 (2 g). The crude 
product was purified by column chromatography (90 : 10 v/v, petroleum ether : 
ethyl acetate) to give the title product as a clear oil 48 (1.69 g, 94 %).   
Vmax(CHCl3)/cm-1 3661(OH), 2878 (C-H), 1642 (C=C arom.), 1102 (C-O), 845 
(C-H arom.); δH ppm (400 MHz.) 1.29 (3H, s, CH3), 1.66 (1H, s, OH), 2.96 (1H, 
dd, JH = 13.6, 6.8 Hz, CHCH3), 3.70 (1H, d, JH = 6.4 Hz, CH2), 7.32 (5H, m, 
aromatic-H); δC ppm (125 MHz.) 17.6 (CH3), 42.5 (CHCH3), 68.7 (CH2), 126.7-
143.8 (aromatic C and CH); m/z (EI) 137.1 (MH+); HRMS (ES); calc. for C9H12O 
(MH+) 136.0911 ; Found 136.0933; 
6.2.12.2 (S)-2-phenylpropan-1-ol  
Using the method described in section 6.2.12.1; Lithium aluminium hydride (0.5 
g, 13.3 mmol) was added to THF (50 mL). Followed 
shortly after by (S)(-)(2)phenylpropionic acid 44 (1 g, 
6.7 mmol) in THF (10 mL). The solvent was removed 
in vacuo to yield a crude off white oil (1.3 g). The 
crude product was purified by column 
chromatography (90 : 10 v/v, petroleum ether : ethyl acetate) to give the title 
product as a clear oil 48 (0.90 g, 99 %).  
Vmax(CHCl3)/cm-1 3671 (OH), 2898 (C-H), 1632 (C=C arom.), 1198 (C-O), 812 
(C-H arom.); δH ppm (400 MHz.) 1.19 (3H, s, CH3), 1.89 (1H, s, OH), 3.02 (1H, 
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dd, JH = 13.4, 6.2 Hz, CHCH3), 3.89 (1H, d, JH = 6.2 Hz, CH2), 7.29 (3H, m, 
aromatic-H), 7.52 (2H, m, aromatic-H); δC ppm (125 MHz.) 17.7 (CH3), 42.5 
(CHCH3), 68.7 (CH2), 125.5-143.7 (aromatic C and CH); m/z (EI) 137.1 (MH+); 
HRMS (ES); calc. for C9H12O (MH+) 136.0911 ; Found 136.0933; 
 
6.2.13 2-(4-chlorophenyl)-3-methylbutan-1-ol 50 
Using the method described in section 6.2.12.1; Lithium 
aluminium hydride (2 g, 47 mmol) was added in small 
portions to THF (150 mL). Followed shortly after by 2-(4-
chlorophenyl)-3-methylbutyric acid 46 (5 g, 23 mmol) in 
THF (15 mL). The solvent was removed in vacuo to yield a 
crude yellow solid (4.7 g). The crude product was purified 
by column chromatography (80 : 20 v/v, petroleum ether : 
ethyl acetate) to give the title product as a clear oil 50 (4.33 g, 93 %).  
Vmax(CHCl3)/cm-1 3367 (OH), 2958 (C-H), 1690 (C=C arom.), 1057 (C-O), 817 
(C-H arom.), 765 (C-Cl); δH ppm (400 MHz.) 0.74 (3H, d, JH = 6.7 Hz, 
CH(CH3)2), 1.01 (1H, d, JH = 6.7  Hz, CH(CH3)2), 1.29-1.33 (1H, s, OH), 1.92 
(1H, dt, JH = 13.3, 8.5, 6.7 Hz, CH(CH3)2), 2.50 (1H, td, JH = 8.7, 4.8 Hz, CH), 
3.77-3.84 (1H, m, CH2OH), 3.89-3.95 (1H, m, CH2OH), 7.12-7.16 (2H, m, 
aromatic-H), 7.30-7.33 (2H, m, aromatic-H); δC ppm (125 MHz.) 20.9 (CH3), 
30.0 (CH(CH3)2), 55.1 (CH), 65.1 (CH2), 127.8-140.4 (aromatic C and CH); m/z 
(EI) 216.0 (MH+NH4+); HRMS (ES); calc. for C11H19ONCl (MH+) 216.1150; 
Found 216.1147; 
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6.2.14  2-cyclopentyl-2-phenylethanol 51 
Using the method described in section 6.2.12.1; Lithium 
aluminium hydride (2 g, 48.9 mmol) was added in small 
portions to THF (150 mL). Followed shortly after by 
cyclopentylphenylacetic acid 47 (5 g, 24.5 mmol) in THF 
(15 mL). The solvent was removed in vacuo to yield a 
crude yellow solid (4.8 g). The crude product was purified by column 
chromatography (80 : 20 v/v, petroleum ether : ethyl acetate) to give the title 
product as a clear oil 51 (4.1 g, 88 %) 142 
Vmax(CHCl3)/cm-1 3358 (OH), 2950 (C-H), 1651(C=C arom.), 1052  (C-O), 823 
(C-H arom.); δH ppm (400 MHz.) 0.98-1.07 (1H, m, cyclo-CH2), 1.28 (2H, ddd, 
JH = 9.1, 4.2, 2.4  Hz, cyclo-CH2), 1.39-1.47 (2H, m, cyclo-CH2 and OH), 1.52-
1.61 (2H, m, cyclo-CH2), 1.64-1.74 (1H, m, cyclo-CH2), 1.93 (1H, dtd, JH = 11.3, 
7.4, 3.7  Hz, cyclo-CH2), 2.02-2.14 (1H, m, cyclo-CH), 2.57 (1H, m, CH), 3.77 
(1H, dd, JH = 10.6, 9.4  Hz, CH2), 3.91 (1H, dd, JH = 10.8, 4.1 Hz, CH2), 7.26 
(3H, ddd, JH = 15.2, 5.7, 2.4  Hz, aromatic-H), 7.32-7.35 (2H, m, aromatic-H); δC 
ppm (400 MHz.) 24.5 (cyclo-CH2), 25.4 (cyclo-CH2), 31.4 (cyclo-CH2), 31.8 
(cyclo-CH2), 42.4 (cyclo-CH), 54.9 (CH), 66.7 (CH2), 126.7-142.6 (aromatic C 
and CH);  m/z (EI) 191 (MH+), 381.4 (2MH+);  
6.2.15 2-phenylbutyl 4-methylbenzenesulfonate 53 
2-phenylbutan-1-ol 49 (4.45 g, 29.6 
mmol) was dissolved in dry pyridine 
(50 mL) and cooled to 0 °C, solid p-
toluenesulfonyl  chloride (11.2 g, 
59.3 mmol) was added. at such a 
rate as to maintain the reaction temperature below 4 °C. Stirring continued for 
51 
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30 minutes and then the reaction mixture was left without stirring in a cold 
room/fridge for 6 days. It was carefully poured into hydrochloric acid (3 M 
solution, 30 mL) with rapid stirring, diethyl ether was added and the organic 
phase was separated. The aqueous phase was extracted with ether (2 x 10 mL) 
and the combined organic phases were washed repeatedly with ice-cold 
hydrochloric acid (3 M) until the water phase remained acidic. The organic 
phase was then washed with distilled water, NaHCO3 (0.5 M), brine, dried over 
MgSO4 and filtered. The diethyl ether was evaporated, leaving white solid 53 
(8.5 g, 94 %), (stored at 0 °C), which was then used in the next step without 
further purification.  
m.p. 141.2-143.0 °C; (no lit. m.p.) Vmax(CHCl3)/cm-1 2976 (C-H), 1602 (C=C 
arom.), 1350 (SO2), 1170 (C-O), 732 (C-H arom.); δH ppm (400 MHz.) 0.62 (3H, 
t, JH = 7.4 Hz, CH2CH3), 1.40 (1H, ddq, JH = 14.6, 9.5, 7.3 Hz, CH2CH3), 1.60-
1.71 (1H, m, CH2CH3), 2.24 (3H, s, Ar-CH3), 2.62-2.71 (1H, m, CHCH2CH3), 
3.93-4.21 (2H, m, OCH2), 6.92-7.01 (2H, m, aromatic-H), 7.03-7.35 (5H, m, 
aromatic-H), 7.51 (2H, d, JH = 8.3 Hz, aromatic-H); δC ppm (125 MHz.) 11.6 
(CH2CH3), 21.6 (Ar-CH3), 24.8 (CH2CH3), 46.8 (CH), 73.8 (OCH2), 126.9-144.7 
(aromatic C and CH); m/z (EI) 305 (M+1), 
 
6.2.16 2-(4-chlorophenyl)-3-methylbutyl 4-methyl benzene 
sulfonate 54 
Using the method described 
in section 6.2.15.1; 2-(4-
chlorophenyl)-3-methylbutan-
1-ol 50 (4.1 g, 20.6 mmol) 
                                      54 
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was dissolved in dry pyridine (35 mL). Solid p-toluenesulfonyl  chloride (7.8 g, 
40 mmol) was added. The solvent was removed leaving a white solid 54 (6.8 g, 
94 %), (stored at 0 °C) and used in the next step without further purification. 
m.p. 96.3-97.4 °C; Vmax(CHCl3)/cm-1 2965 (C-H), 1592 (C=C arom.), 1355 (SO2), 
1181 (C-O), 961 (C-H arom.), 709 (C-Cl); δH ppm (400 MHz.) 0.70 (3H, d, JH = 
6.7 Hz, CH(CH3)2), 0.95 (3H, d, JH = 6.7  Hz, CH(CH3)2), 1.86-2.01 (1H, ddq, JH 
= 6.8, 1.6 Hz, CH(CH3)2), 2.45 (3H, d, JH = 6.0 Hz, Ar-CH3), 2.60 (1H, td, JH = 
8.2, 4.9, 1.6 Hz, CH), 4.18 (1H, dd, JH = 9.7, 8.0 Hz, CH2O-), 4.30 (1H, dd, JH = 
9.7, 4.8 Hz, CH2O-), 6.94-7.11 (1H, m, aromatic-H), 7.16-7.21 (1H, m, aromatic-
H), 7.28 (1H, d, JH = 4.2 Hz, aromatic-H), 7.33  (2H, ddd, JH = 7.6, 4.5, 1.3 Hz, 
aromatic-H), 7.58 (1H, d, JH = 8.3 Hz, aromatic-H), 7.72 (1H, tt, JH = 7.6, 1.7 Hz, 
aromatic-H), 8.65 (1H, d, JH = 4.2 Hz, aromatic-H); δC ppm (125 MHz.) 20.5 
(CH3), 21.6 (Ar-CH3), 29.6 (CH(CH3)2), 51.3 (CH), 71.9 (CH2), 123.9-149.5 
(aromatic C and CH); m/z (EI) 180 (MH+-OTs);  
 
6.2.17 2-cyclopentyl-2-phenylethyl 4- methylbenzenesulfonate 
55 
Using the method described in 
section 6.2.15.1; 2-cyclopentyl-2-
phenylethanol 51 (2.14 g, 11.2 
mmol) was dissolved in dry 
pyridine (25 mL). Solid p-
toluenesulfonyl  chloride (4.24 g, 
22.2 mmol) was added. The solvent was removed leaving white solid 69 (3.6 g, 
95%), (stored at 0 °C), which was then used in the next step without further 
purification. 
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m.p. 111.9-112.2 °C; Vmax(CHCl3)/cm-1 2952 (C-H), 1665 (C=C arom.), 1357 
(SO2), 1195 (C-O), 843 (C-H arom.); δH ppm (400 MHz.) 0.73-0.82 (1H, m, 
cyclo-CH2), 1.02 (1H, dq, JH = 12.2, 8.9 Hz, cyclo-CH2), 1.15-1.21 (2H, m, 
cyclo-CH2), 1.26-1.30 (2H, m, cyclo-CH2), 1.40-1.52 (1H, m, cyclo-CH2), 1.62-
1.72 (1H, m, cyclo-CH2), 1.83-1.91 (1H, m, cyclo-CH), 2.19 (3H, s, Ar-CH3), 
2.50 (1H, ddd, JH = 10.3, 8.0, 4.5 Hz, CH), 4.03 (1H, dd, JH = 9.6, 8.0 Hz, CH2), 
4.16 (1H, dd, JH = 9.7, 4.5 Hz, CH2), 6.90 (2H, dd, JH = 7.6, 1.7 Hz, aromatic H), 
7.00-7.07 (4H, m, aromatic H), 7.39-7.46 (2H, m, aromatic H), 8.41-8.46 (1H, m, 
aromatic H); δC ppm (125 MHz.) 21.3 (Ar-CH3), 24.8 (d, JH = 83.5 Hz, cyclo-
CH2), 31.3 (dd, JH = 35.1, 16.3 Hz, cyclo-CH2), 42.1 (d, JH = 16.0 Hz, cyclo-CH), 
50.9 (CH), 73.5 (OCH2), 123.7-149.5 (aromatic C and CH); m/z (EI) 172 (MH+-
OTs), 345 (MH+); 
 
6.2.18 (1-bromobutan-2-yl)benzene 57 
LiBr (4.9 g, 55.9 mmol) was dissolved in dry acetone 
(60 mL) and 2-phenylbutyl 4-methylbenzenesulfonate 
53 (8.5 g, 27.9 mmol) was then added. was then added 
to the reaction mixture. The reaction was then heated at 
50 °C in the dark for 20 hours. After completion 
(monitored by TLC), the mixture was allowed to cool to room temperature and 
the solid contained within the reaction mixture was removed by filtration. The 
acetone was removed in vacuo, and the residue was partitioned between 
diethyl ether and distilled water. The phases were separated and the aqueous 
phase was extracted with diethyl ether (3 x 10 mL) and the organic layers were 
combined and washed with brine (3 x 10 mL) and dried with MgSO4, filtered. 
The solvent was removed under reduced pressure to give a crude brown oil (6 
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g). The crude compound was purified by column chromatography (96 : 5 
petroleum ether  : ethyl acetate) to yield a colourless oil 57 (3.4 g, 58 %). 
Vmax(CHCl3)/cm-1 2962 (C-H), 1552 (C=C arom.), 811 (C-H arom.), 663 (C-Br); 
δH ppm (400 MHz.) 0.73 (3H, td, JH = 7.4, 0.9 Hz, CH2CH3), 1.48-4.61 (1H, m, 
CH2CH3), 1.82-1.94 (1H, m, CH2CH3), 2.76 (1H, dt, JH = 12.3, 6.8 Hz, 
CHCH2CH3), 3.46 (2H, dd, JH = 7.5, 6.8 Hz, CH2), 7.08 (2H, d, JH = 7.9 Hz, 
aromatic-H), 7.13-7.22 (1H, m, aromatic-H), 7.23-7.45 (2H, dd, JH = 11.2, 4.2 
Hz, aromatic-H); δC ppm (400 MHz.) 11.9 (CH2CH3), 27.2 (CH2CH3), 38.7 (JH = 
80.1 Hz, CH2), 49.9 (CH), 127.0-142.3 (aromatic C and CH); m/z (EI) 213 
(MH+); 
 
6.2.19 1-(1-bromo-3-methylbutan-2-yl)-4-chlorobenzene 58 
Using the method described in section 6.2.18.1; 
LiBr (3.35 g, 38.6 mmol) was dissolved in dry 
acetone (50 mL) and 2-cyclopentyl-2-phenylethyl 
4-methylbenzenesulfonate 54 (6.8 g, 19.3 mmol) 
was then added. The solvent was removed under 
reduced pressure to give a crude brown oil (6 g). The crude compound was 
purified by column chromatography (95 : 5 v/v, petroleum ether : ethyl acetate) 
to yield a colourless oil 58 (4.3 g, 87%). 
Vmax(CHCl3)/cm-1 2961 (C-H), 1607 (C=C arom.), 816 (C-H arom.), 732 (C-Br), 
702 (C-Cl); δH ppm (400 MHz.) 0.67 (3H, d, JH = 6.8 Hz, CH(CH3)2), 0.88 (3H, d, 
JH = 6.7  Hz, CH(CH3)2), 1.94 (1H, tt, JH = 13.5, 6.7 Hz, CH(CH3)2), 2.60  (1H, 
td, JH = 8.3, 4.7 Hz, CH), 3.50 (1H, dd, JH = 10.0, 8.8 Hz, CH2), 3.64 (1H, dd, JH 
= 10.2, 4.7 Hz, CH2), 6.97-7.13 (2H, m, aromatic-H), 7.17-7.28 (2H, m, 
aromatic-H); δC ppm (125 MHz.) 20.2 (CH3), 20.9 (CH3), 31.8 (CH(CH3)2), 36.9 
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(CH2), 54.2 (CH), 128.4-140.0 (aromatic C and CH);  m/z (EI) 181 (MH+-Br),  
261 (MH+);  
 
6.2.20 (2-bromo-1-cyclopentylethyl)benzene 59 
Using the method described in section 6.2.18.1; LiBr 
(1.81 g, 20.9 mmol) was dissolved in dry acetone (25 
mL) and 2-cyclopentyl-2-phenylethyl 4-
methylbenzenesulfonate 55 (3.6 g, 10.45 mmol) was 
then added. The solvent was removed under reduced 
pressure to give a crude brown oil (2.5 g, 96%). The 
crude compound was purified by column chromatography (95 : 5 v/v, petroleum 
ether : ethyl acetate) to yield a colourless oil 59 (1.9 g, 74%) 132.  
Vmax(CHCl3)/cm-1 2952 (C-H), 1601 (C=C arom.), 821 (C-H arom.), 672 (C-Br); 
δH ppm (400 MHz.) 0.88-0.91 (1H, m, cyclo-CH2), 1.16 (1H, ddd, JH = 18.2, 
11.1, 5.9 Hz, cyclo-CH2), 1.27-1.37 (2H, m, cyclo-CH2), 1.41-1.51 (2H, m, cyclo-
CH2), 1.55-1.79 (1H, m, cyclo-CH2), 1.80-1.89 (1H, m, cyclo-CH2), 2.00-2.41 
(1H, m, cyclo-CH), 2.64 (1H, td, JH = 9.6, 3.8 Hz, CH), 3.51 (1H, t, JH = 9.6 Hz, 
CH2), 3.68 (1H, dd, JH = 10.0, 3.8 Hz, CH2), 7.1 (2H, d, JH = 7.8 Hz, aromatic-
H), 7.16 (1H, dd, JH = 8.1, 1.5 Hz, aromatic-H), 7.23 (2H, t, JH = 7.6 Hz, 
aromatic-H); δC ppm (125 MHz.) 25.1 (d, JH = 55.3 Hz, cyclo-CH2), 31.6 (d, JH = 
41.6 Hz, cyclo-CH2), 38.6 (CH2), 44.7 (cyclo-CH), 54.1 (CH), 126.8-142.7 
(aromatic C and CH); m/z (EI) 173 (MH+-Br), 253 (MH+);  
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6.2.21 2-(tert-butyl)-2-phenyloxirane 63  
(3,3-dimethylbut-1-en-2-yl)benzene 64 (0.4 g, 2.49 mmol) 
was added to DCM (20 mL) at 0 °C. Followed directly 
after by MgSO4 (1.5 g) and MCPBA (1.12 g, 4.99 mmol) 
portion wise. After 10 minutes at 0 °C, the reaction was 
warmed to room temperature and was stirred for 2 days at 
this temperature. On completion (monitored by TLC), the reaction was cooled to 
0 °C  and slow addition of sat. sodium thiosulfate (25 mL) until no further heat 
was produced. The mixture was extracted with dichloromethane (2 x 25 mL) 
and the organic layer was washed with brine (2 x 25 mL). The organic layer was 
dried, filtered and solvent was removed in vacuo to yield a yellow oil 63 (0.5 g). 
The oil was used without further purification.  
Vmax(CHCl3)/cm-1 2959 (C-H), 1720 (C=C arom.), 1102 (C-O), 880 (C-H arom.); 
δH ppm (400 MHz.) 0.86 (9H, s, (CH3)3), 2.50 (1H, d, JH = 5.1 Hz, CH2), 2.96 
(1H, d, JH = 5.1 Hz, CH2), 7.15-7.22 (3H, m, aromatic-H), 7.24-7.35 (2H, m, 
aromatic-H); δC ppm (125 MHz.) 26.4 ((CH3)3), 33.8 (C(CH3)3), 50.8 (CH2), 66.8 
(CCH2), 127.3-139.5 (aromatic C and CH); m/z (EI) 159.3, 177.3 (MH+); HRMS 
(ES); calc. for C12H17O (MH+) 177.1274; Found 177.1272; 
 
6.2.22 (3,3-dimethylbut-1-en-2-yl)benzene 64  
Potassium tert butoxide (8.25 g, 73.7 mmol) and 
methyl triphenylphosphonium bromide (26.4 g, 73.7 
mmol) were added to dry THF (150 mL). The reaction 
mixture was allowed to stir for 1 hours, were the 
reaction changed from yellow to orange in colour, after 
which 2,2-dimethyl-1-phenylpropan-1-one 62 (3 g, 18 mmol) was added. After 
63 
 
64 
 
191 
 
stirring for 18 hours, diethyl ether (50 mL) was added and the precipitate was 
filtered. The organic extract was washed with water (10 mL), brine (50 mL) and 
dried over MgSO4 and the solvent was removed in vacuo to give a crude brown 
solid (3.5 g). The crude was purified by column chromatography (100 v/v, 
petroleum ether), Rf 0.9, to remove triphenylphosphine oxide, to give the title 
product  as a clear oil 64 (2.7 g, 91%) 143. 
Vmax(CHCl3)/cm-1 2956 (C-H), 1626 (C=C), 1592 (C=C arom.), 805 (C-H arom.); 
δH ppm (400 MHz.) 1.22 (9H, s, (CH3)3), 4.87 (1H, d, JH = 2.2 Hz, =CH2), 5.27 
(1H, dd, JH = 2.2, 1.3 Hz, =CH2), 7.23-7.31 (2H, m, aromatic-H), 7.36-7.41 (3H, 
m, aromatic-H); δC ppm (125 MHz.) 29.7 ((CH3)3), 36.2 (C(CH3)3), 111.6 (=CH2), 
126.3-129.1 (aromatic C and CH), 143.5 (C=CH2), 159.8 (aromatic-C); m/z (EI) 
161.1 (MH+); HRMS (ES); calc. for C12H17 (MH+) 160.1274; Found 160.1270; 
 
6.2.23 3,3-dimethyl-2-phenylbutan-1-ol 65 
6.2.23.1 Method A:  
To a solution of (3,3-dimethylbut-1-en-2-yl)benzene 64 
(0.5 g, 3.12 mmol) in dry THF (30 mL), borane-THF 
complex (1 M solution in THF, 10.9 mL, 10.9 mmol) was 
added at 0 °C, over a 15 minute period under an argon 
atmosphere. The reaction mixture was stirred at room 
temperature for 1 hour, then warmed to reflux (65 °C) and 
stirred for an additional 14 hours. To the reaction mixture NaOH (2 M, 30 mL) 
was added and H2O2 30% w/w (30 mL) at 0 °C, then stirring continued at room 
temperature for 18 hours. THF was removed in vacuo and the aqueous layer 
was extracted with ether (3 x 10 mL), the organic layer was washed with brine 
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and dried over MgSO4, filtered and the solvent was evaporated under reduced 
pressure to give a white solid (0.80 g). The white solid was separated by 
column chromatography (80 : 20 v/v,  petroleum ether : ethyl acetate) to yield 
the title compound 65 (0.52 g, 95 %).  
6.2.23.2 Method B;  
A flask was charged with 2-(tert-butyl)-2-phenyloxirane 63 (0.5 g, 2.83 mmol), 
acetic acid (0.5 mL) and 10% Pd/C (0.05 g), the flask was evacuated and 
flushed with dry argon. Anhydrous ethyl acetate (8 mL) was added and the flask 
was evacuated and flushed with hydrogen. The reaction was stirred for 7 days 
at room temperature. On completion, monitored by NMR, the mixture was 
filtered through Celite® and washed with dichloromethane (100 mL), the solvent 
was removed in vacuo to yield the title product as an off white solid 65 (0.1 g, 
20 %). No further purification was required 104.   
m.p. 80.7-82 °C; m.p. lit 74-75 °C; Vmax(CHCl3)/cm-1 3303 (OH), 1558 (C=C 
arom.), 1265 (C-O), 789 (C-H arom.); δH ppm (400 MHz.) 0.92 (9H, s, (CH3)3), 
1.14-1.16 (1H, m, OH), 2.71 (1H, dd, JH = 8.8, 6.6 Hz, CH), 4.04 (2H, dd, JH = 
8.9, 4.5 Hz, CH2), 7.31-7.42 (5H, m, aromatic-H); δC ppm (125 MHz.) 28.5 
((CH3)3), 33.1 (C(CH3)3), 59.0 (CH), 62.6 (CH2), 126.8-140.1 (aromatic C and 
CH); m/z (EI) 196.38  (MNH4+); HRMS (ES); calc. for C12H19 (MH+) 196.1694; 
Found 196.1696; 
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6.2.24 3,3-dimethyl-2-phenylbutyl 4- methylbenzenesulfonate 
66 
Using the method described in 
section 6.2.15.1; 3,3-dimethyl-2-
phenylbutan-1-ol 65 (0.5 g, 2.8 
mmol) was dissolved in dry 
pyridine (25 mL). Solid p-
toluenesulfonyl  chloride (1.05 g, 5.6 mmol) was added. The solvent was 
removed leaving white solid 66 (0.89 g, 96 %), (stored at 0 °C), which was then 
used in the next step without further purification. 
m.p. 87.3-87.9°C; Vmax(CHCl3)/cm-1 2964 (C-H), 1647 (C=C arom.), 1343 (SO2), 
1170 (C-O), 870 (C-H arom.); δH ppm (400 MHz.) 0.79 (9H, s, (CH3)3), 2.37 (1H, 
s, CH3), 2.67 (1H, dd, JH = 10.0, 4.4 Hz, CH), 4.27 (1H, t, JH = 9.9 Hz, CH2), 
4.45 (1H, dd, JH = 9.8, 4.4 Hz, CH2), 6.89-6.91 (2H, m, aromatic-H), 7.11 (2H, 
m, aromatic-H), 7.17 (1H, m, aromatic-H), 7.34 (1H, m, aromatic-H), 7.48 (2H, 
m, aromatic-H), 7.86 (1H, m, aromatic-H); δC ppm (125 MHz.) 21.7 (CH3), 28.3 
((CH3)3), 33.3 (C(CH3)3), 54.9 (CH), 70.9 (CH2), 126.6-144.5 (aromatic C and 
CH); m/z (EI) 362 (MC2H5+); HRMS (ES); calc. for C19H25O3S (MNH4+) 
350.1784; Found 350.1784; 
 
6.2.25 (1-bromo-3,3-dimethylbutan-2-yl)benzene 67 
Using the method described in section 6.2.18.1; LiBr 
(0.93 g, 10.7 mmol) was dissolved in dry acetone (35 
mL) and 3,3-dimethyl-2-phenylbutyl 4-
methylbenzenesulfonate 66 (0.89 g, 2.66 mmol) was 
67 
 
194 
 
then added. The solvent was removed under reduced pressure to give a crude 
brown oil (1 g). The crude compound was purified by column chromatography 
(95 : 5 v/v, petroleum ether : ethyl acetate) to yield a brown oil 67 (0.07 g, 12%). 
Vmax(CHCl3)/cm-1 2959 (C-H), 1609 (C=C arom.) 876 (C-H arom.), 724 (C-Br); δH 
ppm (400 MHz.) 0.83 (9H, s, (CH3)3), 2.76  (1H, dd, JH = 12.1, 3.5 Hz, CH), 3.63 
(1H, dd, JH = 12.1, 10.1 Hz, CH2), 3.85 (1H, dd, JH = 10.1, 3.5 Hz, CH2), 7.07-
7.11 (2H, m, aromatic-H), 7.17-7.26 (3H, m, aromatic-H); δC ppm (125 MHz.) 
28.4 ((CH3)3), 34.5 (CH2), 35.2 (C(CH3)3), 59.2 (CH), 126.9-140.3 (aromatic C 
and CH); 
 
6.2.26 (2R*, 3R*) and (2R*, 3S*)-(1-hydroxy-1-(naphthalen-1-
yl)propan-2-yl)diphenylphosphine oxide  
LDA (1.8 M solution in THF, 3.25 mL, 6.5 
mmol) was added drop wise to a stirred 
solution of phosphine oxide (0.5 g, 2.17 
mmol) in THF (15 mL) at -78 °C for 2 hours, 
under an argon atmosphere. After this time 
1-naphthaldehyde 28 (0.93 mL, 1.07 g, 6.5 
mmol), was added drop wise to the resulting 
orange/red solution and it was left to stir at this temperature for a further 4 
hours. After this time saturated ammonium chloride (15 mL) was added, were 
the solution turned clear, here it was allowed to warm up to room temperature. 
THF was removed in situ and the residue was dissolved in dichloromethane and 
water (1 : 1 v/v, 200 mL). The organic layer was combined, dried and filtered to 
yield a yellow oil (1 g), this was purified by flash column chromatography (50 : 
50 v/v, petroleum ether : ethyl acetate), were all relevant fractions were 
2,3-syn 73a; 2,3-anti 73b 
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collected to give a mixture of diastereoisomers as a white solid (0.6 g, 71%). 
The diastereoisomers were separated by column or preparative thin layer 
chromatography (70 : 30 v/v, petroleum ether : ethyl acetate), followed by 
recrystallization techniques (1 : 1 v/v, toluene : hexane).  
 
(2R*, 3R*)-(1-hydroxy-1-(naphthalen-1-yl)propan-2-yl)diphenylphosphine 
oxide 73a; m.p. 123.2-124.2 °C; Vmax(CHCl3)/cm-1 3264 (OH), 2934 (C-H), 1638 
(C=C arom.), 1132 (P=O), 1156 (C-O), 811 (C-H arom.); δH ppm (400 MHz.) 
0.92 (3H, dd, JH = 7.5, JP = 17.0 Hz,  CH3), 3.17 (1H, ddq, JH = 7.2, <1.0, JP = 
9.4 Hz, PCH), 5.65 (1H, dd, JH = 7.5, JP = 14.9 Hz,  CHOH), 5.69 (1H, d, JH = 
3.5 Hz, CHOH), 7.27 (3H, d, JH = 10.0, 5.3 Hz,  aromatic-H), 7.37-7.49 (6H, m, 
aromatic-H), 7.53-7.69 (4H, m, aromatic-H), 7.71-7.79 (3H, m, aromatic-H),  
8.03-8.15 (1H, m, aromatic-H); δP ppm (400 MHz.) 41.68; δC ppm (125 MHz.) 
13.7 (CH3), 37.9 (JP = 68.6 Hz, PCH), 73.9 (CHOH), 121.8-136.8 (aromatic C 
and CH); m/z (EI) 387.3 (MH+); HRMS (ES); calc. for C25H24O2P (MH+) 
387.1505; Found 387.1508; 
 
(2R*, 3S*)-(1-hydroxy-1-(naphthalen-1-yl)propan-2-yl)diphenylphosphine 
oxide 73b; m.p. 164-165.2 °C; Vmax(CHCl3)/cm-1 3264 (OH), 2934 (C-H), 1638 
(C=C arom.), 1156 (P=O), 1003 (C-O), 707 (C-H arom.); δH ppm (400 MHz.) 
1.05 (3H, dd, JH = 7.4, JP = 16.7 Hz,  CH3), 2.58 (1H, dq, JH = 7.2, 1.0, JP = 13.5 
Hz, PCH), 4.82 (1H, s, CHOH),  5.98 (1H, d, JH = 9.7 Hz, CHOH), 7.02 (1H, d, 
JH = 8.6 Hz,  aromatic-H), 7.19-7.39 (1H, m, aromatic-H), 7.41-7.51 (1H, dd, JH 
= 11.1, 4.0 Hz, aromatic-H), 7.55-7.61 (4H, m, aromatic-H), 7.62-7.77 (3H, m, 
aromatic-H), 7.75 (1H, d, JH = 8.1 Hz, aromatic-H), 7.79-8.11 (4H, m, aromatic-
H), 8.13-8.17 (2H, m, aromatic-H); δP ppm (400 MHz.) 39.91; δC ppm (125 
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MHz.) 5.9 (CH3), 37.4 (d, JP = 68.1 Hz, PCH), 67.1 (d, JP = 2.3 Hz, CHOH), 
121.9-136.4 (aromatic C and CH); m/z (EI) 387.3 (MH+); HRMS (ES); calc. for 
C25H24O2P (MH+) 387.1505; Found 387.1508; 
 
6.2.27 (2R*, 3R*) and (2R*, 3S*)-(1-hydroxy-1-(naphthalen-1-yl)-
3-phenylpropan-2-yl)diphenylphosphine oxide  
PhLi (1.8 M solution in THF, 2.7 mL, 4.9 
mmol) was added drop wise to a stirred 
solution of phosphine oxide (0.5 g, 1.6 mmol) 
in THF (35 mL) at -72 °C, under an argon 
atmosphere. The resulting red solution was 
stirred for 30 minutes at this temperature. 
After this time 1-naphthaldehyde 28 (0.69 
mL, 0.76 g, 4.9 mmol), was added drop wise 
and was left to stir at this temperature for a further 2 hours. After these 2 hours 
further PhLi (1.8 M solution in THF, 2.7 mL, 4.9 mmol) was added to the 
reaction at -78 °C, the reaction. After 3 hours the reaction was warmed to RT 
and left stirring for 12 hours, sat. aq. ammonium chloride (15 mL) was added, 
the solution turned clear. THF was removed in situ and the residue was 
dissolved in dichloromethane and water (1 : 1 v/v, 50 mL). The organic layer 
was combined, dried and filtered to yield orange oil (1 g), this was purified by 
flash column chromatography (50 : 50 v/v, petroleum ether : ethyl acetate) 
collecting all relevant fractions, to afford a mixture of both diastereoisomers 
(0.68 g, 91 %). The white solid was further purified using a combination of 
column and preparative chromatography to separate out the 2 diastereoisomers 
(50 : 50 v/v, petroleum ether : ethyl acetate). The first eluted was dried in vacuo 
2,3-syn 74a; 2,3-anti 74b 
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to give 74b (0.262 g, 39 %), Rf 0.50, followed directly after by 74a (0.012 g, 
2%), Rf 0.48 and further purified by recrystallization (1:1 v/v, toluene : hexane).   
 
(2R*,3R*)-(1-hydroxy-1-(naphthalen-1-yl)-3-phenylpropan-2-yl) 
diphenylphosphine oxide 74a; m.p. 191-192 °C; Vmax(CHCl3)/cm-1 3358 (OH), 
1436 (C-H), 1620 (C=C arom.), 1123 (C-O), 854 (P=O), 765 (C-H arom.); δH 
ppm (400 MHz.) 2.65 (1H, dtd, JH = 13.5, 2.8, JP = 8.6 Hz, CH2Ph), 3.08 (1H, 
ddt, JH = 11.9, 2.4,  JP = 7  Hz, PCH), 3.32 (1H, td, JH = 12.1, 1.6, JP = 4.9 Hz, 
CH2Ph), 5.57 (1H, ddd, JH = 10.1, 2.1 Hz, JP = 26.6 Hz  CHOH), 6.10 (1H, d, JH 
= 9.8 Hz, OH), 6.76 (2H, td, JH = 7.7, 3.0 Hz, aromatic-H), 6.81 (2H, d, JH = 11.6 
Hz, aromatic-H), 6.92 (2H, JH = 11.4, 7.2 Hz, aromatic-H), 6.99 (1H, dd, JH = 
7.5, 6.2 Hz, aromatic-H), 7.11-7.25 (2H, m, aromatic-H), 7.27 (4H, dt, JH = 10.3, 
7.0 Hz, aromatic-H), 7.31-7.51 (4H, m, aromatic-H), 7.52-7.63 (5H, m, aromatic-
H); δP ppm (400 MHz.) 40.01; δC ppm (125 MHz.) 32.3 (CH2Ph), 41.8 (d, JP = 
66.1 Hz, PCH), 69.8 (d, JP = 6 Hz, CHOH), 121.8-137.5 (aromatic C and CH); 
m/z (EI); 445.3 (MH+-OH), 463.17 (MH+); HRMS (ES); calc. for C31H28O2P  
(MH+) 463.1814; Found 463.1821; 
 
(2R*,3S*)-(1-hydroxy-1-(naphthalen-1-yl)-3-phenylpropan-2-yl) 
diphenylphosphine oxide 74b; m.p. 170-172 °C; Vmax(CHCl3)/cm-1 3358 (OH), 
2777 (C-H), 1663 (C=C arom.), 1336 (P=O), 1162 (C-O), 843 (C-H arom.); δH 
ppm (400 MHz.) 2.74-2.87 (2H, m, CH2Ph, PCH), 3.20 (1H, dd, JH = 19.4, 5.8, 
JP = 13.2 Hz, CH2Ph), 5.17 (1H, s, OH), 5.70 (2H, JP = 7.5 Hz, aromatic-H), 
5.94 (1H, d, JH = 9.9 Hz, CHOH), 6.57 (2H, t, JH = 7.6 Hz, aromatic-H), 6.72 
(1H, t, JH = 7.4 Hz,  aromatic-H), 6.99 (1H, d, JH = 8.5 Hz, aromatic-H), 7.14-
7.22 (3H, m, aromatic-H), 7.29-7.41 (3H, m, aromatic-H), 7.46-7.51 (2H, m, 
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aromatic-H), 7.55-7.61 (3H, m, aromatic-H), 7.68 (1H, d, JH = 8.1 Hz, aromatic-
H), 7.82 (2H, dd, JH = 15.4, 7.7 Hz, aromatic-H), 7.98-8.10 (2H, m, aromatic-H); 
δP ppm (400 MHz.) 39.50; δC ppm (125 MHz.) 45.4 (CH2Ph), 45.4 (d, JP = 66.2 
Hz, PCH), 67.8 (d, JP = 2.2 Hz, CHOH ), 121.8-140.7 (aromatic C and CH); m/z 
(EI); 445.3 (MH+-OH), 463.17 (MH+); HRMS (ES); calc. for C31H28O2P  (MH+) 
463.1814; Found 463.1821; 
 
6.2.28 (E)-1-(3-phenylprop-1-en-1-yl)naphthalene 75b 
Potassium bis(trimethylsilyl)amide solution 
(0.5 M solution in THF, 0.649 mL, 0.32 
mmol) was added to a solution of (2R*, 3S*)-
(1-hydroxy-1-(naphthalen-1-yl)-3-
phenylpropan-2-yl)diphenylphosphine oxide 
74b (0.05 g, 0.1 mmol) in THF (5 mL) under 
argon conditions, upon which the reaction turned peach in colour. The reaction 
was stirred for 8 hours at RT, and then at 50 °C overnight. After the stated time, 
the reaction was complete (monitored by TLC). The mixture was partitioned 
between dichloromethane and brine (1 : 1 v/v). The organic layer was then 
dried over MgSO4, filtered and the solvent was removed in vacuo to give a 
residue (0.029g). Further purification via column chromatography (90 : 10 v/v, 
petroleum ether : ethyl acetate) gave the title compound as a colourless gum 
75b (0.011 g, 37.9 %).The title products could not be isolated in high purity to 
fully characterise, but the double bond peaks could be observed, showing; 5.97 
(1H, t, JH = 11.1 Hz, CH=CH(Naph)), 6.15 (1H,  d, JH = 10.9 Hz, 
CH=CH(Naph)); 
75b 
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6.2.29 (1R*, 2R*, 3R*) and (1R*, 2R*, 3S*)-(1-hydroxy-1-
(naphthalen-1-yl)-3-phenylpentan-2-yl)diphenylphosphine oxide  
Using the method described in section 
6.2.26; LDA (2 M solution in THF, 2.3 mL, 
4.5  mmol) was added to a stirred solution of 
phosphine oxide 37 (0.5 g, 1.5 mmol) in THF 
(30 mL). After this time 1-naphthaldehyde 
(0.64 mL, 0.7 g, 4.5 mmol), was added The 
organic layer was combined, dried and 
filtered to yield a yellow oil (0.8 g), which was 
purified by column chromatography (70 : 30, 
petroleum ether : ethyl acetate) to give a 
yellow solid (0.5 g, 68 %). This was purified further to separate out the 
diastereoisomers, the samples (0.1 g) were dissolved in 1 : 1 v/v, MeOH : 
DMSO (1 mL) and purified by Open Access Mass Directed Auto Prep on 
Sunfire C18 column using Acetonitrile Water with a Formic acid modifier. The 
gradient employed was method E, selected from 5 pre-set methods (A, B, C, D 
or E). The solvent was removed under a stream of nitrogen in the Radley's 
blow-down apparatus to give the required products; 76a (0.079 g, 11 %), 76b 
(0.06 g, 8 %), 76c (0.19 g, 26 %) and 76d (0.12 g, 16 %).   
 
2,3-syn-(1-hydroxy-1-(naphthalen-1-yl)-3-phenylpentan-2-yl) 
diphenylphosphine oxide 76a; m.p. 141.2-142.0 °C; Vmax(CHCl3)/cm-1 3324 
(OH), 2968(C-H), 1620 (C=C arom.), 1338 (P=O), 1033 (C-O), 772 (C-H arom.); 
δH ppm (400 MHz.) 0.59 (3H, t, JH = 7.1 Hz, CH3), 2.48-2.52 (1H, m, CH2eq), 
2.78-2.83 (1H, m, CH2eq), 2.89-2.93 (1H, m, PCH), 3.06 (1H, dd, JH = 2.8, 1.6, 
2,3-syn 76a; 2,3-anti 76b; 
2,3-syn 76c; 2,3-anti 76d 
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JP = 10.7 Hz CHPhEt), 5.93 (1H, dd, JH = 9.9, 1.6, JP = 26.6 Hz, CHOH), 6.12 
(1H, dd, JP = 8.5 Hz, OH), 6.58 (1H, d, JH = 10 Hz, aromatic-H), 6.82 (2H, td, JH 
= 7.8, 3.2 Hz, aromatic-H), 6.94-7.05 (4H, m, aromatic-H), 7.06 (1H, td, JH = 
7.4, 1.3 Hz, aromatic-H), 7.22 (2H, d,  JH = 8.2 Hz, aromatic-H),  7.31-7.39 (2H, 
m, aromatic-H), 7.46-7.52 (7H, m, aromatic-H), 7.62 (2H, dd, JH = 7.5, 3.5 Hz, 
aromatic-H), 7.78-7.82 (1H, m, aromatic-H); δP ppm (400 MHz.) 40.30;  δC ppm 
(125 MHz.) 13.1 (CH3), 22.5 (CH2), 46.3 (d, JP = 63.8 Hz, PCH), 47.7 (CHPhEt), 
69.5 (d, JP = 4.9 Hz, CHOH), 121.6-141.9 (aromatic C and CH); m/z (EI) 473.3 
(MH+-OH, 1-naph),  491.4 (MH+); HRMS (ES); calc. for C33H32O2P (MH+) 
491.2127; Found 491.2134; 
                                                                                                                                                                                                                                          
2,3-anti-(1-hydroxy-1-(naphthalen-1-yl)-3-phenylpentan-2-yl) 
diphenylphosphine oxide 76b; m.p. 201.2-202.4 °C; Vmax(CHCl3)/cm-1 3324 
(OH), 2968 (C-H), 1620 (C=C arom.), 1338 (P=O), 1033 (C-O), 775 (C-H 
arom.); δH ppm (400 MHz.) 0.27 (3H, t, JH = 7.2 Hz, CH3), 1.11 (1H, dqd, JH = 
14.6, 7.3, 4.2 Hz, CH2eq), 1.79 (1H, ddq, JH = 15, 7.2, 2.7 Hz, CH2eq), 3.12 (1H, 
ddd, JH = 3.3, 2.1 JP = 8.5 Hz, PCH), 3.32 (1H, tt, JH = 11.2, 3.2, JP = 15.03 Hz 
CHPhEt), 5.42 (1H, s, OH), 6.03 (1H, d, JH = 2.1, 8.9, JP = 8.9 Hz, CHOH), 
6.34-6.41 (5H, m, aromatic-H), 7.05 (1H, d, JH = 8.5 Hz, aromatic-H), 7.26 (1H, 
ddd, JH = 8.3, 4.9, 1.5 Hz, aromatic-H), 7.34-7.42 (3H, m, aromatic-H), 7.45 
(2H, ddddd,  JH = 8.3, 7.3, 6.8, 5.4 Hz, aromatic-H),  7.56-7.67 (5H, m, 
aromatic-H), 7.70 (1H, d, JH = 8.1 Hz, aromatic-H), 7.79 (1H, d, JH = 8.0 Hz, 
aromatic-H), 8.05 (1H, t, JH = 5.4 Hz, aromatic-H), 8.07-8.13 (2H, m, aromatic-
H); δP ppm (400 MHz.) 37.00; δC ppm (125 MHz.) 12.1 (CH3), 26.9 (d, JP = 4.1 
Hz, CH2), 42.4 (CHPhEt), 49.2 (d, JP = 66.5 Hz, PCH), 68.9 (d, JP = 1.4 Hz, 
CHOH), 122.0-139.5 (aromatic C and CH);                                                                                                                  
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m/z (EI) 473.3 (MH+-OH, 1-naph),  491.4 (MH+) ; HRMS (ES); calc. for 
C33H32O2P (MH+) 491.2127; Found 491.2134; 
 
2,3-syn-(1-hydroxy-1-(naphthalen-1-yl)-3-phenylpentan-2-yl) 
diphenylphosphine oxide 76c; m.p. 204.1-204.2 °C; Vmax(CHCl3)/cm-1 3324 
(OH), 2968 (C-H), 1620 (C=C arom.), 1338 (P=O), 1033 (C-O), 770 (C-H 
arom.); δH ppm (400 MHz.) 0.47 (3H, t, JH = 7.2 Hz, CH3), 1.48 (1H, ddd, JH = 
13.7, 7.2, 3.1 Hz, CH2eq), 1.64 (1H, ddd, JH = 18.2, 13.8, 7.1 Hz, CH2ax), 3.31 
(1H, ddd, JH = 7.0, 3.3, JP = 10.9 Hz, CHPhEt), 3.48 (1H, ddd, JH = 6.6, 3.0, JP 
= 10.6 Hz, PCH), 5.65 (1H, dd, JH = 7.2, JP = 25.1 Hz, CHOH), 5.96 (1H, d, JH = 
8.9 Hz, OH), 6.89-6.91 (2H, m, aromatic-H), 6.98-7.02 (1H, m, aromatic-H), 
7.08-7.12 (3H, m, aromatic-H), 7.25 (1H, dd,  JH = 2.7, 1.7 Hz, aromatic-H), 
7.41-7.60 (10H, m, aromatic-H), 7.62-7.91 (5H, m, aromatic-H); δP ppm (400 
MHz.) 38.50; δC ppm (125 MHz.) 12.7 (d, JP = 5.1 Hz, CH3), 27.9 (d,  JP = 3.6 
Hz, CH2), 47.0 (CHPhEt), 47.6 (d, JP = 65.9 Hz, PCH), 72.3 (d, JP = 5.0 Hz, 
CHOH), 122.3-141.7 (aromatic C and CH); m/z (EI) 473.3 (MH+-OH, 1-naph),  
491.4 (MH+) ; HRMS (ES); calc. for C33H32O2P (MH+) 491.2127; Found 
491.2134; 
 
2,3-anti-(1-hydroxy-1-(naphthalen-1-yl)-3-phenylpentan-2-yl) 
diphenylphosphine oxide 76d; m.p. 177.9-180 °C; Vmax(CHCl3)/cm-1 3324 
(OH), 2968 (C-H), 1620 (C=C arom.), 1338 (P=O), 1033 (C-O), 734 (C-H 
arom.); δH ppm (400 MHz.) 0.75 (3H, t, JH = 7.2 Hz, CH3), 1.87 (1H, ddq, JH = 
20.5, 13.6, 6.8 Hz, CH2eq), 2.71 (1H, ddq, JH = 15, 7.4, 2.9 Hz, CH2eq), 2.96 (1H, 
dt, JH = 1.5, 12, JP = 8.1 Hz, PCH), 3.18 (1H, dd, JH = 12.3, 2.96, JP = 22.9 Hz 
CHPhEt), 5.41 (1H, d, JH = 8.9 Hz, OH), 5.81 (2H, d, JH = 7.5 Hz, aromatic-H), 
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6.07 (1H, d, JH = 1.5, JP = 8.7 Hz, CHOH), 6.72 (2H, dd, JH = 10.6, 4.8 Hz, 
aromatic-H), 6.86 (1H, t, JH = 7.3 Hz, aromatic-H), 6.93 (1H, d, JH = 8.5 Hz, 
aromatic-H), 7.23 (1H, ddd,  JH = 8.3, 6.8, 1.3 Hz, aromatic-H),  7.32 (2H, dt,  JH 
= 7.8, 3.1 Hz, aromatic-H), 7.46 (2H, dddd, JH = 15.1, 8.0, 7.1, 1.1 Hz, aromatic-
H), 7.56-7.71 (6H, m, aromatic-H), 7.82 (1H, t, JH = 6.5 Hz, aromatic-H), 7.90 
(1H, d,  JH = 8.0 Hz, aromatic-H), 8.01-8.14 (3H, m, aromatic-H); δP ppm (400 
MHz.) 36.42; δC ppm (125 MHz.) 13.4 (CH3), 23.3 (d, JP = 7.3 Hz, CH2), 42.1 
(CHPhEt), 50.7 (d, JP = 63.7 Hz, PCH), 69.9 (d, JP = 1.9 Hz, CHOH), 121.9-
143.2 (aromatic C and CH); m/z (EI) 473.3 (MH+-OH, 1-naph),  491.4 (MH+); 
HRMS (ES); calc. for C33H32O2P (MH+) 491.2127; Found 491.2134; 
 
6.2.30 (1R*, 2R*, 3R*) and (1R*, 2R*, 3S*)-(3-(4-chlorophenyl)-1-
hydroxy-4-methyl-1-(naphthalen-1-yl)pentan-2-yl) 
diphenylphosphine oxide 
Using the method described in section 
6.2.26; LDA (2 M solution in THF, 2.2 
mL, 3.9 mmol) was added to a stirred 
solution of phosphine oxide 38 (0.5 g, 
1.3 mmol) in THF (100 mL). After this 
time 1-naphthaldehyde 28 (0.56 mL, 
0.61 g, 3.9 mmol) was added. The 
organic layer was combined, dried and 
filtered to yield a yellow oil (0.9 g), 
which was purified by column chromatography (70 : 30, petroleum ether : ethyl 
acetate) to give a yellow solid (0.45 g, 64%). This was purified further to 
separate out the diastereoisomers, the samples (0.1 g) were dissolved in 1 : 1 
2,3-syn 77a; 2,3-anti 77b;  
2,3-syn 77c; 2,3-anti 77d 
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v/v MeOH : DMSO (1 mL) and purified by Open Access Mass Directed Auto 
Prep on Sunfire C18 column using Acetonitrile Water with a Formic acid 
modifier. The gradient employed was method E, selected from 5 pre-set 
methods (A, B, C, D or E). The solvent was removed under a stream of nitrogen 
in the Radley's blow-down apparatus to give the required products; 77a (0.037 
g, 5 %), 77b (0.016 g, 3 %), 77c (0.24 g, 34 %) and 77d (0.1 g, 14 %).  
 
2,3-syn-(3-(4-chlorophenyl)-1-hydroxy-4-methyl-1-(naphthalen-1-yl)pentan-
2-yl)diphenylphosphine oxide, 77a; m.p. 211.1-212.6 °C; Vmax(CHCl3)/cm-1 
3474 (OH), 3100 (C-H), 1592 (C=C arom.), 1337 (P=O), 1174 (C-O), 781 (C-H 
arom.), 702 (C-Cl); δH ppm (400 MHz.) 0.93 (3H, d, JH = 6.7 Hz, CH3), 1.05 (3H, 
d, JH = 6.7 Hz, CH3), 3.24 (1H, ddq, JH = 10.4, 6.7 Hz, CH(CH3)2), 3.39 (1H, td, 
JP = 14.2, JH = 10.5, 3.7 Hz, PCHCH), 3.72 (1H, td, JP = 15.1, JH = 10.0, 2.8 Hz, 
PCH), 6.16 (1H, dd, JP = 28.9, JH = 8.9 Hz, CHOH), 6.71-6.79 (3H, m, aromatic-
H), 6.80-6.91 (3H, m, aromatic-H), 6.93 (1H, td, JH = 7.4, 1.4 Hz, aromatic-H), 
6.98 (2H, d, JH = 8.5 Hz, aromatic-H), 7.02-7.04 (2H, m, aromatic-H), 7.07-7.12 
(2H, m, aromatic-H), 7.17 (1H, dd, JH = 13.2, 5.2 Hz, aromatic-H), 7.21 (1H, dd, 
JH = 7.3, 1.4 Hz, aromatic-H), 7.25 (1H, dd, JH = 7.8, 4.7 Hz, aromatic-H), 7.43 
(1H, dd, JH = 11.0, 3.9 Hz, aromatic-H), 7.53-7.69 (2H, m, aromatic-H), 7.81 
(1H, t, JH = 6.8 Hz, aromatic-H), 7.94 (1H, d, JH = 7.3 Hz, aromatic-H); δP ppm 
(400 MHz.) 40.53; δC ppm (125 MHz.) 19.1 (CH3), 22.6 (CH3), 27.4 (d, JH = 8.4 
Hz, CH(CH3)2), 43.9 (d, JH = 66.3 Hz, PCH), 48.5 (PCHCH), 70.9 (d, JH = 5.5 
Hz CHOH), 121.8-138.5 (aromatic C and CH); m/z (EI) 383.3 (MH+-OH, 1-
naph),  539.4 (MH+); HRMS (ES); calc. for C34H33ClO2P (MH+) 539.1899; Found 
539.1910; 
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2,3-syn-(3-(4-chlorophenyl)-1-hydroxy-4-methyl-1-(naphthalen-1-yl)pentan-
2-yl)diphenylphosphine oxide, 77c; m.p. 192.5-193.7 °C; Vmax(CHCl3)/cm-1 
3474 (OH), 3100 (C-H), 1592 (C=C arom.), 1337 (P=O), 1174 (C-O), 781 (C-H 
arom.), 702 (C-Cl); δH ppm (400 MHz.) 0.75 (3H, d, JH = 6.5 Hz, CH3), 0.9 (3H, 
d, JH = 6.5 Hz, CH3), 2.21 (1H, dq, JH = 13.2, 6.5 Hz, CH(CH3)2), 3.15 (1H, ddd, 
JP = 14.2, JH = 8.5, 4.4 Hz, PCHCH), 3.65 (1H, ddd, JP = 10.3, JH = 4.3, 2.4 Hz, 
PCH), 5.58 (1H, d, JH = 8.4 Hz, CHOH), 6.00 (1H, dd, JP = 25.6, JH = 6.9 Hz, 
CHOH), 6.93-6.83 (3H, m, aromatic-H), 7.01-7.12 (3H, m, aromatic-H), 7.34 
(4H, q, JH = 8.7 Hz, aromatic-H), 7.41-7.54 (5H, m, aromatic-H), 7.53-7.64 (2H, 
m, aromatic-H), 7.69 (2H, ddd, JH = 8.2, 3.8, 1.9 Hz, aromatic-H), 7.75 (1H, t, JH 
= 6.9 Hz, aromatic-H), 7.91 (1H, d, JH = 8.4 Hz, aromatic-H); δP ppm (400 MHz.) 
39.31; δC ppm (125 MHz.) 20.7 (CH3), 22.1 (CH3), 30.3 (d, JH = 7.6 Hz, 
CH(CH3)2), 42.6 (d, JH = 66.2 Hz, PCH), 50.3 (PCHCH), 70.5 (d, JH = 5.3 Hz, 
CHOH), 121.9-138.2 (aromatic C and CH); m/z (EI) 383.3 (MH+-OH, 1-naph),  
539.4 (MH+); HRMS (ES); calc. for C34H33ClO2P (MH+) 539.1899; Found 
539.1910; 
 
2,3-anti-(3-(4-chlorophenyl)-1-hydroxy-4-methyl-1-(naphthalen-1-yl)pentan-
2-yl)diphenylphosphine oxide, 77b; m.p. 202.5-203.2 °C; Vmax(CHCl3)/cm-1 
3474 (OH), 3100 (C-H), 1592 (C=C arom.), 1337 (P=O), 1174 (C-O), 781 (C-H 
arom.), 702 (C-Cl); δH ppm (400 MHz.) -0.16 (3H, d, JH = 6.6 Hz, CH3), 0.19 
(3H, d, JH = 6.6 Hz, CH3), 1.90 (1H, ddq, JH = 19.4, 12.9, 6.5 Hz, CH(CH3)2), 
2.99 (1H, ddd, JP = 18.1, JH = 10.5, 2.2 Hz, PCHCH), 3.20 (1H, dd, JP = 8.4, JH 
= 1.1 Hz, PCH), 5.14 (1H, s, CHOH), 6.08 (1H, d, JP = 10.0, JH = ~1.1 Hz, 
CHOH), 6.77 (3H, d, JH = 8.4 Hz, aromatic-H), 6.92 (2H, d, JH = 8.7 Hz, 
aromatic-H), 7.20 (1H, ddd, JH = 8.3, 6.8, 1.3 Hz, aromatic-H), 7.41 (1H, ddd, JH 
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= 8.0, 6.9, 0.8 Hz, aromatic-H), 7.44-7.52 (2H, m, aromatic-H), 7.53-7.59 (2H, 
m, aromatic-H), 7.59-7.64 (3H, m, aromatic-H), 7.65-7.72 (2H, m, aromatic-H), 
7.78 (1H, d, JH = 8.1 Hz, aromatic-H), 7.84 (1H, d, JH = 7.8 Hz, aromatic-H), 
8.05-8.12 (3H, m, aromatic-H); δP ppm (400 MHz.) 36.30; δC ppm (125 MHz.) 
20.1 (CH3), 21.4 (CH3), 30.5 (d, JH = 2.4 Hz, CH(CH3)2), 44.5 (d, JH = 67.6 Hz, 
PCH), 47.2 (PCHCH), 69.1 (JH = 1.8 Hz CHOH), 121.9-138.9 (aromatic C and 
CH); m/z (EI) 383.3 (MH+-OH, 1-naph),  539.4 (MH+);HRMS (ES); calc. for 
C34H33ClO2P (MH+) 539.1899; Found 539.1910; 
 
2,3-anti-(3-(4-chlorophenyl)-1-hydroxy-4-methyl-1-(naphthalen-1-yl)pentan-
2-yl)diphenylphosphine oxide, 77d; m.p. 228.1-229.3 °C; Vmax(CHCl3)/cm-1 
3474 (OH), 3100 (C-H), 1592 (C=C arom.), 1337 (P=O), 1174 (C-O), 781 (C-H 
arom.). 702 (C-Cl); δH ppm (400 MHz.) 0.36 (3H, d, JH = 6.5 Hz, CH3), 0.92 (3H, 
d, JH = 6.3 Hz, CH3), 2.31-2.33 (1H, m, CH(CH3)2), 3.12 (1H, ddd, JP = 11.5, JH 
= 8.7, 4.3 Hz, PCHCH), 3.50 (1H, s, CHOH), 3.80 (1H, dq, JP = 8.8, JH = 4.5, 
PCH), 5.74 (1H, t, JP = 12.6, JH = 6.3, CHOH), 6.84 (2H, d, JH = 8.1 Hz, 
aromatic-H), 6.99 (2H, d, JH = 8.5 Hz, aromatic-H), 7.14-7.21 (3H, m, aromatic-
H), 7.23-7.31 (1H, m, aromatic-H), 7.35-7.42 (2H, m, aromatic-H), 7.45-7.56 
(5H, m, aromatic-H), 7.63-7.76 (4H, m, aromatic-H), 7.98 (2H, ddd, JH = 10.7, 
6.8, 3.1 Hz, aromatic-H); δP ppm (400 MHz.) 34.98; δC ppm (125 MHz.) 21.4 
(CH3), 21.9 (CH3), 30.4 (d, JH = 9.6 Hz, CH(CH3)2), 44.9 (d, JH = 66.8 Hz, PCH), 
49.8 (PCHCH), 71.1 (d, JH = 1.9 Hz CHOH), 122.9-138.9 (aromatic C and CH); 
m/z (EI) 383.3 (MH+-OH, 1-naph),  539.4 (MH+); HRMS (ES); calc. for 
C34H33ClO2P (MH+) 539.1899; Found 539.1910; 
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6.2.31 E/Z-1-(3-phenylbut-1-en-1-yl)naphthalene 
6.2.31.1 Method A:  
LDA (2.34 mL, 4.68 
mmol) was added 
dropwise to a stirred 
solution of diphenyl(2-
phenylpropyl)phosphine 
oxide 27 (0.5 g, 1.56 
mmol)  in THF (60 mL) 
at -72 °C under a 
nitrogen atmosphere. The resulting red solution was stirred for 2 hours at this 
temperature. After this time 1-naphthaldehyde (0.64 mL, 0.73 g, 4.68 mmol) 
was added dropwise, here the solution turned yellow and was left to stir at this 
temperature for a further 4 hours. After the stated time, the reaction was 
warmed to room temperature, ~1 hour, and turned orange on warm up. On the 
addition of potassium bis(trimethylsilyl)amide solution  (0.5 M solution, 9.36 mL, 
4.68 mmol) at 25 °C, the reaction at this point turned brown then deep green. It 
was left at this temperature overnight, 21 hours. The reaction was monitored 
31P NMR to observe only the starting phosphine oxide (N.B : this is the retro-
addition reaction which occurs with the formation of the cis isomer). After the 
stated time, sat.aq ammonium chloride (10 mL) was added, were the solution 
turned clear, the aqueous and organic phases were separated, the organic 
layer was washed with brine (2 x 20 mL) and the aqueous layer was washed 
with ethyl acetate (2 x 20 mL). The organic phases were combined, dried, 
filtered and the solvent was removed in vacuo to yield a crude orange oil. 
Further purification was required via preparative chromatography (90 : 10 v/v, 
78a    78b 
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petroleum ether : ethyl acetate) to give a white viscous liquid as a mixture of 
(Z)/(E)-1-(3-phenylbut-1-en-1-yl)naphthalene (0.12 g, 29%) 140. NMR observed 
: cis:trans 1:1  
6.2.31.2. Method B:  
Using the method described in section 6.2.43.1; Potassium 
bis(trimethylsilyl)amide solution  (0.5 M solution, 9.36 mL, 4.68 mmol) at 55 °C. 
Purification was required via preparative chromatography (90 : 10 v/v, 
petroleum ether : ethyl acetate) to give a white viscous liquid as a mixture of 
(Z)/(E)-1-(3-phenylbut-1-en-1-yl)naphthalene (0.10 g, 27%). NMR observed : 
cis:trans 1:1  
 
E and Z isomers; 78a and 78b; Vmax(CHCl3)/cm-1 2765 (C-H), 1601 (C=C 
arom.), 1656 (C=C), 856 (C-H arom.); δH ppm (400 MHz.) eqv. 1.28 (3H, d, JH = 
7.0 Hz, CH3trans), 1.48 (3H, t, JH = 4.9 Hz, CH3cis),  3.59-3.75 (2H, m, C3Htrans 
and C3Hcis), 6.04 (1H, t, JH = 10.0 Hz, C2Hcis),  6.34 (1H, dd, JH = 15.6, 6.9 Hz, 
C2Htrans),  6.81 (1H, d, JH = 11.0 Hz, C1Hcis), 7.08 (1H, d, JH = 15.5 Hz, C1Htrans), 
7.11-.7.25 (9H, m, aromatic-H), 7.27-7.29 (1H, m, aromatic-H), 7.32-7.45 (7H, 
m, aromatic-H), 7.49 (1H, d, JH = 7.2 Hz,  aromatic-H), 7.69 (2H, dd, JH = 19.0, 
8.2 Hz, aromatic-H), 7.74-7.81 (2H, m, aromatic-H), 7.90-7.95 (1H, m, aromatic-
H), 8.00-8.04 (1H, m, aromatic-H); δC ppm (125 MHz.) 21.4 (CH3trans), 22.4 
(CH3cis), 38.2 (C3Hcis), 42.9 (C3Htrans),  123.7-125.7 (aromatic C and CH), 125.7 
(C1Htrans), 125.8 (aromatic CH), 125.8 (C1Hcis), 126.0-134.5 (aromatic C and 
CH), 138.6  (C2Htrans), 138.8 (C1Hcis), 145.5-145.8 (aromatic C); 
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6.2.32 E/Z-1-(3-phenylpent-1-en-1-yl)naphthalene  
6.2.32.1 Method A; 
Using the method 
described in section 
6.2.31.1; LDA (2M, 2.24 
mL, 4.49 mmol) was 
added to a stirred 
solution of diphenyl(2-
phenylbutyl)phosphine 
oxide 37 (0.5 g, 1.50 
mmol)  in THF (50 mL). 1-naphthaldehyde (0.61 mL, 0.7 g, 4.49 mmol) was 
added. Followed by the addition of potassium bis(trimethylsilyl)amide solution 
(0.5 M solution, 8.97 mL, 4.49 mmol) at 25 °C. Purification was required via 
preparative chromatography (90 : 10 v/v, petroleum ether : ethyl acetate) to give 
a white viscous liquid as a mixture of (Z)/(E)-1-(3-phenylpent-1-en-1-
yl)naphthalene (0.2 g, 50%). NMR observed : cis:trans 2:1  
6.2.32.2 Method B:  
Using the method described in section 6.2.31.1; LDA (2M, 2.24 mL, 4.49 
mmol) was added to a stirred solution of diphenyl(2-phenylbutyl)phosphine 
oxide 37 (0.5 g, 1.50 mmol) in THF (50 mL). 1-naphthaldehyde (0.61 mL, 0.7 g, 
4.49 mmol) was added. Followed by the addition of potassium 
bis(trimethylsilyl)amide solution (0.5 M solution, 8.97 mL, 4.49 mmol) at 55 °C. 
Purification was required via preparative chromatography (90 : 10 v/v, 
petroleum ether : ethyl acetate) to give a white viscous liquid as a mixture of 
(Z)/(E)-1-(3-phenylpent-1-en-1-yl)naphthalene. NMR observed : cis:trans 2:1  
79a    79b 
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E and Z isomers; 79a and 79b; Vmax(CHCl3)/cm-1 2745 (C-H), 1684 (C=C), 
1559 (C=C arom.), 843 (C-H arom.); δH ppm (400 MHz.) eqv.  0.83 (3H, d, JH = 
6.2 Hz, CH3cis), 0.97 (3H, d, JH = 7.7 Hz, CH3trans), 1.89 (2H, d, JH = 8.7 Hz, 
CH2cis), 1.99 (2H, d, JH = 8.7 Hz, CH2trans),  3.42-3.47 (2H, m, C3Hcis and 
C3Htrans), 6.19 (1H, t, JH = 11.1 Hz, C2Hcis),  6.37 (1H, dd, JH = 15.2, 9.2 Hz, 
C2Htrans), 6.92 (1H, d, JH = 11.4 Hz, C1Hcis), 7.11 (1H, d, JH = 9.1 Hz, C1Htrans), 
7.05-8.5 (24H, m, aromatic-H); δC ppm (125 MHz.) 12.2 (C5H3trans), 12.5 
(C5H3cis), 29.1 (C4H2cis), 30.3 (C4H2trans), 46.1 (C3Htrans), 51.5 (C3Hcis), 123.8-
126.4 (aromatic C and CH), 126.9 (C1Htrans), 127.1 (C1Hcis), 127.4-135.6 
(aromatic-C), 137.6 (C2Htrans), 137.7 (C1Hcis), 144.7-145.3 (aromatic C); m/z (EI) 
273.1 (MH+); HRMS (ES); calc. for C21H21 (MH+) 273.1638; Found 273.1638; 
 
6.2.33  E/Z-1-(3-(4-chlorophenyl)-4-methylpent-1-en-1-
yl)naphthalene  
6.2.33.1 Method A; 
Using the method 
described in 
section 6.2.31.1; 
LDA (1.96 mL, 3.92 
mmol) was added 
to a stirred solution 
of (2-(4-chlorophenyl)-3-methylbutyl)diphenylphosphine oxide 38 (0.5 g, 1.31 
mmol) in THF (70 mL).  1-naphthaldehyde (0.53 mL, 0.61 g, 3.92 mmol) was 
added, followed by the addition of potassium bis(trimethylsilyl)amide solution  
(0.5 M solution, 7.84 mL, 3.92 mmol) at 25 °C. Purification was required via 
80a     80b 
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preparative chromatography (90 : 10 v/v, petroleum ether : ethyl acetate) to give 
a white viscous liquid as a mixture of (Z)/(E)-1-(3-(4-chlorophenyl)-4-
methylpent-1-en-1-yl)naphthalene (0.187 g, 45%). NMR observed : cis:trans 
3:1 
6.2.33.2 Method B:  
Using the method described in section 6.2.31.1; LDA (1.96 mL, 3.92 mmol) 
was added to a stirred solution of (2-(4-chlorophenyl)-3-
methylbutyl)diphenylphosphine oxide 38 (0.5 g, 1.31 mmol) in THF (70 mL). 1-
naphthaldehyde (0.53 mL, 0.61 g, 3.92 mmol) was added followed by the 
addition of potassium bis(trimethylsilyl)amide solution  (0.5 M solution, 7.84 mL, 
3.92 mmol) at 55 °C. Purification was required via preparative chromatography 
(90 : 10 v/v, petroleum ether : ethyl acetate) to give a white viscous liquid as a 
mixture of (Z)/(E)-1-(3-(4-chlorophenyl)-4-methylpent-1-en-1-yl)naphthalene. 
NMR observed : cis:trans 4:1  
 
E and Z isomers; 80a and 80b; Vmax(CHCl3)/cm-1 3212 (C-H), 1654 (C=C), 
1598 (C=C arom.), 849 (C-H arom.), 821(C-Cl); δH ppm (400 MHz.) eqv.  0.53 
(3H, d, JH = 6.7 Hz, CH3cis), 0.77 (3H, d, JH = 6.7 Hz, CH3trans), 0.80 (3H, d, JH = 
6.7 Hz, CH3cis), 0.99 (3H, d, JH = 6.7 Hz, CH3trans),  1.78 (1H, ddt, JH = 13.3, 8.7, 
6.6 Hz, C4Hcis), 1.99 (1H, ddt, JH = 13.4, 8.5, 6.7 Hz, C4Htrans), 3.05 (1H, dd, JH = 
10.4, 9.1 Hz, C3Hcis),  3.12 (1H, t, JH = 8.9 Hz, C3Htrans), 6.06 (1H, t, dd, JH = 
11.0 Hz, C2Hcis),   6.27 (1H, dd, JH = 15.4, 9.1 Hz, C2Htrans), 6.85 (1H, d, JH = 
11.3 Hz, C1Hcis), 6.92 (2H, d, JH = 6.3 Hz, aromatic-H), 7.03 (1H, d, JH = 8.9 Hz, 
C1Htrans), 7.05-8.5 (20H, m, aromatic-H); δC ppm (125 MHz.) 20.5 (CH3trans), 20.7 
(CH3trans), 20.9 (CH3cis), 21.1 (CH3cis), 33.3 (C4Htrans), 33.9 (C4Hcis), 51.2 (C3Hcis), 
57.2 C3Htrans), 123.2-125.8 (aromatic C and CH), 125.8 (C1Htrans), 125.9 
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(aromatic CH), 125.9 (C1Hcis), 126.1-145.6 (aromatic C and CH), 142.7 
(C2Htrans), 143.3 (C1Hcis); m/z (EI) 321.1 (MH+); HRMS (ES); calc. for C22H22Cl 
(MH+) 321.1410; Found 321.1405, 322.1438 and 323.1375; 
 
6.2.34  (2R*, 3R*) and (2R*, 3S*)-(1-hydroxy-1-phenylpropan-
2-yl)diphenylphosphine oxide  
LDA (1.8 M solution in THF, 3.25 mL, 6.5 mmol) 
was added drop wise to a stirred solution of 
phosphine oxide 34  (0.5 g, 2.17 mmol) in THF 
(15 mL) at -78 °C for 2 hours, under an argon 
atmosphere. After this time benzaldehyde 81 
(0.67 mL, 0.68 g, 6.5 mmol), was added drop 
wise to the resulting orange/red solution and it 
was left to stir at this temperature for a further 7 hours. After this time sat.aq. 
ammonium chloride (15 mL) was added, were the solution turned clear, here it 
was allowed to warm up to room temperature. THF was removed in situ and the 
residue was dissolved in dichloromethane and water (1 : 1 v/v, 200 mL). The 
organic layer was combined, dried and filtered to yield a yellow oil (0.92 g), this 
was purified by flash column chromatography (50 : 50 v/v, petroleum ether : 
ethyl acetate) to yield (0.53 g, 73 %). This was purified further to separate out 
the diastereoisomers, the samples (0.1 g) at a time were dissolved in 1 : 1 v/v 
MeOH:DMSO (1 mL) and purified by Open Access Mass Directed Auto Prep on 
Sunfire C18 column using Acetonitrile Water with a Formic acid modifier. The 
gradient employed was method C, selected from 5 pre-set methods (A, B, C, D 
or E). The solvent was removed under a stream of nitrogen in the Radley's 
blow-down apparatus to give the required products, these were then purified 
2,3-syn 82a; 2,3-anti 82b 
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further using recrystallization techniques (1 : 1 v/v, toluene : hexane). To give 
82a (0.051g, 7 %) and 82b (0.2677 g, 37 %) 92. 
 
(2R*, 3R*)-(1-hydroxy-1-phenylpropan-2-yl)diphenylphosphine oxide 82a; 
m.p. 149.3-150.1°C; m.p. lit 145-146°C; Vmax(CHCl3)/cm-1 3263 (OH), 2979 (C-
H), 1641 (C=C arom.), 1333 (P=O), 1159 (C-O), 844 (C-H arom.); δH ppm (400 
MHz.) 0.77 (3H, dd, JH = 7.4  JP = 17.3 Hz, CH3), 2.96 (1H, ddq, JH = 10.6, 7.4  
JP = 9.0 Hz, PCH), 4.83 (1H, dd, JH = 9.1, 1.3, JP = 19.8 Hz,  CHOH), 5.60 (1H, 
s, CHOH), 7.29-7.51 (5H, m, aromatic-H), 7.55-7.77 (6H, m, aromatic-H), 7.81-
8.01 (4H, m, aromatic-H); δP ppm (400 MHz.) 42.16; δC ppm (125 MHz.) 13.1 
(CH3), 39.5 (d, JH = 68.5 Hz, PCH), 75.9 (d, JH = 3.3 Hz, CHOH), 126.9-141.9 
(aromatic C and CH); m/z (EI) 337.2 (MH+);  
 
(2R*, 3S*)-(1-hydroxy-1-phenylpropan-2-yl)diphenylphosphine oxide 82b; 
m.p. 155-157 °C; m.p. lit 169-171 °C; Vmax(CHCl3)/cm-1 3263 (OH), 2937 (C-H), 
1650 (C=C arom.), 1332 (P=O), 1117 (C-O), 883 (C-H arom.); δH ppm (400 
MHz.) 0.95 (3H, dd, JH = 16.5, 7.4 Hz, CH3), 2.51 (1H, dqd, JH = 7.6, JP = 6.6 
Hz, PCH), 4.55 (1H, s, OH), 5.20 (1H, d, JH = < 1.0,  JP = 9 Hz, CHOH), 7.15 
(1H, dddd, JH = 5.9, 3.3, 1.6 Hz,  aromatic-H), 7.23-7.40 (3H, m, aromatic-H), 
7.41-7.49 (3H, m, aromatic-H), 7.50-7.69 (3H, m, aromatic-H), 7.71-7.89 (2H, 
m, aromatic-H), 7.89-7.95 (2H, m, aromatic-H); δP ppm (400 MHz.) 40.12; δC 
ppm (125 MHz.) 5.3 (CH3), 39.0 (d, JP = 68.6 Hz, PCH), 70.7 (d, JP = 2.4 Hz, 
CHOH), 125.6-141.9 (aromatic C and CH); m/z (EI) 337.2 (MH+);  
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6.2.35 (2R*, 3R*) and (2R*, 3S*)-(1-hydroxy-1,3-diphenylpropan-
2-yl)diphenylphosphine oxide  
Using the method described in section 6.2.34; 
LDA (1.8 M solution in THF, 4.5 mL, 8.2 mmol) 
was added to a stirred solution of phosphine 
oxide 36 (0.5 g, 1.6 mmol) in THF (15 mL). 
Benzaldehyde 81 (0.86 mL, 0. 87 g, 8.16 mmol), 
was added and left for a further 5 hours. The 
organic layer was combined, dried and filtered to 
yield a yellow oil (1g). Separation by flash 
column chromatography (70 : 30 v/v, petroleum ether : ethyl acetate) to give 
(0.6 g, 89 %). This yellow oil was further purified using a combination of column 
and preparative chromatography (70 : 30 v/v, petroleum ether : ethyl acetate). 
The first eluted was dried in vacuo to give 83b (0.106 g, 16 %), followed directly 
after by 83a (0.031 g, 2 %) 144. 
 
(2R*, 3S*)-(1-hydroxy-1,3-diphenylpropan-2-yl)diphenylphosphine oxide 
83b; m.p. 172-174 °C; m.p. lit 164-168 °C; Vmax(CHCl3)/cm-1 3300 (OH), 2923 
(C-H), 1637 (C=C arom.), 1376 (P=O), 1114 (C-O), 767 (C-H arom.); δH ppm 
(400 MHz.) 2.80-2.84 (2H, m, JH = 8.6, 3.2, 7.9, 2.0, JP = 17.2, 12.3 Hz, 
PCHCH2), 3.12 (1H, ddd, JH = 14.2, 1.9, JP = 14.2  Hz, PCHCH2), 4.99 (1H, s, 
OH), 5.38 (1H, d, JH = 9.5 Hz, CH(OH)Ph), 6.11 (1H, d, JP = 7.4 Hz, aromatic-
H), 6.82 (2H, d, JP = 7.5 Hz, aromatic-H), 6.86-6.98 (1H, m, aromatic-H), 7.28 
(3H, dt, JH = 7.4, 2.6 Hz, aromatic-H), 7.32-7.47 (5H, m, aromatic-H), 7.50-7.68 
(5H, m, aromatic-H), 7.92-7.99 (2H, m, aromatic-H); δP ppm (400 MHz.) 39.31; 
δC ppm (125 MHz.) 26.6 (PCHCH2), 47.4 (d, JP = 66.6 Hz, PCH), 71.1 (CHOH), 
2,3-syn 83a; 2,3-anti 83b  
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125.4-141.9 (aromatic C and CH); m/z (EI) 395.3 (MH+-OH), 413.3 (MH+); 
HRMS (ES); calc. for C27H26O2P (MH+) 413.1658; Found 413.1665; 
 
(2R*, 3R*)-(1-hydroxy-1,3-diphenylpropan-2-yl)diphenylphosphine oxide 
83a; m.p. 149-151.2 °C; m.p. lit 155-157.2 °C Vmax(CHCl3)/cm-1 3300 (OH), 2923 
(C-H), 1637 (C=C arom.), 1376 (P=O), 1114 (C-O), 767(C-H arom.); δH ppm 
(400 MHz.) 2.72 (1H, ddd, JH = 14.0, 3.5, JP = 10.8 Hz, PCHCH2), 2.94-3.07 
(1H, m, JH = 7.3, 3.7, JP = 14.4 Hz, PCHCH2), 3.09 (1H, ddd, JH = 13.0, 10.7, JP 
= 7.2  Hz, PCHCH2), 4.92 (1H, d, JH = 3.5, JP = 24 Hz, CH(OH)Ph), 5.59 (1H,  s, 
OH), 6.83-6.91 (3H, m, aromatic-H), 6.98 (3H, d, JP = 7.1 Hz, aromatic-H), 7.13 
(7H, ddd, JH = 12.5, 9.6, 4.4 Hz,  aromatic-H), 7.34-7.44  (5H, m, aromatic-H), 
7.69 (2H, ddd, JH = 11.0, 7.7, 1.4 Hz, aromatic-H); δP ppm (400 MHz.) 39.28; δC 
ppm (125 MHz.) 32.9 (PCHCH2), 45.9 (d, JP = 66.2 Hz, PCH), 73.4 (d, JP = 4.46 
Hz, CHOH), 125.9-142.2 (aromatic C and CH); m/z (EI) 395.3 (MH+-OH), 413.3 
(MH+); HRMS (ES); calc. for C27H26O2P (MH+) 413.1658; Found 413.1665; 
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6.2.36 (1R*, 2R*, 3R*) and (1R*, 2R*, 3S*)-(1-hydroxy-1,3-
diphenylbutan-2-yl)diphenylphosphine oxide  
Using the method described in section 6.2.34; 
LDA (2 M solution in THF, 0.82  mL, 1.6 mmol) 
was added to a stirred solution of phosphine 
oxide 27 (0.350 g, 1.09 mmol) in THF (6 mL). 
Benzaldehyde 81 (0.112 mL, 0.0116 g, 1.09 
mmol), was added and was left for a further 4 
hours. The organic layer was combined, dried 
and filtered to yield a yellow oil (0.50 g), which 
was purified by column chromatography (70 : 30 
v/v, petroleum ether : ethyl acetate) collecting all 
relevant fractions, to afford a mixture of all four 
diastereomers  as a yellow solid (0.421 g, 90%), The diastereomers were 
separated by column or preparative thin layer chromatography (70 : 30 v/v, 
petroleum ether : ethyl acetate). The first eluted was dried in vacuo to give 84b 
(0.125 g, 2%), Rf  0.75, followed by 84a  (0.02g, 4 %), Rf  0.73,  The third elute 
was dried in vacuo to give 84d (0.078g, 17 %), Rf  0.69, followed by 84c 
(0.031g, 7 %) Rf  0.55 and further purified by recrystallization (1:1 v/v, toluene : 
hexane) 101. 
 
(1R*, 2R*, 3S*)-(1-hydroxy-1,3-diphenylbutan-2-yl)diphenylphosphine 
oxide 84b;  m.p. 130-131.5 °C; (no lit. m.p.); Vmax(CHCl3)/cm-1 3210 (OH), 3095 
(C-H), 1635 (C=C arom.), 1294 (P=O), 1123 (C-O), 788 (C-H arom.); δH ppm 
(400 MHz.) 1.26 (3H, d, JH = 2.0 Hz, CH3), 3.23 (1H, ddd, JH = 5.5, 1.6, JP = 7.5  
Hz, PCH), 3.52 (1H, dq, JH = 6.9, 1.6, JP = 20.4 Hz, CHPhMe), 5.06 (1H, s, 
2,3-syn : 1,2-syn 84a;  
2,3-anti : 1,2-syn 84b; 
 2,3-syn : 1.2-anti 84c;  
2,3-anti : 1,2-syn 84d 
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OH), 5.46 (1H, d, JP = 10.1 Hz, CHOH), 6.77 (2H, dd, JH = 6.4, 2.8 Hz, 
aromatic-H), 6.87-6.92 (3H, m, aromatic-H), 7.14 (1H, t, JH = 7.3 Hz, aromatic-
H), 7.23  (2H, t, JH = 7.6 Hz,  aromatic-H), 7.26-7.37 (5H, m, aromatic-H), 7.51 
(3H, dd, JH = 5.3, 3.0 Hz, aromatic-H), 7.58-7.62 (2H, m, aromatic-H), 7.97 (2H, 
ddd, JH = 10.7, 7.1, 4.1 Hz, aromatic-H); δP ppm (400 MHz.) 39.03; δC ppm (125 
MHz.) 14.2 (CH3), 36.1 (CHPhMe), 49.5 (d, JP = 66.5 Hz, PCH), 71.1 (d, JP = 
1.39 Hz, CHOH), 125.3-145.1 (aromatic C and CH); m/z (EI) 321.2 (MH+-OH, 
Ph), 427.3 (MH+); HRMS (ES); calc. for C28H28O2P (MH+) 427.1817; Found 
427.1821; 
 
(1R*, 2R*, 3R*)-(1-hydroxy-1,3-diphenylbutan-2-yl)diphenylphosphine 
oxide 84a;  m.p. 175-176 °C; (no lit. m.p.); Vmax(CHCl3)/cm-1 3210 (OH), 3095 
(C-H), 1635 (C=C arom.), 1294 (P=O), 1123 (C-O), 788 (C-H arom.); δH ppm 
(400 MHz.) 1.68 (3H, d, JH = 7.3 Hz, CH3), 2.92 (1H, ddd, JH = 3.1, 1.7, JP = 9.6 
Hz, PCH), 3.24 (1H, dhex, JH = 2.9, 6.8, JP = 16.2 Hz, CHPhMe), 5.19 (1H, d, 
JH =  6.9,1.6, JP = 24.6 Hz, CHOH), 5.95 (1H, d, JH = 7.8 Hz, OH), 6.57-6.62 
(2H, m, aromatic-H), 6.72 (3H, dd, JH = 6.5, 3.6 Hz aromatic-H), 6.99-7.05 (2H, 
m, aromatic-H), 7.15  (4H, ddd, JH = 8.9, 7.6, 2.5 Hz, aromatic-H), 7.24-7.35 
(4H, m, aromatic-H), 7.37-7.47 (3H, m, aromatic-H), 7.70-7.82 (2H, m, aromatic-
H); δP ppm (400 MHz.) 38.18; δC ppm (125 MHz.) 13.7 (CH3), 36.4 (CHPhMe), 
48.5 (d, JP = 26.7 Hz, PCH), 69.6 (d, JP = 4.85 Hz, CHOH), 122.9-142.8 
(aromatic C and CH); m/z (EI) 321.2 (MH+-OH, Ph), 427.3 (MH+); HRMS (ES); 
calc. for C28H28O2P (MH+) 427.1817; Found 427.1821; 
 
(1R*, 2S*, 3R*)-(1-hydroxy-1,3-diphenylbutan-2-yl)diphenylphosphine 
oxide 84d;  m.p. 142-144 °C; (no lit. m.p.); Vmax(CHCl3)/cm-1 3210 (OH), 3095 
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(C-H), 1635 (C=C arom.), 1294 (P=O), 1123 (C-O), 788 (C-H arom.); δH ppm 
(400 MHz.) 1.61 (3H, d, JH = 7.3 Hz, CH3), 2.88 (1H, d, JP = 8.4  Hz, PCH), 3.30 
(1H, dq, JH = 7.1, 1.4, JP = 24.1 Hz, CHPhMe), 5.03  (1H, s, OH), 5.36 (1H, d, 
JP = 8.5 Hz, CHOH), 6.19 (2H, d, JH = 7.5 Hz, aromatic-H), 6.81 (2H, t, JH = 7.4 
Hz aromatic-H), 6.88  (1H, t, JH = 7.2 Hz,  aromatic-H), 7.11  (2H, td, JH = 7.7, 
2.8 Hz, aromatic-H), 7.22  (1H, dd, JH = 6.1, 2.4 Hz, aromatic-H), 7.26-7.39 (7H, 
m, aromatic-H), 7.45 (3H, dd, JH = 3.9, 1.9 Hz,  aromatic-H), 7.84 (2H, ddd, JH = 
7.2, 5.9, 3.1 Hz,  aromatic-H); δP ppm (400 MHz.) 36.22; δC ppm (125 MHz.) 
17.1 (d, JP = 6.8 Hz CH3), 33.4 (CHPhMe), 52.1 (d, JP = 65.1 Hz, PCH), 73.0 (d, 
JP = 2.17 Hz, CHOH), 125.4-146.1 (aromatic C and CH); m/z (EI) 321.2 (MH+-
OH, Ph), 427.3 (MH+); HRMS (ES); calc. for C28H28O2P (MH+) 427.1817; Found 
427.1821; 
 
(1R*, 2S*, 3S*)-(1-hydroxy-1,3-diphenylbutan-2-yl)diphenylphosphine 
oxide 84c;  m.p. 213-214 °C; (no lit. m.p.); Vmax(CHCl3)/cm-1 3210 (OH), 3095 
(C-H), 1635 (C=C arom.), 1294 (P=O), 1123 (C-O), 788 (C-H arom.); δH ppm 
(400 MHz.) 1.23 (3H, d, JH = 7.1 Hz, CH3), 3.16 (1H, ddd, JH = 4.5, 1.3 JP = 7.0 
Hz, PCH), 3.45 (1H, dq, JH = 6.9, 1.5,  JP = 25.3 Hz, CHPhMe), 4.48  (1H, d, JH 
= 5.9 Hz, OH), 5.04 (1H, d, JH = 4.5, 9, JP = 19.2 Hz, CHOH), 6.91-7.01 (5H, m, 
aromatic-H), 7.06 (3H, dd, JH = 6.9, 4.8 Hz aromatic-H), 7.09-7.19  (4H, m, 
aromatic-H), 7.20-7.27 (3H, m, aromatic-H), 7.28-7.35 (1H, m, aromatic-H), 
7.43-7.49 (2H, m, aromatic-H), 7.52-7.63 (2H, m,  aromatic-H); δP ppm (400 
MHz.) 34.25; δC ppm (125 MHz.) 19.8 (d, JP = 5.1 Hz, CH3), 38.6 (CHPhMe), 
52.4 (d, JP = 66.1 Hz, PCH), 74.0 (d, JP = 4.07 Hz, CHOH), 125.6-144.0 
(aromatic C and CH); m/z (EI) 321.2 (MH+-OH, Ph), 427.3 (MH+); HRMS (ES); 
calc. for C28H28O2P (MH+) 427.1817; Found 427.1821; 
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6.2.37 (1R*, 2R*, 3R*) and (1R*, 2R*, 3S*)-(1-hydroxy-1,3-
diphenylpentan-2-yl)diphenylphosphine oxide  
Using the method described in section 
6.2.34; LDA (2 M solution in THF, 2.3 mL, 
4.5 mmol) was added to a stirred solution of 
phosphine oxide 37 (0.5 g, 1.5 mmol) in THF 
(30 mL). Benzaldehyde 81 (0.5 mL, 0.4 g, 
4.5 mmol) was added and left for a further 4 
hours. The organic layer was combined, 
dried and filtered to yield a yellow oil (0.55 
g), which was purified by column chromatography (70 : 30, petroleum ether : 
ethyl acetate) to give a yellow solid (0.40 g, 62 %). This was purified further to 
separate out the diastereoisomers, the samples (0.1 g) were dissolved in 1 : 1 
v/v, MeOH : DMSO (1 mL) and purified by Open Access Mass Directed Auto 
Prep on Sunfire C18 column using Acetonitrile Water with a Formic acid 
modifier. The gradient employed was method E, selected from 5 pre-set 
methods (A, B, C, D or E). The solvent was removed under a stream of nitrogen 
in the Radley's blow-down apparatus to give the required products as a clear 
oil, (0.16 g, 26 %), 85b and 85a, (0.083 g, 13 %), 85d and 85a (0.053 g, 8%). 
 
2,3-anti and 2,3-syn-(1-hydroxy-1,3-diphenylpentan-2-yl) 
diphenylphosphine oxide 85bmajor and 85aminor; Vmax(CHCl3)/cm-1 3242(OH), 
2982 (C-H), 1654 (C=C arom.), 1052 (P=O), 1009 (C-O), 765 (C-H arom.); δH 
ppm (400 MHz.) eqv. 0.35 (3H, t, JH = 7.3 Hz, CH3major), 0.5  (3H, t, JH = 6.2 Hz, 
CH3minor), 1.44-1.51 (1H, m, CH2major), 1.95-2.08 (1H, m, CH2major), 2.44-2.49 
(2H, m, CH2minor), 2.91-3.01 (2H, m, PCHCHminor, PCHminor), 3.19-3.27 (2H, m, 
2,3-syn 85a; 2,3-anti 85b; 
2,3-syn 85c; 2,3-anti 85d 
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PCHCHmajor, PCHmajor), 5.05 (1H, s, OHmajor), 5.32 (1H, dd, JH = 8.5, JP = 25.7 
Hz, CHOHminor), 5.41 (1H, dd, JP = 10.6 Hz, CHOHmajor), 6.11 (1H, d, JH = 8.8 
Hz,  OHminor), 6.66-7.94 (40H, m, aromatic-H); δP ppm (400 MHz.) 39.15major, 
39.12minor; δC ppm (125 MHz.) 12.6 (CH3major), 12.9 (CH3minor), 22.5 (CH2minor), 
27.1 (d, JP = 6.4 Hz, CH2major), 43.7 (PCHCHmajor), 47.1 (PCHCHminor), 49.7 (d, 
JP = 66.4 Hz, PCHmajor), 50.7 (d, JP = 62.8 Hz, PCHminor), 71.1 (CHOHmajor), 71.9 
(d, JP = 4.9 Hz, CHOHminor), 125.1-141.8 (aromatic C and CH); m/z (EI) 441.2 
(MH+); HRMS (ES); calc. for C29H30O2P (MH+) 441.1971; Found 441.1978; 
 
2,3-anti-(1-hydroxy-1,3-diphenylpentan-2-yl)diphenylphosphine oxide 85d; 
m.p. 173.7-173.9 °C; Vmax(CHCl3)/cm-1 3242(OH), 2982 (C-H), 1654 (C=C 
arom.), 1052 (P=O), 1009 (C-O), 765 (C-H arom.); δH ppm (400 MHz.) 0.67 (3H, 
s, CH3), 1.90-2.02 (1H, m, CH2eq), 2.62-2.71 (1H, m, CH2ax),  2.86 (1H, dt, JH = 
1.6, JP = 8.5 Hz, PCH), 3.14 (1H, dd, JH = 12.4, JP = 22.6 Hz, PCHCH), 4.96 
(1H, s, OH), 5.39 (1H, d, JP = 9 Hz, CHOH), 6.09-6.12 (2H, m, aromatic-H), 
6.86-6.91 (2H, m, aromatic-H), 6.95-7.11 (1H, m, aromatic-H), 7.30-7.37 (5H, 
m, aromatic-H), 7.37-7.40 (2H, m, aromatic-H), 7.49-7.52 (4H, m, aromatic-H), 
7.58-7.61 (2H, m, aromatic-H), 7.91-8.01 (2H, m, aromatic-H); δP ppm (400 
MHz.) 36.41; δC ppm (400 MHz.) 13.4 (CH3), 23.5 (CH2), 42.0 (PCHCH), 52.3 
(d, JP = 64.3 Hz, PCH), 72.9 (CHOH), 125.5-143.5 (aromatic C and CH); m/z 
(EI) 441.2 (MH+); HRMS (ES); calc. for C29H30O2P (MH+) 441.1971; Found 
441.1978; 
 
2,3-syn-(1-hydroxy-1,3-diphenylpentan-2-yl)diphenylphosphine oxide 85a; 
m.p. 195-197 °C; Vmax(CHCl3)/cm-1 3242(OH), 2982 (C-H), 1654 (C=C arom.), 
1052 (P=O), 1009 (C-O), 765 (C-H arom.); δH ppm (400 MHz.) 0.55 (3H, s, 
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CH3), 1.71-1.81 (2H, m, CH2), 3.20-3.31 (2H, m, PCH and PCHCH), 4.58 (1H, 
d, JP = 6.6 Hz, OH), 5.14 (1H, ddd, JH = 6.0, 2.1, JP = 17.6 Hz, CHOH), 7.00-
7.19 (4H, m, aromatic-H), 7.20-7.29 (4H, m, aromatic-H), 7.30-7.34 (4H, m, 
aromatic-H), 7.35-7.39 (1H, m, aromatic-H), 7.42-7.47 (2H, m, aromatic-H), 
7.48-7.52 (3H, m, aromatic-H), 7.74-7.81 (2H, m, aromatic-H); δP ppm (400 
MHz.) 35.69; δC ppm (125 MHz.) 12.6 (CH3), 27.8 (CH2), 46.5 (PCHCH), 51.5 
(d, JP = 65.3 Hz, PCH), 73.5 (CHOH), 125.4-144.8 (aromatic C and CH); m/z 
(EI) 441.2 (MH+); HRMS (ES); calc. for C29H30O2P (MH+) 441.1971; Found 
441.1978; 
 
6.2.38 (1R*, 2R*, 3R*) and (1R*, 2R*, 3S*)-(3-(4- chlorophenyl)-
1-hydroxy-4-methyl-1-phenylpentan-2-yl)diphenylphosphine 
oxide  
Using the method described in section 
6.2.34; LDA (2 M solution in THF, 1.96 
mL, 3.9 mmol) was added to a stirred 
solution of phosphine oxide 38 (0.5 g, 
1.3 mmol) in THF (100 mL). 
Benzaldehyde 81 (0.41 mL, 0.4 g, 3.9 
mmol), was added and left for a further 
4 hours. The organic layer was 
combined, dried and filtered to yield a 
yellow oil (1 g), which was purified by column chromatography (70 : 30, 
petroleum ether : ethyl acetate) to give a yellow solid (0.56 g, 87%). This was 
purified further to separate out the diastereoisomers, the samples (0.1 g) were 
dissolved in 1 : 1 v/v MeOH : DMSO (1 mL) and purified by Open Access Mass 
2,3-syn 86a; 2,3-anti 86b;  
2,3-syn 86c; 2,3-anti 86d 
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Directed Auto Prep on Sunfire C18 column using Acetonitrile Water with a 
Formic acid modifier. The gradient employed was method D, selected from 5 
pre-set methods (A, B, C, D or E). The solvent was removed under a stream of 
nitrogen in the Radley's blow-down apparatus to give the required products. Not 
all diastereoisomers could be isolated. To give (0.14 g, 22 %), 86b all other 
products could not be isolated. 
 
2,3-anti-(3-(4-chlorophenyl)-1-hydroxy-4-methyl-1-phenylpentan-2-yl) 
diphenylphosphine oxide 86b; m.p. 195.1-196.2 °C; Vmax(CHCl3)/cm-1 3411 
(OH), 2967 (C-H), 1627 (C=C arom.), 1179 (P=O), 1001 (C-O), 704 (C-H 
arom.), 675 (C-Cl); δH ppm (400 MHz.) -0.01 (3H, d, JH = 6.6 Hz,  CH3), 0.44 
(3H, d, JH = 6.7 Hz, CH3), 2.04-2.19 (1H, m, CH(CH3)2), 3.10 (1H, dt, JH = 6.7, 
JP = 16.7 Hz, PCHCH), 3.24 (1H, t, JH = 6.6, JP = 7.1 Hz, PCH), 4.71 (1H, s, 
OH),  5.35 (1H, d, JP = 12.1 Hz, CHOH), 6.65 (2H, d, JH = 8.5 Hz, aromatic-H), 
6.74-6.81 (2H, m, aromatic-H), 7.09-7.22 (3H, m, aromatic-H), 7.22-7.36 (5H, 
m, aromatic-H), 7.43 (5H, ddd, JH = 7.0, 6.3, 4.7 Hz, aromatic-H), 7.84 (2H, ddd, 
JH = 8.6, 6.5, 3.8 Hz, aromatic-H); δP ppm (400 MHz.) 38.13;  δC ppm (125 
MHz.) 19.1 (CH3), 21.8 (d, JP = 34.9 Hz, CH3), 29.2 (CH(CH3)2), 47.2 (d, JP = 
67.9 Hz, PCH), 47.2 (CHPhMe), 71.8 (CHOH), 125.5-142.8 (aromatic C and 
CH); m/z (EI) 489.17, 491.0, 492.1 (MH+); HRMS (ES); calc. for C30H31ClO2P 
(MH+) 489.1741; Found 489.1745; 
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6.2.39 (2R*, 3R*) and (2R*, 3S*)-(1-cyclohexyl-1-hydroxypropan-
2-yl)diphenylphosphine oxide  
Using the method described in section 6.2.34; 
LDA (1.8 M solution in THF, 1.65 mL, 3.5 mmol) 
was added to a stirred solution of phosphine 
oxide 34 (0.25 g, 1.08 mmol) in THF (15 mL). 
Cyclohexanecarboxaldehyde 87 (0.4 mL, 0.365 
g, 3.25 mmol), was added and was left for 4 
hours. The organic layer was combined, dried 
and filtered to yield a yellow oil (0.62g), this was 
purified by column chromatography (50 : 50 v/v, petroleum ether : ethyl acetate) 
to give a mixture of both diastereoisomers (0.35 g, 93%). The crude oil was 
purified by a combination of column and preparative thin layer chromatography 
(70 : 30 v/v, petroleum ether : ethyl acetate) to yield both diastereoisomers in 
acceptable yield, 88a (0.06 g, 16 %) and 88b (0.17 g, 46 %). For further 
purification, recrystalisation was used (1 : 1 v/v, toluene : hexane) 92. 
 
(2R*, 3R*)-(1-cyclohexyl-1-hydroxypropan-2-yl)diphenylphosphine oxide 
88a; m.p. 146.7-147.5 °C; m.p. lit 144-146 °C; Vmax(CHCl3)/cm-1 3414 (OH), 
2922 (C-H), 1637 (C=C arom.), 1324 (P=O), 1163 (C-O), 717 (C-H arom.); δH 
ppm (400 MHz.) 0.92 (3H, dd, JH = 17.8, 7.4 Hz, CH3), 1.02-1.10 (2H, m, cyclo-
CH2), 1.20 (1H, dd, JH = 22.1, 8.8 Hz, cyclo-CH2), 1.30 (3H, dt, JH = 13.7, 8.9 
Hz, cyclo-CH2 and cyclo-CH), 1.52 (1H, s, cyclo-CH2), 1.57-1.72 (4H, s, cyclo-
CH2), 2.69-2.82 (1H, dt, JH = 7.5, 4.7, JP = 11.02 Hz, PCH), 3.58 (1H, dd, JH = 
8.8, 3.7, JP = 22.1 Hz, CHOH), 4.70 (1H, s, CHOH),  7.39-7.63 (6H, m, 
aromatic-H), 7.65-7.89 (4H, m, aromatic-H); δP ppm (400 MHz.) 42.29; δC ppm 
2,3-syn 88a; 2,3-anti 88b 
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(125 MHz.) 12.6 (CH3), 25.1 (cyclo-CH2), 26.2 (cyclo-CH2), 26.4 (cyclo-CH2), 
26.5 (cyclo-CH2), 30.4 (cyclo-CH2), 34.7 (d, JP = 70.3 Hz, PCH), 40.2 (d, JP = 
8.7 Hz, cyclo-CH), 76.3 (d, JP = 11.4 Hz, CHOH), 128.6-133.1 (aromatic C and 
CH); m/z (EI) 343.2 (MH+);  
 
(2R*, 3S*)-(1-cyclohexyl-1-hydroxypropan-2-yl)diphenylphosphine oxide 
88b; m.p. 163.4-164.5 °C; m.p. lit 171-173 °C; Vmax(CHCl3)/cm-1 3414 (OH), 
2922 (C-H), 1637 (C=C arom.), 1324 (P=O), 1163 (C-O), 717 (C-H arom.); δH 
ppm (400 MHz.) 0.59-0.80 (2H, m, cyclo-CH2), 0.99 (1H, ddd, JH = 12.6, 7.8, 3.4 
Hz, cyclo-CH2), 1.08 (4H, dt, JH = 12.7, 5.8 Hz, CH3 and cyclo-CH2), 1.13-1.19 
(1H, m, cyclo-CH2), 1.39-1.47 (1H, m, cyclo-CH), 1.54-1.56 (1H, m, cyclo-CH2), 
1.60-1.66 (2H, m, cyclo-CH2), 2.05 (2H, d, JH = 13.1 Hz, cyclo-CH2), 2.49 (1H, 
p, JH = 7.2, JP = 7.2 Hz, PCH), 3.56 (1H, t, JH = 9.5, JP = 9.6 Hz, CHOH), 4.19 
(1H, s, CHOH), 7.39-7.48 (6H, m, aromatic-H), 7.72 (4H, dddd, JH = 28.3, 11.2, 
7.8, 1.5 Hz, aromatic-H); δP ppm (400 MHz.) 41.18; δC ppm (125 MHz.) 5.5 
(CH3), 25.7 (cyclo-CH2), 25.9 (cyclo-CH2), 26.2 (cyclo-CH2), 28.6 (cyclo-CH2), 
29.8 (cyclo-CH2), 32.7 (d, JP = 70.9 Hz, PCH), 40.1 (d, JP = 11.2 Hz, cyclo-CH), 
73.6 (d, JP = 3.7 Hz, CHOH), 128.8-132.2 (aromatic C and CH); m/z (EI) 343.2 
(MH+);  
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6.2.40 (2R*, 3R*) and (2R*, 3S*)-(1-cyclohexyl-1-hydroxy-3-
phenylpropan-2-yl)diphenylphosphine oxide  
Using the method described in section 6.2.34; 
LDA (1.8 M solution in THF, 1.2 mL, 2.5 mmol) 
was added to a stirred solution of phosphine 
oxide 36 (0.25 g, 0.8 mmol) in THF (15 mL). 
Cyclohexanecarboxaldehyde 87 (0.31 mL, 0.27 
g, 2.5 mmol), was added and left for 4 hours. 
The organic layer was combined, dried and 
filtered to yield a yellow oil (0.46 g), this was 
purified by column chromatography (50 : 50 v/v, petroleum ether : ethyl acetate) 
to give a mixture of both diastereoisomers (0.29 g, 85 %). The crude oil was 
purified by a combination of column and preparative thin layer chromatography 
(70 : 30 v/v, petroleum ether : ethyl acetate) to yield both diastereoisomers in 
acceptable yield, 89b (0.11 g, 34 %), and 89a (0.09 g, 26 %). For further 
purification, recrystallization was used (1 : 1 v/v, toluene : hexane). 
 
 (2R*,3S*)-(1-cyclohexyl-1-hydroxy-3-phenylpropan-2-yl) 
diphenylphosphine oxide 89b; m.p. 182.5-184 °C; Vmax(CHCl3)/cm-1 3443 
(OH), 2920 (C-H), 1637 (C=C arom.), 1161 (P=O), 1109 (C-O), 834 (C-H 
arom.);  δH ppm (400 MHz.) 0.69-0.71 (2H, m, cyclohex-CH2), 1.00-1.05 (4H, m, 
cyclohex-CH2), 1.49 (2H, d, JH = 12.2 Hz, cyclohex-CH2 and cyclohex-CH), 1.57 
(1H, d, JH = 11.1 Hz,  cyclohex-CH2), 1.67 (1H, d, JH = 13.9 Hz, cyclohex-CH2), 
2.14 (1H, d, JH = 13.1 Hz, cyclohex-CH2), 2.92-3.02 (2H, m, PCHCH2), 3.32-
3.41 (1H, m, CH2), 3.72 (1H, t, JH = 9.4,  JP = 10.3 Hz, CHOH), 4.34 (1H, s, 
CHOH),  6.87-6.92 (2H, m, aromatic-H), 7.09-7.21 (3H, m, aromatic-H), 7.35-
2,3-syn 89a; 2,3-anti 89b  
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7.42 (2H, ddd, JH = 8.2, 5.3, 2.3 Hz, aromatic-H), 7.44-7.52 (1H, m, aromatic-
H), 7.54-7.63 (3H, m, aromatic-H), 7.68 (2H, dddd, JH = 26.4, 14.0, 12.6 Hz, 
aromatic-H), 7.87-7.98 (2H, m, aromatic-H); δP ppm (400 MHz.) 40.40; δC ppm 
(125 MHz.) 25.7 (cyclohex-C), 26.2 (cyclohex-C), 27.3 (PCHCH2), 29.1 
(cyclohex-C), 29.7 (cyclohex-C), 40.0 (d, JP = 30.7 Hz, cyclohex-CH), 40.4 (d, 
JP = 63.9 Hz, PCH), 74.5 (d, JP = 3.0 Hz, CHOH), 125.8-140.9 (aromatic C and 
CH); m/z (EI) 419.2 (MH+); HRMS (ES); calc. for C27H32O2P (MH+) 419.2129; 
Found 419.2134; 
 
(2R*,3R*)-(1-cyclohexyl-1-hydroxy-3-phenylpropan-2-yl) 
diphenylphosphine oxide 89a; m.p. 172.5 °C; Vmax(CHCl3)/cm-1 3443 (OH), 
2920 (C-H), 1637 (C=C arom.), 1161 (P=O), 1109 (C-O), 834 (C-H arom.);  δH 
ppm (400 MHz.) 0.27 (1H, t, JH = 12.5 Hz, cyclohex-CH2), 0.36-0.51 (1H, m, 
cyclohex-CH2), 0.53-0.71 (2H, m, cyclohex-CH2), 0.73-0.82 (2H, m, cyclohex-
CH2), 1.13 (2H, s, cyclohex-CH2), 1.24 (1H, d, JH = 13.4 Hz, cyclohex-CH), 1.31 
(1H, d, JH = 11.7 Hz, cyclohex-CH2), 1.47 (1H, d, JH = 11.3 Hz, cyclohex-CH2),  
2.14 (1H, dd, JH = 13.9, 2.7, JP = 10.6 Hz, CH2), 2.85-2.89 (1H, m, JH = 8.6, 2.8 
Hz, PCH), 3.02-3.11 (1H, m, JH = 12.1 Hz, CH2),  3.27-3.37 (1H, m, JH = 8.6, JP 
= 25.9 Hz, CHOH), 4.49 (1H, s, CHOH), 5.05-5.15 (1H, m, aromatic-H), 7.03-
7.08 (2H, d, JH = 7.1 Hz, aromatic-H), 7.11 (1H, d, JH = 7.2 Hz, aromatic-H), 
7.16 (1H, d, JH = 7.5 Hz, aromatic-H), 7.41-7.52 (6H, m, aromatic-H), 7.77 (2H, 
dd, JH = 13.9, 4.8 Hz, aromatic-H), 7.87-7.93 (2H, m, aromatic-H); δP ppm (400 
MHz.) 38.43; δC ppm (125 MHz.) 25.6 (cyclohex-C), 26.1 (cyclohex-C), 29.2 
(cyclohex-C), 29.9 (cyclohex-C), 32.8 (d, JP = 30.7 Hz, PCHCH2), 40.3 (d, JP = 
63.9 Hz, PCH), 41.7 (d, JP = 30.7 Hz, cyclohex-CH), 76.2 (CHOH), 125.0-139.5 
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(aromatic C and CH); m/z (EI) 419.2 (MH+); HRMS (ES); calc. for C27H32O2P 
(MH+) 419.2129; Found 419.2134; 
 
6.2.41 (1R*, 2R*, 3R*) and (1R*, 2R*, 3S*)-(1-cyclohexyl-1-
hydroxy-3-phenylbutan-2-yl)diphenylphosphine oxide  
Using the method described in section 6.2.34; 
LDA (2 M solution in THF, 4.7 mL, 9.4 mmol) 
was added to a stirred solution of phosphine 
oxide 27 (1 g, 3.1 mmol) in THF (25 mL). 
Cyclohexanecarboxaldehyde 87 (1.2 mL, 1.05 g, 
9.4 mmol), was added and left for 4 hours. The 
organic layer was combined, dried and filtered to 
yield a yellow oil (1.42 g), this was purified by 
column chromatography (50 : 50 v/v, petroleum 
ether : ethyl acetate) to give a mixture of all four diastereoisomers (0.9 g, 69%). 
The crude oil was purified by a combination of column and preparative thin layer 
chromatography (70 : 30 v/v, petroleum ether : ethyl acetate) to yield both 
diastereoisomers in acceptable yield. For further purification, recrystallization 
was used (1 : 1 v/v, toluene : hexane). To give 90a (0.1 g, 8 %), 90c white solid, 
(0.15 g, 12 %), 90b (0.23 g, 18 %) and 90d (0.11 g, 8 %). 
 
2,3-syn-(1-cyclohexyl-1-hydroxy-3-phenylbutan-2-yl)diphenylphosphine 
oxide 90a; m.p. 182.3-183.9 °C; Vmax(CHCl3)/cm-1 3681 (OH), 3161 (C-H), 1922 
(C=C arom.), 1437 (P=O), 1033 (C-O), 754 (C-H arom.); δH ppm (400 MHz.) 
0.33 (1H, ddd, JH = 24.0, 12.2, 3.4 Hz, cyclo-CH2), 0.48 (1H, dt, JH = 12.8, 3.4 
Hz, cyclo-CH2), 0.6 (1H, ddd, JH = 16.1, 12.7, 6.3 Hz, cyclo-CH2), 0.88 (2H, 
2,3-syn 90a; 2,3-anti 90b; 
2,3-syn 90c; 2,3-anti 90d 
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dddd, JH = 15.9, 12.6, 9.2, 4.8 Hz, cyclo-CH2), 1.06 (1H, d, JH = 12.2 Hz, cyclo-
CH2), 1.31 (1H, d, JH = 14.0 Hz, cyclo-CH2), 1.40-1.45 (2H, m, cyclo-CH2 and 
cyclo-CH), 1.50 (1H, s, cyclo-CH2), 1.63 (3H, d, JH = 7.4 Hz, CH3), 2.02 (1H, d, 
JH = 13.1 Hz, cyclo-CH2), 2.92 (1H, dd, JH = 3.9, JP = 10.2 Hz, PCH), 3.32 (1H, 
ddd, JH = 11.9, 7.2 JP = 24.4 Hz, CHPhMe), 3.72 (1H, t, JH = 9.8, JP = 20.6 Hz, 
CHOH), 4.35 (1H, s, OH),  6.98-7.04 (1H, m, aromatic-H), 7.04-7.11 (4H, m, 
aromatic-H), 7.29-7.38 (3H, m, aromatic-H), 7.39-7.46 (3H, m, aromatic-H), 
7.63-7.70 (2H, m, aromatic-H), 7.79 (2H, ddd, JH = 9.8, 6.0, 1.9 Hz,  aromatic-
H); δP ppm (400 MHz.) 40.83;  δC ppm (125 MHz.) 19.0 (CH3), 25.6 (cyclo-CH2), 
25.7 (cyclo-CH2), 26.2 (cyclo-CH2), 29.5 (cyclo-CH2), 30.1 (cyclo-CH2), 36.3 
(CHPhMe), 40.9 (d, JP = 12.0 Hz, cyclo-CH), 42.2 (d, JP = 66.7 Hz, PCH), 76.3 
(CHOH), 126.0-145.9 (aromatic C and CH); m/z (EI) 415 (MH+-H2O), 433.29 
(MH+); HRMS (ES); calc. for C28H34O2P  (MH+) 433.2289; Found 433.2291; 
 
2,3-syn-(1-cyclohexyl-1-hydroxy-3-phenylbutan-2-yl)diphenylphosphine 
oxide 90c; m.p. 201.2-203.0 °C; Vmax(CHCl3)/cm-1 3681 (OH), 3161 (C-H), 1922 
(C=C arom.), 1437 (P=O), 1033 (C-O), 754 (C-H arom.); δH ppm (400 MHz.) -
0.02 (1H, ddd, JH = 24.0, 12.6, 3.3 Hz, cyclo-CH2), 0.07 (1H, m, cyclo-CH2), 
0.32-0.55 (2H, m, cyclo-CH2), 0.56-0.70 (2H, m, cyclo-CH2 and cyclo-CH), 0.81 
(1H, t, JH = 12.4 Hz, cyclo-CH2), 1.16-1.19 (2H, m, cyclo-CH2), 1.28 (1H, s, 
cyclo-CH2), 1.32 (3H, d, JH = 7.2 Hz,  CH3), 1.73-1.79 (1H, m, cyclo-CH2), 2.71 
(1H, ddd, JH = 3.7, 1.9, JP = 9.6 Hz, PCH), 3.11 (1H, ddq, JH = 7.1, 3.9 JP = 7.5 
Hz, CHPhMe), 3.37 (1H, dtd, JH = 7.9, 1.3, JP = 23.3 Hz, CHOH), 4.66 (1H, d, 
JH = 8.1 Hz, OH),  6.85-6.96 (3H, m, aromatic-H), 6.98-7.21 (2H, m, aromatic-
H), 7.26-7.57 (6H, m, aromatic-H), 7.60-7.85 (4H, m, aromatic-H); δP ppm (400 
MHz.) 37.7; δC ppm (400 MHz.) 16.5 (d, JP = 2.6 Hz, CH3), 25.6 (cyclo-CH2), 
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26.0 (cyclo-CH2), 28.9 (cyclo-CH2), 29.7 (cyclo-CH2), 38.3 (CHPhMe), 42.4 (d, 
JP = 1.8 Hz, cyclo-CH), 44.1 (d, JP = 65.0 Hz, PCH), 75.6 (d, JP = 5.0 Hz, 
CHOH), 126.3-145.3 (aromatic C and CH); m/z (EI) 415 (MH+-H2O), 433.29 
(MH+); HRMS (ES); calc. for C28H34O2P  (MH+) 433.2289; Found 433.2295; 
 
2,3-anti-(1-cyclohexyl-1-hydroxy-3-phenylbutan-2-yl)diphenylphosphine 
oxide 90b; m.p 152.4-154.6 °C; Vmax(CHCl3)/cm-1 3681 (OH), 3161 (C-H), 1922 
(C=C arom.), 1437 (P=O), 1033 (C-O), 754 (C-H arom.); δH ppm (400 MHz.) 
0.55 (1H, q, JH = 11.3 Hz, cyclo-CH2), 0.64-0.67 (1H, m, cyclo-CH2), 0.9-1.04 
(1H, m, cyclo-CH2), 1.04-1.14 (2H, m, cyclo-CH2), 1.14-1.19-1.25 (1H, m, cyclo-
CH2), 1.51-1.56 (4H, m, cyclo-CH and CH3), 1.56 (4H, s, cyclo-CH2), 2.89 (1H, 
dd, JH = 2.6, JP = 9.2 Hz, PCH), 3.53-3.62 (1H, m, CHPhMe), 3.65 (1H, t, JH = 
9.5, JP = 10 Hz, CHOH), 4.41 (1H, s, OH),  6.78 (2H, dd, JH = 6.5, 2.8 Hz, 
aromatic-H), 6.96-7.10 (3H, m, aromatic-H), 7.14 (2H, dd, JH = 7.6, 2.9 Hz, 
aromatic-H), 7.23-7.30 (1H, m, aromatic-H), 7.30-7.39 (3H, m, aromatic-H), 
7.42-7.51 (2H, m, aromatic-H), 7.69 (2H, ddd, JH = 9.8, 6.4, 1.9 Hz, aromatic-
H); δP ppm (400 MHz.) 37.4; δC ppm (125 MHz.) 19.2 (d, JP = 6.8 Hz, CH3), 25.4 
(cyclo-CH2), 29.3 (cyclo-CH2), 34.9 (CHPhMe), 39.9 (d, JP = 11.1 Hz, cyclo-
CH), 44.9 (d, JP = 67.3 Hz, PCH), 75.9 (d, JP = 2.6 Hz, CHOH), 125.7-146.7 
(aromatic C and CH); m/z (EI) 415 (MH+-H2O), 433.29 (MH+); HRMS (ES); calc. 
for C28H34O2P  (MH+) 433.2289; Found 433.2301; 
 
2,3-anti-(1-cyclohexyl-1-hydroxy-3-phenylbutan-2-yl)diphenylphosphine 
oxide 90d; m.p. 161.2-162.7 °C; Vmax(CHCl3)/cm-1 3681 (OH), 3161 (C-H), 1922 
(C=C arom.), 1437 (P=O), 1033 (C-O), 754 (C-H arom.); δH ppm (400 MHz.) 
0.48-0.53 (3H, m, cyclo-CH2), 0.71-0.82 (3H, m, cyclo-CH2), 0.92-1.02 (1H, m, 
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cyclo-CH), 1.14 (3H, d, JH = 7.1 Hz, CH3), 1.30 (1H, d, JH = 6.9 Hz, cyclo-CH2), 
1.37 (1H, s, cyclo-CH2), 1.50 (1H, d, JH = 14.3 Hz, cyclo-CH2), 1.79 (1H, d, JH = 
12.7 Hz, cyclo-CH2),  2.93 (2H, dtd, JH = 6.8, 2.8, JP = 6.8 Hz, PCH), 3.38-3.46 
(1H, m, CHPhMe and CHOH), 3.75 (1H, d, JH = 6.8 Hz, OH), 7.03-7.10 (3H, m, 
aromatic-H), 7.11-7.18 (2H, m, aromatic-H), 7.32 (2H, ddd, JH = 8.4, 5.3, 2.2 
Hz, aromatic-H), 7.36-7.44 (4H, m, aromatic-H), 7.62-7.67 (2H, m, aromatic-H), 
7.81 (2H, ddd, JH = 11.2, 7.7, 1.7 Hz, aromatic-H); δP ppm (400 MHz.) 36.24; δC 
ppm (125 MHz.) 20.9 (d, JP = 5.2 Hz, CH3), 25.8 (cyclo-CH2), 26.1 (cyclo-CH2), 
28.6 (cyclo-CH2), 30.1 (cyclo-CH2), 39.2 (CHPhMe), 41.3 (cyclo-CH), 47.1 (d, JP 
= 66.9 Hz, PCH), 77.6 (d, JP = 5.1 Hz, CHOH), 126.3-144.4 (aromatic C and 
CH); m/z (EI) 415 (MH+-H2O), 433.29 (MH+); HRMS (ES); calc. for C28H34O2P  
(MH+) 433.2289; Found 433.2292; 
 
6.2.42 (1R*, 2R*, 3R*) and (1R*, 2R*, 3S*)-(1-cyclohexyl-1-
hydroxy-3-phenylpentan-2-yl)diphenylphosphine oxide  
Using the method described in section 
6.2.34; LDA (2 M solution in THF, 2.3 mL, 
4.5 mmol) was added to a stirred solution of 
phosphine oxide 37 (0.5 g, 1.5 mmol) in THF 
(30 mL). Cyclohexanecarboxaldehyde 87 
(0.6 mL, 0.5 g, 4.5 mmol), was added and 
left for 4 hours. The organic layer was 
combined, dried and filtered to yield a yellow 
oil (0.75g), which was purified by column 
chromatography (70 : 30, petroleum ether : ethyl acetate) to give a yellow solid 
(0.51 g, 78%). This was purified further to separate out the diastereoisomers, 
2,3-syn 91a; 2,3-anti 91b; 
2,3-syn 91c; 2,3-anti 91d 
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the samples (0.1 g) were dissolved in 1 : 1 v/v, MeOH : DMSO (1 mL) and 
purified by Open Access Mass Directed Auto Prep on Sunfire C18 column using 
Acetonitrile Water with a Formic acid modifier. The gradient employed was 
method E, selected from 5 pre-set methods (A, B, C, D or E). The solvent was 
removed under a stream of nitrogen in the Radley's blow-down apparatus to 
give the required products; 91b (0.065 g, 10 %) and 91a (0.099 g, 15 %).    
 
2,3-anti-(1-cyclohexyl-1-hydroxy-3-phenylpentan-2-yl)diphenylphosphine 
oxide 91b; m.p. 164.4-166.7 °C; Vmax(CHCl3)/cm-1 3163 (OH), 2923 (C-H), 1637 
(C=C arom.), 1033 (P=O), 1002 (C-O), 775 (C-H arom.); δH ppm (400 MHz.) 
0.42-0.45 (1H, m, cyclo-CH2), 0.58 (3H, t, JH = 7.3 Hz, CH3), 0.60-0.63 (1H, m, 
cyclo-CH2), 0.71-0.75 (1H, m, cyclo-CH2), 0.85-0.93 (1H, m, cyclo-CH2), 1.04 
(2H, dtdd, JH = 13.1, 9.9, 6.6 Hz, cyclo-CH2), 1.16 (1H, d, JH = 12.2 Hz, cyclo-
CH2), 1.54-1.62 (4H, m, cyclo-CH2 and cyclo-CH), 2.12-2.16 (1H, m, cyclo-
CH2), 2.23-2.29 (1H, m, CH2eq), 2.48 (1H, dqd, JH = 14.4, 7.3, 2.8 Hz, CH2ax), 
3.01-3.07 (1H, m, PCH), 3.08-3.12 (1H, m, PCHCH), 3.81 (1H, dd, JH = 10.4, JP 
= 11.5 Hz, CHOH), 4.34 (1H, s, CHOH), 7.13-7.35 (5H, m, aromatic-H), 7.41-
7.50 (3H, m, aromatic-H), 7.51-7.62 (3H, m, aromatic-H), 7.72-7.81 (2H, m, 
aromatic-H), 7.87-7.93 (2H, m, aromatic-H); δP ppm (400 MHz.) 40.71; δC ppm 
(125 MHz.) 13.1 (CH3), 24.9 (CH2), 24.9 (cyclo-CH2), 29.9 (cyclo-CH2), 41.2 
(cyclo-CH), 44.1 (d, JP = 66.6 Hz, PCH), 44.6 (PCHCH), 76.2 (CHOH), 126.0-
143.9 (aromatic C and CH);  m/z (EI) 447.2 (MH+); HRMS (ES); calc. for 
C29H36O2P (MH+) 447.2442; Found 447.2447; 
 
2,3-syn-(1-cyclohexyl-1-hydroxy-3-phenylpentan-2-yl)diphenylphosphine 
oxide 91a; m.p. 147-148 °C; Vmax(CHCl3)/cm-1 3163 (OH), 2923 (C-H), 1637 
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(C=C arom.), 1033 (P=O), 1002 (C-O), 775 (C-H arom.); δH ppm (400 MHz.) 
0.41 (3H, t, JH = 7.2 Hz, CH3), 0.63-0.69 (3H, m, cyclo-CH2), 0.69-0.71 (2H, m, 
cyclo-CH2), 1.17 (1H, dd, JH = 20.5, 10.8 Hz, cyclo-CH), 1.36-1.41 (1H, m, 
cyclo-CH2), 1.47-1.51 (1H, m, cyclo-CH2), 1.56-1.64 (2H, m, cyclo-CH2), 1.65-
1.69 (2H, m, CH2), 1.91-2.11 (1H, m, cyclo-CH2), 2.97 (1H, ddt, JH = 8.0, 1.7, JP 
= 16.9 Hz, PCH), 3.12 (1H, ddd, JH = 10.0, 3.8, JP = 16.2 Hz, PCHCH), 3.36 
(1H, dt, JH = 8.5, JP = 23.4 Hz, CHOH), 4.00 (1H, d, JH = 7.8 Hz, CHOH), 7.19-
7.21 (3H, m, aromatic-H), 7.28-7.35 (2H, m, aromatic-H), 7.52-7.69 (6H, m, 
aromatic-H), 7.82-7.91 (2H, m, aromatic-H), 7.94-8.03 (2H, m, aromatic-H); δP 
ppm (400 MHz.) 38.24; δC ppm (125 MHz.) 12.4 (CH3), 25.6 (CH2), 26.1 (cyclo-
CH2), 29.0 (d, JP = 4.8 Hz, cyclo-CH2), 29.1 (cyclo-CH2), 30.1 (cyclo-CH2), 41.6 
(cyclo-CH), 46.5 (d, JP = 66.3 Hz, PCH), 47.0 (PCHCH), 77.2 (CHOH), 126.5-
142.0 (aromatic C and CH);  m/z (EI) 447.2 (MH+); HRMS (ES); calc. for 
C29H36O2P (MH+) 447.2442; Found 447.2447; 
 
6.2.43 (1R*, 2R*, 3R*) and (1R*, 2R*, 3S*)-(3-(4- chlorophenyl)-
1-cyclohexyl-1-hydroxy-4-methylpentan-2-yl) 
diphenylphosphine oxide  
Using the method described in section 
6.2.34; LDA (2 M solution in THF, 2 
mL, 3.9 mmol) was added to a stirred 
solution of phosphine oxide 38 (0.5 g, 
1.3 mmol) in THF (100 mL). 
Cyclohexanecarboxaldehyde 87 (0.5 
mL, 0.4 g, 3.9 mmol), was added and 
2,3-syn 92a; 2,3-anti 92b; 
2,3-syn 92c; 2,3-anti 92d 
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left for 4 hours. The organic layer was combined, dried and filtered to yield a 
yellow oil (0.6 g), which was purified by column chromatography (70 : 30, 
petroleum ether : ethyl acetate) to give a yellow solid (0.6 g, 93%). This was 
purified further to separate out the diastereoisomers, the samples (0.1 g) were 
dissolved in 1 : 1 v/v MeOH : DMSO (1 mL) and purified by Open Access Mass 
Directed Auto Prep on Sunfire C18 column using Acetonitrile Water with a 
Formic acid modifier. The gradient employed was method D, selected from 5 
pre-set methods (A, B, C, D or E). The solvent was dried under a stream of 
nitrogen in the Radley's blow-down apparatus to give the required products. To 
give 92d (0.018 g, 3 %), 92a (0.06 g, 9 %), 92c (0.08 g, 13 %) and 92b (0.16 g, 
25 %). 
 
2,3-anti-(3-(4-chlorophenyl)-1-cyclohexyl-1-hydroxy-4-methylpentan-2-
yl)diphenylphosphine oxide 92d; m.p. 101.1-103.1 °C; Vmax(CHCl3)/cm-1 3412 
(OH), 2924 (C-H), 1638 (C=C arom.), 1014 (P=O), 879 (C-O), 705 (C-H arom.), 
692 (C-Cl); δH ppm (400 MHz.) 0.22-0.25 (1H, m, cyclo-CH2), 0.66-0.69 (6H, m, 
2CH3), 0.69-0.71 (1H, m, cyclo-CH2), 0.79-0.82 (2H, m, cyclo-CH2), 1.02-1.05 
(2H, m, cyclo-CH2), 1.35 (2H, d, JH = 10.7 Hz, cyclo-CH2), 1.47 (1H, d, JH = 7.5 
Hz, cyclo-CH2), 1.72-1.81 (1H, m, JH = 10.6 Hz, cyclo-CH), 2.32-2.39 (2H, m, 
cyclo-CH2), 2.63 (1H, d, JH = 6.8 Hz,  CHCH3(CH3)), 3.13-3.17 (1H, m, PCHCH 
and PCH), 3.79 (1H, dt, JH = 10.9, JP = 21.8 Hz, CHOH), 5.44 (1H, d, JH = 11.3 
Hz, CHOH), 6.54 (2H, d, JH = 8.4 Hz, aromatic-H), 6.92 (2H, d, JH = 8.5 Hz, 
aromatic-H), 7.10 (2H, ddd, JH = 10.5, 7.8, 3.1 Hz, aromatic-H), 7.17-7.25 (2H, 
m, aromatic-H), 7.27-7.42 (2H, m, aromatic-H), 7.56-7.79 (2H, dt, JH = 7.5, 3.5 
Hz, aromatic-H), 7.81-7.91 (2H, m, aromatic-H); δP ppm (400 MHz.) 41.08; δC 
ppm (125 MHz.) 16.5 (CH3), 21.9 (CH3), 25.3 (cyclo-CH2), 25.8 (cyclo-CH2), 
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26.2 (cyclo-CH2), 27.3 (d, JP = 9.9 Hz, CHCH3(CH3)), 29.9 (cyclo-CH2), 30.9 
(cyclo-CH2), 41.8 (cyclo-CH), 42.2 (d, JP = 52.6 Hz, PCH), 47.2 (PCHCH), 77.1 
(CHOH), 127.4-138.2 (aromatic C and CH); m/z (EI) 495.21 (MH+); HRMS (ES); 
calc. for C30H37ClO2P (MH+) 495.2210; Found 495.2214; 
 
2,3-syn-(3-(4-chlorophenyl)-1-cyclohexyl-1-hydroxy-4-methylpentan-2-
yl)diphenylphosphine oxide 92a; m.p. 140.1-141.2 °C; Vmax(CHCl3)/cm-1 3412 
(OH), 2924 (C-H), 1638 (C=C arom.), 1014 (P=O), 879 (C-O), 705 (C-H arom.), 
692 (C-Cl); δH ppm (400 MHz.) 0.68-0.71 (5H, m, CH3 and cyclo-CH2), 0.89 (3H, 
d, JH = 6.7 Hz, CH3), 1.00-1.14 (1H, m, cyclo-CH2), 1.21-1.29 (1H, m, cyclo-
CH2), 1.71-1.81 (4H, m, cyclo-CH2), 1.83 (2H, dt, JH = 10.8, 8.5 Hz, cyclo-CH2 
and cyclo-CH), 2.23 (1H, d, JH = 15.1 Hz, cyclo-CH2), 2.55-3.23 (1H, m, 
CHCH3(CH3)), 3.24 (1H, dd, JH = 9.4, JP = 17.4, Hz, PCH), 3.32 (1H, td, JH = 
8.5, 3.5, JP = 8.4 Hz, PCHCH), 3.81 (1H, dd, JH = 10.0, JP = 21.7 Hz, CHOH), 
4.11 (1H, s, CHOH), 6.80 (2H, dd, JH = 8.9, 2.0 Hz, aromatic-H), 6.84-6.91 (2H, 
m, aromatic-H), 7.20-7.34 (2H, m, aromatic-H), 7.34-7.45 (1H, m, aromatic-H), 
7.47-7.71 (5H, m, aromatic-H), 7.79-7.97 (2H, m, aromatic-H); δP ppm (400 
MHz.) 39.47; δC ppm (125 MHz.) 19.4 (CH3), 22.4 (CH3), 25.7 (cyclo-CH2), 26.2 
(cyclo-CH2), 25.9 (cyclo-CH2), 29.1 (d, JP = 9.0 Hz, CHCH3(CH3)), 30.2 (d, JP = 
5.6 Hz, cyclo-CH2), 40.9 (d, JP = 50.6 Hz, PCH), 41.4 (cyclo-CH), 47.7 
(PCHCH), 75.6 (d, JP = 5.2 Hz, CHOH), 127.1-138.4 (aromatic C and CH); m/z 
(EI) 495.21 (MH+); HRMS (ES); calc. for C30H37ClO2P (MH+) 495.2210; Found 
495.2214; 
 
2,3-anti-(3-(4-chlorophenyl)-1-cyclohexyl-1-hydroxy-4-methylpentan-2-
yl)diphenylphosphine oxide 92b; m.p. 111.4-113.6 °C; Vmax(CHCl3)/cm-1 3412 
234 
 
(OH), 2924 (C-H), 1638 (C=C arom.), 1014 (P=O), 879 (C-O), 705 (C-H arom.), 
692 (C-Cl); δH ppm (400 MHz.) 0.32 (3H, d, JH = 6.6 Hz, CH3), 0.51-0.71 (2H, m, 
cyclo-CH2), 0.80-0.91 (2H, m, cyclo-CH2), 0.92 (3H, d, JH = 6.6 Hz, CH3), 1.08-
1.10 (1H, m, cyclo-CH), 1.27-1.31 (1H, m, cyclo-CH2), 1.49-1.51 (3H, m, cyclo-
CH2), 1.65 (1H, s, cyclo-CH2), 1.87 (1H, d, JH = 13.0 Hz, cyclo-CH2), 2.18 (1H, 
dq, JH = 13.0, 6.4 Hz, CHCH3(CH3)), 3.27 (1H, ddd, JH = 6.8, 2.1, JP = 10.6, Hz, 
PCH), 3.36 (1H, dd, JH = 6.5, JP = 14.6 Hz, PCHCH), 3.45 (1H, s, CHOH), 3.68 
(1H, dd, JH = 9.9, JP = 12 Hz, CHOH), 7.14-7.21 (2H, m, aromatic-H), 7.24-7.32 
(2H, m, aromatic-H), 7.50-7.81 (6H, m, aromatic-H), 7.88-7.91 (2H, ddd, JH = 
10.3, 6.2, 2.0 Hz, aromatic-H), 7.94-8.12 (2H, m, aromatic-H); δP ppm (400 
MHz.) 37.77; δC ppm (125 MHz.) 20.1 (CH3), 22.7 (CH3), 25.6 (d, JH = 2.4 Hz, 
cyclo-CH2), 26.1 (cyclo-CH2), 29.3 (cyclo-CH2), 29.7 (cyclo-CH2), 30.3 (d, JH = 
6.8 Hz, CHCH3(CH3)), 40.7 (d, JH = 9.8 Hz, cyclo-CH), 43.2 (d, JH = 66.6 Hz, 
PCH), 48.4 (PCHCH), 75.5 (CHOH), 127.7-140.4 (aromatic C and CH); m/z (EI) 
495.21 (MH+); HRMS (ES); calc. for C30H37ClO2P (MH+) 495.2210; Found 
495.2214; 
2,3-syn-(3-(4-chlorophenyl)-1-cyclohexyl-1-hydroxy-4-methylpentan-2-
yl)diphenylphosphine oxide 92c; m.p. 122.4-123.2 °C; Vmax(CHCl3)/cm-1 3412 
(OH), 2924 (C-H), 1638 (C=C arom.), 1014 (P=O), 879 (C-O), 705 (C-H arom.), 
692 (C-Cl); δH ppm (400 MHz.) 0.59 (3H, d, JH = 6.5 Hz, CH3), 0.68-0.72 (2H, m, 
cyclo-CH2), 0.80-0.83 (2H, m, cyclo-CH2), 0.91 (3H, d, JH = 6.6 Hz, CH3), 1.01-
1.08 (1H, m, cyclo-CH), 1.52-1.57 (5H, m, cyclo-CH2), 1.99 (1H, d, JH = 12.6 
Hz, cyclo-CH2), 2.10 (1H, dq, JH = 13.2, 6.6 Hz, CHCH3(CH3)), 2.91 (1H, ddd, 
JH = 9.0, 4.7, JP = 10.5, Hz, PCHCH), 3.27  (1H, ddd, JH = 4.7, 3.7, JP = 11.6 
Hz, PCH), 3.79 (1H, ddd, JH = 7.8, 5.6, JP = 24.8 Hz, CHOH), 3.99 (1H, d, JH = 
6.3 Hz, CHOH), 6.99 (2H, d, JH = 8.5 Hz, aromatic-H), 7.19 (2H, t, JH = 7.1 Hz, 
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aromatic-H), 7.52-7.69 (6H, m, aromatic-H), 7.90 (4H, dddd, JH = 18.7, 10.8, 
7.9, 1.7 Hz, aromatic-H); δP ppm (400 MHz.) 36.22; δC ppm (125 MHz.) 20.8 
(CH3), 21.7 (CH3), 25.8 (d, JH = 5.3 Hz, cyclo-CH2), 26.1 (cyclo-CH2), 29.5 
(cyclo-CH2), 30.1 (d, JH = 9.4 Hz, CHCH3(CH3)), 30.4 (cyclo-CH2), 40.9 (d, JH = 
67.5 Hz, PCH), 42.4 (cyclo-CH), 51.1 (PCHCH), 75.7 (d, JH = 5.2 Hz, CHOH), 
127.6-138.2 (aromatic C and CH);  m/z (EI) 495.21 (MH+); HRMS (ES); calc. for 
C30H37ClO2P (MH+) 495.2210; Found 495.2214; 
 
6.2.44 bis(3-methoxyphenyl)(phenethyl)phosphine oxide  94 
Bis(3-methoxyphenyl)phosphine oxide 
100 (0.25 g, 0.95 mmol) in toluene (20 
mL) was then charged with potassium 
hydroxide (0.08 g, 1.42 mmol) at room 
temperature. After 5 minutes, tetra(n-
butyl)ammonium iodide (0.176 g, 0.47 
mmol) was added along with (2-
bromoethyl)benzene (0.27 g, 0.19 mL, 
1.42 mmol). The yellow suspension was then heated to 70 °C for 1 hour 30 
minutes. Once the reaction was completed (monitored by TLC), it was allowed 
to cool to room temperature were water (50 mL) was added to the cloudy 
reaction mixture, the organic layer was removed and washed with ethyl acetate, 
dried, filtered and reduced in vacuo, to give a clear oil.  The oil was purified 
using column chromatography (70 : 30 v/v;  ethyl acetate : petroleum ether), Rf  
0.32, to yield a clear oil 94 (0.2g, 59 %). 
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Vmax(CHCl3)/cm-1 2937 (C-H), 1590 (C=C arom.), 1235 (P=O), 1150 (C-O), 743 
(C-H arom.); δH ppm (400 MHz.) 2.53 (2H, ddd, JP = 10.8, JH = 9.7, 4.5 Hz, 
CH2CH2), 2.89 (2H, dtd, JH = 10.3, JP = 24.8, 12.7 Hz, CH2CH2), 3.79 (6H, s, 
OCH3), 7.01-7.09 (2H, m, aromatic-CH), 7.14-7.16 (3H, m, aromatic-CH), 7.19 
(2H, dd, JP = 7.2, 5.3 Hz, aromatic-CH), 7.24-7.29 (2H, m, aromatic-CH), 7.34 
(4H, ddd, JP = 13.9, 7.0, 3.0 Hz, aromatic-CH); δP ppm (400 MHz.) 31.69; δC 
ppm (125 MHz.) 27.5 (d, JP = 3.1 Hz, CH2CH2), 31.9 (d, JP = 70.0 Hz, CH2CH2), 
55.4 (OCH3), 115.7-171.1 (aromatic C and CH);  m/z (EI) 367 (MH+); HRMS 
(ES); calc. for C22H24O3P (MH+) 367.1457; Found 367.1458; 
 
6.2.45 bis(4-fluorophenyl)(phenethyl)phosphine oxide 95 
Using the method described in section 
6.2.44; Bis(4-fluorophenyl)phosphine 
oxide 101 (0.3 g, 1.26 mmol) in toluene 
(40 mL), with potassium hydroxide (0.11 
g, 1.89 mmol). Tetra(n-butyl)ammonium 
iodide (0.232 g, 0.6 mmol) and (2-
bromoethyl)benzene (0.35 g, 0.26 mL, 
1.89 mmol) were added. The oil was purified using column chromatography 
(100  v/v ;  ethyl acetate), to year a white solid 95 (0.2 g, 47 %). 
m.p. 97.7-98.3 °C; Vmax(CHCl3)/cm-1 3132 (C-H), 1592 (C=C arom.), 1351(P=O), 
814 (C-H arom.), 765 (C-F); δH ppm (400 MHz.) 2.47 (2H, ddd, JP = 26.3, JH = 
45.3, 20.6 Hz, PCH2), 2.71-2.90 (2H, m, PCH2CH2), 6.92-7.25 (9H, m, aromatic-
H), 7.67 (4H, ddd, JH = 11.0, 8.4, 5.6 Hz, aromatic-H); δP ppm (400 MHz.) 
30.49; δC ppm (125 MHz.) 27.4 (d, JP = 3.1 Hz, PCH2CH2), 32.1 (d, JP = 70.9 
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Hz, PCH2CH2), 116.2-171.3 (aromatic C and CH);  m/z (EI) 343.1 (MH+); HRMS 
(ES); calc. for C20H18F2OP(MH+) 343.1050; Found 343.1058; 
 
6.2.46 bis(4-methoxyphenyl)(phenethyl)phosphine oxide 96 
Using the method described in section 
6.2.44; Bis(4-methoxyphenyl)phosphine 
oxide 102 (0.42 g, 1.6 mmol) in toluene 
(70 mL), with potassium hydroxide 
(0.14g, 2.4 mmol). Tetra(n-
butyl)ammonium iodide (0.29 g, 0.8 
mmol) and (2-bromoethyl)benzene 
(0.45 g, 0.33 mL, 2.4 mmol) were 
added. The yellow suspension was then 
heated to 90 °C for 5 days. The oil was purified using column chromatography 
(100  v/v ;  ethyl acetate), to year a white solid 96 (0.15 g, 23 %). 
m.p. 85.7-86.3 °C; Vmax(CHCl3)/cm-1 3154 (OH), 2875 (C-H), 1561 (C=C arom.), 
1350 (P=O), 1214 (C-O), 857 (C-H arom.); δH ppm (400 MHz.) 2.95 (2H, t, JH = 
6.9 Hz, PCH2), 3.75 (6H, s, OCH3), 4.07- 4.13 (2H, m, PCH2CH2), 6.82 (3H, dd, 
JP = 8.7, 2.5 Hz, aromatic-H), 7.09-7.26 (6H, m, aromatic-H), 7.53 (4H, dd, JP = 
11.7, 8.5 Hz, aromatic-H); δP ppm (400 MHz.) 32.36; δC ppm (125 MHz.) 37.1 
(d, JP = 7.1 Hz, PCH2), 55.3 (OCH3), 65.1 (d, JP = 5.9 Hz, PCH2CH2), 113.9-
171.2 (aromatic C and CH);  m/z (EI) 367.2 (MH+); HRMS (ES); calc. for 
C22H24O4P (MH+OH)+ 383.1402; Found 383.1407; 
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6.2.47 isobutyldimesitylphosphine oxide 98 
THF (10 mL) was added to bis-(2,4,6-
trimethylphenyl)-phosphine 109 (0.15 g, 0.55 mmol) 
under an argon atmosphere and the remaining 
solution was then cooled to 0 °C. After 10 minutes, 
KHMDS (0.7 M solution, 2.39 mL, 1.66 mmol) was 
added generating a deep orange solution. The 
reaction was left for 40 minutes at this temperature, 
1-bromo-2-methylpropane (0.18 mL, 0.22 g, 1.66 
mmol) was added. After 1 hour at this temperature, 
the reaction was slowly allowed to warm to room temperature and left for a 
further 1 hour, resulting in a clear solution. After the reaction was complete 
(monitored by TLC), H2O2 30 % w/w (10 mL) was added at 0 °C and left for 40 
minutes, on addition of sat.aq. ammonium chloride (60 mL), the solution turned 
colourless almost immediately. THF was then removed and the residue was 
partitioned between dichloromethane and distilled water (1 : 1 v/v), the aqueous 
layer was washed with dichloromethane (3 x 100 mL) and the combined organic 
extracts where washed with sat.aq. brine (3 x 100 mL), dried with MgSO4, 
filtered and the solvent was removed in vacuo to yield a  crude compound as a 
white solid (0.2 g). The white solid was purified by column chromatography (95 : 
5 v/v, petroleum ether : ethyl acetate), to yield a white solid 98 (0.18 g, 95 %).  
m.p. 55.6-57.9 °C; Vmax(CHCl3)/cm-1 2955 (C-H), 1604 (C=C arom.), 1460 
(P=O), 1181 (C-H arom.); δH ppm (400 MHz.) 0.93 (6H, d, JH = 6.6 Hz, 
CH(CH3)2), 1.91 (1H, ddd, JH = 19.6, 6.4, JP = 12.9  Hz, CH(CH3)2), 2.20 (6H, s, 
mes-CH3), 2.26 (1H, dd, JH = 5.4, JP = 10.1 Hz, PCH), 2.30 (12H, s, mes-CH3), 
6.75 (1H, d, JH = 3.3 Hz,  aromatic-H); δP ppm (400 MHz.) 41.07; δC ppm (125 
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MHz.) 20.9 (mes-CH3), 22.9 (d, JP = 3.8 Hz, mes-CH3), 24.6 (d, JP = 3.5 Hz, 
CH3), 25.3 (d, JP = 8.5 Hz, CH(CH3)3), 44.3 (d, JP = 66.3 Hz, PCH), 130.4-141.2 
(aromatic C and CH); m/z (EI) 343.4 (MH+);  
 
6.2.48 bis(3-methoxyphenyl)phosphine oxide 100 
A 250 mL flask was equipped with an additional funnel to 
evacuate/argon filled (x3) then charged with 3-
methoxyphenylmagnesium bromide (1M in THF solution, 25 
mL, 25 mmol), the solution was cooled to 0 °C. A solution of 
diethylphosphonate (0.98 mL, 7.57 mmol) in THF (10 mL) 
was added dropwise over 15 minutes. The mixture was 
aged 15 minutes at 0 °C, allowed to warm to room temperature and stirred for 2 
hours. After this time, the mixture was again cooled to 0 °C, were HCl (0.1 M 
solution, 19 mL) was added dropwise over 20 minutes, followed directly after by 
MTBE (19 mL), the mixture was well agitated for 5 minutes. The upper organic 
phase was decanted from the gel and saved. To the remaining gel, DCM (100 
mL) was added and the mixture was well agitated for 10 minutes. The  resulting 
mixture was then filtered through a pad of Celite®, washing well with DCM. The 
filtrate phases where separated and recombined with the first organic phase, 
dried with MgSO4 and the solvent removed in vacuo to give a clear oil. The oil 
was purified using column chromatography (100 % v/v ethyl acetate), Rf  0.4, to 
yield a off white solid 110 (1.45 g, 74 %). 
m.p. 111.7-112.1 °C; Vmax(CHCl3)/cm-1 2940 (OH), 2833 (P-H), 2773 (C-H), 
1591 (C=C arom.), 1239 (P=O), 907 (C-O), 765 (C-H arom.); δH ppm (400 
MHz.) 3.50 (6H, d, JP = 1.8 Hz, OCH3), 6.79 (2H, dd, JP = 8.2, JH = 1.0 Hz, 
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aromatic-H), 6.92-6.99 (1H, m, aromatic-H), 6.99-7.06 (3H, m, aromatic-H), 
7.06-7.14 (2H, m, aromatic-H), 7.76 (1H, d, JP = 483.7 Hz, PH); δP ppm (400 
MHz.) 20.96; δC ppm (125 MHz.) 55.1 (d, JP = 5.5 Hz, OCH3), 115.1-159.6 
(aromatic C and CH); m/z (EI) 263 (MH+); HRMS (ES); calc. for C14H16O3P 
(MH+) 263.0827; Found 263.0832; 
 
6.2.49 bis(4-methoxyphenyl)phosphine oxide 101 
Using the method described in section 6.2.48; A 
solution of diethylphosphonate (0.98 mL, 7.57 mmol) 
in THF (10 mL) was added to 4-
methoxyphenylmagnesium bromide (0.5 M in THF 
solution, 50 mL, 25 mmol). The oil was purified using 
column chromatography (100 % v/v ethyl acetate), Rf  
0.51, to yield a off white solid 101 (1.59 g, 83 %) 145. 
m.p. 127.3-129.1 °C; m.p. lit 124-125 °C; Vmax(CHCl3)/cm-1 2540 (P-H), 2143 (C-
H), 1691 (C=C arom.), 1301 (P=O), 1325 (C-O), 712 (C-H arom.); δH ppm (400 
MHz.) 3.78 (6H, s, OCH3), 6.92 (4H, dd, JP = 8.6, JH =  2.0 Hz, aromatic-H), 
7.54 (4H, dd, JP = 13.1, JH = 8.5 Hz, aromatic-H) 7.96 (1H, d, JP = 477.8 Hz, 
PH); δP ppm (400 MHz.) 20.72; δC ppm (125 MHz.) 55.4 (OCH3), 114.5-162.9 
(aromatic C and CH); m/z (EI) 263.2 (MH+); HRMS (ES); calc. for C14H16O3P 
(MH+) 263.0828; Found 263.0832; 
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6.2.50 bis(4-fluorophenyl)phosphine oxide 102 
Using the method described in section 6.2.48; A 
solution of diethylphosphonate (0.98 mL, 7.57 mmol) in 
THF (10 mL) was added to 4-fluorophenylmagnesium 
bromide (1 M in THF solution, 25 mL, 25 mmol), The 
oil was purified using column chromatography (100 % 
v/v ethyl acetate), Rf  0.42, to yield a off white solid 102 
(1.62 g, 83 %) 146.  
m.p. 122.7-123.1 °C; (no lit. m.p.); Vmax(CHCl3)/cm-1 2943 (P-H), 2134 (C-H), 
1599 (C=C arom.), 1305 (P=O), 977 (C-O), 840 (C-H arom.), 698 (C-F); δH ppm 
(400 MHz.) 7.06-7.15 (4H, m, aromatic-H), 7.56-7.65 (4H, m, aromatic-H), 7.99 
(1H, d, JP = 486.6 Hz, PH); δP ppm (400 MHz.) 18.99; δC ppm (125 MHz.) 116.5-
166.7 (aromatic C and CH); m/z (EI) 239 (MH+); HRMS (ES); calc. for 
C12H10F2OP (MH+) 239.0432; Found 239.0432; 
 
6.2.51 dicyclohexylphosphine oxide 104 
Using the method described in section 6.2.48; A solution of 
diethylphosphite (0.98 mL, 7.57 mmol) in THF (10 mL) was 
added to cyclohexylmagnesium bromide (1M in THF 
solution, 25 mL, 25 mmol). The oil was purified using 
column chromatography (100 % v/v ethyl acetate), Rf  0.1, 
to yield a white solid104 (1.53 g, 78 %) 109. 
m.p. 81-83 °C; m.p. lit 71-73 °C;  Vmax(CHCl3)/cm-1 2852 (P-H), 2448 (C-H), 254 
(P=O); δH ppm (400 MHz.) 0.63-0.71 (7H, m, cyclo-CH2), 0.81-0.97 (4H, m, 
cyclo-CH2), 1.13-1.19 (7H, m, cyclo-CH2), 1.21-1.31 (2H, m, cyclo-CH2), 1.35-
102 
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1.39 (2H, m, cyclo-CH), 5.67 (1H, dt, JH = 2.8, JP = 434.3 Hz, PH); δP ppm (400 
MHz.) 49.8; δC ppm (125 MHz.) 24.3 (d, JP = 3.5 Hz, cyclo-CH2), 25.1 (d, JP = 
1.3 Hz, cyclo-CH2), 25.3 (cyclo-CH2), 25.4 (cyclo-CH2), 25.6 (cyclo-CH2), 33.8 
(cyclo-CH), 34.5 (cyclo-CH); m/z (EI) 215.4 (MH+); HRMS (ES); calc. for C11H15 
(MH+) 215.1560; Found 215.1559; 
 
6.2.52 3,5-dinitrobenzaldehyde 121 
To a solution of oxalyl chloride (0.71  g, 0.47 mL, 5.55  
mmol) in dry DCM (24 mL) a solution of dry DMSO (0.95 
g, 0.86 mL, 12.1 mmol) in dry DCM (5 mL) was added at 
-72 °C. After 10 minutes, a solution of 3(3,5-
dinitrophenyl)methanol  122 (1 g, 5.0 mmol) in dry DCM 
(30 mL) was added at this temperature. After 15 
minutes, triethylamine (7.1 mL 50.4 mmol) was added portion wise over a 5 
minute period. After a further 5 minutes at this temperature, the reaction was 
allowed to warm to room temperature of 1 hour. Once the reaction was 
completed (monitored by TLC), H2O (100 mL) to terminate the reaction. The 
phases were separated and the organic layer was washed with brine, dried, 
filtered and the solvent was reduced in vacuo to yield a yellow oil (1.2 g). The 
yellow oil was further purified by difficult column chromatography (50  :  50 v/v, 
petroleum ether : ethyl acetate) to yield the title product as a orange solid 121 
(0.85 g, 98 %).  
m.p. 82-83 °C; m.p. lit 70 °C 147;  Vmax(CHCl3)/cm-1 3212 (C-H), 1754 (CHO), 
1652 (C=C arom.), 1342 (NO2), 776 (C-H arom.); δH ppm (400 MHz.) 8.99 (2H, 
d, JH = 2.1 Hz, aromatic-H), 9.23 (1H, t, JH = 2.1 Hz, aromatic-H), 10.15 (1H, 
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HC=O); δC ppm (125 MHz.) 123.4-149.4 (aromatic C and CH), 187.2 (HC=O); 
m/z (EI) 197 (MH+); HRMS (ES); calc. for C9H11N3O7 (MNH4OAc+) 272.; Found 
272.1259; 
6.2.53 (2R*, 3R*) and (2R*, 3S*)-(3-cyclohexyl-1-hydroxy-1-
(naphthalen-1-yl)propan-2-yl)diphenylphosphine oxide  
LDA (2 M solution in THF, 0.96 mL, 1.92 
mmol) was added drop wise to a stirred 
solution of phosphine oxide 40 (0.2 g, 0.64 
mmol) in dry THF (20 mL) at -72 °C under an 
argon atmosphere. The resulting red solution 
was stirred for 2 hours at this temperature. 
After this time 1-naphthaldehyde 28 (0.26 mL, 
0.30 g, 1.92 mmol), was added drop wise and 
was left to stir at this temperature for a further 4 hours. After the stated time, 
sat.aq. ammonium chloride (10 mL) was added, were the solution turned clear, 
here it was allowed to warm up to room temperature. THF was removed in situ 
and the residue was dissolved in dichloromethane and water (1 : 1 v/v, 50 mL). 
The organic layer was combined, dried and filtered to yield a yellow oil (0.38 g), 
which was purified by preparative chromatography (40 : 40, petroleum ether : 
ethyl acetate) to give a yellow solid (0.29 g, 96 %), to give the required 
products; 123a (0.16 g, 54 %) and 123b (0.11 g, 36 %). 
 
(2R*,3R*)-(3-cyclohexyl-1-hydroxy-1-(naphthalen-1-yl)propan-2-yl) 
diphenylphosphine oxide 123a; Vmax(CHCl3)/cm-1 3325 (OH) , 2922 (C-H), 
1723 (C=C arom.), 1438 (P=O), 1232 (C-O), 967 (C-H arom.); δH ppm (400 
MHz.) -0.19 (1H, ddd, JH = 24.6, 12.4, 3.5 Hz, cyclo-CH2), 0.2-0.22 (2H, cyclo-
2,3-syn 123a; 2,3-anti 123b 
244 
 
CH2), 0.32-0.46 (2H, m, cyclo-CH2), 0.78 (1H, d, JH = 13.2 cyclo-CH), 1.27-1.29 
(3H, m, cyclo-CH2), 1.40-1.47 (2H, m, cyclo-CH2),  1.50-1.60 (1H, m, PCHCH2), 
1.71 (1H, ddd, JH = 13.8, 11.0, JP = 6.8 Hz, PCHCH2), 2.53 (1H, q, JH = 5.1, JP 
= 5.1 Hz, PCH), 5.13 (1H, s, OH), 5.72 (1H, d, JP = 23.2 Hz, CHOH), 6.86-6.92 
(2H, m, aromatic-H), 6.97-7.02 (1H, m, aromatic-H), 7.08 (3H, dd, JH 9.0, 6.0 
Hz,  aromatic-H), 7.25 (1H, dt, JH 10.9, 2.7 Hz, aromatic-H), 7.53-7.63 (5H, m, 
aromatic-H), 7.52-7.58 (3H, m, aromatic-H), 8.08-8.14 (2H, m, aromatic-H); δP 
ppm (400 MHz.) 41.54; δC ppm (125 MHz.) 25.8 (cyclo-CH2), 26.2 (cyclo-CH2), 
31.8 (cyclo-CH2), 33.9 (cyclo-CH2), 34.5 (PCHCH2), 36.8 (cyclo-CH), 38.5 (d, JP 
= 67.7 Hz, PCH), 72.8 (CHOH), 122.4-133.6 (aromatic C and CH); m/z (EI) 469 
(MH+); HRMS (ES); calc. for C31H33O2P (MH+) 469.2286; Found 469.2291; 
 
(2R*,3S*)-(3-cyclohexyl-1-hydroxy-1-(naphthalen-1-yl)propan-2-yl) 
diphenylphosphine oxide 123b; Vmax(CHCl3)/cm-1 3325 (OH) , 2922 (C-H), 
1723 (C=C arom.), 1438 (P=O), 1232 (C-O), 967 (C-H arom.); δH ppm (400 
MHz.) -0.12 (1H, ddd, JH = 13.9, 7.0, 3.5 Hz, cyclo-CH), 0.02 (1H, ddd, JH = 
24.8, 12.4, 3.5 Hz, cyclo-CH2), 0.29-0.53 (2H, m, cyclo-CH2), 0.54-0.70 (1H, 
ddd, JH = 24.8, 12.4, 3.5 Hz, cyclo-CH2), 0.74-0.91 (2H, m, cyclo-CH2), 0.98 
(1H, d, JH = 13.7 Hz, cyclo-CH2),  1.20-1.42 (3H, m, cyclo-CH2), 1.42-1.57 (1H, 
m, PCHCH2), 1.82-1.98 (1H, m, PCHCH2), 2.74 (1H, dd, JH = 5.0, JP = 10.1 Hz, 
PCH), 5.33 (1H, s, OH), 6.05 (1H, d, JP = 9.6 Hz, CHOH), 7.33-7.40 (1H, m, 
aromatic-H), 7.46 (1H, ddd, JH = 8.25, 5.7, 1.3 Hz,  aromatic-H) 7.57-7.66 (5H, 
m, aromatic-H), 7.79-7.83 (2H, m, aromatic-H), 7.87 (1H, d, JH = 8.1 Hz, 
aromatic-H) 7.91-7.90 (1H, m, aromatic-H), 8.00 (4H, ddd, JH = 7.7, 5.6, 3.1 Hz, 
aromatic-H), 8.28 (2H, m, aromatic-H); δP ppm (400 MHz.) 40.67; δC ppm (125 
MHz.) 25.9 (cyclo-CH2), 28.1 (PCHCH2), 31.8 (cyclo-CH2), 32.8 (cyclo-CH2), 
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36.8 (cyclo-CH), 40.5 (d, JP = 66.9 Hz, PCH), 67.6 (d, JP = 2.4 Hz, CHOH), 
121.9-136.9 (aromatic C and CH); m/z (EI) 469 (MH+); HRMS (ES); calc. for 
C31H33O2P (MH+) 469.2286; Found 469.2291; 
 
6.2.54 (2R*, 3R*) and (2R*, 3S*)-(3-cyclohexyl-1-hydroxy-1-
phenylpropan-2-yl)diphenylphosphine oxide  
Using the method described in section 6.2.53; 
LDA (2 M solution in THF, 0.96 mL, 1.92 mmol) 
was added to a stirred solution of phosphine 
oxide  40 (0.2 g, 0.64 mmol) in dry THF (20 mL). 
Benzaldehyde 81 (0.19 mL, 0.20 g,  1.92 mmol) 
was added. The organic layer was combined, 
dried and filtered to yield a yellow oil (0.3 g), 
which was purified by preparative 
chromatography (40 : 40, petroleum ether : ethyl acetate) to give a yellow solid 
(0.25 g, 93 %), to give the required products; 124a (0.183 g, 67 %) and 124b 
(0.06 g, 22 %). 
 
(2R*,3R*)-(3-cyclohexyl-1-hydroxy-1-phenylpropan-2-yl) 
diphenylphosphine oxide 124a; m.p. 125.4-125.9 °C; Vmax(CHCl3)/cm-1 3316 
(OH), 2922 (C-H), 1637 (C=C arom.), 1432 (P=O), 1161 (C-O), 719 (C-H 
arom.); δH ppm (400 MHz.) -0.11 (1H, dtd, JH = 10.3, 7.0, 3.4 Hz, cyclo-CH), 
0.02 (1H, ddd, JH = 24.8, 12.5, 3.0 Hz, cyclo-CH2), 0.15-0.31 (1H, m, cyclo-
CH2), 0.35-0.50 (1H, m, cyclo-CH2), 0.50-0.60 (1H, m, cyclo-CH2), 0.60-0.78 
(1H, m, cyclo-CH2), 1.00 (2H, dd, JH = 11.5, 10.0 Hz, cyclo-CH2), 1.22 (3H, d, JH 
2,3-syn 124a; 2,3-anti 124b 
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= 10.0 Hz, cyclo-CH2), 1.26-1.42 (1H, m, CH2), 1.53-1.65 (1H, m, CH2), 
2.41(1H, q, JH = 5.2 Hz, PCH), 4.71 (1H, s, OH), 4.93 (1H, d, JP = 18.9, JH = 4.8 
Hz, CHOH), 7.05-7.13 (1H, m, aromatic-H), 7.14-7.19 (3H, m, aromatic-H), 
7.21-7.27 (1H, m, aromatic-H), 7.30-7.36 (2H, m, aromatic-H), 7.39 (1H, ddt, JH 
= 11.2, 8.8, 2.7 Hz, aromatic-H), 7.47 (3H, dt, JH = 8.3, 3.1 Hz, aromatic-H), 
7.63-7.71 (2H, m, aromatic-H), 7.91 (2H, ddd, JH = 10.4, 6.7, 3.2 Hz, aromatic-
H); δP ppm (400 MHz.) 40.68;  δC ppm (125 MHz.) 26.0 (d, JP = 19.7 Hz, cyclo-
CH2), 27.4 (CH2), 32.1 (cyclo-CH2), 32.9 (cyclo-CH2), 36.4 (cyclo-CH), 42.1 (d, 
JP = 67.3 Hz, PCH), 70.9 (CHOH), 125.5-142.3 (aromatic C and CH); m/z (EI) 
419.2 (MH+); HRMS (ES); calc. for C27H32O2P (MH+) 419.2136; Found 
419.2134; 
 
(2R*,3S*)-(3-cyclohexyl-1-hydroxy-1-phenylpropan-2-yl)diphenylphosphine 
oxide 124b; m.p. 131.6-132.4°C; Vmax(CHCl3)/cm-1 3316 (OH), 2922 (C-H), 
1637 (C=C arom.), 1432 (P=O), 1161 (C-O), 719 (C-H arom.); δH ppm (400 
MHz.) 0.32-0.43 (1H, m, cyclo-CH2), 0.46-0.59 (2H, m, cyclo-CH2), 0.81-0.91 
(3H, m, cyclo-CH2), 1.12-1.21 (1H, m, cyclo-CH2), 1.27 (1H, t, JH = 4.5 Hz, 
cyclo-CH2), 1.40-1.49 (5H, m, cyclo-CH2 and CH), 2.74 (1H, tdd, JP = 9.4, JH = 
6.0, 3.4 Hz, PCH), 5.17 (1H, d, JP = 9.9 Hz, CHOH), 7.05-7.13 (1H, m, 
aromatic-H), 5.63 (1H, d, JP = 4.8 Hz, OH), 6.99 (3H, ddd, JH = 10.9, 9.7, 5.7 
Hz, aromatic-H), 7.16-7.24 (5H, m, aromatic-H), 7.28 (1H, dd, JH = 7.4, 1.4 Hz, 
aromatic-H), 7.41 (2H, ddd, JH = 8.2, 6.6, 2.7 Hz, aromatic-H), 7.48-7.53 (2H, 
m, aromatic-H), 7.63-7.72 (2H, m, aromatic-H); δP ppm (400 MHz.) 41.52; δC 
ppm (400 MHz.) 26.0 (d, JP = 4.9 Hz, cyclo-CH2), 26.3 (cyclo-CH2), 31.9 (cyclo-
CH2), 33.7 (cyclo-CH2), 33.9 (CH2), 35.4 (d, JP = 9.3 Hz, cyclo-CH), 41.7 (d, JP 
= 66.8 Hz, PCH), 75.1 (d, JP = 4.0 Hz, CHOH), 126.4-142.6 (aromatic C and 
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CH); m/z (EI) 419.2 (MH+); HRMS (ES); calc. for C27H32O2P (MH+) 419.2136; 
Found 419.2134; 
 
6.2.55 (2R*, 3R*) and (2R*, 3S*)-(1,3-dicyclohexyl-1-
hydroxypropan-2-yl)diphenylphosphine oxide  
Using the method described in section 6.2.53;  
LDA (2 M solution in THF, 0.96 mL, 1.92 mmol) 
was added to a stirred solution of phosphine 
oxide 40 (0.2 g, 0.64 mmol) in dry THF (20 mL).  
Cyclohexanecarboxaldehyde 87 (0.23 mL, 0.22 
g, 1.92 mmol) was added. The organic layer 
was combined, dried and filtered to yield a 
yellow oil (0.36 g), which was purified by 
preparative chromatography (40 : 40, petroleum ether : ethyl acetate) to give a 
yellow solid (0.24 g, 80 %), to give the required products; 125b (0.019 g, 7 %) 
and 125a (0.026 g, 10 %). 
 
(2R*,3S*)-(1,3-dicyclohexyl-1-hydroxypropan-2-yl)diphenylphosphine 
oxide 125b; m.p. 126.4-127.4 °C; Vmax(CHCl3)/cm-1 3380 (OH), 2921 (C-H), 
1638 (C=C arom.), 1123 (P=O), 1001 (C-O), 709 (C-H arom.); δH ppm (400 
MHz.) 0.35-0.54 (2H, m, cyclo-CH2 and cyclo-CH), 0.67-0.71 (4H, m, cyclo-
CH2), 0.85-0.95 (2H, m, cyclo-CH2), 0.95-1.03 (1H, m, cyclo-CH2), 1.04-1.17 
(3H, m, cyclo-CH2), 1.22-1.34 (1H, m, cyclo-CH2), 1.43 (3H, m, cyclo-CH2, CH2 
and cyclo-CH), 1.50-1.66 (7H, m, cyclo-CH2 and CH2), 2.04 (1H, d, JH = 13.1 
Hz, cyclo-CH2),  2.45 (1H, dd, JP = 10.7, JH = 6.7 Hz, PCH), 3.57 (1H, t, JP = 
10.7 Hz, CHOH), 4.16 (1H, s, OH), 7.31-7.51 (6H, m, aromatic-H), 7.68 (2H, dd, 
2,3-syn 125a;2,3-anti 125b 
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JP = 11.1, 7.1 Hz, aromatic-H), 7.79 (2H, dd, JP = 13.2, 4.8 Hz, aromatic-H); δP 
ppm (400 MHz.) 41.06; δC ppm (125 MHz.) 25.7 (cyclo-CH2), 25.8 (cyclo-CH2) 
26.2 (CH2), 26.3 (cyclo-CH2), 28.6 (cyclo-CH2), 29.4 (cyclo-CH2), 29.5 (cyclo-
CH2), 32.9 (cyclo-CH2), 33.6 (cyclo-CH2), 35.3 (d, JP = 69.8 Hz, PCH) 36.8 (d, 
JP = 4.6 Hz, cyclo-CH), 40.2 (d, JP = 12.1 Hz, cyclo-CH), 74.4 (CHOH), 128.5-
132.4 (aromatic C and CH); m/z (EI) 214.30, 425.33 (MH+); HRMS (ES); calc. 
for C27H38O2P (MH+) 425.2604; Found 425.2604; 
 
(2R*,3R*)-(1,3-dicyclohexyl-1-hydroxypropan-2-yl)diphenylphosphine 
oxide 125a; m.p. 116.0-117.8 °C; Vmax(CHCl3)/cm-1 3380 (OH), 2921 (C-H), 
1638 (C=C arom.), 1123 (P=O), 1001 (C-O), 709 (C-H arom.); δH ppm (400 
MHz.) 0.44 (1H, dt, JH = 25.4, 8.0 Hz, cyclo-CH2), 0.51-0.60 (1H, m, cyclo-CH2), 
0.63-0.82 (2H, m, cyclo-CH2 and CH2), 0.85-1.08 (4H, m, cyclo-CH2), 1.08-1.22 
(4H, m, cyclo-CH2 and cyclo-CH), 1.30-1.37 (1H, m, cyclo-CH2), 1.41 (1H, d, JH 
= 6.4 Hz, cyclo-CH2), 1.54 (7H, dt, JH = 24.2, 12.0 Hz, cyclo-CH2), 1.74 (1H, dd, 
JH = 17.5, 9.6 Hz, cyclo-CH2),  1.96-2.07 (1H, m, cyclo-CH2), 2.64 (1H, dd, JP = 
14.7, JH = 6.5 Hz, PCH), 3.35-3.50 (1H, dt, JP = 24.4, JH = 9.2, 3.2 Hz, CHOH), 
4.47 (1H, s, OH), 7.39-7.46 (6H, m, aromatic-H), 7.66-7.72 (2H, m, aromatic-H), 
7.80-7.86 (2H, m, aromatic-H); δP ppm (400 MHz.) 39.99; δC ppm (125 MHz.) 
25.7 (cyclo-CH2),  25.8 (cyclo-CH2), 26.1 (cyclo-CH2), 26.2 (cyclo-CH2), 26.3 
(CH2), 26.4 (cyclo-CH2), 29.1 (cyclo-CH2), 30.3 (cyclo-CH2), 32.0 (cyclo-CH2), 
33.9 (cyclo-CH2), 34.5 (cyclo-CH2), 35.4 (d, JP = 10.4 Hz, cyclo-CH), 35.9 (d, JP 
= 66.7 Hz, PCH), 41.9 (cyclo-CH),  77.9 (CHOH), 128.6-134.3 (aromatic C and 
CH); m/z (EI) 214.30, 425.33 (MH+); HRMS (ES); calc. for C27H38O2P (MH+) 
425.2604; Found 425.2604; 
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6.2.56 (2R*, 3R*) and (2R*, 3S*)-diethyl (1-hydroxy-1,3-
diphenylpropan-2-yl)phosphonate  
Using the method described in section 6.2.53; 
LDA (2 M solution in THF, 1.24 mL, 2.47 mmol) 
was added to a stirred solution of phosphine 
oxide 110 (0.2 g, 0.83 mmol) in dry THF (20 mL).  
Benzaldehyde 81 (0.25 mL, 0.26 g,  2.47 mmol) 
was added. The organic layer was combined, 
dried and filtered to yield a yellow oil (0.4 g), 
which was purified by column chromatography 
(80 : 20, petroleum ether : ethyl acetate) to give a 
yellow solid (0.14 g, 49 %), to give the required products; 126b (0.12 g, 29 %) 
and 126a (0.07 g, 2 %). 
 
(2R*, 3S*)-diethyl (1-hydroxy-1,3-diphenylpropan-2-yl)phosphonate 126b; 
m.p. 82.1-82.9 °C; Vmax(CHCl3)/cm-1 3298 (OH), 2981 (C-H), 1613 (C=C arom.), 
1295 (P-O), 1056 (P=O), 1054 (C-O), 897 (C-H arom.); δH ppm (400 MHz.) 1.07 
(3H, t, JH = 7.1 Hz, CH3), 1.14 (3H, t, JH = 7.1 Hz, CH3), 2.45-2.47 (1H, m, 
PCH), 2.81-2.85 (2H, m, PCHCH2) 3.82-3.89 (4H, m, CH2), 4.02 (1H, d, JP = 8.3 
Hz, OH), 5.29 (1H, d, JP = 13.2 Hz, CHOH), 6.72-6.90 (2H, m, aromatic-H), 
6.96-7.12 (3H, m, aromatic-H), 7.11-7.23 (1H, m, aromatic-H), 7.23-7.21 (2H, 
m, aromatic-H), 7.34 (2H, t, d, JH = 10.1 Hz,  aromatic-H); δP ppm (400 MHz.) 
32.7; δC ppm (125 MHz.) 16.2 (d, JP = 10.5, 6.2 Hz, CH3), 28.6 (d, JP = 2.0 Hz, 
PCHCH2), 46.4 (d, JP = 134.6 Hz, PCH), 61.9 (d, JP = 16.2 Hz, CH2), 71.2 (d, JP 
= 7.9 Hz, CHOH), 125.9-141.6 (aromatic C and CH);  m/z (EI) 331 (MNH4+), 
349 (MH+); HRMS (ES); calc. for C19H26O4P (MH+) 349.1564; Found 349.1563; 
2,3-syn 126a;  
2,3-anti 126b 
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(2R*, 3R*)-diethyl (1-hydroxy-1,3-diphenylpropan-2-yl)phosphonate 126a; 
Vmax(CHCl3)/cm-1 3298 (OH), 2981 (C-H), 1613 (C=C arom.), 1295 (P-O), 1056 
(P=O), 1054 (C-O), 897 (C-H arom.); δH ppm (400 MHz.) 0.86 (3H, dd, JH = 5.4, 
JP = 12.4 Hz, CH3), 1.27 (3H, dd, JH = 5.2, JP = 9.0 Hz, CH3), 2.46 (1H, ddd, JH 
= 14.2, 6.8, JP = 18.0 Hz,  PCH), 2.71 (1H, ddd, JH = 14.1, 7.7 JP = 17.9 Hz,  
PCHCH2) 2.87 (1H, ddd, JH = 14.0, 6.9, JP = 11.7 Hz, PCHCH2), 3.36-3.50 (1H, 
m, CH2), 3.62-3.76 (1H, m, CH2), 4.00-4.11 (2H, m, CH2), 4.74 (1H, d, JH = 
12.6, JP = 22.7 Hz, CHOH), 4.81 (1H, d, JP = 5.8 Hz, OH), 7.01-7.03 (2H, m, 
aromatic-H), 7.08-7.12 (1H, m, aromatic-H), 7.13-7.20 (3H, m, aromatic-H), 
7.21-7.28 (4H, m, aromatic-H); δP ppm (400 MHz.) 31.9; δC ppm (125 MHz.) 
15.9 (d, JP = 6.5 Hz, CH3), 16.4 (d, JP = 5.9 Hz, CH3), 32.6 (d, JP = 3.0 Hz, 
PCHCH2), 46.6 (d, JP = 133.1 Hz, PCH), 61.9 (d, JP = 15.9 Hz, CH2), 72.3 (d, JP 
= 4 Hz, CHOH), 126.4-142.2 (aromatic C and CH);  m/z (EI) 331 (MNH4+), 349 
(MH+); HRMS (ES); calc. for C19H26O4P (MH+) 349.1564; Found 349.1563; 
  
6.2.57 (2R*, 3R*) and (2R*, 3S*)-diethyl (1-(3,5-
dimethoxyphenyl)-1-hydroxy-3-phenylpropan-2-yl)phosphonate  
Using the method described in section 
6.2.53;  LDA (2 M solution in THF, 1.24 
mL, 2.47 mmol) was added to a stirred 
solution of phosphine oxide 110 (0.2 g, 
0.83 mmol) in dry THF (20 mL). 3,5-
dimethoxybenzaldehyde 116 (0.41 g,  
2.47 mmol) was added. The organic layer 
was combined, dried and filtered to yield 
2,3-syn 127a; 2,3-anti 127b 
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a yellow oil (0.37 g), which was purified by preparative chromatography (40 : 40, 
petroleum ether : ethyl acetate) to give a yellow solid (0.32 g, 94 %), to give the 
required products as a mixture of 127a and 127b (0.132 g, 39 %).  
 
(2R*, 3S*) and (2R*, 3R*)-diethyl (1-(3,5-dimethoxyphenyl)-1-hydroxy-3-
phenylpropan-2-yl)phosphonate 127bmajor and 127aminor; Vmax(CHCl3)/cm-1 
3325 (OH), 2981 (C-H), 1597 (C=C arom.), 1299 (P-O), 1204 (P=O), 1154 (C-
O), 1056 (C-H arom.); δH ppm (400 MHz.) 0.97 (3H, t, JH = 7.0 Hz, CH3minor), 
1.00-1.10 (3H, t, JH = 7.2 Hz, CH3major), 1.15 (3H, t, JH = 7.1 Hz, CH3minor), 1.23 
(3H, t, JH = 13.2 Hz, CH3major), 2.35-2.55 (2H, m, PCHmajor and PCHCH2minor), 
2.63-2.76 (1H, m, PCHminor), 2.82 (3H, m, PCHCH2major and PCHCH2minor), 3.33 
(12H, s, OCH3minor and OCH3major), 3.60-3.66 (2H, m, CH2minor), 3.87-3.95 (4H, 
m, CH2major), 3.98-4.06 (2H, m, CH2minor), 4.69 (1H, ddd, JH = 6.4, 4.4, JP = 19.2 
Hz, CHOHminor), 4.76 (1H, d, JP = 3.6 Hz, OHmajor), 5.03 (1H, d, JP = 4.5 Hz, 
OHminor), 5.25 (1H, d, JP = 10.3 Hz, CHOHmajor), 6.28 (2H, dd, JH = 4.6, 2.3 Hz, 
3,5-dimethoxyphenyl-Hminor), 6.43 (2H, d, JH = 2.2 Hz, 3,5-dimethoxyphenyl-
Hminor and 3,5-dimethoxyphenyl-Hmajor), 6.52 (2H, d, JH = 2.2 Hz, 3,5-
dimethoxyphenyl-Hmajor), 3.82-6.87 (2H, m, aromatic-H), 7.01-7.05 (3H, m, 
aromatic-H), 7.06-7.13 (3H, m, aromatic-H), 7.14-7.23 (2H, m, aromatic-H); δP 
ppm (400 MHz.) 32.66minor, 31.92major; δC ppm (125 MHz.) 15.9 (CH3major and 
CH3minor), 28.6 (PCHCH2major), 32.3 (PCHCH2minor), 46.4 (d, JP = 134.5 Hz, 
PCHmajor), 46.8 (d, JP = 135.7 Hz, PCHminor), 49.9 (OCH3major and OCH3minor), 
61.7 (d, JP = 7.0 Hz, CH2major), 62.1 (d, JP = 7.2 Hz, CH2minor),  62.3 (d, JP = 6.9 
Hz, CH2minor), 70.8 (CHOHmajor), 72.5 (CHOHminor), 99.2 (3,5-dimethoxyphenyl-
CHmajor), 99.6 (3,5-dimethoxyphenyl-CHminor), 103.8 (3,5-dimethoxyphenyl-
CHmajor), 104.7 (3,5-dimethoxyphenyl-CHminor),  126.1-160.6 (aromatic C and 
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CH);  m/z (EI) 391 (MNH4+), 409 (MH+); HRMS (ES); calc. for C21H30O6P (MH+) 
409.1774; Found 409.1775; 
 
6.2.58 (2R*, 3R*) and (2R*, 3S*)-diethyl (1-(3,5-difluorophenyl)-1-
hydroxy-3-phenylpropan-2-yl)phosphonate  
Using the method described in section 
6.2.53; LDA (2 M solution in THF, 1.24 mL, 
2.47 mmol) was added to a stirred solution of 
phosphine oxide 110 (0.2 g, 0.83 mmol) in 
dry THF (20 mL). 3,5-difluorobenzaldehyde 
117 (0.34 mL, 0.44 g,  2.47 mmol) was 
added. The organic layer was combined, 
dried and filtered to yield a yellow oil (0.41 g), 
which was purified by preparative 
chromatography (40 : 40, petroleum ether : ethyl acetate) to give a yellow solid 
(0.30 g, 94 %), to give the required products; 128b  (0.061 g, 19 %) and128a 
(0.113 g, 35 %). 
 
(2R*, 3S*)-diethyl (1-(3,5-difluorophenyl)-1-hydroxy-3-phenylpropan-2-
yl)phosphonate 128b; m.p. 113.5-114.2 °C; Vmax(CHCl3)/cm-1 3309 (OH), 2982 
(C-H), 1596 (C=C arom.), 1342 (P-O), 1115 (P=O), 1055 (C-O), 987 (C-H 
arom.), 765 (C-F); δH ppm (400 MHz.) 1.11 (6H, dd, JH = 15.0, 7.2 Hz, CH3), 
2.43 (1H, dtd, JH = 8.5, 2.6, JP = 20.9 Hz, PCH), 2.58-2.93 (2H, m, PCHCH2) 
3.78-4.00 (4H, m, CH2), 4.59 (1H, s, OH), 5.24 (1H, dd, JP = 12.2 Hz, CHOH), 
6.49-6.65 (1H, s, 3,5-difluorophenyl-H), 6.80-6.91 (4H, m, 3,5-difluorophenyl-H 
and aromatic-H), 6.97-7.12 (3H, m, aromatic-H);δP ppm (400 MHz.) 31.81; δC 
2,3-syn 128a; 2,3-anti 128b 
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ppm (125 MHz.) 16.2 (d, JP = 6.1 Hz, CH3), 28.6 (d, JP = 2.1 Hz, PCHCH2), 46.1 
(d, JP = 136.0 Hz, PCH), 62.2 (d, JP = 33.2 Hz, CH2),  70.4 (CHOH), 102.5 (t, JP 
= 25.4 Hz, 3,5-difluorophenyl-CH), 108.9 (3,5-difluorophenyl-CH), 126.2-164.2  
(aromatic C and CH);  m/z (EI) 383.2, 385.3, 386.3  (MH+); HRMS (ES); calc. for 
C19H24F2O4P (MH+) 385.1376; Found 385.1375; 
 
(2R*, 3R*)-diethyl (1-(3,5-difluorophenyl)-1-hydroxy-3-phenylpropan-2-
yl)phosphonate 128a; m.p. 89.3-89.8 °C; Vmax(CHCl3)/cm-1 3309 (OH), 2982 
(C-H), 1596 (C=C arom.), 1342 (P-O), 1115 (P=O), 1055 (C-O), 987 (C-H 
arom.), 765 (C-F); δH ppm (400 MHz.) 0.92 (3H, t, JH = 7.1 Hz, CH3), 1.27 (3H, t, 
JH = 7.1 Hz, CH3), 2.40 (1H, dtd, JH = 10.2, 4.5, JP = 10.2 Hz, PCH), 2.67-2.89 
(1H, m, PCHCH2) 2.95 (1H, dtd, JH = 14.1, 5.9, JP = 10.4 Hz, PCHCH2), 3.48-
3.65 (1H, m, CH2), 3.68-3.81 (1H, m, CH2), 3.97-4.15 (2H, m, CH2), 4.65 (1H, 
dd, JH = 4.3, JP = 26.2 Hz, CHOH), 4.96 (1H, s, OH), 6.58 (1H, tt, JH = 8.8, 2.3 
Hz, 3,5-difluorophenyl-H), 6.80 (2H, dd, JH = 29.5, 4.9 Hz, 3,5-difluorophenyl-
H), 7.04-7.17 (3H, m, aromatic-H), 7.20 (2H, dd, JH = 10.2, 4.5 Hz,  aromatic-H); 
δP ppm (400 MHz.) 30.75; δC ppm (125 MHz.) 15.9 (d, JP = 6.5 Hz, CH3), 16.4 
(d, JP = 6.5 Hz, CH3), 32.4 (d, JP = 2.3 Hz, PCHCH2), 46.1 (d, JP = 134.0 Hz, 
PCH), 61.8 (d, JP = 6.8 Hz, CH2), 62.5 (d, JP = 7.0 Hz, CH2), 71.1 (CHOH), 
102.6 (t, JP = 25.4 Hz, 3,5-difluorophenyl-CH), 109.3 (3,5-difluorophenyl-CH), 
126.7-164.1  (aromatic C and CH);  m/z (EI) 383.2, 385.3, 386.3  (MH+); HRMS 
(ES); calc. for C19H24F2O4P (MH+) 385.1376; Found 385.1375; 
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6.2.59 (2R*, 3R*) and (2R*, 3S*)-diethyl (1-(3,5-dinitrophenyl)-1-
hydroxy-3-phenylpropan-2-yl)phosphonate  
Using the method described in section 
6.2.53; LDA (2 M solution in THF, 0.92 mL, 
1.85 mmol) was added to a stirred solution 
of phosphine oxide 110 (0.15  g, 0.61  
mmol) in dry THF (20 mL). 3,5-
dinitrobenzaldehyde 121 (0.36 g, 1.85 
mmol) in THF (1 mL) was added. The 
organic layer was combined, dried and 
filtered to yield a yellow oil (0.27g), which 
was purified by preparative chromatography (40 : 40, petroleum ether : ethyl 
acetate) to give a yellow solid (0.24 g, 90 %), to give the required products; 
129a (0.05 g, 19 %) and 129b could not be isolated. 
 
(2R*, 3R*)-diethyl (1-(3,5-dinitrophenyl)-1-hydroxy-3-phenylpropan-2-
yl)phosphonate 129a; Vmax(CHCl3)/cm-1 3645 (OH),  2984 (C-H), 1767 (C=C 
arom.), 1267 (P-O), 1359 (NO2), 1332 (P=O), 1218 (C-O), 1000 (C-H arom.); δH 
ppm (400 MHz.) 1.00 (3H, t, JH = 7.1 Hz, CH3), 1.31 (3H, t, JH = 7.1 Hz, CH3), 
2.46-2.64 (1H, m, PCH), 2.76 (1H, dt, JH = 14.2, 10.1 Hz, PCHCH2), 3.10 (1H, 
ddd, JH = 14.4, 10.4, 4.3 Hz, PCHCH2), 3.78 (1H, dt, JH = 10.0, 8.3 Hz, CH2), 
3.88 (1H, ddd, JH = 16.3, 10.4, 4.7 Hz, CH2), 4.07-4.22 (2H, m, CH2), 4.87 (1H, 
dd,  JH = 7.2, JP = 25.8 Hz, CHOH), 5.10 (1H, s, OH), 7.01 (2H, d, JH = 7.9 Hz, 
aromatic-H), 7.10 (1H, d, JH = 7.2 Hz, aromatic-H), 7.16 (2H, t, JH = 7.2 Hz, 
aromatic-H), 8.33 (2H, t, JH = 6.5 Hz, aromatic-H), 8.76 (1H, d, JH = 1.9 Hz, 
aromatic-H); δP ppm (400 MHz.) 29.47; δC ppm (125 MHz.) 16.1 (CH3), 16.5 
2,3-syn 129a; 2,3-anti 129b 
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(CH3), 32.1 (PCHCH2), 45.6 (d, JP = 134.9 Hz, PCH), 62.1 (CH2), 63.2 (CH2), 
71.1 (CHOH), 117.7-148.1 (aromatic C and CH);  m/z (EI) 439.0 (MH+); HRMS 
(ES); calc. for C19H24N2O8P (MH+) 439.1264; Found 439.1265; 
 
6.2.60 (2R*, 3R*) and (2R*, 3S*)-diethyl (1-cyclohexyl-1-hydroxy-
3-phenylpropan-2-yl)phosphonate  
Using the method described in section 6.2.53;  
LDA (2 M solution in THF, 1.24 mL, 2.47 mmol) 
was added to a stirred solution of phosphine 
oxide 110 (0.2 g, 0.83 mmol) in dry THF (20 
mL). Cyclohexanecarboxaldehyde 87 (0.3 mL, 
0.28 g,  2.47 mmol) was added. The organic 
layer was combined, dried and filtered to yield a 
yellow oil (0.32 g), which was purified by 
preparative chromatography (40 : 40, petroleum ether : ethyl acetate) to give a 
yellow solid (0.22 g, 76 %), to give the required products; 130b (0.045 g, 16 %) 
and 130a (0.079 g, 27 %).  
 
(2R*,3S*)-diethyl(1-cyclohexyl-1-hydroxy-3-phenylpropan-2-yl) 
phosphonate 130b; m.p. 61.2-63.4 °C; Vmax(CHCl3)/cm-1 3382 (OH), 2924 (C-
H), 2852 (C=C arom.), 1222 (P-O), 1055 (P=O). 1023 (C-O), 765 (C-H arom.); 
δH ppm (400 MHz.) 0.69-1.10 (5H, m, cyclo-CH2), 1.15 (6H, dt, JH = 10.9, 7.0 
Hz, CH3), 1.31-1.44 (2H, m, cyclo-CH2 and cyclo-CH), 1.54 (2H, d, JH = 8.7 Hz, 
cyclo-CH2), 1.67 (1H, d, JH = 11.7 Hz, cyclo-CH2), 2.08 (1H, d, JH = 13.1 Hz, 
cyclo-CH2), 2.35 (1H, dt, JH = 6.3, JP = 22.2 Hz, PCH), 2.95 (2H, dtd, JH = 15.0, 
2,3-syn 130a; 2,3-anti 130b 
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6.4, JP = 22.4 Hz, PCHCH2) 3.13 (1H, s, OH), 3.70 (1H, t, JP = 10.1 Hz, CHOH), 
3.86-4.00 (4H, m, CH2), 7.08-7.23 (5H, m, aromatic-H); δP ppm (400 MHz.) 
34.55; δC ppm (125 MHz.) 16.3 (d, JP = 6.0 Hz, CH3), 25.8 (d, JP = 2.6 Hz, 
cyclo-CH2), 26.2 (cyclo-CH2), 28.3 (d, JP = 2.2 Hz, PCHCH2), 29.1 (cyclo-CH2), 
29.9 (cyclo-CH2), 39.9 (d, JP = 4.2 Hz, cyclo-CH), 40.7 (d, JP = 117.9 Hz, PCH), 
61.9 (d, JP = 12.1 Hz, CH2), 74.2 (d, JP = 4.8 Hz, CHOH), 126.1-140.67 
(aromatic C and CH); m/z (EI) 355 (MH+); HRMS (ES); calc. for C19H32O4P 
(MH+) 355.2034; Found 355.2033; 
 
(2R*,3R*)-diethyl(1-cyclohexyl-1-hydroxy-3-phenylpropan-2-yl) 
phosphonate 130a; m.p. 57.1-58.3 °C; Vmax(CHCl3)/cm-1 3382 (OH), 2924 (C-
H), 2852 (C=C arom.), 1222 (P-O), 1055 (P=O). 1023 (C-O), 765 (C-H arom.); 
δH ppm (400 MHz.) 0.57-0.82 (2H, m, cyclo-CH2), 0.87-1.16 (3H, m, cyclo-CH2), 
1.25 (6H, dt, JH = 21.6, 7.1 Hz, CH3), 1.56-1.79 (5H, m, cyclo-CH2 and cyclo-
CH), 1.90 (1H, d, JH = 12.7 Hz, cyclo-CH2), 2.29-2.41 (1H, m, PCH), 2.85-3.04 
(2H, m, PCHCH2) 3.11 (1H, ddd, JP = 32.7, JH = 8.3, 3.7 Hz, CHOH), 3.45 (1H, 
s, OH), 3.92-4.15 (4H, m, CH2), 7.08-7.25 (5H, m, aromatic-H); δP ppm (400 
MHz.) 33.09; δC ppm (125 MHz.) 16.4 (d, JP = 17.2 Hz, CH3), 25.7 (d, JP = 9.9 
Hz, cyclo-CH2), 26.0 (cyclo-CH2), 26.2 (d, JP = 11.0 Hz, cyclo-CH2), 28.8 (cyclo-
CH2), 29.6 (cyclo-CH2), 32.5 (d, JP = 1.6 Hz, PCHCH2), 40.8 (d, JP = 133.6 Hz, 
PCH), 41.62 (d, JP = 4.2 Hz, cyclo-CH), 61.9 (d, JP = 102.6 Hz, CH2), 74.33 (d, 
JP = 5.3 Hz, CHOH), 126.3-139.3 (aromatic C and CH); m/z (EI) 355 (MH+); 
HRMS (ES); calc. for C19H32O4P (MH+) 355.2034; Found 355.2033; 
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6.2.61 (2R*, 3R*) and (2R*, 3S*)-(1-(3,5-dimethoxyphenyl)-1-
hydroxy-3-phenylpropan-2-yl)diphenylphosphine oxide  
Using the method described in section 
6.2.53; LDA (2 M solution in THF, 2.5 mL, 
4.9 mmol) was added to a stirred solution of 
phosphine oxide 36 (0.5 g, 1.6 mmol) in THF 
(100 mL). 3,5-dimethoxybenzaldehyde 116 
(0.81 g, 4.9 mmol) was added. The organic 
layer was combined, dried and filtered to 
yield a yellow oil (0.88 g), this was purified 
by flash column chromatography (50 : 50 v/v, petroleum ether : ethyl acetate) 
collecting all relevant fractions, to afford a mixture of both diastereoisomers 
(0.68 g, 88 %). The white solid was further purified using a combination of 
column and preparative chromatography to separate out the 2 diastereoisomers 
(50 : 50 v/v, petroleum ether : ethyl acetate). The diastereoisomers eluted and 
were dried in vacuo to give 131b (0.12 g, 16 %), and 131a (0.02 g, 3%). 
 
(2R*,3S*)-(1-(3,5-dimethoxyphenyl)-1-hydroxy-3-phenylpropan-2-yl) 
diphenylphosphine oxide 131b; Vmax(CHCl3)/cm-1 3410 (OH), 3004 (C-H), 
1721 (C=C arom.), 1155 (P=O), 731 (C-O), 705 (C-H arom.); δH ppm (400 
MHz.) 2.72-2.89 (2H, m, CH2 and PCH), 3.02-3.19 (1H, m, CH2) 3.69 (6H, s, 
CH3), 4.87 (1H, s, OH), 5.18 (1H, d, JP = 9.6 Hz, CHOH), 6.15 (2H, d, JH = 7.2 
Hz, 3,5-dimethoxyphenyl-H), 6.28 (1H, dd, JH = 8.7, 2.2 Hz, 3,5-
dimethoxyphenyl-H), 6.45 (2H, d, JH = 2.2 Hz, aromatic-H), 6.75 (2H, dd, JH = 
10.0, 4.3 Hz, aromatic-H), 6.79-6.90 (1H, m, aromatic-H), 7.12-7.21 (2H, m, 
aromatic-H), 7.30 (1H, tt, JH = 18.7, 9.3 Hz, aromatic-H), 7.41-7.53 (5H, m, 
2,3-syn 131a; 2,3-anti 131b 
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aromatic-H), 7.78-7.93 (2H, m, aromatic-H); δP ppm (400 MHz.) 39.83; δC ppm 
(400 MHz.) 26.9 (CH2), 47.3 (d, JP = 66.5 Hz, PCH), 55.4 (CH3), 71.1 (CHOH), 
98.9 (3,5-dimethoxyphenyl-CH), 103.9 (3,5-dimethoxyphenyl-CH), 125.5-160.8 
(aromatic C and CH); m/z (EI) 472.18 (MH+); HRMS (ES); calc. for C29H30O4P 
(MH+) 473.1871; Found 473.1876; 
 
(2R*,3R*)-(1-(3,5-dimethoxyphenyl)-1-hydroxy-3-phenylpropan-2-yl) 
diphenylphosphine oxide 131a; Vmax(CHCl3)/cm-1 3410 (OH), 3004 (C-H), 
1721 (C=C arom.), 1155 (P=O), 731 (C-O), 705 (C-H arom.); δH ppm (400 
MHz.) 2.70 (1H, ddd, JH = 10.2, 3.1, JP = 13.6 Hz,  PCHCH2), 2.83-2.92 (1H, m, 
PCH), 3.10 (1H, ddd, JH = 13.8, 11.4, JP = 6.5 Hz,  PCHCH2) 3.53 (6H, s, 
OCH3), 4.83 (1H, ddd, JH = 7.8, 3.0, JP = 25.3 Hz, CHOH), 5.63 (1H, d, JP = 8.5 
Hz, OH), 5.84 (1H, s, 3,5-dimethoxyphenyl-H), 6.14 (1H, d, JH = 1.9 Hz, 3,5-
dimethoxyphenyl-H), 7.02 (1H, d, JH = 7.4 Hz, aromatic-H), 7.08-7.21 (5H, m, 
aromatic-H), 7.28-7.34 (2H, m, aromatic-H), 7.38-7.50 (5H, m, aromatic-H), 
7.65-7.71 (2H, m, aromatic-H); δP ppm (400 MHz.) 38.71; δC ppm (400 MHz.) 
32.8 (PCHCH2), 45.8 (d, JP = 66.1 Hz, PCH), 55.23 (OCH3), 73.1 (CHOH), 99.0 
(3,5-dimethoxyphenyl-CH), 104.2 (3,5-dimethoxyphenyl-CH), 126.6-160.1 
(aromatic C and CH);  m/z (EI) 472.18 (MH+); HRMS (ES); calc. for C29H30O4P 
(MH+) 473.1871; Found 473.1876; 
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6.2.62 (2R*, 3R*) and (2R*, 3S*)-(1-(3,5-difluorophenyl)-1-
hydroxy-3-phenylpropan-2-yl)diphenylphosphine oxide  
Using the method described in section 
6.2.53; LDA (2 M solution in THF, 2.5 mL, 
4.9 mmol) was added to a stirred solution of 
phosphine oxide 36 (0.5 g, 1.6 mmol) in THF 
(100 mL). 3,5-difluorobenzaldehyde 117 
(0.54 mL, 0.70 g, 4.9 mmol) was added. The 
organic layer was combined, dried and 
filtered to yield a yellow oil (0.81 g), this was 
purified by flash column chromatography (50 : 50 v/v, petroleum ether : ethyl 
acetate) collecting all relevant fractions, to afford a mixture of both 
diastereoisomers (0.7 g, 96 %). The white solid was further purified using a 
combination of column and preparative chromatography to separate out the 2 
diastereoisomers (50 : 50 v/v, petroleum ether : ethyl acetate). The 
diastereoisomers eluted and were dried in vacuo to give 132b (0.1 g, 14 %), 
and 132a (0.05 g, 7%). 
 
(2R*,3S*)-(1-(3,5-difluorophenyl)-1-hydroxy-3-phenylpropan-2-yl) 
diphenylphosphine oxide 132b; Vmax(CHCl3)/cm-1 3308 (OH), 2936 (C-H), 
1596 (C=C arom.), 1152 (P=O), 832 (C-O), 776 (C-H arom.), 702 (C-F); δH ppm 
(400 MHz.) 2.69-2.90 (2H, m, CH2 and PCH), 3.03-3.20 (1H, m, CH2) 4.85 (1H, 
s, OH), 5.17 (1H, d, JP = 9.7 Hz, CHOH), 6.16 (2H, d, JH = 7.2 Hz, 3,5-
difluorophenyl-H), 6.26 (1H, dd, JH = 14.1, 11.8 Hz, 3,5-difluorophenyl-H), 6.44 
(2H, d, JH = 2.2 Hz, aromatic-H), 6.76 (2H, dd, JH = 10.0, 4.6 Hz,  aromatic-H), 
6.80-6.87 (1H, m, aromatic-H), 7.12-7.20 (2H, m, aromatic-H), 7.32 (1H, td, JH = 
2,3-syn 132a; 2,3-anti 132b 
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7.4, 1.3 Hz, aromatic-H), 7.42-7.53 (5H, m, aromatic-H), 7.80-7.91 (2H, m, 
aromatic-H); δP ppm (400 MHz.) 39.93; δC ppm (125 MHz.) 26.9 (CH2), 47.3 (d, 
JP = 66.5 Hz, PCH), 70.9 (d, JP = 2.1 Hz, CHOH), 98.9 (3,5-difluorophenyl-CH), 
103.9 (3,5-difluorophenyl-CH), 125.5-160.8 (aromatic C and CH); m/z (EI) 474 
(MC2H2+); HRMS (ES); calc. for C27H2419F2O2P (MH+) 474.1866; Found 
474.1873; 
 
(2R*,3R*)-(1-(3,5-difluorophenyl)-1-hydroxy-3-phenylpropan-2-yl) 
diphenylphosphine oxide 132a; Vmax(CHCl3)/cm-1 3308 (OH), 2936 (C-H), 
1596 (C=C arom.), 1152 (P=O), 832 (C-O), 776 (C-H arom.), 702 (C-F);  δH ppm 
(400 MHz.) 2.70 (1H, ddd, JH = 13.7, 3.3, JP = 10.2 Hz, CH2), 2.89 (1H, m, 
PCH), 3.12 (1H, m, CH2) 3.73 (1H, d, JH = 5.8 Hz, OH),  4.85 (1H, d, JP = 25.1 
Hz, CHOH), 5.83 (1H, t, JP = 2.2 Hz, 3,5-dimethoxyphenyl-H), 6.15 (1H, d, JH = 
2.0 Hz, 3,5-dimethoxyphenyl-H), 7.03 (1H, d, JH = 2.0 Hz, aromatic-H), 7.12-
7.24 (7H, m, aromatic-H), 7.40-7.50 (5H, m, aromatic-H), 7.70 (2H, ddd, JH = 
11.2, 7.7, 1.6 Hz,  aromatic-H); δP ppm (400 MHz.) 38.49; δC ppm (125 MHz.) 
32.8 (CH2), 45.7 (d, JP = 66.2 Hz, PCH), 73.1 (CHOH), 98.9 (3,5-
dimethoxyphenyl-CH), 104.2 (3,5-dimethoxyphenyl-CH), 126.6-144.8 (aromatic 
C and CH);  m/z (EI) 474 (MC2H2+); HRMS (ES); calc. for C27H2419F2O2P (MH+) 
474.1866; Found 474.1873; 
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6.2.63 (2R*, 3R*) and (2R*, 3S*)-(1-(3,5-dinitrophenyl)-1-hydroxy-
3-phenylpropan-2-yl)diphenylphosphine oxide  
Using the method described in section 
6.2.53;  LDA (2 M solution in THF, 0.74 
mL, 1.47 mmol) was added to a stirred 
solution of phosphine oxide 36 (0.15  g, 
0.49 mmol) in dry THF (20 mL). 3,5-
dinitrobenzaldehyde 121 (0.29 g, 1.47 
mmol) was added. The organic layer was 
combined, dried and filtered to yield a 
purple oil (0.29 g), which was purified by 
preparative chromatography (40 : 40, petroleum ether : ethyl acetate) to give a 
yellow solid (0.21 g, 88 %), to give the required products; 133b (0.10 g, 42 %) 
and 133a (0.07 g, 29 %). 
 
(2R*,3S*)-(1-(3,5-dinitrophenyl)-1-hydroxy-3-phenylpropan-2-yl) 
diphenylphosphine oxide 133b; m.p. 121.6-121.9 °C; Vmax(CHCl3)/cm-1 3456 
(OH), 2823 (C-H), 1552 (C=C arom.), 1432 (NO2), 1351 (P=O), 1352 (C-O), 
1112 (C-H arom.); δH ppm (400 MHz.) 2.80 (1H, dd, JH = 21.5, 10.8 Hz, 
PCHCH2), 3.02-3.17 (1H, m, PCHCH2), 3.18-3.29 (1H, m, PCH) 5.32 (1H, d, JP 
= 10.1 Hz, CHOH), 5.49 (1H, s, OH), 6.55 (2H, dd, JH = 14.8, 8.7 Hz, aromatic-
H), 6.70-6.79 (2H, m, aromatic-H), 7.39-7.53 (3H, m, aromatic-H), 7.53-7.60 
(3H, m, aromatic-H), 7.60-7.72 (1H, m, aromatic-H), 7.79 (2H, dt, JH = 20.6, 
10.3 Hz, aromatic-H), 7.89-8.00 (2H, m, aromatic-H), 8.12 (2H, d, JH = 2.0 Hz, 
aromatic-H), 8.53 (1H, s, aromatic-H); δP ppm (400 MHz.) 39.67; δC ppm (125 
MHz.) 27.9 (PCHCH2), 46.3 (d, JP = 66.8 Hz, PCH), 68.8 (CHOH), 116.9-147.7 
2,3-syn 133a; 2,3-anti 133b 
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(aromatic C and CH); m/z (EI) 503.0 (MH+); HRMS (ES); calc. for C27H24NO6P 
(MH+) 503.1358; Found 503.1366; 
 
(2R*,3R*)-(1-(3,5-dinitrophenyl)-1-hydroxy-3-phenylpropan-2-yl) 
diphenylphosphine oxide 133a; m.p. 131.3-131.8 °C; Vmax(CHCl3)/cm-1 3456 
(OH), 2823 (C-H), 1552 (C=C arom.), 1432 (NO2), 1351 (P=O), 1352 (C-O), 
1112 (C-H arom.); δH ppm (400 MHz.) 2.88 (2H, m, PCH and PCHCH2), 3.20 
(1H, dt, JH = 13.1, 5.1 Hz, PCHCH2), 4.98 (1H, dd, JH = 7.2, JP = 22.4 Hz,  
CHOH), 6.27 (1H, d, JH = 8.6 Hz, OH), 7.09 (2H, td, JH = 7.5, 2.7 Hz, aromatic-
H), 7.17 (4H, s, aromatic-H), 7.28 (2H, dd, JH = 14.0, 6.1 Hz, aromatic-H), 7.46 
(5H, ddd, JH = 18.8, 12.7, 7.2 Hz,  aromatic-H), 7.75 (2H, dd, JH = 10.7, 7.4 Hz,  
aromatic-H), 8.10 (2H, s, aromatic-H), 8.38 (1H, s, aromatic-H); δP ppm (400 
MHz.) 37.72; δC ppm (125 MHz.) 32.7 (PCHCH2), 45.3 (d, JP = 65.8 Hz, PCH), 
71.8 (CHOH), 117.2-147.9 (aromatic C and CH);  m/z (EI) 503.0 (MH+); HRMS 
(ES); calc. for C27H24NO6P (MH+) 503.1358; Found 503.1366; 
 
6.2.64 (2R*, 3R*) and (2R*, 3S*)-(1-hydroxy-1,3-diphenylpropan-
2-yl)bis(3-methoxyphenyl)phosphine oxide  
Using the method described in section 
6.2.53;  LDA (2 M solution in THF, 0.82 
mL, 1.64 mmol) was added to a stirred 
solution of phosphine oxide 94 (0.2 g, 
0.55 mmol) in dry THF (20 mL). 
Benzaldehyde 81 (0.17 mL, 0.17 g, 
1.64 mmol) was added. The organic 
2,3-syn 134a; 2,3-anti 134b 
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layer was combined, dried and filtered to yield a yellow oil (0.3 g), which was 
purified by preparative chromatography (40 : 40, petroleum ether : ethyl 
acetate) to give a yellow solid (0.2g, 77 %), to give the required products; 134b 
(0.091 g, 36 %) and 134a (0.06 g, 23 %).  
 
(2R*,3S*)-(1-hydroxy-1,3-diphenylpropan-2-yl)bis(3-methoxyphenyl) 
phosphine oxide 134b; m.p. 135.6-135.9 °C; Vmax(CHCl3)/cm-1 3295 (OH), 
2912 (C-H), 1594 (C=C arom.), 1590 (P=O), 1220 (C-O), 1115 (C-H arom.); δH 
ppm (400 MHz.) 2.73 (1H, dd, JP = 7.3, JH = 4.2 Hz, PCH), 2.80 (1H, ddd, JP = 
13.9, JH = 14.9, 6.6 Hz, CH2), 3.00-3.17 (1H, m, CH2), 3.58 (3H, s, OCH3) 3.72 
(3H, s, OCH3) 4.82 (1H, s, OH), 5.26 (1H, d, JP = 9.6 Hz, CHOH), 6.03 (2H, d, 
JP = 7.4 Hz, aromatic-H), 6.74 (2H, t, JP = 7.5 Hz, aromatic-H),  6.79-6.87  (2H, 
m, aromatic-H), 6.95-7.04 (2H, m, aromatic-H), 7.04-7.12 (2H, m, aromatic-H), 
7.14-7.20 (1H, m, aromatic-H), 7.24-7.31 (4H, m, aromatic-H), 7.37-7.42 (2H, 
m, aromatic-H), 7.45 (1H, d, JH = 12.3, 2.0 Hz, aromatic-H); δP ppm (400 MHz.) 
39.77; δC ppm (125 MHz.) 26.6 (CH2), 47.4 (d, JP = 66.9 Hz, PCH), 55.3 
(OCH3), 55.4 (OCH3), 71.1 (d, JP = 2.2 Hz, CHOH), 115.3-160.1 (aromatic C 
and CH);  m/z (EI) 473.3 (MH+); HRMS (ES); calc. for C29H30O4P (MH+) 
473.1873; Found 473.1876; 
 
(2R*,3R*)-(1-hydroxy-1,3-diphenylpropan-2-yl)bis(3-methoxyphenyl) 
phosphine oxide 134a; m.p. 142.2-142.6 °C; Vmax(CHCl3)/cm-1 3295 (OH), 
2912 (C-H), 1594 (C=C arom.), 1590 (P=O), 1220 (C-O), 1115 (C-H arom.); δH 
ppm (400 MHz.) 2.75 (1H, ddd, JP = 10.6, JH = 14.0, 3.6 Hz, CH2), 2.91 (1H, qd, 
JP = 7.4, JH = 10.4, 3.6 Hz, PCH), 3.12 (1H, ddd, JP = 10.8, JH = 14.0, 7.1 Hz, 
CH2), 3.63 (3H, s, OCH3) 3.73 (3H, s, OCH3) 4.91 (1H, ddd, JP = 24.8, JH = 8.4, 
264 
 
3.6 Hz, CHOH), 5.52 (1H, d, JP = 8.5 Hz, OH),  6.68-6.73 (1H, m, aromatic-H), 
6.79-6.89 (3H, m, aromatic-H),  6.93  (2H, ddd, JH = 13.6, 8.7, 6.2 Hz, aromatic-
H), 6.97-7.04 (5H, m, aromatic-H), 7.10 (1H, t, JH = 7.2 Hz,  aromatic-H), 7.17 
(3H, dd, JH = 10.1, 4.1 Hz, aromatic-H), 7.22 (1H, dd, JH = 10.8, 2.5 Hz, 
aromatic-H), 7.26-7.33 (2H, m, aromatic-H); δP ppm (400 MHz.) 39.22; δC ppm 
(125 MHz.) 32.8 (CH2), 46.1 (d, JP = 66.3 Hz, PCH), 55.4 (OCH3), 55.5 (OCH3), 
73.3 (d, JP = 4.7 Hz, CHOH), 115.3-159.8 (aromatic C and CH); m/z (EI) 473.3 
(MH+); HRMS (ES); calc. for C29H30O4P (MH+) 473.1873; Found 473.1876; 
 
6.2.65 (2R*, 3R*) and (2R*, 3S*)-(1-(3,5-dimethoxyphenyl)- 1-
hydroxy-3-phenylpropan-2-yl)bis(3-methoxyphenyl)phosphine 
oxide  
Using the method described in 
section 6.2.53; LDA (2 M solution 
in THF, 0.82 mL, 1.64 mmol) was 
added to a stirred solution of 
phosphine oxide 94 (0.2 g, 0.55 
mmol) in dry THF (20 mL). 3, 5-
dimethoxybenzaldehyde 117 (0.27 
g, 1.64 mmol) was added.  The 
organic layer was combined, dried 
and filtered to yield a yellow oil (0.3 g), which was purified by preparative 
chromatography (40 : 40, petroleum ether : ethyl acetate) to give a yellow solid 
(0.28 g, 96 %), to give the required products; 135b (0.12 g, 41 %) and 135a 
could not be isolated. 
 
2,3-syn 135a; 2,3-anti 135b 
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(2R*, 3S*)-(1-(3,5-dimethoxyphenyl)-1-hydroxy-3-phenylpropan-2-yl)bis(3-
methoxyphenyl)phosphine oxide 135b; m.p. 110.4-110.6 °C; Vmax(CHCl3)/cm-
1 3502 (OH),  2901 (C-H), 1579 (C=C arom.), 1215 (P=O), 1113 (C-O), 857 (C-
H arom.); δH ppm (400 MHz.) 2.66-2.79 (1H, m, PCH), 2.79-2.90 (1H, m, CH2), 
3.11 (1H, JP = 18.7, JH = 14.9 Hz, CH2) 3.70 (12H, m, OCH3), 4.85 (1H, s, OH), 
5.21 (1H, t, JP = 9.4 Hz, CHOH), 6.18 (2H, d, JH = 7.2 Hz, aromatic-H), 6.23-
6.31 (1H, m, aromatic-H), 6.46 (2H, d, JH = 2.2 Hz, aromatic-H), 6.82 (4H, dt, JH 
= 14.6, 4.9 Hz, aromatic-H), 6.92-7.13 (4H, m, aromatic-H), 7.32-7.48 (3H, m, 
aromatic-H); δP ppm (400 MHz.) 39.45; δC ppm (125 MHz.) 26.9 (CH2), 47.2 (d, 
JP = 66.7 Hz, PCH), 55.4 (OCH3), 71.1 (CHOH), 98.97 (3,5-dimethoxyphenyl-
CH), 103.9 (3,5-dimethoxyphenyl-CH), 115.2-160.8 (aromatic C and CH); m/z 
(EI) 533.5 (MH+); HRMS (ES); calc. for C31H34O6P (MH+) 533.2084; Found 
533.2088; 
 
(2R*, 3R*)-(1-(3,5-dimethoxyphenyl)-1-hydroxy-3-phenylpropan-2-yl)bis(3-
methoxyphenyl)phosphine oxide 135a;  
Can be observed in the crude reaction NMR but cannot be isolated 
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6.2.66 (2R*, 3R*) and (2R*, 3S*)-(1-(3,5-difluorophenyl)-1-
hydroxy-3-phenylpropan-2-yl)bis(3-methoxyphenyl)phosphine 
oxide  
Using the method described in 
section 6.2.53;  LDA (2 M solution in 
THF, 0.82 mL, 1.64 mmol) was 
added to a stirred solution of 
phosphine oxide 94 (0.2 g, 0.55 
mmol) in dry THF (20 mL). 3, 5 
difluorobenzaldehyde 117 (0.18 mL, 
0.23 g, 1.64 mmol) was added. The 
organic layer was combined, dried 
and filtered to yield a yellow oil (0.32 g), which was purified by preparative 
chromatography (40 : 40, petroleum ether : ethyl acetate) to give a yellow solid 
(0.25 g, 90 %), to give the required products as a mixture.  
 
(2R*, 3S*) and (2R*, 3R*)-(1-(3,5-difluorophenyl)-1-hydroxy-3-
phenylpropan-2-yl)bis(3-methoxyphenyl)phosphine oxide 136bmajor and 
136aminor; Vmax(CHCl3)/cm-1 3495 (OH),  2891 (C-H), 1581 (C=C arom.), 1311 
(P=O), 1123 (C-O), 698 (C-H arom.). 650 (C-F); δH ppm (400 MHz.) eqv. 2.66-
2.91 (4H, m, CH2minor, CH2major, PCHminor and PCHmajor), 2.92-3.09 (1H, m, 
CH2major), 3.18-3.42 (1H, m, CH2minor), 3.58 (3H, s, OCH3minor), 3.68 (3H, s, 
OCH3major), 3.74 (3H, s, OCH3minor), 3.79 (3H, s, OCH3major), 4.82 (1H, d, JP = 
26.7 Hz, CHOHminor), 5.01 (1H, s, OHmajor), 5.20 (1H, d, JP = 9.2 Hz, CHOHmajor), 
5.87 (1H, s, OHminor), 6.08-6.24 (3H, m, aromatic-H), 6.25-6.34 (1H, m, 
aromatic-H), 6.49 (2H, d, JH = 6.5 Hz, aromatic-H), 6.55 (2H, ddd, JH = 19.7, 
2,3-syn 136a; 2,3-anti 136b 
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11.0, 7.6 Hz, aromatic-H), 6.59-6.68 (1H, m, aromatic-H), 6.68-6.89 (8H, m, 
aromatic-H), 6.89-7.04 (4H, m, aromatic-H), 7.06-7.19 (5H, m, aromatic-H), 
7.21-7.48 (6H, m, aromatic-H); δP ppm (400 MHz.) 39.51major and 38.66minor; δC 
ppm (125 MHz.) 25.3 (CH2major), 31.1 (CH2minor), 43.9 (d, JP = 65.8 Hz, 
PCHminor), 45.2 (d, JP = 66.8 Hz, PCHmajor), 53.8 (OCH3minor),  53.9 (OCH3major), 
53.9 (OCH3minor),  53.9 (OCH3major),  68.8 (CHOHmajor), 70.5 (CHOHminor), 100.5-
162.7 (aromatic C and CH); m/z (EI) 509.4 (MH+); HRMS (ES); calc. for 
C29H28F2O4P (MH+) 509.1684; Found 509.1688; 
 
6.2.67 (2R*, 3R*) and (2R*, 3S*)-(1-(3,5-dinitrophenyl)-1-hydroxy-
3-phenylpropan-2-yl)bis(3- methoxyphenyl)phosphine oxide  
Using the method described in 
section 6.2.53;  LDA (2 M solution 
in THF, 0.61 mL, 1.22 mmol) was 
added to a stirred solution of 
phosphine oxide 94 (0.15  g, 0.41 
mmol) in dry THF (20 mL). 3,5-
dinitrobenzaldehyde 121 (0.24 g, 
1.22 mmol) was added. The 
organic layer was combined, dried 
and filtered to yield a purple oil (0.19 g), which was purified by preparative 
chromatography (40 : 40, petroleum ether : ethyl acetate) to give a yellow solid 
(0.17 g, 74 %), to give the required products; 137b (0.10  g, 43 %) and 137a 
(0.03 g, 13 %). 
 
2,3-syn 137a; 2,3-anti 137b 
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(2R*, 3S*)-(1-(3,5-dinitrophenyl)-1-hydroxy-3-phenylpropan-2-yl)bis(3-
methoxyphenyl)phosphine oxide 137b; m.p. 123.4-123.7 °C; Vmax(CHCl3)/cm-
1 3512 (OH), 2922 (C-H), 1589 (C=C arom.), 1337 (NO2), 1342 (C-O), 1149 (C-
H arom.); δH ppm (400 MHz.) 2.82 (1H, dd, JH = 19.2, 7.6 Hz, PCHCH2), 2.99-
3.20 (2H, m, PCH and PCHCH2), 3.75 (3H, s, 3-OCH3), 3.82 (3H, s, 3-OCH3), 
5.30-5.34 (2H, m, CHOH and CHOH), 6.56 (2H, d, JH = 6.3 Hz, aromatic-H), 
6.78 (3H, dt, JH = 14.3, 74 Hz, aromatic-H), 6.99 (1H, dd, JH = 6.7, 3.0 Hz, 
aromatic-H), 7.04-7.11 (1H, m, aromatic-H), 7.29-7.41 (3H, m, aromatic-H), 
7.45-7.54 (3H, m, aromatic-H), 8.14 (2H, d, JH = 1.9 Hz, aromatic-H), 8.54 (1H, 
s, aromatic-H); δP ppm (400 MHz.) 39.67; δC ppm (125 MHz.) 27.7 (PCHCH2), 
45.7 (d, JP = 66.6 Hz, PCH), 55.6 (OCH3), 55.7 (OCH3), 69.3 (CHOH), 115.9-
171.2 (aromatic C and CH);  m/z (EI) 563.0 (MH+); HRMS (ES); calc. for 
C29H28N2O8P (MH+) 563.1570; Found 563.1562; 
 
(2R*, 3R*)-(1-(3,5-dinitrophenyl)-1-hydroxy-3-phenylpropan-2-yl)bis(3-
methoxyphenyl)phosphine oxide 137a; Vmax(CHCl3)/cm-1 3512 (OH), 2922 (C-
H), 1589 (C=C arom.), 1337 (NO2), 1342 (C-O), 1149 (C-H arom.);  δH ppm 
(400 MHz.) 2.87 (2H, dd, JH = 18.2, 4.1 Hz, PCH and PCHCH2), 3.25 (1H, td, JH 
= 13.4, 5.0 Hz,  PCHCH2), 3.61 (3H, s, 3-OCH3), 3.78 (3H, s, 3-OCH3), 4.99 
(1H, dd,  JP = 26.6, JH = 7.8 Hz, CHOH), 6.18 (1H, OH), 6.62 (1H, d, JH = 7.1 
Hz, aromatic-H), 8.83 (1H, d, JH = 13.1 Hz,  aromatic-H), 6.95-7.01 (3H, 
aromatic-H), 7.20-7.23 (3H, aromatic-H), 7.28 (4H, d, JH = 7.3 Hz, aromatic-H), 
7.34-7.40 (1H, m, aromatic-H), 8.12 (2H, s,  aromatic-H), 8.41 (1H, s, aromatic-
H); δP ppm (400 MHz.) 37.41; δC ppm (125 MHz.) 32.5 (PCHCH2), 45.3 (d, JP = 
65.5 Hz, PCH), 55.3 (OCH3), 55.6 (OCH3), 71.6 (CHOH), 115.8-172.1 (aromatic 
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C and CH);  m/z (EI) 563.0 (MH+); HRMS (ES); calc. for C29H28N2O8P (MH+) 
563.1570; Found 563.1562; 
  
6.2.68 (2R*, 3R*) and (2R*, 3S*)-(1-cyclohexyl-1-hydroxy-3-
phenylpropan-2-yl)bis(3-methoxyphenyl)phosphine oxide  
Using the method described in section 
6.2.53; LDA (2 M solution in THF, 0.82 
mL, 1.64 mmol) was added to a stirred 
solution of phosphine oxide 94 (0.2 g, 
0.55 mmol) in dry THF (20 mL). 
Cyclohexanecarboxaldehyde 87 (0.20 
mL, 0.18 g, 1.64 mmol) was added. The 
organic layer was combined, dried and 
filtered to yield a yellow oil (0.32 g), which was purified by preparative 
chromatography (40 : 40, petroleum ether : ethyl acetate) to give a yellow solid 
(0.23 g, 88 %), to give a mixture of products. 
 
(2R*, 3S*) and (2R*, 3R*) -(1-cyclohexyl-1-hydroxy-3-phenylpropan-2-
yl)bis(3-methoxyphenyl)phosphine oxide 138bmajor and 138aminor; 
Vmax(CHCl3)/cm-1 3422 (OH), 2919 (C-H), 1592 (C=C arom.), 1426 (P=O), 1143 
(C-O), 896 (C-H arom.); δH ppm (400 MHz.) eqv. 0.29-0.47 (2H, m, cyclo-CH2), 
0.52-0.70 (3H, m, cyclo-CH2), 0.74-0.87 (3H, m, cyclo-CH2), 0.90-1.03 (2H, m, 
cyclo-CH2), 1.17 (3H, t, JH = 11.1 Hz, cyclo-CH2 and cyclo-CHminor), 1.32 (4H, 
dd, JH = 27.1, 13.3 Hz, cyclo-CH2 and cyclo-CHmajor), 1.48 (2H, d, JH = 9.5 Hz, 
cyclo-CH2), 1.58 (1H, d, JH = 12.5 Hz, cyclo-CH2), 1.87-1.98 (1H, m, cyclo-CH2), 
1.98-2.11 (1H, m, cyclo-CH2), 2.68-2.88 (4H, m, PCHminor, PCHmajoir, CH2minor and 
2,3-syn 138a; 2,3-anti 138b 
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CH2major) 3.03 (1H, m, CH2minor), 3.24 (2H, ddd, m, CH2major and CHOHminor),  
3.59-3.69 (4H, m, CHOHmajor and OCH3minor), 3.714-3.80 (9H, m, OCH3minor, 
OCH3major and OCH3major), 4.23 (1C, d, JP = 9.2 Hz,  CHOHmajor), 4.41 (1C, s, 
CHOHminor), 6.81-6.88 (2H, m, aromatic-H), 6.86 (1H, d, JH = 7.1 Hz, aromatic-
H), 6.95-7.03 (8H, m, aromatic-H), 7.11-7.19 (7H, m, aromatic-H), 7.25 (1H, d, 
JH = 7.8 Hz, aromatic-H), 7.28-7.35 (5H, m, aromatic-H), 7.42 (2H, t, JH = 9.1 
Hz, aromatic-H); δP ppm (400 MHz.) 40.76major and 38.81minor; δC ppm (125 
MHz.) 25.5 (cyclo-CH2), 25.7 (cyclo-CH2), 26.2 (cyclo-CH2), 27.4 (CH2major), 
29.01 (cyclo-CH2), 29.7 (cyclo-CH2), 30.05 (cyclo-CH2), 33.4 (CH2minor), 40.1 (d, 
JP = 66.1 Hz, PCHminor), 40.7 (d, JP = 66.9 Hz, PCHmajor), 40.8 (cyclo-CHmajor), 
41.8 (cyclo-CHminor), 55.4 (OCH3minor) 55.5 (OCH3major), 55.5 (OCH3major), 55.6 
(OCH3major), 74.43 (CHOHmajor), 76.8 (CHOHminor), 115.3-159.8 (aromatic C and 
CH); m/z (EI) 478.3 (MH+); HRMS (ES); calc. for C29H36O4P (MH+) 479.2347; 
Found 479.2346; 
 
6.2.69 (2R*, 3R*) and (2R*, 3S*)-(1-hydroxy-1-(4-methoxyphenyl)-
3-phenylpropan-2-yl)diphenylphosphine oxide  
Using the method described in section 
6.2.53;  LDA (2 M solution in THF, 1.22 
mL, 2.45 mmol) was added to a stirred 
solution of phosphine oxide 36 (0.25 g, 
0.81 mmol) in dry THF (20 mL).  p-
anisaldehyde (0.33 g, 0.29 mL, 2.45 
mmol) was added. The organic layer was 
combined, dried and filtered to yield a 2,3-syn 139a; 2,3-anti 139b 
 
271 
 
yellow oil (0.29 g), which was purified by preparative chromatography (40 : 40, 
petroleum ether : ethyl acetate) to give a yellow solid (0.28 g, 97 %), to give the 
required products; 139a (0.185 g, 64 %) and 139b (0.111 g, 38 %). 
 
(2R*,3R*)-(1-hydroxy-1-(4-methoxyphenyl)-3-phenylpropan-2-yl) 
diphenylphosphine oxide 139a; m.p. 85.6-86.2 °C; Vmax(CHCl3)/cm-1 3356 
(OH), 2925 (C-H), 1511 (C=C arom.), 1245 (P=O), 1169 (C-O), 1044 (C-H 
arom.); δH ppm (400 MHz.) 2.78 (1H, dd, JH = 18.3, 7.4 Hz, PCHCH2), 3.03-3.13 
(2H, m, PCH and PCHCH2) 3.63 (3H, s, p-OCH3), 4.96 (1H, td, JH = 10.4, 5.84,  
JP = 21.2 Hz, CHOH), 5.50 (1H, d, JH = 7.3 Hz, OH), 6.48 (2H, d, JH = 8.6 Hz, 
aromatic-H), 6.98-7.03 (4H, m, aromatic-H), 7.15 (3H, d, JH = 13.2, 6.5 Hz, 
aromatic-H), 7.20-7.28 (2H, m, aromatic-H), 7.30-7.35 (1H, m, aromatic-H), 7.48 
(5H, dtd, JH = 13.9, 8.6, 6.7 Hz, aromatic-H), 7.73 (2H, dd, JH = 10.5, 7.5 Hz, 
aromatic-H); δP ppm (400 MHz.) 39.91; δC ppm (125 MHz.) 32.6 (PCHCH2), 
46.6 (d, JP = 66.7 Hz, PCH), 55.2 (OCH3),  73.1 (d, JP = 4.6 Hz, CHOH), 113.3-
158.5 (aromatic C and CH); m/z (EI) 307.38, 425.36 (MH+ - OH), 443.45 (MH+); 
HRMS (ES); calc. for C28H28O3P (MH+) 443.1770; Found 443.1771; 
 
(2R*,3S*)-(1-hydroxy-1-(4-methoxyphenyl)-3-phenylpropan-2-yl) 
diphenylphosphine oxide 139b; Vmax(CHCl3)/cm-1 3356 (OH), 2925 (C-H), 
1511 (C=C arom.), 1245 (P=O), 1169 (C-O), 1044 (C-H arom.); δH ppm (400 
MHz.) 2.68-2.87 (2H, m, PCH and PCHCH2), 3.03-3.14 (1H, m, PCHCH2), 3.71 
(3H, s, p-OCH3), 4.85 (1H, OH), 5.23 (1H, d,  JP = 9.9 Hz, CHOH), 6.04 (2H, d, 
JH = 7.4 Hz, aromatic-H), 6.77-6.92 (5H, m, aromatic-H), 7.17-7.21 (5H, 
aromatic-H), 7.31 (1H, d, JH = 7.8, 7.1 Hz, aromatic-H), 7.45-7.50 (4H, m, 
aromatic-H), 7.82-7.92 (2H, m, aromatic-H); 
272 
 
δP ppm (400 MHz.) 39.11; δC ppm (125 MHz.) 26.5 (PCHCH2), 47.4 (d, JP = 
66.3 Hz, PCH), 55.3 (OCH3), 70.9 (d, JP = 2.2 Hz, CHOH), 113.8-158.8 
(aromatic C and CH); m/z (EI) 307.38, 425.36 (MH+ - OH), 443.45 (MH+); HRMS 
(ES); calc. for C28H28O3P (MH+) 443.1770; Found 443.1771; 
 
6.2.70 (2R*, 3R*) and (2R*, 3S*)-(1-(4-fluorophenyl)-1- hydroxy-
3-phenylpropan-2-yl)diphenylphosphine oxide  
Using the method described in section 
6.2.53; LDA (2 M solution in THF, 0.95 mL, 
1.96 mmol) was added to a stirred solution 
of phosphine oxide 36 (0.2 g, 0.65 mmol) in 
dry THF (20 mL). 4-fluorobenzaldehyde 120 
(0.23 g, 0.21 mL, 1.96 mmol) was added.  
The organic layer was combined, dried and 
filtered to yield a yellow oil (0.42 g), which 
was purified by preparative chromatography 
(40 : 40, petroleum ether : ethyl acetate) to give a yellow solid (0.24 g, 86 %), to 
give the required products; 140a (0.154 g, 55 %) and 140b (0.05 g, 18 %).  
 
(2R*,3R*)-(1-(4-fluorophenyl)-1-hydroxy-3-phenylpropan-2-yl) 
diphenylphosphine oxide 140a; m.p. 122.4-122.5 °C; Vmax(CHCl3)/cm-1 2841 
(OH), 2133 (C-H), 1584 (C=C arom.), 1423 (P=O), 892 (C-O), 802 (C-H arom.), 
779(C-F); δH ppm (400 MHz.) 2.67-2.76 (1H, m, PCHCH2), 2.88 (1H, JP = 12.0, 
JH = 4.1 Hz, PCH), 3.07 (1H, JP = 11.0, JH = 13.9, 6.6 Hz, PCHCH2), 4.83-4.94 
(1H, d, JP = 23.9 Hz, CHOH), 5.68 (1H, d, JH = 8.4 Hz, CHOH), 6.50 (2H, t, JH = 
8.7 Hz, aromatic-H), 6.89-6.93 (2H, m, aromatic-H), 7.01 (1H, d, JH = 7.2 Hz, 
2,3-syn 140a; 2,3-anti 140b 
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aromatic-H), 7.11-7.18 (3H, m, aromatic-H), 7.21-7.28 (2H, m, aromatic-H), 
7.35-7.45 (5H, m, aromatic-H), 7.50 (1H, d, JH = 9.3 Hz, aromatic-H), 7.64-7.72 
(2H, m, aromatic-H); δP ppm (400 MHz.) 39.45; δC ppm (125 MHz.) 32.8 
(PCHCH2), 46.2 (d, JP = 66.7 Hz, PCH), 72.7 (CHOH), 114.4-139.0 (aromatic C 
and CH); m/z (EI) 431.1 (MH+); HRMS (ES); calc. for C27H25FO2P (MH+) 
431.1571; Found 431.1571; 
 
(2R*,3S*)-(1-(4-fluorophenyl)-1-hydroxy-3-phenylpropan-2-yl) 
diphenylphosphine oxide 140b; m.p. 129.8-130.1 °C; Vmax(CHCl3)/cm-1 2841 
(OH), 2133 (C-H), 1584 (C=C arom.), 1423 (P=O), 892 (C-O), 802 (C-H arom.), 
779(C-F); δH ppm (400 MHz.) 2.60-2.79 (2H, m, CHOH and PCH),  2.79-2.90 
(1H, m, PCHCH2), 2.99-3.14 (1H, m, PCHCH2), 5.27 (1H, d, JP = 9.4 Hz, 
CHOH), 6.08 (2H, d, JH = 7.5 Hz, aromatic-H), 6.78 (2H, t, JH = 7.5 Hz, 
aromatic-H), 6.80-6.89 (1H, m, aromatic-H), 6.97 (2H, dd, JH = 12.0, 5.3 Hz, 
aromatic-H), 7.18-7.29 (4H, m, aromatic-H), 7.32-7.39 (1H, m, aromatic-H), 
7.45-7.57 (5H, m aromatic-H), 7.87-7.94 (2H, m, aromatic-H); δP ppm (400 
MHz.) 39.24; δC ppm (125 MHz.) 26.5 (PCHCH2), 47.3 (d, JP = 66.2 Hz, PCH), 
70.6 (CHOH), 115.2-160.7 (aromatic C and CH); m/z (EI) 431.1 (MH+); HRMS 
(ES); calc. for C27H25FO2P (MH+) 431.1571; Found 431.1571; 
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6.2.71 (2R*, 3R*) and (2R*, 3S*)-(3-(3,5-difluorophenyl)-1- (3,5-
dimethoxyphenyl)-1-hydroxypropan-2-yl)diphenylphosphine 
oxide  
Using the method described in section 
6.2.53;  LDA (2 M solution in THF, 2.2 
mL, 4.4 mmol) was added to a stirred 
solution of phosphine oxide 42 (0.5 g, 
1.5 mmol) in THF (100 mL). 3,5-
dimethoxybenzaldehyde 116 (0.72 g, 
4.4 mmol) was added. The organic layer 
was combined, dried and filtered to yield 
a yellow oil (0.8 g), which was purified by column chromatography (70 : 30, 
petroleum ether : ethyl acetate) to give a yellow solid (0.69 g, 93%). This was 
purified further to separate out the diastereoisomers, the samples (0.1 g) were 
dissolved in 1 : 1 v/v, MeOH : DMSO (1 mL) and purified by Open Access Mass 
Directed Auto Prep on Sunfire C18 column using Acetonitrile Water with a 
Formic acid modifier. The gradient employed was method E, selected from 5 
pre-set methods (A, B, C, D or E). The solvent was removed under a stream of 
nitrogen in the Radley's blow-down apparatus to give the required products; 
141b (0.07 g, 9 %). 
 
(2R*,3R*)-(3-(3,5-difluorophenyl)-1-(3,5-dimethoxyphenyl)-1-hydroxypropa 
n-2-yl)diphenylphosphine oxide 141a; minor quantities visable in crude 
spectra; δH ppm (400 MHz.) 4.80 (1H, dd, JH = 4.6, JP = 24.6 Hz, CHOH),  δP 
ppm (400 MHz.) 39.34;  
 
2,3-syn 141a; 2,3-anti 141b 
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(2R*,3S*)-(3-(3,5-difluorophenyl)-1-(3,5-dimethoxyphenyl)-1-hydroxypropa 
n-2-yl)diphenylphosphine oxide 141b; m.p. 143.3-146.3 °C; Vmax(CHCl3)/cm-1 
3303 (OH), 2924 (C-H), 1594 (C=C arom.), 1197 (P=O), 791 (C-O), 743 (C-H 
arom.), 703 (C-F); δH ppm (600 MHz.) 2.73 (1H, ddd, JH = 4.3, 2.2, JP =  7.5 Hz, 
PCH), 2.84 (1H, ddd, JH = 15.4, 7.5, JP =  16.7 Hz, CH2),  3.12 (1H, ddd, JH = 
15.3, 3.1, JP =  18.4 Hz, CH2), 3.80 (6H, s, CH3), 4.86 (1H, s, OH), 5.25 (1H, d, 
JP = 9.2 Hz, CHOH), 5.67 (2H, d, JH = 6.5 Hz, 3,5-dimethoxyphenyl-H), 6.35-
6.39 (2H, m, 3,5-dimethoxyphenyl-H and 3,5-difluorophenyl-H), 6.51 (2H, d, JH 
= 1.8 Hz, 3,5-difluorophenyl-H), 7.34 (2H, td, JH = 7.7, 3.1 Hz, aromatic-H), 7.47 
(1H, td, JH = 7.4, 1.3 Hz, aromatic-H), 7.53 (1H, dd, JH = 5.7, 3.3 Hz, aromatic-
H), 7.59 (2H, dt, JH = 4.2, 3.0 Hz, aromatic-H), 7.62 (1H, td, JH = 5.5, 2.2 Hz, 
aromatic-H), 7.71 (1H, dd, JH = 5.7, 3.3 Hz, aromatic-H), 7.97 (2H, ddd, JH = 
10.7, 7.5, 2.0 Hz, aromatic-H); δP ppm (600 MHz.) 38.34; δC ppm (250 MHz.) 
26.7 (CH2), 47.1 (d, JP = 66.6 Hz, PCH), 55.3 (CH3), 70.8 (CHOH), 98.9 (3,5-
dimethoxyphenyl-CH), 103.9 (3,5-dimethoxyphenyl-CH and 3,5-difluorophenyl-
CH), 111.7 (3,5-difluorophenyl-CH), 128.6-160.9 (aromatic C and CH); m/z (EI) 
509.5, 510.4, 511.5 (MH+); HRMS (ES); calc. for C29H2819F2O4P (MH+) 
509.1683; Found 509.1688; 
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6.2.72 (2R*, 3R*) and (2R*, 3S*)-(3-(3,5-difluorophenyl)-1-
hydroxy-1-phenylpropan-2-yl)diphenylphosphine oxide   
Using the method described in section 
6.2.53; LDA (2 M solution in THF, 1.1 
mL, 2.2 mmol) was added to a stirred 
solution of phosphine oxide 42 (0.25 g, 
0.73 mmol) in THF (70 mL). 
Benzaldehyde 81 (0.22 mL, 0.23 g, 2.2 
mmol) was added. The organic layer 
was combined, dried and filtered to yield a yellow oil (0.4g), which was purified 
by column chromatography (70 : 30, petroleum ether : ethyl acetate) to give a 
yellow solid (0.29 g, 90 %). This was purified further to separate out the 
diastereoisomers, the samples (0.1 g) were dissolved in 1 : 1 v/v, MeOH : 
DMSO (1 mL) and purified by Open Access Mass Directed Auto Prep on 
Sunfire C18 column using Acetonitrile Water with a Formic acid modifier. The 
gradient employed was method E, selected from 5 pre-set methods (A, B, C, D 
or E). The solvent was removed under a stream of nitrogen in the Radley's 
blow-down apparatus to give the required products; 142b (0.1 g, 31 %). 
 
(2R*,3S*)-(3-(3,5-difluorophenyl)-1-hydroxy-1-phenylpropan-2-yl) 
diphenylphosphine oxide  142b; m.p. 116.3-117.4 °C; Vmax(CHCl3)/cm-1 2849 
(OH), 2132 (C-H), 1555 (C=C arom.), 1222 (P=O), 824 (C-O), 799 (C-H arom.), 
722 (C-F); δH ppm (400 MHz.) 2.75-2.81 (1H, m, JH = 7.3, 2.4 Hz, PCH), 2.86 
(1H, ddd, JH = 15.4, 7.3, JP = 17.3 Hz, CH2), 3.14 (1H, ddd, JH = 15.5, 3.0, JP = 
18.2 Hz, CH2), 4.85-4.92 (1H, m, CHOH), 5.37 (1H, d, JP = 9.3 Hz, CHOH), 
5.56-5.63 (2H, m, 3,5-difluorophenyl-H), 6.35 (1H, tt, JH = 9.0, 2.3 Hz 3,5-
2,3-syn 142a; 2,3-anti 142b 
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difluorophenyl-H), 7.25-7.30 (2H, m, aromatic-H), 7.33-7.42 (5H, m, aromatic-
H), 7.44-7.51 (1H, m, aromatic-H), 7.59-7.78 (5H, m, aromatic-H), 7.98-8.13 
(2H, m, aromatic-H); δP ppm (400 MHz.) 38.47; δC ppm (125 MHz.) 26.7 (CH2), 
47.4 (d, JP = 66.8 Hz, PCH), 70.8 (d, JP = 2.3 Hz, CHOH), 101.2 (3,5-
difluorophenyl-CH), 110.9 (3,5-difluorophenyl-CH), 125.5-162.8 (aromatic C and 
CH); m/z (EI) 449.1 (MH+); HRMS (ES); calc. for C27H2419F2O2P (MH+) 
449.1474; Found 449.1476; 
 
(2R*,3R*)-(3-(3,5-difluorophenyl)-1-hydroxy-1-phenylpropan-2-yl) 
diphenylphosphine oxide  142a; minor quantities visable in crude spectra; δH 
ppm (400 MHz.) 4.91 (1H, dd, JH = 3.5, JP = 20.2 Hz, CHOH),  δP ppm (400 
MHz.) 38.30;  
 
6.2.73 (2R*, 3R*) and (2R*, 3S*)-(1,3-bis(3,5- difluorophenyl)-1-
hydroxypropan-2-yl)diphenylphosphine oxide  
Using the method described in section 
6.2.53; LDA (2 M solution in THF, 2.2 
mL, 4.4 mmol) was added to a stirred 
solution of phosphine oxide 42 (0.5 g, 
1.5 mmol) in THF (100 mL). 3,5-
difluorobenzaldehyde 117 (0.48 mL, 
0.62 g, 4.4 mmol) was added. The 
organic layer was combined, dried and 
filtered to yield a yellow oil (0.78 g), which was purified by column 
chromatography (70 : 30, petroleum ether : ethyl acetate) to give a yellow solid 
(0.54 g, 77 %). This was purified further to separate out the diastereoisomers, 
2,3-syn 143a;2,3-anti 143b 
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the samples (0.1 g) were dissolved in 1 : 1 v/v, MeOH : DMSO (1 mL) and 
purified by Open Access Mass Directed Auto Prep on Sunfire C18 column using 
Acetonitrile Water with a Formic acid modifier. The gradient employed was 
method E, selected from 5 pre-set methods (A, B, C, D or E). The solvent was 
removed under a stream of nitrogen in the Radley's blow-down apparatus to 
give the required products; 143b (0.03 g, 4 %) and 143a (0.065 g, 9%).  
 
(2R*,3S*)-(1,3-bis(3,5-difluorophenyl)-1-hydroxypropan-2-yl) 
diphenylphosphine oxide 143b; Vmax(CHCl3)/cm-1 3302 (OH), 2935 (C-H), 
1595 (C=C arom.), 1149 (P=O), 791 (C-O), 777 (C-H arom.), 654 (C-F); δH ppm 
(400 MHz.) 2.73 (1H, dt, JH = 6.3, 5.7, JP =  7.0 Hz, PCH), 2.86 (1H, tdd, JH = 
15.6, 7.2, JP =  2.6 Hz, CH2), 3.02 (1H, tdd, JH = 15.0, 4.0, JP =  18.0 Hz, CH2), 
4.96 (1H, d, JP = 16.3 Hz, OH), 5.24 (1H, d, JP = 9.4 Hz, CHOH), 5.73-5.81 (2H, 
m, 3,5-difluorophenyl-H), 5.82-5.85 (1H, m, 3,5-difluorophenyl-H), 6.37 (1H, tt, 
JH = 9.0, 2.3 Hz, 3,5-difluorophenyl-H), 6.61-6.73 (2H, m, 3,5-difluorophenyl-H), 
7.33-7.41 (2H, m, aromatic-H), 7.48-7.55 (1H, m, aromatic-H), 7.61-7.67 (5H, 
m, aromatic-H), 7.97-8.04 (2H, m, aromatic-H); δP ppm (400 MHz.) 38.40; δC 
ppm (125 MHz.) 26.8 (d, JP = 10.5 Hz, CH2), 46.7 (d, JP = 66.9 Hz, PCH), 70.2 
(CHOH), 101.4 (3,5-difluorophenyl-CH), 102.7 (3,5-difluorophenyl-CH), 108.6 
(3,5-difluorophenyl-CH), 111.0 (3,5-difluorophenyl-CH), 111.7-163.7 (aromatic 
C and CH); m/z (EI) 485.0, 486.0, 487.1 (MH+); HRMS (ES); calc. for 
C27H2219F4O2P (MH+) 485.1277; Found 485.1288; 
 
(2R*,3R*)-(1,3-bis(3,5-difluorophenyl)-1-hydroxypropan-2-yl) 
diphenylphosphine oxide 143a; Vmax(CHCl3)/cm-1 3302 (OH), 2935 (C-H), 
1595 (C=C arom.), 1149 (P=O), 791 (C-O), 777 (C-H arom.), 654 (C-F);  δH ppm 
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(400 MHz.) 2.75 (1H, dt, JH = 14.1, 3.5 Hz, CH2),  2.86 (1H, tt, JH = 15.4, 4.5, JP 
= 11.8 Hz, PCH), 3.16 (1H, ddd, JH = 14.1, 10.7, JP =  7.6 Hz, CH2), 4.86 (1H, 
ddd, JH = 8.8, 3.1, JP = 24.3 Hz, CHOH), 5.82 (1H, d, JP = 8.9 Hz, OH), 6.26-
6.31 (1H, m, 3,5-difluorophenyl-H), 6.60-6.69 (2H, m, 3,5-difluorophenyl-H), 
6.69-6.87 (2H, m, 3,5-difluorophenyl-H), 6.91-7.01 (1H, m, 3,5-difluorophenyl-
H), 7.32-7.42 (3H, m, aromatic-H), 7.49-7.69 (5H, m, aromatic-H), 7.73-7.79 
(2H, m, aromatic-H); δP ppm (400 MHz.) 38.18; δC ppm (125 MHz.) 32.6 (CH2), 
45.1 (d, JP = 68.9 Hz, PCH), 72.6 (CHOH), 102.6 (3,5-difluorophenyl-CH), 108.9 
(3,5-difluorophenyl-CH), 112.1 (3,5-difluorophenyl-CH), 128.3 (3,5-
difluorophenyl-CH), 129.1-164.0 (aromatic C and CH); m/z (EI) 485.0, 486.0, 
487.1 (MH+); HRMS (ES); calc. for C27H2219F4O2P (MH+) 485.1277; Found 
485.1288; 
 
6.2.74 (2R*, 3R*) and (2R*, 3S*)-(1-cyclohexyl-3-(3,5-
difluorophenyl)-1-hydroxypropan-2-yl)diphenylphosphine oxide  
Using the method described in section 
6.2.53; LDA (2 M solution in THF, 2.2 
mL, 4.4 mmol) was added to a stirred 
solution of phosphine oxide 42 (0.5 g, 
1.5 mmol) in THF (100 mL). 
Cyclohexanecarboxaldehyde 87 (0.53 
mL, 0.49 g, 4.4 mmol) was added.  
The organic layer was combined, dried and filtered to yield a yellow oil (0.89 g), 
this was purified by flash column chromatography (50 : 50 v/v, petroleum ether : 
ethyl acetate) collecting all relevant fractions, to afford a mixture of both 
diastereoisomers (0.51 g, 77 %). The white solid was further purified using a 
2,3-syn 144a; 2,3-anti 144b 
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combination of column and preparative chromatography to separate out the 2 
diastereoisomers (50 : 50 v/v, petroleum ether : ethyl acetate). The 
diastereoisomers eluted together and were dried in vacuo to give 144b and 
144a as a mixture (0.15 g, 22 %). 
 
(2R*, 3S*) and (2R*, 3R*)-(1-cyclohexyl-3-(3,5-difluorophenyl)-1-
hydroxypropan-2-yl)diphenylphosphine oxide 144bmajor and 144aminor; 
Vmax(CHCl3)/cm-1 3379 (OH), 2925 (C-H), 1647 (C=C arom.), 1321 (P=O), 1007 
(C-O), 721 (C-H arom.), 709 (C-F); δH ppm (400 MHz.) eqv. 0.36 (1H, q, JH = 
12.5 Hz, cyclo-CH2), 0.57 (1H, t, JH = 12.2 Hz, cyclo-CH2), 0.73 (2H, dd, JH = 
14.2, 6.6 Hz, cyclo-CH2), 0.89 (2H, dd, JH = 16.0, 6.9 Hz, cyclo-CH2), 1.04 (1H, 
d, JH = 10.0 Hz, cyclo-CH2), 1.12-1.16 (2H, m, cyclo-CH2), 1.25 (2H, d, JH = 
12.2 Hz, cyclo-CH2 and cyclo-CHminor), 1.36 (1H, d, JH = 11.2 Hz, cyclo-CH2), 
1.53 (1H, d, JH = 12.4 Hz, cyclo-CH2), 1.66 (5H, m, cyclo-CH2), 1.78-1.81 (2H, 
m, cyclo-CH2 and cyclo-CHmajor), 1.99 (1H, m, cyclo-CH2), 2.39-2.47 (1H, m, 
cyclo-CH2), 2.73 (1H, ddd, JH = 14.3, 10.8, 3.8 Hz, CH2major), 2.81 (1H, d, JH = 
6.4 Hz, PCHminor), 2.88 (1H, dd, JH = 9.7, 5.2 Hz, PCHmajor), 3.09 (1H, ddd, JH = 
14.1, 10.5, 7.9 Hz, CH2major), 3.15-3.27 (1H, m, CH2minor), 3.33-3.35 (1H, m, 
CH2minor), 3.70 (1H, t, JP = 10.5 Hz, CHOHmajor), 4.25 (1H, s, OHmajor), 4.47 (1H, 
d, JP = 9.5 Hz, OHminor), 4.53  (1H, dt, JP = 20.8, JH = 10.9, 2.9 Hz, CHOHminor), 
6.63 (2H, d, JH = 8.7 Hz, 3,5-difluorobenzyl-H), 6.60 (2H, d, JH = 8.9 Hz, 3,5-
difluorobenzyl-H),  7.35-7.40 (2H, m, 3,5-difluorobenzyl-H), 7.46-7.55 (11H, m, 
aromatic-H), 7.64-7.70 (2H, m, aromatic-H), 7.77-7.88 (5H, m, aromatic-H), 
7.93-7.99 (2H, m, aromatic-H); δP ppm (400 MHz.) 39.71major and 37.87minor; δC 
ppm (125 MHz.) 25.4 (cyclo-CH2), 25.7 (cyclo-CH2), 25.8 (cyclo-CH2), 26.1 
(cyclo-CH2), 26.3 (cyclo-CH2), 27.2 (CH2minor), 29.1 (cyclo-CH2), 29.2 (cyclo-
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CH2), 29.6 (cyclo-CH2), 29.8 (cyclo-CH2), 30.0 (cyclo-CH2), 33.1 (CH2major), 39.7 
(PCHminor), 41.7 (PCHmajor), 43.6 (cyclo-CHminor), 43.7 (cyclo-CHmajor), 71.2 (d, JP 
= 10.7 Hz, CHOHmajor), 74.2 (d, JP = 2.9 Hz, CHOHminor), 111.8 (dd, JP = 26.2, 
12.1 Hz, 3,5-difluorobenzyl-CH), 128.6-161.7 (aromatic C and CH); m/z (EI) 
455.3 (MH+);  
 
6.2.75 (2R*, 3R*) and (2R*, 3S*)-(3-(3,5-difluorophenyl)-1-(3,5-
dinitrophenyl)-1-hydroxypropan-2-yl)diphenylphosphine oxide  
Using the method described in section 
6.2.53; LDA (2 M solution in THF, 0.66 mL, 
1.32 mmol) was added to a stirred solution 
of phosphine oxide 42 (0.15  g, 0.44  
mmol) in dry THF (20 mL). 3,5-
dinitrobenzaldehyde 121 (0.26 g, 1.32 
mmol) was added. The organic layer was 
combined, dried and filtered to yield a 
purple oil (0.21 g), which was purified by 
preparative chromatography (40 : 40, petroleum ether : ethyl acetate) to give a 
yellow solid (0.20 g, 85 %), but they could not be separated. Cannot be isolated 
but can be observed in the crude 31P-1H coupling and can be confirmed as; 
(2R*, 3S*)-(3-(3,5-difluorophenyl)-1-(3,5-dinitrophenyl)-1-hydroxypropan-2-
yl)diphenylphosphine oxide 145b,  5.23 (1H, td, JH = 5.84,  JP = 10.2 Hz, 
CHOH), and (2R*, 3R*)-(3-(3,5-difluorophenyl)-1-(3,5-dinitrophenyl)-1-
hydroxypropan-2-yl)diphenylphosphine oxide 145a, 4.92 (1H, d,  JP = 21.2 
Hz, CHOH). 
 
2,3-syn 145a; 2,3-anti 145b 
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6.2.76 (2R*, 3R*) and (2R*, 3S*)-(3-(3,5-difluorophenyl)-1-
hydroxy-1-(3-nitrophenyl)propan-2-yl)diphenylphosphine oxide  
Using the method described in section 
6.2.53; LDA (2 M solution in THF, 0.67 
mL, 1.3 mmol) was added to a stirred 
solution of phosphine oxide 42 (0.15  g, 
0.43  mmol) in dry THF (20 mL). 3-
nitrobenzaldehyde 118 (0.19 g, 1.3 mmol) 
in THF (1 mL) was added. The organic 
layer was combined, dried and filtered to 
yield a orange oil (0.22 g), which was purified by preparative chromatography 
(40 : 40, petroleum ether : ethyl acetate) to give a yellow solid (0.19 g, 90 %), 
but they could not be separated.  
 
(2R*, 3S*) and (2R*, 3R*)-(3-(3,5-difluorophenyl)-1-hydroxy-1-(3-
nitrophenyl)propan-2-yl)diphenylphosphine oxide 146bmajor and 146aminor; 
Vmax(CHCl3)/cm-1 3412 (OH), 2962 (C-H), 1588 (C=C arom.), 1357 (NO2), 1298 
(P=O), 1099 (C-O), 876 (C-F); δH ppm (400 MHz.) eqv. 2.65-2.82 (3H, m, 
PCHCH2major, PCHCH2minor and PCHmajor), 2.93 (2H, m, PCHCH2major and 
PCHminor), 3.13 (1H, ddd, JH = 18.5, 7.0, JP =  11.6 Hz, PCHCH2minor),  4.89 (1H, 
dd, JH = 6.7, JP =  24.6 Hz, CHOHminor), 4.99 (1H, d, JH = 4.1 Hz, OHmajor), 5.26 
(1H, d, JP =  9.3 Hz, CHOHmajor), 5.74 (2H, dd, JH = 9.0, 3.9 Hz, 3,5-
difluorophenyl-Hmajor),  5.84 (1H, d, JH = 9.0 Hz, OHminor), 6.0 (2H, s,  3,5-
difluorophenyl -Hminor), 6.21 (1H, s,  3,5-difluorophenyl -Hminor), 6.67 (1H, d, JH = 
8.0 Hz,  3,5-difluorophenyl -Hmajor), 7.07 (1H, dd, JH = 9.8, 6.0 Hz, aromatic-H), 
7.16 (1H, dd, JH = 7.4 Hz, aromatic-H), 7.22-7.32 (3H, m, aromatic-H), 7.40 (7H, 
2,3-syn 146a; 2,3-anti 146b 
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dddd, JH = 15.9, 10.9, 7.9, 2.8 Hz, aromatic-H), 7.49-7.56 (4H, m, aromatic-H), 
7.58-7.67 (4H, m, aromatic-H), 7.71 (1H, d, JH = 1.7 Hz, aromatic-H), 7.91 (3H, 
dd, JH = 9.4, 8.1 Hz, aromatic-H), 8.00-8.07 (3H, m, aromatic-H), 8.19 (1H, s, 
aromatic-H); δP ppm (400 MHz.) 38.69major, 39.03minor; δC ppm (125 MHz.) 26.9 
(PCHCH2major), 32.6 (PCHCH2minor),  44.9 (d, JP = 64.9 Hz, PCHminor), 46.4 (d, JP 
= 66.9 Hz, PCHmajor),  65.6 (3,5-difluorophenyl-CHminor), 65.7 (3,5-
difluorophenyl-CHminor), 69.9 (CHOHmajor), 72.2 (CHOHminor), 11.8 (d, JP = 25.3 
Hz, 3,5-difluorophenyl-CHmajor), 112.6 (3,5-difluorophenyl-CHmajor), 120.4 (3-
nitrophenyl-CH),  120.6 (3-nitrophenyl-CH),  120.7 (3-nitrophenyl-CH),  121.4 
(3-nitrophenyl-CH),  122.2 (3-nitrophenyl-CH),  122.4 (3-nitrophenyl-CH), 128.4-
161.5 (aromatic C and CH); m/z (EI) 494.0 (MH+); HRMS (ES); calc. for 
C27H22F2NO4P (MH+) 563.1578; Found 563.1578; 
 
6.2.77 (2R*, 3R*) and (2R*, 3S*)-(1,3-bis(3,5- dimethoxyphenyl)-
1-hydroxypropan-2-yl)diphenylphosphine oxide  
Using the method described in section 
6.2.53; LDA (2 M solution in THF, 2.1 
mL, 4.1 mmol) was added to a stirred 
solution of phosphine oxide 43 (0.5 g, 
1.3 mmol) in THF (100 mL). 3,5-
dimethoxybenzaldehyde 116 (0.68 g, 
4.1 mmol) was added. The organic 
layer was combined, dried and filtered to yield a yellow oil (0.77 g), which was 
purified by column chromatography (70 : 30, petroleum ether : ethyl acetate) to 
give a yellow solid (0.62 g, 86 %). This was purified further to separate out the 
diastereoisomers, the samples (0.1 g) were dissolved in 1 : 1 v/v, MeOH : 
2,3-syn 147a; 2,3-anti 147b 
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DMSO (1 mL) and purified by Open Access Mass Directed Auto Prep on 
Sunfire C18 column using Acetonitrile Water with a Formic acid modifier. The 
gradient employed was method E, selected from 5 pre-set methods (A, B, C, D 
or E). The solvent was removed under a stream of nitrogen in the Radley's 
blow-down apparatus to give the required products; 147b (0.085 g, 12 %) and 
147a (0.066 g, 9 %). 
 
(2R*,3S*)-(1,3-bis(3,5-dimethoxyphenyl)-1-hydroxypropan-2-yl) 
diphenylphosphine oxide 147b; m.p. 110.0-111.3 °C; Vmax(CHCl3)/cm-1 3315 
(OH), 2960 (C-H), 1595 (C=C arom.), 1200 (P=O), 792 (C-O), 745 (C-H arom.); 
δH ppm (400 MHz.) 2.80-2.85 (2H, m, CH2 and PCH), 3.16 (1H, dd, JH = 12.8, JP 
= 19.2 Hz, CH3), 3.49 (6H, s, CH3), 3.77 (6H, s, CH3), 4.94-4.99 (1H, m, 
CHOH), 5.25 (1H, d, JP = 9.4 Hz, CHOH), 5.36 (2H, d, JH = 2.2 Hz, 3,5-
dimethoxyphenyl-H), 6.04 (1H, t, JH = 2.3 Hz, 3,5-dimethoxyphenyl-H), 6.33 
(1H, d, JH = 2.3 Hz, 3,5-dimethoxyphenyl-H), 6.54-6.79 (2H, m, 3,5-
dimethoxyphenyl-H), 7.31 (2H, ddd, JH = 7.4, 3.8, 2.3 Hz,  aromatic-H), 7.39-
7.51 (1H, m, aromatic-H), 7.52-7.59 (3H, m, aromatic-H), 7.59-7.66 (2H, m, 
aromatic-H), 7.92-7.99 (2H, m, aromatic-H); δP ppm (400 MHz.) 39.44; δC ppm 
(400 MHz.) 27.2 (CH2), 47.3 (d, JH = 66.3 Hz, PCH), 54.9 (CH3), 55.4 (CH3), 
71.1 (d, JH = 2.2 Hz, CHOH), 98.5 (3,5-dimethoxyphenyl-CH), 98.9 (3,5-
dimethoxyphenyl-CH), 103.9 (3,5-dimethoxyphenyl-CH), 106.0 (3,5-
dimethoxyphenyl-CH), 128.3-160.9 (aromatic C and CH); m/z (EI) 533.1, 534.1, 
535.1 (MH+); HRMS (ES); calc. for C31H34O6P (MH+) 533.2074; Found 
533.2088; 
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(2R*,3R*)-(1,3-bis(3,5-dimethoxyphenyl)-1-hydroxypropan-2-yl) 
diphenylphosphine oxide 147a; m.p. 175.4-176.3 °C; Vmax(CHCl3)/cm-1 3315 
(OH), 2960 (C-H), 1595 (C=C arom.), 1200 (P=O), 792 (C-O), 745 (C-H arom.); 
δH ppm (400 MHz.) 2.71 (1H, ddd, JH = 13.8, 3.2, JP = 10.7 Hz, CH2), 2.95 (1H, 
ddt, JH = 7.2, 3.5, JP = 10.9 Hz, PCH), 3.10 (1H, ddd, JH = 13.8, 11.0, JP = 6.3 
Hz, CH2), 3.62 (6H, s, CH3), 3.75 (6H, s, CH3), 4.97 (1H, ddd, JH = 8.2, 3.5, JP = 
24.6 Hz, CHOH), 5.69 (1H, d, JP = 8.4 Hz, CHOH), 5.92 (1H, t, JH = 2.3 Hz, 3,5-
dimethoxyphenyl-H), 6.24 (2H, d, JH = 2.2 Hz, 3,5-dimethoxyphenyl-H), 6.27 
(2H, d, JH = 2.0 Hz, 3,5-dimethoxyphenyl-H), 6.29 (1H, d, JH = 2.2 Hz, 3,5-
dimethoxyphenyl-H), 7.18-7.22 (2H, m, aromatic-H), 7.27-7.33 (1H, m, 
aromatic-H), 7.44-7.59 (5H, m, aromatic-H), 7.75 (2H, ddd, JH = 11.3, 7.8, 1.7 
Hz,  aromatic-H); δP ppm (400 MHz.) 39.35; δC ppm (125 MHz.) 33.2 (CH2), 45.8 
(d, JH = 65.9 Hz, PCH), 55.3 (CH3), 55.4 (CH3), 73.5 (d, JH = 4.6 Hz, CHOH), 
98.5 (3,5-dimethoxyphenyl-CH), 99.2 (3,5-dimethoxyphenyl-CH), 104.3 (3,5-
dimethoxyphenyl-CH), 107.1 (3,5-dimethoxyphenyl-CH), 128.0 (d, JP = 11.9 Hz, 
aromatic-CH), 128.9 (d, JP = 11.6 Hz, aromatic-CH), 130.1 (d, JP = 9.2 Hz, 
aromatic-CH), 130.8-160.9 (aromatic C and CH); m/z (EI) 533.1, 534.1, 535.1 
(MH+); HRMS (ES); calc. for C31H34O6P (MH+) 533.2074; Found 533.2088; 
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6.2.78 (2R*, 3R*) and (2R*, 3S*)-(3-(3,5-dimethoxyphenyl)-1-
hydroxy-1-phenylpropan-2-yl)diphenylphosphine oxide  
Using the method described in 
section 6.2.53;  LDA (2 M solution 
in THF, 1.0 mL, 2 mmol) was added 
to a stirred solution of phosphine 
oxide 43 (0.25 g, 0.7 mmol) in THF 
(70 mL). Benzaldehyde 81 (0.20 
mL, 0.21 g, 2 mmol) was added. 
The organic layer was combined, dried and filtered to yield a yellow oil (0.38 g), 
which was purified by column chromatography (70 : 30, petroleum ether : ethyl 
acetate) to give a yellow solid (0.31 g, 97 %). This was purified further to 
separate out the diastereoisomers, the samples (0.1 g) were dissolved in 1 : 1 
v/v, MeOH : DMSO (1 mL) and purified by Open Access Mass Directed Auto 
Prep on Sunfire C18 column using Acetonitrile Water with a Formic acid 
modifier. The gradient employed was method E, selected from 5 pre-set 
methods (A, B, C, D or E). The solvent was removed under a stream of nitrogen 
in the Radley's blow-down apparatus to give the required products; 148b (0.12 
g, 36 %) and 148a (0.047 g, 15%).  
 
(2R*,3S*)-(3-(3,5-dimethoxyphenyl)-1-hydroxy-1-phenylpropan-2-yl) 
diphenylphosphine oxide 148b; m.p. 130.1-131.2 °C; Vmax(CHCl3)/cm-1 3681 
(O-H), 2920 (C-H), 1594 (C=C arom.), 1147 (P=O), 1022 (C-O), 750 (C-H 
arom.); δH ppm (400 MHz.) 2.85-2.91 (2H, m, CH2eq and PCH), 3.16 (1H, dt, JH 
= 11.0, 5.3, JP = 21.8 Hz, CH2ax), 3.48 (6H, s, 2(CH3)), 4.94 (1H, s, CHOH), 5.28 
(2H, s, 3,5-dimethoxyphenyl-H), 5.37 (1H, d, JP = 9.5 Hz, CHOH), 6.05-6.15 
2,3-syn 148a; 2,3-anti 148b 
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(1H, m, 3,5-dimethoxyphenyl-H), 7.36-7.52 (8H, m, aromatic-H), 7.57-7.61 (3H, 
m, aromatic-H), 7.65-7.71 (2H, m, aromatic-H), 8.00-8.10 (2H, m, aromatic-H); 
δP ppm (400 MHz.) 39.41; δC ppm (125 MHz.) 26.6 (CH2), 47.2 (d, JP = 87.7 Hz, 
PCH), 54.9 ((CH3)2), 70.8 (CHOH), 98.4 (3,5-dimethoxyphenyl-CH), 106.1 (3,5-
dimethoxyphenyl-CH), 125.7-160.2 (aromatic C and CH); m/z (EI) 473.5 (MH+); 
HRMS (ES); calc. for C29H30O4P (MH+) 473.1877; Found 473.1876; 
 
(2R*,3R*)-(3-(3,5-dimethoxyphenyl)-1-hydroxy-1-phenylpropan-2-yl) 
diphenylphosphine oxide 148a; Vmax(CHCl3)/cm-1 3681 (O-H), 2920 (C-H), 
1594 (C=C arom.), 1147 (P=O), 1022 (C-O), 750 (C-H arom.); δH ppm (400 
MHz.) 2.76 (1H, dtd, JH = 13.7, 3.8, JP = 11.9 Hz, CH2eq), 3.01 (1H, ddd, JH = 
14.2, 3.5, JP = 7.1 Hz, CH2ax), 3.09 (1H, ddd, JH = 13.4, 10.5, JP = 7.0 Hz, PCH), 
3.76 (6H, s, 2(CH3)), 5.08 (1H, d, JP = 23.9 Hz, CHOH), 5.61 (1H, s, CHOH), 
6.21 (2H, d, JH = 2.2 Hz, 3,5-dimethoxyphenyl-H), 6.30 (1H, dt, JH = 4.2, 2.1 Hz, 
3,5-dimethoxyphenyl-H), 6.96 (2H, s, aromatic-H), 7.13-7.20 (2H, m, aromatic-
H), 7.20-7.28 (2H, m, aromatic-H), 7.30-7.41 (2H, m, aromatic-H), 7.50-7.71 
(5H, m, aromatic-H), 7.77-7.88 (2H, m, aromatic-H); δP ppm (400 MHz.) 39.12; 
δC ppm (125 MHz.) 32.9 (CH2), 45.3 (d, JP = 92.6 Hz, PCH), 55.1 ((CH3)2), 73.5 
(d, JP = 28.9 Hz, CHOH), 98.3 (3,5-dimethoxyphenyl-CH), 106.7 (3,5-
dimethoxyphenyl-CH), 126.0-160.6 (aromatic C and CH); m/z (EI) 473.5 (MH+); 
HRMS (ES); calc. for C29H30O4P (MH+) 473.1877; Found 473.1876; 
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6.2.79 (2R*, 3R*) and (2R*, 3S*)-(1-(3,5-difluorophenyl)-3-(3,5-
dimethoxyphenyl)-1-hydroxypropan-2-yl)diphenylphosphine 
oxide  
Using the method described in 
section 6.2.53; LDA (2 M solution 
in THF, 1 mL, 2 mmol) was added 
to a stirred solution of phosphine 
oxide 43 (0.25 g, 0.7 mmol) in 
THF (70 mL). 3,5-
difluorobenzaldehyde 117 (0.22 
mL, 0.29 g, 2 mmol) was added. 
The organic layer was combined, dried and filtered to yield a yellow oil (0.43 g), 
which was purified by column chromatography (70 : 30, petroleum ether : ethyl 
acetate) to give a yellow solid (0.31 g, 89%). This was purified further to 
separate out the diastereoisomers, the samples (0.1 g) were dissolved in 1 : 1 
v/v, MeOH : DMSO (1 mL) and purified by Open Access Mass Directed Auto 
Prep on Sunfire C18 column using Acetonitrile Water with a Formic acid 
modifier. The gradient employed was method E, selected from 5 pre-set 
methods (A, B, C, D or E). The solvent was removed under a stream of nitrogen 
in the Radley's blow-down apparatus to give the required products; 149b (0.096 
g, 27 %) and 149a (0.023 g, 7 %). 
 
(2R*,3S*)-(1-(3,5-difluorophenyl)-3-(3,5-dimethoxyphenyl)-1-hydroxyprop 
an-2-yl)diphenylphosphine oxide 149b; m.p. 122.1-123.0 °C; Vmax(CHCl3)/cm-
1 3681 (O-H), 2967 (C-H), 1594 (C=C arom.), 1148 (P=O), 1056 (C-O), 699 (C-
H arom.), 691 (C-F); δH ppm (400 MHz.) 2.78-2.81 (2H, m, CH2 and PCH), 3.05-
2,3-syn 149a; 2,3-anti 149b 
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3.10 (1H, m, CH2), 3.56 (6H, s, CH3), 5.08 (1H, s, OH), 5.26 (1H, d, JP = 9.5 Hz, 
CHOH), 5.47 (2H, d, JH = 2.2 Hz, 3,5-difluorophenyl-H), 6.07 (1H, t, JH = 2.2 Hz, 
3,5-difluorophenyl-H), 6.63-6.79 (1H, m, 3,5-dimethoxyphenyl-H), 6.85-6.91 
(2H, m, 3,5-dimethoxyphenyl-H), 7.31-7.32 (2H, m, aromatic-H), 7.43-7.49 (1H, 
m, aromatic-H), 7.60 (3H, tt, JH = 5.1, 2.7 Hz, aromatic-H), 7.64-7.69 (2H, m, 
aromatic-H), 7.95-8.02 (2H, m, aromatic-H); δP ppm (400 MHz.) 39.26; δC ppm 
(125 MHz.) 27.2 (CH2), 46.8 (d, JP = 66.7 Hz, PCH), 55.2 (d, JP = 32.4 Hz, 
CH3), 70.4 (d, JP = 2.1 Hz, CHOH), 98.3 (aromatic-CH), 102.5 (t, JP = 25.4 Hz, 
3,5-dimethoxyphenyl-CH), 106.2 (3,5-difluorophenyl-CH), 108.1 (3,5-
dimethoxyphenyl-CH), 128.4 (d, JP = 12.0 Hz, 3,5-difluorophenyl-CH), 129.2-
164.3 (aromatic C and CH); m/z (EI) 508.5, 509.5, 510.4, 511.5 (MH+); HRMS 
(ES); calc. for C29H2819F2O4P (MH+) 509.1683; Found 509.1688; 
 
(2R*, 3R*)-(1-(3,5-difluorophenyl)-3-(3,5-dimethoxyphenyl)-1-hydroxyprop 
an-2-yl)diphenylphosphine oxide 149a; m.p. 127.5-128.0 °C; Vmax(CHCl3)/cm-
1 3681 (O-H), 2967 (C-H), 1594 (C=C arom.), 1148 (P=O), 1056 (C-O), 699 (C-
H arom.), 691 (C-F);  δH ppm (400 MHz.) 2.67-2.71 (1H, m, CH2), 2.87 (1H, dtd, 
JH = 10.1, 3.2, JP = 6.5 Hz, PCH), 3.16 (1H, ddd, JH = 13.9, 11.7, JP = 5.6 Hz, 
CH2), 3.78 (6H, s, CH3), 4.96 (1H, dd, JH = 6.2, JP = 26.0 Hz, CHOH), 5.95 (1H, 
d, JH = 9.1 Hz, 3,5-difluorophenyl-H), 6.14-6.21 (1H, m, 3,5-dimethoxyphenyl-
H), 6.50-6.66 (2H, m, 3,5-dimethoxyphenyl-H), 7.20-7.37 (5H, m, 3,5-
difluorophenyl-H and aromatic-H), 7.43-7.49 (6H, m, aromatic-H), 7.77-7.89 
(2H, m, aromatic-H); δP ppm (400 MHz.) 35.58; δC ppm (125 MHz.) 33.1 (CH2), 
45.3 (d, JP = 65.69 Hz,  PCH), 55.4 (CH3), 72.5 (CHOH), 98.4 (3,5-
dimethoxyphenyl-CH), 102.0 (t, JP = 25.5 Hz, 3,5-difluorophenyl-CH), 107.0 
(3,5-dimethoxyphenyl-CH), 108.9 (d, JP = 25.8 Hz, 3,5-difluorophenyl-CH), 
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128.2-163.6 (aromatic C and CH); m/z (EI) 508.5, 509.5, 510.4, 511.5 (MH+); 
HRMS (ES); calc. for C29H2819F2O4P (MH+) 509.1683; Found 509.1688; 
 
6.2.80 (2R*, 3R*) and (2R*, 3S*)-(1-cyclohexyl-3-(3,5-
dimethoxyphenyl)-1-hydroxypropan-2-yl)diphenylphosphine 
oxide  
Using the method described in 
section 6.2.53; LDA (2 M solution 
in THF, 2.1 mL, 4.1 mmol) was 
added to a stirred solution of 
phosphine oxide 43 (0.5 g, 1.3 
mmol) in THF (100 mL). 
Cyclohexanecarboxaldehyde 87 
(0.50 mL, 0.46 g, 4.1 mmol) was added. The organic layer was combined, dried 
and filtered to yield a yellow oil (0.71 g), which was purified by column 
chromatography (70 : 30, petroleum ether : ethyl acetate) to give a yellow solid 
(0.49 g, 77 %). This was purified further to separate out the diastereoisomers, 
the samples (0.1 g) were dissolved in 1 : 1 v/v, MeOH : DMSO (1 mL) and 
purified by Open Access Mass Directed Auto Prep on Sunfire C18 column using 
Acetonitrile Water with a Formic acid modifier. The gradient employed was 
method E, selected from 5 pre-set methods (A, B, C, D or E). The solvent was 
removed under a stream of nitrogen in the Radley's blow-down apparatus to 
give the required products; 150b and 150a (0.18 g, 28 %). 
 
(2R*, 3S*) and (2R*, 3R*) -(1-cyclohexyl-3-(3,5-dimethoxyphenyl)-1-
hydroxypropan-2-yl)diphenylphosphine oxide 150bmajor and 150aminor; 
2,3-syn 150a; 2,3-anti 150b 
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Vmax(CHCl3)/cm-1 3321 (O-H), 2922 (C-H), 1594 (C=C arom.), 1201 (P=O), 1122 
(C-O), 997 (C-H arom.); δH ppm (400 MHz.) eqv. 0.37-0.39 (1H, m, cyclo-CH2), 
0.57-0.59 (1H, m, cyclo-CH2), 0.71-0.73 (3H, m, cyclo-CH2), 0.88 (1H, ddd, JH = 
22.1, 14.3, 6.6 Hz, cyclo-CH2), 1.15-1.21 (5H, m, cyclo-CH2), 1.38-1.41 (2H, m, 
cyclo-CH2 and cyclo-CHminor), 1.62-1.67 (6H, m, cyclo-CH2 and cyclo-CHmajor), 
2.01-2.13 (2H, m, cyclo-CH2), 2.13-2.16 (1H, m, cyclo-CH2), 2.76 (1H, ddd, JH = 
14.2, 5.0, JP =  10.8 Hz, PCHCH2minor), 2.85-2.98 (3H, m, PCHminor, PCHmajor, 
PCHCH2major), 3.06 (1H, ddd, JH = 13.9, 10.8, JP =  6.5 Hz, PCHCH2minor), 3.23-
3.29 (1H, m, PCHCH2major), 3.40 (1H, dt, JH = 14.7, 10.9, JP = 26.10 Hz, 
CHOHminor), 3.55 (6H, s, CH3major), 3.70 (1H, d, JP = 10.7 Hz, CHOHmajor),  3.75 
(6H, s, CH3minor), 4.34 (1H, s, OHmajor), 4.53 (1H, s, OHminor), 6.00 (2H, d, JH = 
2.2 Hz, 3,5-dimethoxyphenyl-Hmajor), 6.17 (1H, t, JH = 2.2 Hz,  3,5-
dimethoxyphenyl-Hmajor), 6.24 (2H, d, JH = 2.2 Hz, 3,5-dimethoxyphenyl-Hminor), 
6.28 (1H, t, JH = 2.2 Hz, 3,5-dimethoxyphenyl-Hminor), 7.96-2.22 (20H, m, 
aromatic-H); δP ppm (400 MHz.) 40.40major, 38.55minor; δC ppm (125 MHz.) 25.4 
(cyclo-CH2), 27.6 (CH2major), 29.5 (cyclo-CH2), 33.7 (CH2minor), 39.3 (d, JP = 4.0 
Hz, PCHminor), 40.3 (d, JP = 11.8 Hz, cyclo-CHmajor), 40.3 (d, JP = 68.9 Hz, 
PCHmajor), 41.8 (d, JP = 3.3 Hz, cyclo-CHminor), 55.2 (3,5-dimethoxyphenyl-
CH3major), 55.3 (3,5-dimethoxyphenyl-CH3minor), 74.4 (d, JP = 3.1 Hz, CHOHmajor), 
77.3 (d, JP = 1.1 Hz, CHOHminor),  97.9 (3,5-dimethoxyphenyl-CHmajor), 98.1 (3,5-
dimethoxyphenyl-CHminor), 106.8 (3,5-dimethoxyphenyl-CHmajor), 106.9 (3,5-
dimethoxyphenyl-CHminor), 127.98 (aromatic C and CH);  m/z (EI) 479.2 (MH+); 
HRMS (ES); calc. for C29H36O4P (MH+) 479.2342; Found 479.2346; 
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6.2.81 (2R*, 3R*) and (2R*, 3S*)-(3-(3,5-dimethoxyphenyl)-1-(3,5-
dinitrophenyl)-1-hydroxypropan-2-yl)diphenylphosphine oxide  
Using the method described in section 
6.2.53; LDA (2 M solution in THF, 0.61 
mL, 1.22 mmol) was added to a stirred 
solution of phosphine oxide 43 (0.15  g, 
0.41 mmol) in dry THF (20 mL). 3,5-
dinitrobenzaldehyde 121 (0.24 g, 1.22 
mmol) was added. The organic layer was 
combined, dried and filtered to yield a 
purple oil (0.26 g), which was purified by 
preparative chromatography (40 : 40, 
petroleum ether : ethyl acetate) to give a yellow solid (0.19 g, 83 %), but could 
not be separated. 
 
(2R*, 3S*) and (2R*, 3R*) -(3-(3,5-dimethoxyphenyl)-1-(3,5-dinitrophenyl)-1-
hydroxypropan-2-yl)diphenylphosphine oxide 151bmajor and 151aminor; m.p. 
89.5-90.1 °C; Vmax(CHCl3)/cm-1 3520 (O-H), 2913 (C-H), 1582 (C=C arom.), 
1351 (NO2), 1347 (P=O), 1142 (C-O), 1009 (C-H arom.); δH ppm (400 MHz.) 
eqv. 2.70 (1H, dd, JH = 18.6, 7.2 Hz, PCHCH2major), 2.74-2.83 (1H, m, 
PCHCH2minor), 2.90-3.00 (1H, m, PCHCH2minor), 3.00-3.12 (3H, m, PCHmajor, 
PCHminor and PCHCH2major), 3.40 (3H, s, OCH3), 3.46 (6H, s, OCH3), 3.69 (3H, 
s, OCH3), 5.08 (1H, dd, JH = 5.0,  JP = 24.2 Hz, CHOHminor), 5.31 (1H, d, JP = 
9.6 Hz, CHOHmajor), 5.44 (1H, s, OH), 5.68 (2H, d, JH = 2.1 Hz, 3,5-
dimethoxyphenyl-Hmajor), 5.78 (1H, t, JH = 2.1 Hz, 3,5-dimethoxyphenyl-Hmajor), 
6.23 (1H, d, JH = 2.0 Hz, 3,5-dimethoxyphenyl-Hminor), 6.26 (2H, d, JH = 2.1 Hz, 
2,3-syn 151a; 2,3-anti 151b 
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3,5-dimethoxyphenyl-Hminor), 7.05-7.23 (4H, m, aromatic-H), 7.38-7.58 (10H, m, 
aromatic-H), 7.67-7.83 (3H, m, aromatic-H), 7.92-8.00 (3H, m, aromatic-H), 8.11 
(1H, d, JH = 1.9 Hz, aromatic-H), 8.18 (2H, d, JH = 1.9 Hz, aromatic-H), 8.39 
(1H, dd, JH = 7.9, 5.9 Hz, aromatic-H), 8.50-8.56 (2H, m, aromatic-H); δP ppm 
(400 MHz.) 40.09major and 38.05minor; δC ppm (125 MHz.) 28.1 (PCHCH2major), 
32.9 (PCHCH2minor), 45.5 (d, JP = 66.7 Hz, PCHmajor), 45.5 (d, JP = 66.7 Hz, 
PCHminor), 50.7 (OCH3minor), 54.9 (OCH3major), 55.3 (OCH3minor),  69.1 
(CHOHmajor), 71.9 (CHOHminor), 96.9-171.2 (aromatic C and CH); m/z (EI) 563.1 
(MH+);  
 
6.2.82 (2R*, 3R*) and (2R*, 3S*)-(3-(3,5-dimethoxyphenyl)-1-
hydroxy-1-(3-nitrophenyl)propan-2-yl)diphenylphosphine oxide  
Using the method described in section 
6.2.53;  LDA (2 M solution in THF, 0.81 mL, 
1.63 mmol) was added to a stirred solution of 
phosphine oxide 43 (0.20 g, 0.54 mmol) in 
dry THF (20 mL). 3-nitrobenzaldehyde 118 
(0.25 g, 1.63 mmol) was added. The organic 
layer was combined, dried and filtered to yield 
a yellow oil (0.33 g), which was purified by 
preparative chromatography (40 : 40, 
petroleum ether : ethyl acetate) to give a yellow solid (0.268 g, 96 %), but the 
diastereoisomers could not be separated.  
 
(2R*, 3S*) and (2R*, 3R*) -(3-(3,5-dimethoxyphenyl)-1-hydroxy-1-(3-
nitrophenyl)propan-2-yl)diphenylphosphine oxide (152bmajor and 152aminor); 
2,3-syn 152a;2,3-anti 152b 
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Vmax(CHCl3)/cm-1 3319 (O-H), 2981 (C-H), 1545 (C=C arom.), 1299 (NO2), 1342 
(P=O), 1319 (C-O), 987 (C-H arom.); δH ppm (400 MHz.) eqv. 2.65-2.82 (2H, m, 
PCHCH2minor and PCHCH2major), 2.90-3.01 (3H, m, PCHCH2major, PCHminor and 
PCHmajor), 3.02-3.15 (1H, m, PCHCH2minor), 3.43 (6H, s, CH3major), 3.69 (6H, s, 
CH3minor), 5.02 (1H, dd, JP = 25.4, JH = 5.5 Hz, CHOHminor), 5.14 (1H, s, 
CHOHmajor),  5.28 (1H, d, JP = 9.5 Hz, CHOHmajor), 5.40 (2H, d, JP = 2.1 Hz, 
aromatic-H), 5.90 (2H, t, JP = 2.0 Hz,aromatic-H), 6.16-6.31 (2H, m, aromatic-
H), 7.00-7.10 (3H, m, aromatic-H), 7.11-7.19 (1H, m, aromatic-H), 7.29 (3H, tt, 
JH = 19.6, 9.9 Hz, aromatic-H), 7.33-7.48 (5H, m, aromatic-H), 7.47-7.82 (12H, 
m, aromatic-H), 7.85-7.98 (3H, m, aromatic-H), 8.04 (1H, s, aromatic-H); δP ppm 
(400 MHz.) 39.56major and 38.39minor; δC ppm (125 MHz.) 27.3 (PCHCH2major), 
33.0 (PCHCH2minor), 45.5 (d, JH = 65.9 Hz, PCHminor), 46.3 (d, JH = 66.7 Hz, 
PCHmajor), 55.0 (CH3major), 55.4 (CH3minor), 70.2 (CHOHmajor), 72.4 (CHOHminor), 
97.7-161.05 (aromatic C and CH); m/z (EI) 518.1 (MH+); HRMS (ES); calc. for 
C29H29NO6P (MH+) 518.1727; Found 518.1718; 
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6.2.83 (2R*, 3R*) and (2R*, 3S*)-(1-hydroxy-1-(3- nitrophenyl)-3-
phenylpropan-2-yl)diphenylphosphine oxide  
Using the method described in section 
6.2.53; LDA (2 M solution in THF, 0.98 mL, 
1.96 mmol) was added to a stirred solution of 
phosphine oxide 36 (0.20 g, 0.65 mmol) in dry 
THF (20 mL). 3-nitrobenzaldehyde 118 (0.29 
g, 1.96 mmol) was added. The organic layer 
was combined, dried and filtered to yield a 
yellow oil (0.29 g), which was purified by 
preparative chromatography (40 : 40, 
petroleum ether : ethyl acetate) to give a yellow solid (0.276 g, 92 %), but the 
diastereoisomers could not be separated. 
 
(2R*, 3S*) and (2R*, 3R*)-(1-hydroxy-1-(3-nitrophenyl)-3-phenylpropan-2-
yl)diphenylphosphine oxide 153bmajor and 153aminor; m.p. 85.6-86.2 °C; 
Vmax(CHCl3)/cm-1 3366 (O-H), 2930 (C-H), 1565 (C=C arom.), 1365 (NO2), 1345 
(P=O), 1369 (C-O), 1231 (C-H arom.); δH ppm (400 MHz.) eqv. 2.72-2.86 (1H, 
m, PCHCH2minor), 2.86-2.97 (2H, m, PCHmajor and PCHCH2major), 3.00-3.10 (1H, 
m, PCHminor), 3.11-3.17 (2H, m, PCHCH2major and PCHCH2minor), 4.95 (1H, dd, JH 
= 5.3 JP = 25.5 Hz, CHOHminor), 5.14 (1H, s, CHOHmajor), 5.27 (1H, d, JP = 11.6 
Hz, CHOHmajor), 5.94 (1H, d, JH = 8.6 Hz, CHOHminor), 6.20-6.26 (2H, m, 
aromatic-H), 6.67-6.83 (3H, m, aromatic-H), 6.96-7.23 (7H, m, aromatic-H), 
7.24-7.31 (5H, m, aromatic-H), 7.33-7.46 (5H, m, aromatic-H), 7.49-7.57 (5H, 
m, aromatic-H), 7.59-7.66 (4H, m, aromatic-H), 7.67-7.74 (2H, m, aromatic-H), 
7.81-7.94 (5H, m, aromatic-H); δP ppm (400 MHz.) 39.79major and 38.74minor;  δC 
2,3-syn 153a; 2,3-anti 153b 
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ppm (125 MHz.) 27.1 (PCHCH2major), 32.7 (PCHCH2minor), 45.6 (d, JP = 65.9 Hz, 
PCHminor), 46.6 (d, JP = 66.8 Hz, PCHmajor), 69.9 (CHOHmajor), 72.1 (CHOHminor), 
120.9-147.9 (aromatic C and CH); m/z (EI) 458.1 (MH+);  HRMS (ES); calc. for 
C27H25NO4P (MH+) 458.1509; Found 458.1516; 
 
6.2.84 (2R*, 3R*) and (2R*, 3S*)-(3-cyclohexyl-1-(3,5-
dimethoxyphenyl)-1-hydroxypropan-2-yl)diphenylphosphine 
oxide  
Using the method described in section 
6.2.53; LDA (2 M solution in THF, 0.96 
mL, 1.92 mmol) was added to a stirred 
solution of phosphine oxide 40 (0.2 g, 
0.64 mmol) in dry THF (20 mL). 3,5 
dimexthoxybenzaldehyde 116 (0.32 g, 
1.92 mmol) was added. The organic layer 
was combined, dried and filtered to yield 
a yellow oil (0.31 g), which was purified 
by preparative chromatography (40 : 40, petroleum ether : ethyl acetate) to give 
a yellow solid (0.271 g, 90 %), to give the required products; 154a (0.027 g, 9 
%) and 154b (0.011 g, 4 %).  
 
(2R*, 3R*)-(3-cyclohexyl-1-(3,5-dimethoxyphenyl)-1-hydroxypropan-2-
yl)diphenylphosphine oxide 154a; m.p. 124.1-124.9 °C; Vmax(CHCl3)/cm-1 
3289 (O-H), 2922 (C-H), 1596 (C=C arom.), 1204 (P=O), 1145 (C-O), 1001 (C-
H arom.); δH ppm (400 MHz.) 0.46 (1H, dd, JH = 20.8, 11.4 Hz, cyclo-CH2), 0.56-
0.71 (1H, m, cyclo-CH2), 0.82 (1H, dt, JH = 11.2, 7.8 Hz, cyclo-CH), 0.88-1.02 
2,3-syn 154a; 2,3-anti 154b 
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(2H, m, cyclo-CH2), 1.05-1.22 (2H, m, cyclo-CH2), 1.46-1.57 (3H, m, cyclo-CH2 
and cyclo-CH2), 1.57-1.69 (2H, m, cyclo-CH2), 1.76 (1H, s, cyclo-CH2), 2.63-
2.79 (1H, m, PCH), 3.62 (6H, s, OMe), 4.91 (1H, dt, JP = 21.8, JH = 5.6 Hz, 
CHOH), 5.69 (1H, d, JH = 6.6 Hz, OH), 5.99 (1H, t, JH = 2.2 Hz, 3,5-
dimethoxyphenyl-H), 6.35 (2H, t, JH = 2.2 Hz, 3,5-dimethoxyphenyl-H), 7.16-
7.24 (2H, m, aromatic-H), 7.24-7.30 (1H, m, aromatic-H), 7.36-7.47 (3H, m, 
aromatic-H), 7.47-7.55 (2H, m, aromatic-H), 7.60-7.75 (2H, m, aromatic-H); δP 
ppm (400 MHz.) 41.31; δC ppm (125 MHz.) 26.1 (d, JP = 6.0 Hz, cyclo-CH2), 
26.4 (CH2), 31.9 (cyclo-CH2), 33.9 (d, JP = 6.5 Hz, cyclo-CH2), 35.3 (d, JP = 9.7 
Hz, cyclo-CH), 41.1 (d, JP = 66.8 Hz, PCH), 55.3 (d, JP = 8.0 Hz, CH3), 74.8 (d, 
JP = 4.4 Hz, CHOH), 99.3 (3,5-dimethoxyphenyl-H), 104.4 (3,5-
dimethoxyphenyl-H), 127.9-160.5 (aromatic C and CH); m/z (EI) 478.9 (MH+);  
 
(2R*, 3S*)-(3-cyclohexyl-1-(3,5-dimethoxyphenyl)-1-hydroxypropan-2-
yl)diphenylphosphine oxide 154b; m.p. 119.2-120.3 °C; Vmax(CHCl3)/cm-1 
3289 (O-H), 2922 (C-H), 1596 (C=C arom.), 1204 (P=O), 1145 (C-O), 1001 (C-
H arom.); δH ppm (400 MHz.) -0.07-0.08 (1H, m, cyclo-CH), 0.21 (2H, dddd, JH 
= 24.8, 15.3, 12.4, 3.1 Hz, cyclo-CH2), 0.42-0.76 (3H, m, cyclo-CH2), 0.96-1.17 
(2H, m, cyclo-CH2), 1.17-1.40 (3H, m, cyclo-CH2 and CH2), 1.63 (1H, ddd, JH = 
13.3, 8.1, 3.5 Hz, cyclo-CH2), 1.72 (1H, d, JH = 29.2 Hz, cyclo-CH2), 2.42 (1H, q, 
JH = 5.5 Hz, PCH), 3.69 (6H, s, OMe), 4.71 (1H, s, OH), 5.09 (1H, d, JP = 10.0 
Hz, CHOH), 6.25 (1H, t, JH = 16.9, 2.3 Hz, 3,5-dimethoxyphenyl-H), 6.37 (2H, t, 
JH = 2.3 Hz, 3,5-dimethoxyphenyl-H), 7.26-7.44 (3H, m, aromatic-H), 7.44-7.60 
(3H, m, aromatic-H), 7.60-7.78 (2H, m, aromatic-H), 7.90 (2H, ddd, JH = 9.9., 
5.0, 2.6 Hz,  aromatic-H); δP ppm (400 MHz.) 40.56; δC ppm (125 MHz.) 25.9 (d, 
JP = 1.4 Hz, cyclo-CH2), 26.2 (CH2), 27.9 (cyclo-CH2), 28.9 (cyclo-CH2), 32.6 (d, 
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JP = 6.7 Hz, cyclo-CH2), 36.4 (d, JP = 5.6 Hz, cyclo-CH), 42.1 (d, JP = 67.2 Hz, 
PCH), 55.4 (d, JP = 7.7 Hz, OMe), 69.2 (d, JP = 4.7 Hz, CHOH), 99.3 (3,5-
dimethoxyphenyl-H), 103.6 (3,5-dimethoxyphenyl-H), 128.6-160.8 (aromatic C 
and CH); m/z (EI) 478.9 (MH+);  
 
6.2.85 (2R*, 3R*) and (2R*, 3S*)-(3-cyclohexyl-1-(3,5-
difluorophenyl)-1-hydroxypropan-2-yl)diphenylphosphine oxide  
Using the method described in section 
6.2.53; LDA (2 M solution in THF, 0.96 mL, 
1.92 mmol) was added to a stirred solution of 
phosphine oxide 40 (0.2 g, 0.64 mmol) in dry 
THF (20 mL). 3,5 difluorobenzaldehyde 117 
(0.21 mL, 0.27 g, 1.92 mmol) was added. The 
organic layer was combined, dried and 
filtered to yield a yellow oil (0.29 g), which 
was purified by preparative chromatography 
(40 : 40, petroleum ether : ethyl acetate) to give a yellow solid (0.23 g, 79 %), to 
give the required products; 155b (0.21 g, 72 %) and 155a (0.053 g, 18 %). 
 
(2R*, 3S*)-(3-cyclohexyl-1-(3,5-difluorophenyl)-1-hydroxypropan-2-
yl)diphenylphosphine oxide 155b; m.p. 170.3-171.1 °C; Vmax(CHCl3)/cm-1 
3423 (O-H), 2929 (C-H), 1596 (C=C arom.), 1437 (P=O), 1155 (C-O), 698 (C-H 
arom.), 654 (C-F); δH ppm (400 MHz.) -0.10-0.30 (1H, m, cyclo-CH), 0.01 (1H, 
qd, JH = 12.5, 3.1 Hz, cyclo-CH2), 0.12-0.27 (1H, m, cyclo-CH2), 0.33-0.46 (1H, 
m, cyclo-CH2), 0.50 (1H, ddd, JH = 15.3, 9.7, 7.6 Hz, cyclo-CH2), 0.58-0.72 (1H, 
m, cyclo-CH2), 0.89-1.03 (2H, m, cyclo-CH2), 1.19 (1H, d, JH = 11.1 Hz, cyclo-
2,3-syn 155a; 2,3-anti 155b 
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CH2), 1.24-1.34 (1H, m, CH2), 1.34-1.50 (1H, m, CH2), 1.72 (1H, s, cyclo-CH2), 
2.27 (1H, q, JP = 5.7 Hz, PCH), 4.76 (1H, s, OH), 4.99 (1H, d, JP = 9.9 Hz, 
CHOH), 6.49 (1H, dt, JP = 8.9, 2.3 Hz, 3,5-difluorophenyl-H), 6.61-6.76 (2H, m, 
3,5-difluorophenyl-H), 7.28 (2H, ddd, JH = 6.8, 5.3, 2.2 Hz, aromatic-H), 7.32-
7.37 (1H, m, aromatic-H), 7.43 (3H, dt, JH = 4.9, 2.4 Hz, aromatic-H), 7.56-7.63 
(2H, m, aromatic-H), 7.78-7.84 (2H, m, aromatic-H); δP ppm (400 MHz.) 40.44; 
δC ppm (125 MHz.) 25.9 (cyclo-CH2),  26.1 (cyclo-CH2), 27.8 (CH2), 32.1 (cyclo-
CH2), 32.9 (cyclo-CH2), 36.4 (d, JP = 5.2 Hz, cyclo-CH), 41.9 (d, JP = 67.5 Hz, 
PCH), 70.4 (d, JP = 2.2 Hz, CHOH), 102.2 (3,5-difluorophenyl-CH), 108.6 (3,5-
difluorophenyl-CH), 128.7-164.2 (aromatic C and CH); m/z (EI) 455 (MH+); 
HRMS (ES); calc. for C27H3019F2O2P (MH+) 455.1945; Found 455.1946; 
 
(2R*, 3R*)-(3-cyclohexyl-1-(3,5-difluorophenyl)-1-hydroxypropan-2-
yl)diphenylphosphine oxide 155a; m.p. 149.9-150.3 °C; Vmax(CHCl3)/cm-1 
3423 (O-H), 2929 (C-H), 1596 (C=C arom.), 1437 (P=O), 1155 (C-O), 698 (C-H 
arom.), 654 (C-F); δH ppm (400 MHz.) 0.54 (1H, dd, JH = 21.0, 11.4 Hz, cyclo-
CH2), 0.61-0.74 (1H, m, cyclo-CH2), 0.99 (3H, dd, JH = 16.6, 9.8 Hz, cyclo-CH2 
and cyclo-CH), 1.19 (2H, dtd, JH = 14.4, 4.6 Hz, cyclo-CH2), 1.43-1.61 (4H, m, 
cyclo-CH2), 1.65 (1H, s, cyclo-CH2), 1.69-1.79 (1H, m, cyclo-CH2), 2.66 (1H, 
ddd, JP = 12.9, JH = 9.0, 3.7 Hz, PCH), 4.97 (1H, dt, JP = 23.2, JH = 10.3, 5.2 
Hz, CHOH), 5.90 (1H, d, JP = 6.6 Hz, OH), 6.28 (1H, tt, JH = 8.9, 2.2 Hz, 3,5-
difluorophenyl-H), 6.68 (2H, d, JH = 6.4 Hz, 3,5-difluorophenyl-H), 7.20-7.24 
(2H, m, aromatic-H), 7.24-7.32 (1H, m, aromatic-H), 7.40-7.51 (5H, m, aromatic-
H), 7.61-7.69 (2H, m, aromatic-H); δP ppm (400 MHz.) 40.43; δC ppm (400 
MHz.) 26.1 (cyclo-CH2),  26.3 (d, JP = 8.3 Hz, cyclo-CH2), 31.9 (cyclo-CH2), 
33.7 (cyclo-CH2), 33.9 (CH2), 35.3 (d, JP = 9.8 Hz, cyclo-CH), 40.7 (d, JP = 66.9 
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Hz, PCH), 73.9 (CHOH), 102.3 (3,5-difluorophenyl-CH), 109.1 (3,5-
difluorophenyl-CH), 128.2-163.9 (aromatic C and CH); m/z (EI) 455 (MH+); 
HRMS (ES); calc. for C27H3019F2O2P (MH+) 455.1945; Found 455.1946; 
 
6.2.86 (2R*, 3R*) and (2R*, 3S*)-(3-cyclohexyl-1-(3,5-
dinitrophenyl)-1-hydroxypropan-2-yl)diphenylphosphine oxide  
Using the method described in section 
6.2.53; LDA (2 M solution in THF, 0.72 
mL, 1.44 mmol) was added to a stirred 
solution of phosphine oxide 40 (0.15  g, 
0.48 mmol) in dry THF (20 mL). 3,5-
dinitrobenzaldehyde 121 (0.28 g, 1.44 
mmol) was added. The organic layer was 
combined, dried and filtered to yield a 
purple oil (0.28 g), which was purified by 
preparative chromatography (40 : 40, petroleum ether : ethyl acetate) to give a 
yellow solid (0.23 g, 95 %), to give the required products; 156b (0.18 g, 70 %) 
and 156a (0.05 g, 20 %). 
 
(2R*, 3S*)-(3-cyclohexyl-1-(3,5-dinitrophenyl)-1-hydroxypropan-2-
yl)diphenylphosphine oxide 156b; m.p. 86.6-87.2 °C; Vmax(CHCl3)/cm-1 3521 
(O-H), 2967 (C-H), 1512 (C=C arom.), 1355 (NO2), 1353 (P=O), 1139 (C-O), 
1015 (C-H arom.); δH ppm (400 MHz.) 0.01-0.05 (2H, m, cyclo-CH and cyclo-
CH2), 0.33 (1H, d, JH = 22.8, 10.3 Hz, cyclo-CH2), 0.46 (1H, d, JH = 35.4, 17.9 
Hz, cyclo-CH2), 0.60 (1H, d, JH = 23.6, 10.8 Hz, cyclo-CH2), 0.75 (1H, d, JH = 
12.7, 6.5 Hz, cyclo-CH2), 1.04 (2H, d, JH = 11.3 Hz, cyclo-CH2), 1.29 (3H, d, JH 
2,3-syn 156a; 2,3-anti 156b 
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= 10.3 Hz, cyclo-CH2), 1.33-1.45 (1H, m, PCHCH2), 1.45-1.58 (1H, m, 
PCHCH2),  2.52 (1H, dd, JP = 11.5, JH = 5.5 Hz, PCH), 5.30 (1H, d, JP = 10.4 
Hz, CHOH), 5.31 (1H, s, OH), 7.43 (2H, td, JH = 7.4, 3.0 Hz, aromatic-H), 7.48-
7.53 (1H, m, aromatic-H), 7.60 (3H, dd, JH = 4.6, 2.3 Hz, aromatic-H), 7.70-7.77 
(2H, m, aromatic-H), 7.90-7.99 (2H, m, aromatic-H), 8.43 (1H, d, JH = 2.0 Hz, 
aromatic-H), 8.52 (1H, d, JH = 1.5 Hz, aromatic-H), 8.81-8.90 (1H, m, aromatic-
H); δP ppm (400 MHz.) 40.32; δC ppm (125 MHz.) 26.9 (cyclo-CH2), 29.4 
(PCHCH2), 33.5 (cyclo-CH2), 34.0 (cyclo-CH2),  37.5 (cyclo-CH), 42.7 (d, JP = 
67.4 Hz, PCH), 71.5 (CHOH), 118.7-149.7 (aromatic C and CH); m/z (EI) 509.1 
(MH+);  HRMS (ES); calc. for C27H30N2O6P (MH+) 509.1823; Found 509.1836; 
 
(2R*, 3R*)-(3-cyclohexyl-1-(3,5-dinitrophenyl)-1-hydroxypropan-2-
yl)diphenylphosphine oxide 156a; Vmax(CHCl3)/cm-1 3521 (O-H), 2967 (C-H), 
1512 (C=C arom.), 1355 (NO2), 1353 (P=O), 1139 (C-O), 1015 (C-H arom.);  δH 
ppm (400 MHz.) 0.01-0.07 (2H, m, cyclo-CH and cyclo-CH2), 0.34 (1H, d JH = 
23.8, 9.2 Hz, cyclo-CH2), 0.51 (1H, d, JH = 25.4, 19.0 Hz, cyclo-CH2), 0.64 (1H, 
d, JH = 19.6, 8.8 Hz, cyclo-CH2), 0.74 (1H, d, JH = 11.2, 6.9 Hz, cyclo-CH2), 1.05 
(2H, d, JH = 10.1 Hz, cyclo-CH2), 1.35 (3H, d, JH = 8.3 Hz, cyclo-CH2), 1.37-1.41 
(1H, m, PCHCH2), 1.45-1.52 (1H, m, PCHCH2),  2.80 (1H, dd, JP = 11.2, JH = 
7.5 Hz, PCH), 5.29 (1H, d, JH = 5.0, JP = 26.7 Hz, CHOH), 6.16 (1H, s, OH), 
7.62 (2H, td, JH = 7.2, 3.2 Hz, aromatic-H), 7.48 (1H, d, JH = 3.2 Hz, aromatic-
H), 7.54 (2H, dd, JH = 4.8, 2.0 Hz, aromatic-H), 7.62-7.70 (3H, m, aromatic-H), 
7.79-7.89 (2H, m, aromatic-H), 8.44-8.52 (3H, m, aromatic-H), 8.54 (1H, d, JH = 
1.7 Hz, aromatic-H), 8.81 (1H, d, JH = 1.9 Hz, aromatic-H),  8.90-8.99 (2H, m, 
aromatic-H), 9.02-9.19 (2H, m, aromatic-H); δP ppm (400 MHz.) 39.56; δC ppm 
(125 MHz.) 25.9 (cyclo-CH2), 29.7 (PCHCH2), 34.9 (cyclo-CH2), 34.2 (cyclo-
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CH2),  37.1 (cyclo-CH), 40.9 (d, JP = 67.2 Hz, PCH), 72.9 (CHOH), 116.9-149.2 
(aromatic C and CH); m/z (EI) 509.1 (MH+); HRMS (ES); calc. for C27H30N2O6P 
(MH+) 509.1823; Found 509.1836; 
 
6.2.87 (2R*, 3R*) and (2R*, 3S*)-(3-cyclohexyl-1-hydroxy-1-(3-
nitrophenyl)propan-2-yl)diphenylphosphine oxide  
Using the method described in section 6.2.53; 
LDA (2 M solution in THF, 0.96 mL, 1.92 mmol) 
was added to a stirred solution of phosphine 
oxide 40 (0.20 g, 0.64 mmol) in dry THF (20 mL). 
3-nitrobenzaldehyde 118 (0.29 g, 1.92 mmol) was 
added. The organic layer was combined, dried 
and filtered to yield a yellow oil (0.35 g), which 
was purified by preparative chromatography (40 : 
40, petroleum ether : ethyl acetate) to give a 
yellow solid (0.28 g, 95 %), to give the required 
products; 157b (0.1 g, 34 %) and 157a could not be isolated. 
 
(2R*,3S*)-(3-cyclohexyl-1-hydroxy-1-(3-nitrophenyl)propan-2-yl) 
diphenylphosphine oxide 157b; m.p. 98.2-98.9 °C; Vmax(CHCl3)/cm-1 3322 (O-
H), 2911 (C-H), 1561 (C=C arom.), 1350 (NO2), 1329 (P=O), 1211 (C-O), 1119 
(C-H arom.); δH ppm (400 MHz.) -0.09 (1H, dd, JH = 8.5, 5.2 Hz, cyclo-CH), -
0.06-0.09 (1H, m, cyclo-CH2), 0.16-0.34 (1H, m, cyclo-CH2), 0.42-0.61 (2H, m, 
cyclo-CH2), 0.72 (1H, ddd, JH = 16.4, 14.0, 5.2 Hz, cyclo-CH2), 0.99 (1H, d, JH = 
12.0 Hz,  cyclo-CH2), 1.25 (3H, d, JH = 9.3 Hz, CH2 and cyclo-CH2), 1.33-1.42 
(1H, m, cyclo-CH2), 1.48 (1H, ddd, JH = 9.1, 8.4, 5.6 Hz, cyclo-CH2), 2.45 (1H, 
2,3-syn 157a;  
2,3-anti 157b 
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dd, JP = 11.4, JH = 5.6 Hz, PCH), 5.03 (1H, s, OH), 5.23 (1H, d, JP = 10.0 Hz, 
CHOH), 7.35-7.43 (4H, m, aromatic-H), 7.52-7.57 (3H, m, aromatic-H), 7.60-
7.66 (1H, m, aromatic-H), 7.66-7.76 (2H, m, aromatic-H), 7.90-7.97 (2H, m, 
aromatic-H), 8.01 (1H, d, JH = 8.2 Hz, aromatic-H), 8.05 (1H, s, aromatic-H); δP 
ppm (400 MHz.) 40.44; δC ppm (125 MHz.) 25.9 (cyclo-CH2), 25.9 (cyclo-CH2), 
27.9 (cyclo-CH2), 32.1 (CH2), 32.9 (cyclo-CH2), 36.4 (d, JH = 5.2 Hz, cyclo-CH), 
41.9 (d, JP = 67.5 Hz, PCH), 70.4 (CHOH), 120.7-148.10 (aromatic C and CH); 
m/z (EI) 464.1 (MH+); HRMS (ES); calc. for C27H31NO4P (MH+) 464.1976; Found 
464.1985; 
 
6.2.88 2-phenylbutanal 165 
To a solution of oxalyl chloride (2.5  g, 1.67 mL, 19.8  mmol) 
in dry DCM (60 mL), a solution of dry DMSO (3.37 g, 3.06 
mL, 43.2 mmol) in dry DCM (12 mL) was added at -72 °C.  
After 10 minutes, a solution 2-phenylbutan-1-ol 49 (2.7 g, 18 
mmol) in dry DCM (25 mL) was added at this temperature. 
After 15 minutes, triethylamine (25.3 mL 180 mmol) was added portion wise 
over a 5 minute period. After a further 5 minutes at this temperature, the 
reaction was allowed to warm to room temperature of 1 hour. Once the reaction 
was completed (monitored by TLC), H2O (100 mL) to terminate the reaction. 
The phases were separated and the organic layer was washed with brine, 
dried, filtered and the solvent was reduced in vacuo to yield a yellow oil (2.78 
g). The yellow oil was further purified by difficult column chromatography (80  :  
20 v/v, petroleum ether : ethyl acetate) to yield the title product as a clear oil 
165 (1.7 g, 64 %).  
165 
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Vmax(CHCl3)/cm-1 2849 (C-H), 1766 (CHO), 1582 (C=C arom.), 778 (C-H arom.); 
δH ppm (400 MHz.) 0.77 (3H, dt, JH = 4.8, 4.1 Hz, CH3), 1.43-1.78 (1H, m, CH2), 
2.00 (1H, ddd, JH = 21.4, 10.4, 4.8 Hz, CH2),  3.18-3.40 (1H, m, HC=OCH), 
6.96-7.09 (2H, m, aromatic-H), 7.11-7.19 (1H, m, aromatic-H), 7.19-7.32 (2H, 
m, aromatic-H), 9.55 (1H, d, JH = 2.0 Hz, HC=OCH); δC ppm (125 MHz.) 11.72 
(CH3), 22.9 (CH2), 60.9 (HC=OCH), 127.5-136.3 (aromatic C and CH), 200.9 
(C=O); m/z (EI) 148.1 (MH+);  
 
6.2.89 2-(4-chlorophenyl)-3-methylbutanal 166 
Using the method described in section 6.2.88; Oxalyl 
chloride (0.7 g, 0.46 mL, 5.5 mmol) in dry DCM (24 
mL), DMSO (0.94 g, 0.86 mL, 12 mmol) in dry DCM (4 
mL) was added. 2-(4-chlorophenyl)-3-methylbutan-1-ol 
50 (1 g, 5 mmol) in dry DCM (10 mL) was added. The 
solvent was reduced in vacuo to yield a yellow oil (1.05 g). The yellow oil was 
further purified by column chromatography (80  :  20 v/v, petroleum ether : ethyl 
acetate) to yield the title product as a clear oil 166 (0.67 g, 68 %).  
Vmax(CHCl3)/cm-1 3824 (C-H), 1759 (CHO), 1325 (C=C arom.), 833 (C-H arom.), 
775 (C-Cl); δH ppm (400 MHz.) 0.67 (3H, d, JH = 6.7 Hz, CH3), 0.94 (3H, d, JH = 
5.8 Hz, CH3), 2.30 (1H, ddt, JH = 13.3, 9.4, 6.6 Hz, CH(CH3)2), 3.10 (1H, d, JH = 
9.4, 3.1 Hz, CH), 7.04 (2H, s, aromatic-H), 7.25 (2H, s, aromatic-H), 9.59 (2H, s, 
HC=O); δC ppm (400 MHz.) 19.95 (CH3), 21.09 (CH3), 28.92 (CH(CH3)2), 65.99 
(CH), 129.25-133.73 (aromatic C and CH), 200.56 (C=O); m/z (EI) 197 (MH+); 
HRMS (ES); calc. for C11H14ClO (MH+) 197.0726; Found 197.0728; 
 
166 
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6.2.90 methyl 2-(4-chlorophenyl)-3-methylbutanoate 168 
To a solution of 2-(4-chlorophenyl)-3-
methylbutanoic acid 46 (3 g, 14.1 mmol) in dry 
MeOH (60 mL), acetyl chloride (2.01 mL, 28.2 
mmol) in dry MeOH (50 mL) was added portion 
wise over a 45 minute period. After 15 minutes 
at room temperature, the reaction was heated to 65 °C for 20 hours. On 
completion (monitored by TLC), the solvent was evaporated under reduced 
pressure to yield a clear oil 168 (3 g, 94 %), no further purification was required.  
Vmax(CHCl3)/cm-1 2962 (C-H), 1758 (CHO), 1491 (C=C arom.), 1154 (C-O), 817 
(C-H arom.), 722 (C-Cl); δH ppm (400 MHz.) 0.71 (3H, d, JH = 6.7 Hz, CH3), 1.03 
(3H, d, JH = 6.5 Hz, CH3), 2.31-2.33 (1H, m, CH(CH3)2), 3.14 (1H, d, JH = 10.6 
Hz, CH), 3.66 (3H, d, JH = 6.5 Hz, OCH3),  7.28 (4H, s, aromatic-H); δC ppm 
(125 MHz.) 20.12 (CH3), 21.41 (CH3), 32.01 (CH(CH3)2), 51.88 (OCH3), 59.29 
(CH), 128.64-136.80  (aromatic C and CH), 174.32 (C=O); m/z (EI) 225 (MH-), 
227 (MH+); HRMS (ES); calc. for C12H16ClO2 (MH+) 227.0833; Found 227.0831; 
 
6.2.91 methyl 2-phenylbutanoate 169  
Using the method described in section 6.2.90; 2-
phenylbutanoic acid 45 (5 g, 30.5 mmol) in MeOH 
(100 mL), acetyl chloride (4.35 mL, 60.9 mmol) in dry 
MeOH (80 mL) was added. The solvent was 
evaporated under reduced pressure to yield a clear 
oil 169 (5.2 g, 96 %), no further purification was 
required.  
168 
 
169 
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Vmax(CHCl3)/cm-1 2966 (C-H), 1733 (CHO), 1533 (C=C arom.), 1202 (C-H 
arom.); δH ppm (400 MHz.) 0.95 (3H, d, JH = 7.4 Hz, CH3), 1.86-1.89 (1H, m, 
CH2), 2.14-2.17 (1H, m, CH2), 3.51-3.55 (1H, m, CH), 3.67 (3H, d, JH = 13.5 Hz, 
OCH3),  7.31 (4H, s, aromatic-H);  δC ppm (125 MHz.) 12.18 (CH3), 26.87 (CH2), 
51.88 (OCH3), 53.38 (CH), 127.21-138.92 (aromatic C and CH), 174.20  (C=O); 
m/z (EI) 179.35 (MH+), 192.1; HRMS (ES); calc. for C11H15O2 (MH+) 179.1067; 
Found 179.1065. 
 
6.2.92 (2R*, 3R*, 4R*) and (2R*, 3S*, 4R*)-(3-hydroxy-1,4-
diphenylpentan-2-yl)diphenylphosphine oxide  
Using the method described in section 6.2.53; LDA 
(2 M solution in THF, 1.22 mL, 2.45 mmol) was 
added to a stirred solution of phosphine oxide 36 
(0.25 g, 0.8 mmol) in THF (100 mL). 2-
Phenylpropionaldehyde 164 (0.33 mL, 0.33 g, 2.45 
mmol) was added. The organic layer was combined, 
dried and filtered to yield a yellow oil  (0.42 g), this 
was purified by flash column chromatography (50 : 
50 v/v, petroleum ether : ethyl acetate) collecting all 
relevant fractions, to afford a mixture of both 
diastereoisomers (0.30 g, 86 %). The white solid 
was further purified using a combination of column 
and preparative chromatography to separate out the 4 diastereoisomers (50 : 
50 v/v, petroleum ether : ethyl acetate). The diastereoisomers eluted and were 
dried in vacuo to give 170a (0.096 g, 27 %), and 170b (0.03 g, 3%) and further 
2,3-syn 170a;  
2,3-anti 170b;  
2,3-syn 170c;  
2,3-anti 170d 
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purified by recrystallization (1:1 v/v, toluene : hexane). The remaining two 
diastereoisomers were eluted together. 
 
2,3-anti-(3-hydroxy-1,4-diphenylpentan-2-yl)diphenylphosphine oxide 
170b; m.p. 112.1-112.5 °C; Vmax(CHCl3)/cm-1 3376 (O-H), 2927 (C-H), 1602 
(C=C arom.), 1437 (P=O), 1156 (C-O), 988 (C-H arom.); δH ppm (400 MHz.) 
1.12-1.19 (3H, m, CH3), 2.43 (1H, dd, JH = 6.0 JP = 12.2 Hz, PCH), 2.75 (2H, 
dddd, JH = 10.7, 7.9, 4.6 JP = 13.6 Hz, PCHCH2 and CH), 3.19-3.34 (1H, m, 
PCHCH2),  4.11 (1H, dd, JH = 11.8, JP = 10.7 Hz, CHOH), 6.09 (1H, d, JH = 7.2 
Hz, aromatic-H), 6.50 (1H, d, JH = 1.5 Hz,  aromatic-H), 6.62 (1H, d, JH = 2.1 
Hz,  aromatic-H), 6.84 (1H, dd, JH = 10.2, 4.7 Hz,  aromatic-H), 6.88-6.94 (3H, 
m, aromatic-H), 7.05-7.15 (6H, m, aromatic-H), 7.29-7.35 (3H, m, aromatic-H), 
7.39-7.46 (3H, m, aromatic-H), 7.61 (2H, ddd, JH = 10.9, 6.1, 1.5 Hz,  aromatic-
H); δP ppm (400 MHz.) 40.40; δC ppm (125 MHz.) 20.0 (CH3), 27.2 (CH2), 40.2 
(d, JP = 69.4 Hz, PCH), 43.6 (d, JH = 12.5 Hz, CH), 74.4 (CHOH), 125.9-144.3 
(aromatic C and CH); m/z (EI) 441.1 (MH+); HRMS (ES); calc. for C29H30O2P 
(MH+) 441.1971; Found 441.1978; 
 
2,3-syn-(3-hydroxy-1,4-diphenylpentan-2-yl)diphenylphosphine oxide 
170a; m.p. 142.4-142.5 °C; Vmax(CHCl3)/cm-1 3376 (O-H), 2927 (C-H), 1602 
(C=C arom.), 1437 (P=O), 1156 (C-O), 988 (C-H arom.); δH ppm (400 MHz.) 
1.18 (1H, d, JH = 6.7 Hz, CH3), 2.44 (1H, dd, JH = 12.2, 6.6 Hz, PCH), 2.80 (2H, 
dt, JH = 15.3, 7.0 Hz, CHCH3 and PCHCH2), 3.30-3.35 (1H, m, PCHCH2), 4.1 
(1H, d, JP = 21.2 Hz, CHOH), 4.43 (1H, s, OH), 6.54 (2H, d, JH = 7.0 Hz, 
aromatic-H), 6.59-6.66 (2H, m, aromatic-H), 6.84-6.99 (3H, m, aromatic-H), 
7.04-7.25 (6H, m, aromatic-H), 7.34 (4H, dd, JH = 24.2, 13.7 Hz, aromatic-H), 
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7.41-7.52 (3H, m, aromatic-H); δP ppm (400 MHz.) 40.09; δC ppm (125 MHz.) 
19.9 (CH3), 27.1 (d, JP = 66.3 Hz, PCHCH2), 40.1 (d, JP = 69.3 Hz, PCH), 43.5 
(CH), 74.4 (CHOH), 125.8-143.8 (aromatic C and CH); m/z (EI) 441.1 (MH+); 
HRMS (ES); calc. for C29H30O2P (MH+) 441.1971; Found 441.1978; 
 
2,3-anti and 2,3syn-(3-hydroxy-1,4-diphenylpentan-2-yl)diphenylphosphine 
oxide 170dminor and 170cmajor; m.p. 137.7-137.9 °C; Vmax(CHCl3)/cm-1 3376 (O-
H), 2927 (C-H), 1602 (C=C arom.), 1437 (P=O), 1156 (C-O), 988 (C-H arom.);  
δH ppm (400 MHz.) eqv. 0.91 (1H, d, JH = 7.0 Hz, CH3minor), 1.08 (1H, d, JH = 6.8 
Hz, CH3major), 2.56 (1H, dt, JH = 12.9, 5.0 Hz, PCHCH2major and PCHmajor), 2.72-
2.78 (3H, m, CHCH3major, CHCH3minor and PCHminor), 2.90-2.95 (2H, m 
PCHCH2minor and PCHCH2major), 3.20-3.46 (1H, m, PCHCH2minor), 3.81 (1H, dt, 
JH = 7.2, JP = 25.2 Hz, CHOHmajor), 4.89 (1H, s, OHminor), 4.10 (1H, t, JP = 10.4 
Hz, CHOHminor), 4.96 (1H, d, JH = 9.7 Hz, OHmajor), 6.08  (2H, d, JH = 7.3 Hz, 
aromatic-H), 6.54 (1H, d, JH = 6.9 Hz, aromatic-H), 6.64 (1H, d, JH = 6.1 Hz, 
aromatic-H),  6.87 (4H, dt, JH = 12.9, 5.0 Hz, aromatic-H), 6.95 (3H, dt, JH = 
14.6, 7.5 Hz, aromatic-H),  7.07 (3H, dt, JH = 15.4, 7.6 Hz, aromatic-H), 7.15 
(4H, d, JH = 6.6 Hz, aromatic-H), 7.20 (3H, d, JH = 5.0 Hz, aromatic-H), 7.24-
7.31 (2H, m, aromatic-H), 7.33-7.56 (10H, m, aromatic-H), 7.57-7.70 (5H, m,  
aromatic-H), 7.76-7.85 (2H, m, aromatic-H); δP ppm (400 MHz.) 39.60minor and 
39.45major; δC ppm (125 MHz.) 17.1 (CH3minor), 20.5 (CH3major), 28.2 
(PCHCH2minor), 33.9 (PCHCH2major), 40.7 (d, JP = 66.7 Hz, PCHminor), 40.7 (d, JP 
= 66.9 Hz, PCHmajor), 43.9 (CHminor), 44.5 (CHmajor), 74.3 (CHOHminor), 76.2 
(CHOHmajor), 125.2-143.9 (aromatic C and CH); m/z (EI) 441.1 (MH+); HRMS 
(ES); calc. for C29H30O2P (MH+) 441.1971; Found 441.1978; 
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6.2.93 (2R*, 3R*, 4R*) and (2R*, 3S*, 4R*)- (3-hydroxy-1,4-
diphenylhexan-2-yl)diphenylphosphine oxide  
Using the method described in section 
6.2.53; LDA (2 M solution in THF, 0.98 mL, 
1.9  mmol) was added to a stirred solution of 
phosphine oxide (0.2 g, 0.65 mmol) in dry 
THF (20 mL), 2-phenylbutanal 165 (0.29 g, 
1.9 mmol) was added. The organic layer 
was combined, dried and filtered to yield a 
yellow oil (0.9 g), which was purified by 
column chromatography (70 : 30, petroleum 
ether : ethyl acetate) to give a yellow solid (0.62g, 68%). This was purified using 
a combination of column and preparative chromatography to separate out the 4 
diastereoisomers (50 : 50 v/v, petroleum ether : ethyl acetate), to give the 
required products; 171b (0.08 g, 27 %), 171a and 171d (0.011 g, 3.7%) and 
171c could not be isolated.  
 
2,3-anti-(3-hydroxy-1,4-diphenylhexan-2-yl)diphenylphosphine oxide 171b; 
m.p. 97.8-97.9 °C; Vmax(CHCl3)/cm-1 3372 (O-H), 2959 (C-H),1672 (C=C 
arom.),1022 (P=O), 832 (C-O), 765 (C-H arom.); δH ppm (400 MHz.) 0.50 (3H, t, 
JH = 7.4 Hz, CH3), 1.08-1.28 (1H, m, CH2), 2.13 (1H, dqd, JH = 14.8, 7.4, 3.3 Hz, 
CH2), 2.41 (1H, dd, JP = 12.6, JH = 5.6, 3.3 Hz, PCH), 2.55 (1H, td, JH = 10.7, 
3.1 Hz, CH), 2.80 (1H, td, JH = 15.7, 7.4 Hz, PCHCH2), 3.28 (1H, dd, JH = 7.1, 
5.3 Hz, PCHCH2), 4.17 (1H, t, JP = 11.2 Hz, CHOH), 4.49 (1H, s, CHOH), 6.56 
(4H, dd, JH = 21.2, 6.8 Hz, aromatic-H), 6.86-6.95 (3H, m, aromatic-H), 7.07 
(2H, td, JH = 7.7, 2.9 Hz, aromatic-H), 7.18 (4H, dt, JH = 14.4, 4.5 Hz, aromatic-
2,3-syn 171a; 2,3-anti 171b; 
2,3-syn 171c; 2,3-anti 171d 
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H), 7.31 (2H, dd, JH = 11.5, 7.4 Hz, aromatic-H),  7.34-7.41 (2H, m, aromatic-H), 
7.47 (3H, dd, JH = 14.6, 7.6 Hz, aromatic-H); δP ppm (400 MHz.) 40.59; δC ppm 
(125 MHz.) 11.8 (CH3), 25.9 (CH2), 27.1 (PCHCH2), 40.4 (d, JP = 69.2 Hz, 
PCH), 51.3 (CH), 73.4 (CHOH), 125.7-141.5 (aromatic C and CH); m/z (EI) 
455.1 (MH+); HRMS (ES); calc. for C30H32O2P (MH+) 455.2131; Found 
455.2134; 
 
2,3-syn and 2,3-anti-(3-hydroxy-1,4-diphenylhexan-2-yl)diphenylphosphine 
oxide 171aminor and 171dmajor; Vmax(CHCl3)/cm-1 3372 (O-H), 2959 (C-H),1672 
(C=C arom.),1022 (P=O), 832 (C-O), 765 (C-H arom.); δH ppm (400 MHz.) eqv. 
0.29 (3H, t, JH = 7.3 Hz, CH3minor), 0.39 (3H, t, JH = 7.4 Hz, CH3major), 1.08-1.21 
(2H, m, CH2major), 1.41 (1H, dd,  JH = 15.6, 8.2 Hz, CH2minor), 1.95-2.06 (1H, m, 
CH2minor),  2.37-2.46 (1H, m, PCHminor), 2.54 (4H, dt, JH = 17.9, 6.8 Hz, PCHmajor, 
CHminor, CHmajor and PCHCH2major), 2.91 (1H, dd, JH = 15.3, 4.7 Hz, 
PCHCH2major), 2.94-3.05 (1H, m, PCHCH2minor),  3.24-3.37 (1H, m, 
PCHCH2minor), 3.77 (1H, s, OHminor),  3.85 (1H, dt, JH = 4.2, JP = 10.1 Hz, 
CHOHmajor), 4.16 (1H, t, JP = 25.4 Hz, CHOHminor), 4.99 (1H, s, OHmajor), 6.02 
(2H, d, JP = 7.1 Hz, aromatic-H), 6.87-6.93 (6H, m, aromatic-H), 6.94-7.01 (2H, 
m, aromatic-H), 7.05-7.11 (2H, m, aromatic-H), 7.11-7.21 (8H, m, aromatic-H), 
7.29-7.52 (12H, m,  aromatic-H), 7.58-7.72 (7H, m,  aromatic-H), 7.78-7.85 (1H, 
m, aromatic-H);  δP ppm (400 MHz.) 39.51major and 39.72minor;  δC ppm (125 
MHz.) 11.3 (CH3minor), 11.4 (CH3major), 24.7 (CH2minor), 26.5 (CH2major), 27.6 
(PCHCH2minor), 34.9 (PCHCH2major), 40.8 (d, JP = 66.1 Hz, PCHmajor), 41.2 (d JP 
= 68.5 Hz, PCHminor), 50.9 (CHminor), 52.6 (CHminor), 73.2 (CHOHminor), 75.7 
(CHOHmajor),  125.8-141.9 (aromatic C and CH); m/z (EI) 455.1 (MH+); HRMS 
(ES); calc. for C30H32O2P (MH+) 455.2131; Found 455.2134; 
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6.2.94 (2R*, 3R*, 4R*) and (2R*, 3S*, 4R*)-(4-(4- chlorophenyl)-
3-hydroxy-5-methyl-1-phenylhexan-2- yl)diphenylphosphine 
oxide  
Using the method described in section 
6.2.53; LDA (2 M solution in THF, 0.98 
mL, 1.9  mmol) was added to a stirred 
solution of phosphine oxide 36 (0.2 g, 
0.65 mmol) in dry THF (20 mL). 2-(4-
chlorophenyl)-3-methylbutanal 166 
(0.38 g, 1.9 mmol) was added. The 
organic layer was combined, dried and 
filtered to yield a yellow oil (0.13 g), 
which was purified by column chromatography (70 : 30, petroleum ether : ethyl 
acetate) to give a yellow solid (0.246 g, 75%). This was purified further to 
separate out the diastereoisomers, to give the required products; 172b (0.067 
g, 21 %), 172a and 172d (0.099 g, 30 %) and 172c (0.009 g, 3 %). 
 
2,3anti-(4-(4-chlorophenyl)-3-hydroxy-5-methyl-1-phenylhexan-2-yl) 
diphenylphosphine oxide 172b; m.p. 131.2-131.6 °C;Vmax(CHCl3)/cm-1 3244 
(O-H), 2925 (C-H), 1638 (C=C arom.), 1115 (P=O), 822 (C-O), 754 (C-H arom.), 
744 (C-Cl); δH ppm (400 MHz.) 0.50 (6H, t, JH = 7.4 Hz, (CH3)2), 2.23-2.39 (2H, 
m,  CH(CH3)2 and PCH), 2.64 (1H, dt, JH = 11.0, 3.5 Hz, CHCH(CH3)2) 2.75 
(1H, td, JH = 15.8, 6.0 Hz, CH2), 3.26 (1H, td, JH = 15.2, 6.0 Hz, CH2), 4.38 (1H, 
t, JP = 11.5 Hz, CHOH), 4.44 (1H, d, JP = 16.4 Hz, OH), 6.21 (2H, d, JH = 8.3 
Hz, aromatic-H), 6.58 (2H, d, JH = 8.2 Hz, aromatic-H), 6.89-7.06 (5H, m, 
aromatic-H), 7.17 (2H, dd, JH = 7.3, 3.0 Hz,  aromatic-H), 7.24-7.32 (1H, m, 
2,3-syn 172a; 2,3-anti 172b;  
2,3-syn 172c; 2,3-anti 172d 
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aromatic-H), 7.41-7.50 (4H, m, aromatic-H), 7.51-7.58 (1H, m, aromatic-H), 
7.60-7.70 (2H, m, aromatic-H); δP ppm (400 MHz.) 40.2; δC ppm (125 MHz.) 
16.0 (CH3), 21.7 (CH3), 26.8 (CH(CH3)2), 27.2 (CH2), 40.9 (d, JP = 68.9 Hz, 
PCH), 53.2 (CHCH(CH3)2),  69.5 (CHOH), 125.8-140.7 (aromatic C and CH); 
m/z (EI) 503 (MH+); HRMS (ES); calc. for C31H33ClO2P (MH+) 503.1899; Found 
503.1901; 
 
2,3-syn and 2,3-anti-(4-(4-chlorophenyl)-3-hydroxy-5-methyl-1-
phenylhexan-2-yl) diphenylphosphine oxide 172amajor and 172dminor; 
Vmax(CHCl3)/cm-1 3244 (O-H), 2925 (C-H), 1638 (C=C arom.), 1115 (P=O), 822 
(C-O), 754 (C-H arom.), 744 (C-Cl); δH ppm (400 MHz.) eqv. 0.27 (6H, dd, JH = 
14.6, 6.8 Hz, CH3major), 0.32 (6H, dd, JH = 14.3, 6.2 Hz, CH3minor), 1.62 (1H, ddd, 
JH = 13.6, 10.8, 6.9 Hz, CH(CH3)2major), 2.31-2.49 (2H, m, PCHminor and 
CH(CH3)2minor), 2.54 (1H, ddd, JH = 13.2, 3.1, 1.3 Hz, CHCH(CH3)2major), 2.56-
2.59 (2H, m, PCHCH2minor and CHCH(CH3)2minor), 2.76-2.86 (1H, m, 
PCHCH2major), 2.86-2.96 (1H, m, PCHmajor), 3.02 (1H, td, JH = 13.2. 4.9 Hz, 
PCHCH2minor) 3.25 (1H, ddd, JH = 15.0, 6.7, JP = 11.8 Hz, PCHCH2major), 3.99 
(1H, d, JP = 9.8 Hz, OHmajor), 4.06 (1H, dt, JH = 8.5, JP = 10.3 Hz, CHOHminor), 
4.42  (1H, dt, JH = 11.1, JP = 22.1 Hz, CHOHmajor), 5.25 (1H, d, JP = 9.9 Hz, 
OHminor), 5.70 (1H, d, JH = 8.3 Hz, aromatic-H), 6.77 (3H, t, JH = 8.2 Hz,  
aromatic-H), 6.9 (2H, dd, JH = 8.0, 6.2 Hz, aromatic-H), 6.98-7.02 (3H, m, 
aromatic-H), 7.06-7.13 (6H, m, aromatic-H), 7.23 (2H, dd, JH = 11/0, 4.4 Hz,  
aromatic-H), 7.29-7.43 (6H, m, aromatic-H), 7.44-7.53 (6H, m, aromatic-H), 
7.56-7.67 (5H, m, aromatic-H), 7.68-7.75 (2H, m, aromatic-H), 7.88 (2H, ddd, JH 
= 10.7, 7.8, 1.6 Hz,  aromatic-H); δP ppm (400 MHz.) 39.96major and 39.22minor; 
δC ppm (125 MHz.) 15.5 (CH3minor), 16.6 (CH3major), 21.4 (CH3major), 21.6 
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(CH3minor), 27.3 (CH(CH3)2minor), 27.6 (CH2major), 27.8 (CH(CH3)2major), 34.5 
(CH2minor), 40.8 (d, JP = 65.8 Hz, PCHminor), 41.3 (d, JP = 68.4 Hz, PCHmajor), 
53.5 (CHCH(CH3)2major), 54.7 (CHCH(CH3)2minor), 69.4 (CHOHmajor), 71.9 
(CHOHminor), 126.2-140.8 (aromatic C and CH); m/z (EI) 503 (MH+); HRMS 
(ES); calc. for C31H33ClO2P (MH+) 503.1899; Found 503.1901; 
 
2,3-syn-(4-(4-chlorophenyl)-3-hydroxy-5-methyl-1-phenylhexan-2-yl) 
diphenylphosphine oxide 172c; m.p. 177.2-177.4 °C; Vmax(CHCl3)/cm-1 3244 
(O-H), 2925 (C-H), 1638 (C=C arom.), 1115 (P=O), 822 (C-O), 754 (C-H arom.), 
744 (C-Cl);δH ppm (400 MHz.) 0.17 (3H, d, JH = 6.5 Hz, CH3), 0.57 (3H, d, JH = 
6.4 Hz, CH3), 1.67 (1H, dt, JH = 8.7, 4.5 Hz, CHCH(CH3)2), 1.69-1.77 (1H, m, 
CH(CH3)2),  2.58-2.69 (3H, m, PCHCH2 and PCH), 3.81 (1H, d, JP = 5.3 Hz, 
OH), 4.29 (1H, q, JH = 9.9, JP = 21 Hz, CHOH), 6.64 (2H, d, JH = 8.4 Hz, 
aromatic-H), 6.70-6.76 (2H, m, aromatic-H), 6.93-7.03 (6H, m, aromatic-H), 7.16 
(4H, ddd, JP = 11.1, 5.4, 3.0 Hz, aromatic-H), 7.20-7.27 (3H, m, aromatic-H), 
7.37-7.43 (2H, m, aromatic-H); δP ppm (400 MHz.) 38.22; δC ppm (125 MHz.) 
20.9 (CH3), 29.6 (CH(CH3)2), 34.2 (PCHCH2), 42.6 (d, JP = 70.5 Hz, PCH), 55.5 
(d, JP = 5.9 Hz, CHCH(CH3)2), 73.2 (CHOH), 126.5-139.2 (aromatic C and CH); 
m/z (EI) 503 (MH+); HRMS (ES); calc. for C31H33ClO2P (MH+) 503.1899; Found 
503.1901;  
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6.2.95 (2R*, 3R*, 4R*) and (2R*, 3S*, 4R*)-(3-hydroxy-5,5-
dimethyl-1,4-diphenylhexan-2-yl)diphenylphosphine oxide  
Using the method described in section 
6.2.53; LDA (2 M solution in THF, 2.45 mL, 
4.9 mmol) was added to a stirred solution of 
phosphine oxide 36 (0.5 g, 1.63 mmol) in dry 
THF (40 mL). 2-cyclohexyl-3,3-
dimethylbutanal 167 (0.86 g, 4.9 mmol) was 
added. The organic layer was combined, 
dried and filtered to yield a orange oil (1.2 g), 
which was purified by preparative 
chromatography (40 : 40, petroleum ether : 
ethyl acetate) to give a yellow solid (0.613 g, 78 %), to give the required 
products; in poor yield. 
 
2,3-anti-(2R*, 3S*, 4R*)-(3-hydroxy-5,5-dimethyl-1,4-diphenylhexan-2-
yl)diphenylphosphine oxide 173b; m.p. 92.2-92.8 °C; Vmax(CHCl3)/cm-1 3456 
(O-H),  2897 (C-H), 1712 (C=C arom.), 1547 (P=O), 1273 (C-O), 823 (C-H 
arom.); δH ppm (400 MHz.) 0.81 (9H, d, JH = 21.9 Hz, C(CH3)3), 2.34 (1H, dd, JP 
= 12.7, JH = 5.5 Hz, PCH), 2.49-2.62 (1H, m, CHC(CH3)3), 2.80 (1H, td, JH = 
15.9, 7.6 Hz, PCHCH2), 3.28 (1H, ddd, JH = 19.8, 15.5, 4.7 Hz, PCHCH2), 4.44 
(1H, s, CHOH), 5.11 (1H, t, JP = 11.2 Hz, CHOH), 6.44-6.52 (3H, m, aromatic-
H), 6.85-6.91 (2H, m, aromatic-H), 7.04-7.12 (3H, m, aromatic-H), 7.15-7.20 
(4H, m, aromatic-H), 7.23-7.30 (4H, m, aromatic-H), 7.39 (1H, dd, JH = 4.1, 3.1 
Hz, aromatic-H), 7.46-7.56 (3H, m, aromatic-H); δP ppm (400 MHz.) 40.03; δC 
ppm (125 MHz.) 27.7 (PCHCH2), 28.5 (C(CH3)3), 33.7 (C(CH3)3), 41.2 (d, JH = 
2,3-syn 173a; 2,3-anti 173b; 
2,3-syn 173c; 2,3-anti 173d 
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68.7 Hz, PCH), 57.4 (d, JP = 11.5 Hz, CHC(CH3)3), 71.7 (CHOH), 125.6-141.7 
(aromatic C and CH); m/z (EI) 483.1 (MH+); HRMS (ES); calc. for C32H36O2P 
(MH+) 483.2446; Found 483.2447; 
 
2,3-anti-(2R*, 3S*, 4R*)-(3-hydroxy-5,5-dimethyl-1,4-diphenylhexan-2-
yl)diphenylphosphine oxide 173d; m.p. 100.2-100.4 °C; Vmax(CHCl3)/cm-1  
3456 (O-H),  2897 (C-H), 1712 (C=C arom.), 1547 (P=O), 1273 (C-O), 823 (C-H 
arom.); δH ppm (400 MHz.) 0.68 (9H, d, JH = 21.9 Hz, C(CH3)3), 2.34 (1H, d, JH 
= 9.8 Hz, PCH), 2.45-2.66 (2H, m, CHC(CH3)3 and PCHCH2), 2.92 (1H, t, JH = 
13.0 Hz, PCHCH2), 4.24 (1H, d, JP =8.9 Hz CHOH), 5.11 (1H, s, CHOH), 6.48 
(1H, s,  aromatic-H), 6.75 (1H, s, aromatic-H), 6.81-6.94 (3H, m, aromatic-H), 
7.05 (1H, dd, JH = 16.7, 8.5 Hz, aromatic-H), 7.11-7.23 (5H, m, aromatic-H), 
7.27 (1H, d, JH = 13.1 Hz, aromatic-H), 7.32-7.45 (5H, m, aromatic-H), 7.51-
7.55 (1H, m, aromatic-H), 7.64 (1H, d, JH = 7.4 Hz, aromatic-H); δP ppm (400 
MHz.) 39.46; δC ppm (125 MHz.) 29.5 (C(CH3)3), 34.6 (PCHCH2), 39.9 
(C(CH3)3), 41.8 (d, JH = 86.7 Hz, PCH), 58.7 (CHC(CH3)3), 74.4 (CHOH), 125.7-
141.5 (aromatic C and CH); m/z (EI) 483.1 (MH+); HRMS (ES); calc. for 
C32H36O2P (MH+) 483.2446; Found 483.2447; 
 
2,3-syn-(2R*, 3R*, 4R*)-(3-hydroxy-5,5-dimethyl-1,4-diphenylhexan-2-
yl)diphenylphosphine oxide 173a; m.p. 124.3-124.6 °C; Vmax(CHCl3)/cm-1 
3456 (O-H),  2897 (C-H), 1712 (C=C arom.), 1547 (P=O), 1273 (C-O), 823 (C-H 
arom.); δH ppm (400 MHz.) 0.68 (9H, d, JH = 22.3 Hz, C(CH3)3), 2.10 (1H, s, 
CHC(CH3)3), 2.59-2.62 (2H, m, PCH and PCHCH2), 2.85 (1H, dd, JH = 22.3, 
10.7 Hz, PCHCH2), 4.62-4.69 (2H, m, CHOH and CHOH), 6.23 (2H, d, JH = 7.4 
Hz, aromatic-H), 6.63-6.79 (3H, m, aromatic-H), 6.95-7.09 (2H, m, aromatic-H), 
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7.16 (5H, dd, JH = 11.2, 7.0 Hz, aromatic-H), 7.26-7.38 (2H, m, aromatic-H), 
7.44 (3H, s, aromatic-H), 7.72-7.84 (3H, m, aromatic-H); δP ppm (400 MHz.) 
37.92; δC ppm (125 MHz.) 28.7 (PCHCH2), 29.9 (C(CH3)3), 34.9 (C(CH3)3), 45.6 
(d, JH = 68.2 Hz, PCH), 63.1 (d, JP = 10.5 Hz, CHC(CH3)3), 67.7 (CHOH), 
125.1-140.6 (aromatic C and CH); m/z (EI) 483.1 (MH+);  HRMS (ES); calc. for 
C32H36O2P (MH+) 483.2446; Found 483.2447; 
 
6.2.96 3β-(toluene-4-sulfonyloxy)-5-pregnen-20-one 189 
Pregnenolone 188 (5 g, 15.8 
mmol), 4-Di(methylamino)pyridine, 
4-DMAP, (0.19 g, 1.58 mmol) and 
p-toluenesulfonyl chloride (5.7 g, 
29.7 mmol) was stirred in pyridine 
(50 mL) at room temperature for 24 
hours under nitrogen. Additional 4-
DMAP (0.097 g, 0.79 mmol) and p-toluenesulfonyl chloride (1.50 g, 7.8 mmol) 
was added and the mixture was continually stirred at room temperature for 5 
hours (monitored by TLC). The mixture, containing some crystalline material, 
was poured into 10 % aq. sodium bicarbonate (200 mL) and the oil which 
separated soon solidified. After cooling in an ice bath for 30 minutes the mixture 
was filtered, and washed with water (40 mL), and the solid (7 g, 95 %) obtained 
was recrystallised from acetone to give the title product 189 as a white powder 
(5.3 g, 72 %).  
m.p. 136.0 - 136.6 °C; m.p. lit 128 °C 148; Vmax (CHCl3)/cm-1 2895 (C-H), 1698 
(C=C), 1598 (C=C arom.), 1353 (SO2), 1186 (C-O), 1173 (C-H arom.); δH ppm 
(400 MHz.) 0.63 (3H, s, C18H3), 0.90-0.96 (1H, m, C9H), 0.97 (3H, s, C19H3), 
189 
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1.01-1.05 (1H, m, C14H), 1.06-1.28 (2H, m, C15H2ax, C1H2ax), 1.40-1.51 (3H, m, 
C12H2ax, C2H2ax, C8H), 1.53-1.64 (2H, m, C7H2ax, C11H2ax), 1.65-1.78 (3H, m, 
C11H2eq, C16H2ax, C15H2eq), 1.81-1.89 (2H, m, C1H2eq, C2H2eq), 1.95-2.08 (2H, m, 
C7H2eq, C12H2eq), 2.14 (3H, s, C21H3), 2.15-2.23 (1H, m, C16H2eq), 2.26-2.33 (1H, 
m, C4H2ax), 2.36-2.44 (1H, m, C4H2eq), 2.48 (3H, s, Ar-CH3), 2.54 (1H, t, JH = 8.9 
Hz, C17H), 4.21-4.48 (1H, m, C3H), 5.16-5.40 (1H, m, C6H), 7.35 (2H, d, JH = 8.1 
Hz, aromatic-H), 7.82 (2H, d, JH = 8.3 Hz, aromatic-H);  δC ppm (400 MHz.) 13.2 
(C18H3), 19.2 (C19H3), 20.9 (C11H2), 21.7 (aromatic-CH3), 22.8 (C16H2), 24.5 
(C15H2), 28.6 (C2H2), 31.6 (C21H3), 31.7 (C7H2), 31.7 (C8H), 36.4 (C10), 36.9 
(C1H2), 38.7 (C12H2), 38.8 (C4H2), 43.9 (C13), 49.8 (C9H), 56.8 (C14H), 63.6 
(C17H), 82.2 (C3H), 123.2 (C6H), 127.6-134.7 (aromatic C and CH), 138.7 (C5), 
144.5 (aromatic-C), 209.5 (C20); m/z (EI) 299.5 (MH+-OTs), 470 (MH+);  
 
6.2.97 6β-methoxy-3α,5-cyclo-5α-pregnan-20(22)-ene 192  
Potassium tert butoxide (1.02 g, 9.1 mmol) and methyl 
triphenylphosphonium bromide (3.24 g, 9.1 mmol) was 
added to dry THF (30 mL). The reaction mixture was 
allowed to stir for 5 hours, were the reaction changed 
from yellow to orange in colour, after which 6β-
methoxy-3α,5-cyclo-5α-pregnan-20-one 190 (0.5 g, 
1.5 mmol) was added. After stirring for 14 hours 
diethyl ether (20 mL) was added and the precipitate was filtered. The organic 
extract was washed with water (10 mL), brine (10 mL) and dried over MgSO4 
and the solvent was removed in vacuo to give a crude brown solid (1.9 g). The 
crude was purified by column chromatography (98 : 2 v/v, petroleum ether : 
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ethyl acetate) to remove triphenylphosphine oxide, to give the title product 192 
as a white solid (0.49 g, 100%). 
m.p. 33.7-35.2 °C; m.p. lit 40-41 °C 149; Vmax(CHCl3)/cm-1 2944 (C-H), 1649 
(C=C), 1042 (C-O); δH ppm (400 MHz.) 0.37 (1H, dd, JH = 8.0, 5.1 Hz, C4H2ax), 
0.56 (3H, s, C18H3), 0.56-0.60 (1H, m, C4H2eq), 0.74-0.86 (3H, m, C1H2ax, C9H,  
C3H), 0.96 (3H, s, C19H3), 0.98-1.21 (4H, m, C7H2ax, C14H ,C12H2ax ,C15H2ax), 
1.22-1.36 (1H, m, C15H2eq), 1.36-1.40 (1H, m, C2H2ax), 1.40-1.46 (1H, m, 
C1H2eq), 1.46-1.49 (2H, m, C16H2ax,C11H2ax) 1.57-1.67 (3H, m, C11H2eq ,C2H2eq, 
C8H,), 1.69 (3H, s, C21H3), 1.70-1.75 (1H, m, C16H2eq), 1.76-1.88 (2H, m, C7H2eq, 
C12H2eq), 1.97 (1H, t, JH = 9.3 Hz, C17H), 2.70 (1H, t, JH = 2.8 Hz, C6H), 3.26 
(3H, s, OCH3), 4.64 (1H, s, =CH2ax), 4.78 (1H, s, =CH2eq); δC ppm (400 MHz.) 
13.1 (C18H3), 13.1 (C4H2), 19.3 (C19H3), 21.5 (C3H), 22.8 (C16H2) 24.2 (C15H2), 
24.6 (C21H3), 24.9 (C2H2), 25.5 (C11H2), 30.8 (C8H), 33.4 (C1H2), 35.1 (C7H2), 
35.4 (C10), 39.2 (C12H2), 43.5 (C13), 43.5 (C5), 48.3 (C9H), 56.4 (C14H), 56.6 
(OCH3), 57.4 (C17H), 82.4 (C6H), 110.6 (=CH2), 145.8 (C20); m/z (EI) 299.5 
(MH+-OMe), 329.5 (MH+);  
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6.2.98 (20S) and (20R)-6β-methoxy-3α,5α-cyclo-5α-pregnane-22-
ol 193a and 193b                  
6.2.98.1 Method A : using 192 to give 193a 
and 193b 
To a solution of 6β-methoxy-3α,5-cyclo-5α-
pregnan-20(22)-ene  192 (0.4 g, 1.2 mmol) in 
dry THF (12 mL), borane-THF complex (1 M, 
4.29 mL, 4.29 mmol) was added at 0°C, over a 
15 minute period under an argon atmosphere. 
The reaction mixture was stirred at room 
temperature for 1 hour, then warmed to reflux, 70 °C and stirred for an 
additional 13 hours. To the reaction mixture NaOH (2 M, 12 mL) was added and 
H2O2 30% w/w (12 mL) at 0 °C and the reaction continued at room temperature 
for 16 hours. THF was removed in vacuo and the aqueous layer was extracted 
with ether (3 x 25 mL), the organic layer was washed with brine (3 x 25 mL), 
dried over MgSO4, filtered and the solvent was evaporated under reduced 
pressure to give a viscous oil (0.4 g, 96 %). The diastereoisomeric mixture was 
separated by column chromatography (90 : 10 v/v, petroleum ether : ethyl 
acetate) to yield (0.32 g, 78 %), to afford the first diastereoisomer 193a (0.2 g, 
46 %) and the second diastereoisomer 193b (0.13 g, 32 %) in a 1.5:1 ratio. 
6.2.98.2 Method B : using 204 to give 193a  
((3aR,3bS,5aR,6R,8aS,8bS)-6-((2R,5S,E)-5-ethyl-6-methylhept-3-en-2-yl)-10-
methoxy-3a,5a-dimethylhexadecahydrocyclopenta[a]cyclopropa[2,3]cyclopenta 
[1,2-f]naphthalene 204 (0.078  g, 0.18 mmol) was dissolved in dichloromethane 
: methanol (1:1 vv, 10 mL), ozone was passed through the reaction, a pale blue 
R1 = Me, R2 = H  193a (20S); 
R1 = H, R2 = Me  193b (20R) 
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colour was observed, for 2 hours. On completion (monitored by TLC) sodium 
borohydride  (0.035 g, 0.9 mmol) in methanol (5 mL) was added and the 
reaction was left for a further 30 minutes.  The reaction mixture was washed 
with water and dichloromethane (1:1 vv, 25 mL), the organic layer was dried 
over MgSO4, filtered and concentrated to give the crude product as an off white 
solid (0.05 g, 79 %). The crude solid was then purified by column 
chromatography (90 : 10 v/v,  petroleum ether : ethyl acetate) to give the title 
product  (0.034 g, 54 %) as a white solid, 193a. 
 
(20S)-6β-methoxy-3α,5α-cyclo-5α-pregnane-22-ol, 193a; m.p: 76.1-76.4 °C; 
m.p lit 84.5-86 °C 150;  Vmax(CHCl3)/cm-1 3322 (O-H), 3212 (C-H), 1194 (C-O); δH 
ppm (400 MHz.) 0.36 (1H, dd, JH = 8.0, 5.1 Hz, C4H2ax), 0.56-0.60 (1H, m, 
C4H2eq), 0.67 (3H, s, C18H3), 0.73-0.85 (4H, m, C1H2ax, C9H,  C3H, OH ), 0.96 
(3H, d, JH = 4.8 Hz, C21H3), 0.97 (3H, s, C19H3), 1.03-1.16 (4H, m, C7H2ax, C14H, 
C12H2ax, C2H2ax), 1.17-1.38 (4H, m, C20H, C15H2ax, C15H2eq, C16H2ax), 1.45-1.48 
(2H, m, C1H2eq, C11H2ax) 1.49-1.59 (2H, m, C17H ,C2H2eq), 1.65-1.69 (2H, m, 
C8H, C11H2eq), 1.79 (1H, ddd, JH = 13.1, 6.9, 3.9 Hz, C16H2eq), 1.82 (1H, dt, JH = 
13.3, 2.9 Hz, C7H2eq), 1.91 (1H, dt, JH = 12.5, 3.4 Hz, C12H2eq), 2.70 (1H, t, JH = 
2.8 Hz, C6H), 3.25 (3H, s, OCH3), 3.27-3.33 (1H, m, CH2ax-OH), 3.56 (1H, dd, 
JH = 10.5, 3.2 Hz, CH2eq-OH); δC ppm (400 MHz.) 12.3 (C4H2), 13.1 (C18H3), 
16.7 (C21H3), 19.3 (C19H3), 21.5 (C3H), 22.8 (C15H2) 24.3 (C2H2), 24.9 (C11H2), 
27.8 (C16H2), 30.5 (C8H), 33.4 (C1H2), 35.1 (C7H2), 35.3 (C10), 38.7 (C17H), 40.2 
(C12H2), 42.8 (C13), 43.3 (C5), 48.0 (C9H), 56.7 (C20H), 56.3 (C14H), 56.5 
(OCH3), 66.0 (CH2-OH), 82.4 (C6H); m/z (EI) 297.5 (MH+-OMe, H2O), 315.5 
(MH+-OMe), 347.6 (MH+);  
 
321 
 
(20R)-6β-methoxy-3α,5α-cyclo-5α-pregnane-22-ol, 193b; m.p: 76.2-77.1 °C; 
no lit. m.p.; Vmax (CHCl3)/cm-1 3321 (O-H), 3113 (C-H), 1264 (C-O); δH ppm (400 
MHz.) 0.36 (1H, dd, JH = 8.0, 5.1 Hz, C4H2ax), 0.56-0.59 (1H, m, C4H2eq), 0.67 
(3H, s, C18H3), 0.73-0.84 (4H, m, C1H2ax, C9H,  C3H, OH ), 0.89 (3H, d, JH = 5.4 
Hz, C21H3), 0.96 (3H, s, C19H3), 0.99-1.15 (4H, m, C7H2ax, C14H, C12H2ax, 
C2H2ax), 1.19 (1H, dd, JH = 11.7, 6.8 Hz, C20H), 1.22-1.37 (3H, m, C15H2ax, 
C15H2eq, C16H2ax), 1.38-1.47 (2H, m, C1H2eq, C11H2ax) 1.49-1.59 (2H, m, C17H, 
C2H2eq), 1.59-1.70 (2H, m, C8H, C11H2eq), 1.74 (1H, ddd, JH = 12.7, 7.2, 3.6 Hz, 
C16H2eq), 1.78-1.86 (2H, m, C7H2eq, C12H2eq), 2.07 (1H, t, JH = 2.8 Hz, C6H), 3.25 
(3H, s, OCH3), 3.37 (1H, dt, JH = 14.7, 17.4 Hz,CH2ax-OH), 3.66 (1H, dd, JH = 
10.6, 3.6 Hz, CH2eq-OH); δC ppm (125 MHz.) 12.2 (C4H2), 13.1 (C18H3), 16.7 
(C21H3), 19.3 (C19H3), 21.5 (C3H), 22.7 (C15H2) 24.0 (C2H2), 24.9 (C11H2), 27.6 
(C16H2), 30.5 (C8H), 33.5 (C1H2), 35.1 (C7H2), 35.3 (C10), 37.9 (C17H), 39.7 
(C12H2), 42.6 (C13), 43.4 (C5), 48.1 (C9H), 56.7 (C20H), 56.6 (C14H), 56.5 
(OCH3), 66.9 (CH2-OH), 82.4 (C6H); m/z (EI) 297.5 (MH+-OMe, H2O), 315.5 
(MH+-OMe), 347.6 (MH+);  
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6.2.99 2-((3aR,3bS,5aS,6R,8aS,8bS,10R)-10-methoxy-3a,5a-dime 
thylhexadecahydrocyclopenta[a]cyclopropa[2,3]cyclopenta[1,2-
f]naphthalen-6-yl)propanal 194  
6.2.99.1 Method A: using racemic 193  
To a solution of oxalyl chloride (0.46 g, 0.27 mL, 3.17 mmol) in dry DCM (60 
mL) a solution of dry DMSO (0.54 g, 0.49 mL, 
6.9 mmol) in dry DCM (20 mL) was added at -
72 °C. After 10 minutes, a solution 2-
((3aR,5aS,6R,10R)-10-methoxy-3a,5a- 
dimethylhexadecahydrocyclopenta[a]cyclopro
pa[2,3]cyclopenta[1,2-f]naphthalen-6-
yl)propan-1-ol 193 (0.5 g, 1.4 mmol) in dry 
DCM (50 mL) was added at  this temperature. 
After 15 minutes, triethylamine (4.05 mL 28.8 
mmol) was added portion wise over a 5 minute period. After a further 5 minutes 
at this temperature, the reaction was allowed to warm to room temperature over 
1 hour. Once the reaction was completed (monitored by TLC), H2O (100 mL) to 
terminate the reaction. The phases were separated and the organic layer was 
washed with brine, dried, filtered and the solvent was reduced in vacuo to yield 
a yellow solid (0.56 g). Racemic diastereoisomer mixture; 194a : 194b; 1 : 2 
6.2.99.2 Method B: using 193a  
Using the method described in section 6.2.114.1; Oxalyl chloride (0.46 g, 0.27 
mL, 3.17 mmol) in DCM (60 mL), DMSO (0.54 g, 0.49 mL, 6.9 mmol) in DCM 
(20 mL) was added.(2S)-2-((3aR,5aS,6R,10R)-10-methoxy-3a,5a-
dimethylhexadecahydrocyclopenta[a]cyclopropa[2,3]cyclopenta[1,2-
R1 = Me, R2 = H  194a (20S);  
R1 = H, R2 = Me 194b (20R) 
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f]naphthalen-6-yl)propan-1-ol 193a (0.5 g, 1.4 mmol) in DCM (50 mL) was 
added.  The solvent was reduced in vacuo to yield a off white solid (0.52 g). The 
off white solid was further purified by column chromatography (90  :  10 v/v, 
petroleum ether : ethyl acetate) to yield the title product as a white solid 194a 
(0.48 g, 98 %). Compound is stored in the freezer. 
6.2.99.3 Method C: using 193b  
Using the method described in section 6.2.114.1; Oxalyl chloride (0.46 g, 0.27 
mL, 3.17 mmol) in DCM (60 mL), DMSO (0.54 g, 0.49 mL, 6.9 mmol) in DCM 
(20 mL) was added. (2R)-2-((3aR,5aS,6R,10R)-10-methoxy-3a,5a-
dimethylhexadecahydrocyclopenta[a]cyclopropa[2,3]cyclopenta[1,2-
f]naphthalen-6-yl)propan-1-ol 193b (0.5 g, 1.4 mmol) in DCM (50 mL) was 
added.  The solvent was reduced in vacuo to yield a clear oil (0.56 g). The clear 
oil was further purified by column chromatography (90  :  10 v/v, petroleum 
ether : ethyl acetate) to yield the title product as a clear oil 194b (0.49 g, 100 
%). Compound is stored in the freezer. 
 
194b; Vmax(CHCl3)/cm-1 3382 (C-H),  1732 (CHO), 1313 (C-O); δH ppm (400 
MHz.) 0.43 (1H, dd, JH = 7.9, 5.2 Hz, C4H2ax), 0.64 (1H, d, JH = 4.2 Hz, C4H 2eq), 
0.71 (3H, s, C18H3), 0.75-0.81 (1H, m, C9H), 0.82-0.89 (3H, m, C3H, C1H2ax and 
C7H2ax), 1.01 (6H, dd, JH = 14.1, 7.3 Hz, C19H3 and C21H3), 1.04-1.11 (1H, m, 
C12H2ax), 1.12-1.20 (1H, C14H), 1.20-1.28 (1H, m, C2H2ax), 1.30-1.43 (3H, m, 
C15H2ax, C16H2eq and C16H2ax), 1.44-1.54 (2H, m,  C11H2ax  and C17H),  1.56-1.63 
(2H, m, C15H2eq and C2H2eq), 1.63-1.67 (1H, m, C12H2eq), 1.69-1.77 (2H, m, 
C11H2eq and C1H2eq), 1.81- 1.90 (2H, m, C8H and C7H2eq), 2.11-2.49 (1H, m, 
C20H), 2.76 (1H, s, C6H), 3.31 (3H, d, JH = 0.9 Hz,  C23H3), 9.53 (1H, d, JH = 5.0 
Hz, C22H);  δC ppm (125 MHz.) 13.2 (C4H2), 13.4 (C18H3), 13.7 (C19H3), 19.3 
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(C21H3), 21.4 (C3H), 22.6 (C15H2), 23.9 (C2H2), 25.1 (C11H2), 26.7 (C16H2), 30.6 
(C8H), 33.5 (C1H2), 35.2 (C7H2), 35.3 (C13), 39.1 (C12H2), 42.7 (C10), 43.5 (C5), 
48.0 (C9H), 48.9 (C20H), 52.3 (C17H), 56.1 (C14H), 56.7 (C23H3), 82.3 (C6H), 
206.1 (C22=O); m/z (EI) 345.2 (MH+), 313.3 (M-OMe+); HRMS (ES); calc. for 
C23H37O2 (MH+) 345.2131; Found 345.2212; 
 
194a; m.p. 93.3-95.9 °C; m.p. lit 82-83 °C 151;  Vmax(CHCl3)/cm-1 3379 (C-H),  
1733 (CHO), 1369 (C-O); δH ppm (400 MHz. CDCl3) 0.37 (1H, dd, JH = 8.0, 5.1 
Hz, C4H2ax), 0.56-0.61 (1H, m, C4H 2eq), 0.69 (3H, d, JH = 8.9 Hz, C18H3), 0.80 
(4H, ddd, JH = 9.3, 7.0, 3.7 Hz, C9H, C3H, C1H2ax and C7H2ax), 0.96 (3H, s, 
C19H3), 1.01 (1H, dd, JH = 11.9, 3.0 Hz, C14H), 1.05 (3H, s, C21H3), 1.15 (4H, 
ddd, JH = 17.3, 9.8, 4.7 Hz, C12H2ax, C15H2ax, C16H2ax and C15H2eq), 1.28-1.40 
(3H, m, C2H2ax, C17H and C1H2eq), 1.44 (1H, d, JH = 5.6 Hz, C11H2ax), 1.55-1.66 
(2H, m, C11H2eq and C2H2eq), 1.68 (1H, s, C8H), 1.76-1.90 (3H, m, C16H2eq, 
C12H2eq and C7H2eq), 2.30 (1H, dqd, JH = 10.1, 6.8, 3.3 Hz, C20H), 2.71 (1H, t, JH 
= 2.7 Hz, C6H), 3.26 (3H, d, JH = 0.9 Hz, C23H3), 9.58 (1H, d, JH = 3.2 Hz, C22H); 
δC ppm (125 MHz.) 12.6 (C18H3), 13.1 (C4H2), 13.4 (C19H3), 19.3 (C21H3), 21.5 
(C3H), 22.7 (C15H2), 24.6 (C2H2), 24.9 (C11H2), 27.1 (C16H2), 30.5 (C8H), 33.8 
(C1H2), 35.1 (C7H2), 35.2 (C13), 39.9 (C12H2), 43.3 (C10), 43.4 (C5), 48.1 (C9H), 
49.5 (C20H), 51.2 (C17H), 55.8 (C14H), 56.6 (C23H3), 82.3 (C6H), 205.2 (C22=O); 
m/z (EI) 345.2 (MH+), 313.3 (M-OMe+);HRMS (ES); calc. for C23H37O2 (MH+) 
345.2131; Found 345.2212; 
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6.2.100 (20S) and (20R)-3β tert-butyldimethylsilyl-5α-pregnan-
20-ol 196a and 196b   
A flask was charged with 3β-tert-
butyldimethylsilyloxy-5-pregnen-20-
one 195 (0.5 g, 1.16 mmol) and 5% 
Pd/C (0.25 g) under an argon 
atmosphere. Ethyl acetate (25 mL) 
was added and the flask was flushed 
with hydrogen several times. The 
reaction was stirred at room 
temperature for 2 days. The black 
mixture was filtered through Celite® and washed several times with 
dichloromethane (20 mL). The recovered clear, colourless, filtrate was 
concentrated to yield a white solid (0.37 g, 74 %). The crude was purified by 
column chromatography (95 : 5 v/v, petroleum ether : ethyl acetate) to yield 
196b in (0.228 g, 45 %) and 196a in (0.146 g, 29 %) in a 1.5:1 ratio 152. 
 
(20R)-3β tert-butyldimethylsilyl-5α-pregnan-20-ol, 196b; m.p. 168.1-169.2 
°C; Vmax(CHCl3)/cm-1 3479 (O-H), 2929 (C-H), 1322 (C-O); δH ppm (400 MHz.) -
0.01-0.03 (6H, m, Si(CH3)2), 0.53-0.62  (1H, m, C9H), 0.69 (3H, s, C18H3), 0.76 
(3H, s, C19H3), 0.84 (9H, d, JH = 2.8 Hz, Si(C)(CH3)3), 0.87-1.03 (4H, m, C1H2ax, 
C15H2ax, C11H2ax, C5H), 1.05-1.10 (3H, m, C21H3), 1.11-1.45 (13H, m, C14H,  
C2H2ax,  C6H2ax, C6H2eq, C17H, C8H, C12H2ax, C7H2ax, OH, C11H2eq, C15H2eq, 
C16H2ax, C12H2eq), 1.53-1.66 (5H, m, C2H2eq, C1H2eq, C7H2eq, C16H2eq, C4H2ax), 
1.90-2.02 (1H, m, C4H2eq,), 3.49 (1H, dt, JH = 9.8, 5.5 Hz, C3H), 3.62-3.72 (1H, 
m, C20H);  δC ppm (125 MHz.) -4.8 (Si(CH3)2), 12.5 (C19H3), 12.9 (C18H3), 18.4 
R1 = Me, R2 = H  196a (20S);  
R1 = H, R2 = Me 196b (20R) 
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(Si(C)(CH3)3), 20.9 (C11H2), 23.6 (C21H3), 24.7 (C16H2), 25.8 (C15H2), 26.0 
(Si(C)(CH3)3), 28.5 (C6H2), 32.0 (C2H2), 32.4 (C7H2), 35.4 (C8H), 35.9 (C10), 37.7 
(C1H2), 38.9 (C12H2), 40.6 (C4H2), 42.7 (C13), 45.6 (C5H), 55.0 (C9H), 56.7 
(C14H), 58.9 (C17H), 71.6 (C20H), 73.4 (C3H); m/z (EI) 285.4 (MH+-TBDMSOH, 
H2O), 303.5 (MH+-TBDMSOH), 435.7 (MH+); 
 
(20S)-3β tert-butyldimethylsilyl-5α-pregnan-20-ol, 196a; m.p. 168.4-170.0 
°C; Vmax(CHCl3)/cm-1 3479 (O-H), 2929 (C-H), 1321 (C-O); δH ppm (400MHz.) -
0.02-0.02 (6H, m, Si(CH3)2), 0.56 (1H, dd, JH = 11.5, 3.3 Hz, C9H), 0.60 (3H, s, 
C18H3), 0.75 (3H, s, C19H3), 0.81-0.85 (9H, m, Si(C)(CH3)3), 0.86-1.12 (6H, m, 
C1H2ax, C15H2ax, C14H,  C2H2ax, C11H2ax, C5H), 1.17 (3H, d, JH = 6.2 Hz, C21H3), 
1.19-1.51 (11H, m, C6H2ax, C6H2eq, C17H, C8H, C12H2ax, C7H2ax, OH, C11H2eq, 
C15H2eq, C16H2ax, C12H2eq), 1.53-1.66 (4H, m, C2H2eq, C1H2eq, C7H2eq, C16H2eq), 
1.76-1.91 (2H, m, C4H2eq, C4H2ax ), 3.43-3.55 (1H, m, C3H), 3.65 (1H, m, C20H);   
δC ppm (125 MHz.) -4.6 (Si(CH3)2), 12.4 (C19H3), 12.7 (C18H3), 17.93 
(Si(C)(CH3)3), 20.9 (C11H2), 23.5 (C21H3), 24.1 (C16H2), 25.6 (C15H2), 25.9 
(Si(C)(CH3)3), 28.8 (C6H2), 31.9 (C2H2), 32.1 (C7H2), 35.2 (C8H), 35.5 (C10), 37.2 
(C1H2), 38.7 (C12H2), 39.1 (C4H2), 41.9 (C13), 45.1 (C5H), 54.5 (C9H), 56.3 
(C14H), 58.6 (C17H), 70.3 (C20H), 72.2 (C3H); m/z (EI) 285.4 (MH+-TBDMSOH, 
H2O), 303.5 (MH+-TBDMSOH), 435.7 (MH+) 
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6.2.101 3β-tert-butyldimethylsilyloxy-5α-pregnan-20(22)-ene 199 
3β-Hydroxy-5α-pregnan-20(22)-ene  (0.4 
g, 1.2 mmol) in dry THF was treated with 
tert-butyldimethyl silyl chloride (0.38 g, 2.5 
mmol) and imidazole (0.34 g, 5.1 mmol) in 
dry DMF (20 mL) for 24 hours at room 
temperature. The reaction mixture was 
extracted with diethyl ether (5 x 20 mL) 
and then the organic layer was washed with water (5 x 20 mL) and dried over 
MgSO4.The solvent was removed in vacuo to yield a crude white solid. The 
compound was purified by column chromatography (100 v/v, petroleum ether) 
to yield title product 199 (0.50 g, 92 %) and purified further, by washing with 
petroleum ether over suction 153.  
m.p. 145.3-147 °C; Vmax(CHCl3)/cm-1 2926 (C-H), 1641 (C=C), 1086 (C-O); δH 
ppm (400 MHz.) -0.02 (6H, s, Si(CH3)2), 0.50 (3H, s, C18H3), 0.53-0.62 (1H, m, 
C9H ), 0.75 (3H, s, C19H3), 0.84 (9H, d, JH = 2.9 Hz, Si(C)(CH3)3), 0.86-0.91 (1H, 
m, C1H2ax), 0.92-1.44 (12H, m, C16H2ax, C12H2ax, C5H, C14H, C15H2ax, C6H2eq, 
C6H2ax, C4H2ax, C8H, C11H2ax, C4H2eq, C2H2ax), 1.46-1.51 (1H, m, C11H2eq), 1.61-
1.69 (6H, m, C1H2eq, C2H2eq, C7H2ax, C16H2eq, C15H2eq, C7H2eq), 1.70 (3H, d, JH = 
4.6 Hz, C21H3), 1.74-1.80 (1H, m, C12H2eq), 1.96 (1H, t, JH = 9.2 Hz, C17H), 3.43-
3.55 (1H, m, C3H), 4.65 (1H, s, =CH2ax), 4.79 (1H, s, =CH2eq);  δC ppm (125 
MHz. 3) -4.6 (Si(CH3)2), 12.4 (C18H3), 12.9 (C19H3), 18.3 (Si(C)(CH3)3), 21.3 
(C11H2), 24.1 (C16H3), 24.7 (C21H3), 25.4 (C15H2), 25.9 (Si(C)(CH3)3), 28.8 
(C6H2), 31.9, (C2H3), 32.1, (C7H2), 35.5 (C10), 35.9 (C8H), 37.2 (C1H2), 38.7 
(C4H2), 38.9 (C12H2), 43.4 (C13), 45.1 (C5H), 54.6 (C9H), 56.3 (C14H), 57.4 
(C17H), 72.2 (C3H), 110.6 (=CH2), 143.9 (C20); m/z (EI) 431.3 (MH+); 
199 
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6.2.102 3β-Hydroxy-5α-pregnan-20(22)-ene 200        
Potassium tert butoxide (2.8 g, 25.1 mmol) and 
methyl triphenyl phosphonium bromide (8.973 
g, 25.1 mmol) was added to dry THF (25 mL). 
The reaction mixture was allowed to stir for 5 
hours, after which pregnanolone 188 (1 g, 3.1 
mmol) was added. After 24 hours, diethyl ether 
(30 mL) was added and the precipitate was filtered. The organic extract was 
washed with water (30 mL), brine (30 mL) and dried over MgSO4 and the 
solvent was removed in vacuo to give a crude white solid (4.66 g). The crude 
was purified by column chromatography (90 : 10 v/v, petroleum ether  : ethyl 
acetate) to remove the triphenylphosphine oxide, to give the title product 200 as 
a white solid (0.96 g, 97 %).  
m.p. 149.9-150.9 °C; m.p. lit 149.5-150.5 °C 154; Vmax(CHCl3)/cm-1 3296 (O-H), 
2925 (C-H),1639 (C=C), 1037 (C-O); δH ppm (400 MHz.) 0.49 (3H, s, C18H3), 
0.53-0.63 (1H, m, C9H), 0.74 (3H, s, C19H3), 0.81-0.83 (1H, m, OH), 0.90 (1H, 
td, JH = 13.7, 3.2 Hz, C1H2ax), 1.05-1.09 (4H, m, C15H2ax, C14H, C5H, C12H2ax), 
1.16-1.38 (7H, m, C2H2ax, C4H2ax, C7H2ax, C6H2eq, C6H2ax, C8H, C11H2ax), 1.42-
1.53 (3H, m, C4H2eq, C16H2ax, C11H2eq,), 1.55-1.64 (4H, m, C16H2eq, C15H2eq, 
C1H2eq, C7H2eq), 1.68 (3H, s, C21H3 ), 1.70- 1.78 (2H, m, C2H2eq, C12H2eq), 1.88-
1.97 (1H, m, C17H), 3.44-3.61 (1H, m, C3H), 4.63 (1H, s, =CH2ax), 4.77 (1H, s, 
=CH2eq); δC ppm (125 MHz.) 12.4 (C18H3), 12.9 (C19H3), 21.3 (C11H2), 24.2 
(C16H3), 24.6 (C21H3), 25.4 (C15H2), 28.7 (C6H2 ), 31.5 (C2H2), 32.0 (C7H2), 35.5 
(C10), 35.9 (C8H), 37.0 (C1H2), 38.2 (C4H2), 38.9 (C12H2), 43.4 (C13), 44.9 (C5H), 
54.5 (C9H), 56.3 (C14H), 57.4 (C17H), 71.4 (C3H), 110.6 (=CH2), 145.8, (C20); 
m/z (EI) 317, 299 (MH+-OH) 431.3 (MH+); 
200 
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6.2.103 (20S) and (20R)-3β-tert-butyldimethylsilyloxy-5α-
pregnane-22-ol 201a and 201b     
To a solution of 3β-tert-
butyldimethylsilyloxy-5α-pregnan-
20(22)-ene 199 (0.2 g, 0.46 mmol) in 
dry THF (6 mL), borane-THF complex 
(1 M solution, 1.63 mL, 1.63 mmol) 
was added at 0 °C, over a 15 minute 
period under an argon atmosphere. 
The reaction mixture was stirred at 
room temperature for 1 hour, then warmed to reflux and stirred for an additional 
13 hours. To the reaction mixture NaOH (2 M, 6 mL) was added and H2O2 30% 
w/w (6 mL) at 0 °C, then stirring continued at room temperature for 16 hours. 
THF was removed in vacuo and the aqueous layer was extracted with ether (3 x 
10 mL), the organic layer was washed with brine and dried over MgSO4, filtered 
and the solvent was evaporated under reduced pressure to give a white solid 
(0.1805 g, 87 %). The diastereoisomeric mixture of 201a and 201b was 
separated by column chromatography (95 : 5 v/v,  petroleum ether : ethyl 
acetate) to yield (0.19 g, 81 %), to afford the first diastereoisomer (0.12 g, 64 %) 
and the second diastereoisomer (0.07 g, 36 %) in a 1.8:1 ratio 155.  
  
(20R)-3β-tert-butyldimethylsilyloxy-5α-pregnane-22-ol, 201b; m.p.171.9-
172.0 °C; Vmax(CHCl3)/cm-1 3352 (O-H), 2927 (C-H), 1039 (C-O); δH ppm (400 
MHz.) -0.00 (6H, s, Si(CH3)2), 0.51-0.59 (1H, m, C9H), 0.62 (3H, s, C18H3), 0.75 
(3H, s, C19H3), 0.83 (9H, s, Si(C)(CH3)3), 0.85-0.88 (1H, m,  C1H2ax), 0.90 ( 3H, 
d, JH = 6.7, C21H3), 0.93-1.14 (5H, m,  C20H, C14H , C12H2ax, C15H2ax C5H),  1.17-
R1 = Me, R2 = H  201a (20S);  
R1 = H, R2 = Me  201b (20R) 
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1.30 (6H, m, C6H2ax, C6H2eq, C4H2ax, C11H2ax, C8H, C16H2ax), 1.35-1.47 (3H, m, 
C2H2eq, C11H2eq, C4H2eq ), 1.52-1.63 (6H, m, C2H2ax, C17H ,C15H2eq, C1H2eq, 
C7H2ax, C7H2eq), 1.70-1.76 (1H, m, C16H2eq), 1.80 (1H, dt, JH = 12.5 Hz, 3.4, 
C12H2eq), 3.42 (1H, dd, JH = 10.5, 7.0 Hz, CH2ax-OH), 3.49 (1H, ddd, JH = 15.6, 
10.7, 4.8 Hz, C3H), 3.67 (1H, dd, JH = 10.6, 3.1 Hz, CH2eq-OH); δC ppm (125 
MHz.) -4.6 (Si(CH3)2), 12.4 (C18H3), 12.5 (C19H3), 16.7 (C21H3), 18.3 
(Si(C)(CH3)3), 21.2 (C11H2), 24.1 (C15H2) 25.9 (Si(C)(CH3)3), 27.6 (C16H2), 28.8 
(C6H2), 31.9 (C2H2), 21.1 (C7H2), 35.5 (C8H), 35.5 (C10), 37.2 (C1H2), 37.9 
(C17H), 38.7 (C4H2), 39.5 (C12H2), 42.4 (C13), 45.0 (C5H), 52.6 (C14H), 54.5 
(C9H), 56.4 (C20H), 66.9 (CH2-OH), 72.2 (C3H); m/z (EI) 317.4 (MH+-OSilyl), 
431.2 (MH+-H2O), 449.4 (MH+), 450.5; HRMS (ES); calc. for C28H53O2Si (MH+) 
449.1814; Found 449.1821; 
 
(20S)-3β-tert-butyldimethylsilyloxy-5α-pregnane-22-ol, 201a; m.p.179.1-
172.1 °C; Vmax(CHCl3)/cm-1 3303 (O-H), 2927 (C-H), 1095 (C-O); δH ppm (400 
MHz.) -0.00 (6H, s, Si(CH3)2), 0.52-0.59 (1H, m, C9H), 0.62 (3H, s, C18H3), 0.75 
(3H, s, C19H3), 0.83 (9H, s, Si(C)(CH3)3), 0.86-0.95 (2H, m,  C1H2ax, C20H), 0.99 
(3H, d, JH = 6.6 Hz, C21H3), 1.02-1.13 (4H, m,  C14H, C12H2ax, C15H2ax, C5H),  
1.14-1.20 (3H, m, C6H2ax, C6H2eq, C2H2eq), 1.22-1.28 (3H, m, C4H2ax, C11H2ax, 
C8H), 1.28-1.47 (5H, m, C16H2ax, C11H2eq, C4H2eq,  C2H2ax, C17H) 1.53-1.64 (4H, 
m, C15H2eq, C1H2eq, C7H2ax, C7H2eq), 1.75 (1H, dd, JH = 11.1, 7.5 Hz, C16H2eq), 
1.90 (1H,d, JH = 12.4 Hz, C12H2eq), 3.31 (1H, d, JH = 11.1 Hz, CH2ax-OH), 3.44-
3.47 (1H, m, C3H), 3.57-3.66 (1H, m, CH2eq-OH); δC ppm (125 MHz.) -4.6 
(Si(CH3)2), 12.4 (C18H3), 12.5 (C19H3), 16.7 (C21H3), 18.8 (Si(C)(CH3)3), 21.2 
(C11H2), 24.1 (C15H2) 25.9 (Si(C)(CH3)3), 27.6 (C16H2), 28.8 (C6H2), 31.9 (C2H2), 
21.1 (C7H2), 35.5 (C8H), 35.5 (C10), 37.2 (C1H2), 37.9 (C17H), 38.7 (C4H2), 39.5 
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(C12H2), 42.4 (C13), 45.0 (C5H), 52.6 (C14H), 54.5 (C9H), 56.4 (C20H), 66.9 (CH2-
OH), 72.1 (C3H); m/z (EI) 317.4 (MH+-OSilyl), 431.2 (MH+-H2O), 449.4 (MH+), 
450.5; HRMS (ES); calc. for C28H53O2Si (MH+) 449.1814; Found 449.1821; 
 
6.2.104 (2-((3S,8R,9S,10S,13S,14S,17R)-3-((tertbutyldimethylsilyl 
)oxy)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthr 
en-17-yl)propanal  
6.2.104.1 Method A: using racemic 201 to give  202a and 202b  
To a solution of oxalyl chloride (0.31 
g, 0.21 mL, 2.45 mmol) in dry DCM 
(60 mL) a solution of dry DMSO (0.42 
g, 0.38 mL, 5.35 mmol) in dry DCM 
(20 mL) was added at -72 °C. After 10 
minutes, a solution (20S/R)-3β-tert-
butyldimethylsilyloxy-5α-pregnane-22-
ol 201 (0.5 g, 1.11 mmol) in dry DCM 
(50 mL) was added at  this temperature. After 15 minutes, triethylamine (3.1 mL 
22.3 mmol) was added portion wise over a 5 minute period. After a further 5 
minutes at this temperature, the reaction was allowed to warm to room 
temperature over 1 hour. Once the reaction was completed (monitored by TLC), 
H2O (100 mL) to terminate the reaction. The phases were separated and the 
organic layer was washed with brine, dried, filtered and the solvent was reduced 
in vacuo to yield a yellow solid (0.51 g). The yellow solid was further purified by 
column chromatography (90  :  10 v/v, petroleum ether : ethyl acetate) to yield 
R1 = Me, R2 = H  202a (20S);  
R1 = H, R2 = Me  202b (20R) 
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the title product as a white solid (0.49 g, 97 %). The compounds are stored in 
the freezer. Racemic diastereoisomer mixture; 211a : 211b; 1 : 1.5 
6.2.104.2 Method B: 201a to give 202a  
Using the method described in section 6.2.104.1; Oxalyl chloride (0.31 g, 0.21 
mL, 2.45 mmol) in DCM (60 mL), DMSO (0.42 g, 0.38 mL, 5.35 mmol) in DCM 
(20 mL) was added. (20S)-3β-tert-butyldimethylsilyloxy-5α-pregnane-22-ol 201a 
(0.5 g, 1.11 mmol) in dry DCM (50 mL) was added. The solvent was reduced in 
vacuo to yield a yellow solid (0.51 g). The yellow solid was further purified by 
column chromatography (90  :  10 v/v, petroleum ether : ethyl acetate) to yield 
the title product as a white solid 202a (0.48 g, 96 %). Stored in freezer  
6.2.104.3 Method C: 201b to give 202b  
Using the method described in section 6.2.104.1; Oxalyl chloride (0.31 g, 0.21 
mL, 2.45 mmol) in DCM (60 mL), DMSO (0.42 g, 0.38 mL, 5.35 mmol) in dry 
DCM (20 mL) was added. (20R)-3β-tert-butyldimethylsilyloxy-5α-pregnane-22-ol 
201b (0.5 g, 1.11 mmol) in dry DCM (50 mL) was added. The solvent was 
reduced in vacuo to yield a yellow solid (0.54 g). The yellow solid was further 
purified by column chromatography (90  :  10 v/v, petroleum ether : ethyl 
acetate) to yield the title product as a white solid 202b (0.3 g, 60 %). Stored in 
freezer 
 
202a; m.p. 146.2-146.9°C; Vmax(CHCl3)/cm-1 3314 (C-H), 1729 (CHO), 1312 (C-
O); δH ppm (400 MHz.) 0.04 (6H, m, C23H3), 0.63 (1H, s, C9H), 0.59-0.66 (3H, s, 
C18H3), 0.79 (3H, s, C19H3), 0.86 (9H, s, C24H3), 0.92 (1H, d, JH = 13.6 Hz, 
C1H2ax), 0.96-1.07 (2H, m, C5H and C20H), 1.10 (3H, s, C21H3), 1.12-1.19 (2H, 
m, C11H2ax and C12H2eq), 1.21-.1.29 (4H, m, C11H2eq, C16H2ax, C6H2ax and  
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C6H2eq), 1.30-1.36 (3H, m, C14H, C15H2eq and C4H2ax), 1.40-1.48 (3H, m, C4H2eq,  
C8H and C2H2ax), 1.51 (1H, ddd, JH = 13.3, 7.0, 3.8 Hz, C7H2ax), 1.58-1.71 (4H, 
m, C15H2eq, C1H2eq, C7H2eq, and C2H2eq), 1.76-1.87 (1H, m, C16H2eq), 1.90 (1H, 
dt, JH = 12.3, 3.2 Hz, C12H2eq), 2.28-2.40 (1H, m, C17H), 3.46-3.60 (1H, m, C3H), 
9.56 (1H, d, JH = 3.3 Hz, C22H); δC ppm (125 MHz.) -4.43 (C23H3), 12.5 (C21H3), 
12.6 (C18H3), 13.4 (C19H3), 18.3 (C25), 21.2 (C11H2), 24.7 (C15H2), 26.1 (C24H3), 
27.2 (C16H2), 28.8 (C6H2), 32.0 (C2H2), 32.2 (C7H2), 35.6 (C8H), 35.6 (C10), 37.3 
(C1H3), 38.8 (C4H2), 39.8 (C12H2), 43.4 (C13), 45.1 (C5H), 49.7 (C17H), 51.2 
(C14H), 54.5 (C9H), 55.9 (C20H), 72.2 (C3H), 205.4 (HC22=O); m/z (EI) 447.4 
(MH+); HRMS (ES); calc. for C28H51O2Si (MH+) 447.3653; Found 447.3653; 
 
202b; m.p. 143.5-144.1 °C; Vmax(CHCl3)/cm-1 3311 (O-H), 1776 (CHO), 1311 (C-
O); δH ppm (400 MHz.) 0.04 (6H, m, C23H3), 0.52-0.61 (1H, m, C9H), 0.63 (3H, 
s, C18H3), 0.78 (3H, s, C19H3), 0.88 (10H, s, C24H3 and C5H), 0.91 (1H, dd, JH = 
12.7, 9.4 Hz, C1H2ax), 0.99 (1H, s, C20H), 1.02 (3H, s, C21H3), 1.03-1.14 (2H, m, 
C4H2ax and C6H2eq), 1.17-1.26 (3H, m, C11H2ax, C12H2ax, C6H2ax), 1.28-1.36 (3H, 
m, C8H, C15H2ax and  C16H2ax), 1.39-1.50 (3H, m,  C4H2eq,  C7H2ax and  C11H2eq), 
1.51-1.60 (3H, m,  C14H, C12H2eq and C12H2ax), 1.61-1.69 (4H, m, C7H2eq, C2H2eq, 
C15H2eq and C1H2eq), 1.84 (1H, ddd, JH = 13.6, 8.0, 1.6 Hz, C16H2eq), 2.24-2.35 
(1H, m, C17H), 3.45-3.57 (1H, m, C3H), 9.52 (1H, d, JH = 5.0 Hz, C22H); δC ppm 
(125 MHz.) -4.43 (C23H3), 12.5 (C18H3), 13.1 (C19H3), 13.8 (C21H3), 18.4 (C25), 
20.9 (C11H2), 23.9 (C15H2), 26.0 (C24H3), 26.8 (C16H2), 28.8 (C6H2), 32.0 (C2H2), 
32.2 (C7H2), 35.6 (C8H), 35.7 (C10), 37.3 (C1H3), 38.7 (C4H2), 38.8 (C12H2), 43.5 
(C13), 45.1 (C5H), 48.9 (C17H), 52.2 (C14H), 54.5 (C9H), 56.1 (C20H), 72.3 (C3H), 
206.1 (HC22=O); m/z (EI) 447.4 (MH+); HRMS (ES); calc. for C28H51O2Si (MH+) 
447.3653; Found 447.3653; 
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6.2.105 tert-butyl(((3S,8R,9S,10S,13R,14S,17R)-10,13- dimethyl-
17-((20S,E)-5-phenylhex-3-en-2- yl)hexadecahydro-1H-
cyclopenta[a]phenanthren-3-yl)oxy)dimethylsilane 205a and 
205b  
6.2.105.1 Method A: Racemic phosphorous 27 to give 205a and 205b 
LDA (2 M solution in 
THF, 0.25 mL, 0.49 
mmol) was added drop 
wise to a stirred solution 
of phosphine oxide 27 
(0.05 g, 0.16 mmol) in 
dry THF (10 mL) at -72 
°C under an argon 
atmosphere. The resulting red solution was stirred for 2 hours at this 
temperature. After this time (20R)-2-((3S,10S,13S,17R)-3-((tert-
butyldimethylsilyl)oxy)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phen 
anthren-17-yl)propanal 202b (0.22 g,  0.49 mmol), was dissolved in THF (1 mL) 
and added drop wise. The reaction was left to stir at this temperature for a 
further 4 hours. After the stated time, the reaction was warmed to room 
temperature, followed by the addition of KHMDS (0.5 M solution in THF, 0.99 
mL, 0.49 mmol). It was left at 55 °C for a further 21 hours, the reaction was 
monitored by TLC and 31P NMR. After this time, sat.aq. ammonium chloride (10 
mL) was added, were the solution turned yellow, here it was allowed to warm up 
to room temperature. THF was removed in vacuo and the residue was 
dissolved in dichloromethane and water (1 : 1 v/v, 50 mL). The organic layer 
was combined, dried and filtered to yield a yellow oil (0.22 g), which was 
205a (E, C-20S/C-24R) R1 = H, R2 = Me;  
205b (E, C-20S/C-24S) R1 = Me, R2 = H  
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purified by column chromatography (90 : 10, petroleum ether : ethyl acetate) to 
give an off white solid, to give both trans compounds 251a and 251b, (0.066 g, 
77%). 
6.2.105.2 Method B: (S)-diphenyl(2-phenylpropyl)phosphine oxide 27a to 
205a 
Using the method described in section 6.2.105.1; LDA (2 M solution in THF, 
0.47 mL, 0.94 mmol) was added to a stirred solution of phosphine oxide 27a 
(0.1 g, 0.3 mmol) in dry THF (20 mL). (20R)-2-((3S,10S,13S,17R)-3-((tert-
butyldimethylsilyl)oxy)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenan 
thren-17-yl)propanal 202b (0.42 g,  0.94 mmol) was dissolved in THF (1 mL) 
and added.  Followed by KHMDS (0.5 M solution in THF, 1.87 mL, 0.94 mmol), 
it was left at 55 °C for a further 21 hours, The organic layer was combined, 
dried and filtered to yield a yellow oil, which was purified by column 
chromatography (90 : 10, petroleum ether : ethyl acetate) to give an off white 
solid,  trans-tert-butyl(((3S,10S,13R,17R)-10,13-dimethyl-17-((20S,24R, E)-5-
phenylhex-3-en-2-yl)hexadecahydro-1H-cyclopenta[a]phenanthren-3-
yl)oxy)dimethylsilane 205a (0.123 g, 72 %).  
6.2.105.3 Method C: (R)-diphenyl(2-phenylpropyl)phosphine oxide 27b to 
205b 
Using the method described in section 6.2.105.1; LDA (2 M solution in THF, 
0.47 mL, 0.94 mmol) was added to a stirred solution of phosphine oxide 27a 
(0.1 g, 0.3 mmol) in dry THF (20 mL). (20R)-2-((3S,10S,13S,17R)-3-((tert-
butyldimethylsilyl)oxy)-10,13-dimethylhexadecahydro-1H-
cyclopenta[a]phenanthren-17-yl)propanal 202b (0.42 g,  0.94 mmol) was 
dissolved in THF (1 mL) and added.  Followed by KHMDS (0.5 M solution in 
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THF, 1.87 mL, 0.94 mmol), it was left at 55 °C for a further 21 hours, The 
organic layer was combined, dried and filtered to yield a yellow oil, which was 
purified by column chromatography (90 : 10, petroleum ether : ethyl acetate) to 
give an off white solid, trans-tert-butyl(((3S,10S,13R,17R)-10,13-dimethyl-17-
((20S,24S,E)-5-phenylhex-3-en-2-yl)hexadecahydro-1H-cyclopenta[a]phenan 
thren-3-yl)oxy)dimethylsilane 205b (0.11 g, 65 %).  
 
205a and 205b; m.p. 152.2-152.6 °C; Vmax(CHCl3)/cm-1 3341 (C-H), 1788 
(C=C), 1632 (C=C arom.) 1311 (C-O), 1068 (C-H arom.); δH ppm (600 MHz.) (* 
refers to the distinguishable signals of 251b); eqv. 0.02 (6H, m, C29H3), 0.86-
2.21 (45H, m), 3.34-3.42 (1H, m, C24H), 3.52-3.63 (1H, m, C3H), 5.35-5.40 and 
5.34* (1H, m, JH = 9.1, 15.4 Hz*, C22H), 5.52-5.63 and 5.51* (1H, m, JH = 9.6, 
15.3 Hz*, C23H), 7.18-7.47 (5H, m, aromatic-H); δC ppm (600 MHz.) -5.23 
(C23H3), 10.6-60.2 (C), 42.3 and 42.2* (C24H), 40.3 and 40.4* (C20H), 72.7 
(C3H), 125.7-127.2 (aromatic C and CH), 132.3 and 132.7* (C23H), 136.2 and 
136.9* (C22H), 148.1 (aromatic-C); m/z (EI) 548.4 (MH+); HRMS (ES); calc. for 
C37H61OSi (MH+) 549.4486; Found 549.4486; 
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6.2.106 tert-butyl (((3S,8R,9S,10S,13R,14S,17R)-10,13-dimethyl- 
17-((20R,E)-5-phenylhex-3-en-2-yl)hexadecahydro-1H-
cyclopenta [a]phenanthren-3-yl)oxy)dimethylsilane 206a and 
206b  
6.2.106.1 Method A: Racemic phosphorus to give 206a and 206b 
Using the method 
described in section 
6.2.105.1; LDA (2 M 
solution in THF, 0.52 mL, 
1.0 mmol) was added to 
a stirred solution of 
phosphine oxide 27 (0.11 
g, 0.34 mmol) in dry THF 
(20 mL). After this time 
(20S)-2-((3S,10S,13S,17R)-3-((tert-butyldimethylsilyl)oxy)-10,13-dimethylhexa 
decahydro-1H-cyclopenta[a]phenanthren-17-yl)propanal 202a (0.46 g,  1.0 
mmol) was dissolved in THF (1 mL) and added. After the stated time, the 
reaction was warmed to room temperature, followed by the addition of KHMDS 
(0.5 M solution in THF, 2.06 mL, 1.0 mmol) and it was left at 55 °C for a further 
21 hours. The organic layer was combined, dried and filtered to yield a yellow 
oil (0.31 g), which was purified by column chromatography (90 : 10, petroleum 
ether : ethyl acetate) to give an off white solid as trans-tert-
butyl(((3S,10S,13R,17R)-10,13-dimethyl-17-((20R,E)-5-phenylhex-3-en-2-
yl)hexadecahydro-1H-cyclopenta[a]phenanthren-3-yl)oxy)dimethylsilane (0.132 
g, 70 %) only, 206a and 206b.  
206a (E, C-20R/C-24R) R1 = H, R2 = Me;  
206b (E, C-20R/C-24S) R1 = Me, R2 = H  
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6.2.106.2 Method B: (R)-diphenyl(2-phenylpropyl)phosphine oxide  27a 
to give 206b 
Using the method described in section 6.2.105.1; LDA (2 M solution in THF, 
0.56 mL, 1.12 mmol) was added to a stirred solution of phosphine oxide 27a 
(0.12 g, 0.37 mmol) in dry THF (20 mL). (20S)-2-((3S,10S,13S,17R)-3-((tert-
butyldimethylsilyl)oxy)-10,13-dimethylhexadecahydro-1H-
cyclopenta[a]phenanthren-17-yl)propanal 202a (0.5 g, 1.12 mmol) was 
dissolved in THF (1 mL) and added.  Followed by KHMDS (0.5 M solution in 
THF, 2.24 mL, 1.12 mmol), it was left at 55 °C for a further 21 hours, The 
organic layer was combined, dried and filtered to yield a yellow oil, which was 
purified by column chromatography (90 : 10, petroleum ether : ethyl acetate) to 
give an off white solid as a mixture of products; trans-tert-
butyl(((3S,10S,13R,17R)-10,13-dimethyl-17-((20R,E)-5-phenylhex-3-en-2-
yl)hexadecahydro-1H-cyclopenta[a]phenanthren-3-yl)oxy)dimethylsilane 206b 
(0.114 g, 55 %).  
 
206a and 206b; m.p. 149.1-149.5 °C; Vmax(CHCl3)/cm-1 3344 (C-H), 1754 
(C=C), 1523 (C=C arom.), 1367 (C-O), 1044 (C-H arom.); δH ppm (600 MHz.) (* 
refers to the distinguishable signals of 252b); 0.03 (6H, m, C29H3), 0.72 (1H, s, 
C9H), 0.86-2.21 (44H, m), 3.37-3.45 (1H, m, C24H), 3.46-3.60 (1H, m, C3H), 
5.34-5.42 and 5.28* (1H, m, C22H), 5.45-5.67 and 5.49* (1H, m, C23H), 7.22-
7.43 (5H, m, aromatic-H); δC ppm (600 MHz.) -4.53 (C23H3), 10.9-59.4 (C), 42.1 
and 42.3* (C24H), 40.1 and 40.2 (C20H), 72.3 (C3H), 125.6-126.9 (aromatic C 
and CH), 132.2 and 132.3* (C23H), 136.4 and 136.5* (C22H), 147.2 (aromatic-
C); m/z (EI) 548.4 (MH+); HRMS (ES); calc. for C37H61OSi (MH+) 549.4486; 
Found 549.4486; 
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6.2.107 (3aR,3bS,5aR,6R,8aS,8bS,10R)-10-methoxy-3a,5a-dimet 
hyl-6-((2S,E)-5-phenylhex-3-en-2-yl)hexadecahydrocyclopenta 
[a]cyclopropa[2,3]cyclopenta[1,2-f]naphthalene 207a and 207b  
Using the method described in section 
6.2.105.1; LDA (2 M solution in THF, 
0.25 mL, 0.49 mmol) was added to a 
stirred solution of phosphine oxide 27 
(0.05 g, 0.16 mmol) in dry THF (10 mL). 
After this time (20R)-2-
((3S,10S,13S,17R)-3-((tert-butyldimethyl 
silyl)oxy)-10,13-dimethylhexadecahydro-
1H-cyclopenta[a]phenanthren-17-
yl)propanal 194b (0.22 g,  0.49 mmol), 
was dissolved in THF (1 mL) and added. 
The reaction was warmed to room temperature, followed by the addition of 
KHMDS (0.5 M solution in THF, 0.99 mL, 0.49 mmol) and it was left at 55 °C for 
a further 21 hours. The organic layer was combined, dried and filtered to yield a 
yellow oil (0.22 g), which was purified by column chromatography (90 : 10, 
petroleum ether : ethyl acetate) to give an off clear oil, both trans-tert-
butyl(((3S,10S,13R,17R)-10,13-dimethyl-17-((20S,E)-5-phenylhex-3-en-2-
yl)hexadecahydro-1H-cyclopenta[a]phenanthren-3-yl)oxy)dimethylsilane 
compounds 207a and 207b (0.113 g, 52 %).  
 
207a and 207b; Vmax(CHCl3)/cm-1 3411 (C-H),  1781 (C=C), 1514 (C=C arom.), 
1378 (C-O), 1023 (C-H arom.); δH ppm (600 MHz.) (* refers to the 
distinguishable signals of 253a); 0.86-2.21 (38H, m), 3.31-3.37 (1H, m, JH = 6.8 
207a (E, C-20S/C-24R)  
R1 = H, R2 = Me;  
207b (E, C-20S/C-24S)  
R1 = Me, R2 = H 
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Hz*, C24H), 5.14-5.20 and 5.29* (1H, m, JH = 15.5, 9.0 Hz*, C22H), 5.52-5.52 
and 5.46* (1H, m, JH = 15.6, 6.8 Hz*, C23H), 7.08-7.37 (5H, m, aromatic-H); δC 
ppm (600 MHz.) 0.00 - 90.2 (C), 125.7-126.9  (aromatic C and CH), 131.95 and 
132.06* (C23H), 135.9 and 132.1* (C22H), 148.3 (aromatic-C); m/z (EI) 415.7, 
447.4 (MH+); HRMS (ES); calc. for C32H47O (MH+) 447.3616; Found 447.3621; 
 
6.2.108 (3aR,3bS,5aR,6R,8aS,8bS,10R)-10-methoxy-3a,5a-dimet 
hyl-6-((2R,E)-5-phenylhex-3-en-2-yl)hexadecahydrocyclopenta 
[a]cyclopropa[2,3]cyclopenta[1,2-f]naphthalene 208a and 208b 
Using the method described in section 
6.2.105.1; LDA (2 M solution in THF, 
0.52 mL, 1.0 mmol) was added to a 
stirred solution of phosphine oxide  27 
(0.11 g, 0.34 mmol) in dry THF (20 mL). 
(20S)-2-((3S,10S,13S,17R)-3-((tert-
butyldimethylsilyl)oxy)-10,13-dimethyl 
hexadecahydro-1H-cyclopenta[a]phen 
anthren-17-yl)propanal 194a (0.46 g,  
1.0 mmol) was dissolved in THF (1 mL) 
and added.  The reaction was warmed to room temperature, followed by the 
addition of KHMDS (0.5 M solution in THF, 2.06 mL, 1.0 mmol) and it was left at 
55 °C for a further 21 hours. The organic layer was combined, dried and filtered 
to yield a yellow oil (0.31 g), which was purified by column chromatography (90 : 
10, petroleum ether : ethyl acetate) to give an off yellow oil as trans-tert-
butyl(((3S,10S,13R,17R)-10,13-dimethyl-17-((20R,E)-5-phenylhex-3-en-2-
208a (E, C-20R/C-24R)  
R1 = H, R2 = Me;  
208b (E, C-20R/C-24S)  
R1 = Me, R2 = H 
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yl)hexadecahydro-1H-cyclopenta[a]phenanthren-3-yl)oxy)dimethylsilane 208a 
and 208b (0.011 g, 7 %) only.  
Vmax(CHCl3)/cm-1 3455 (C-H),  1721 (C=C), 1501 (C=C arom.), 1278 (C-O), 
1029 (C-H arom.) δH ppm (400 MHz.) 0.86-2.21 (39H, m), 5.34-5.42 (1H, m, 
C22H), 5.55-5.62 (1H, m, C23H), 7.08-7.37 (5H, m, aromatic-H); m/z (EI) 447.4 
(MH+); HRMS (ES); calc. for C32H47O (MH+) 447.3616; Found 447.3621; 
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8.0 CHAPTER 8 - Appendix 
These H-W grids contain all reactions carried out during this PhD and it is 
important to note, each H-W reaction has been repeated at least twice and 
each ratio has been determined using integration on MestReNova NMR 
software. The results have been averaged to determine the following ratio of 
products, were the minor diastereoisomer has been referred to as 1. 
All compounds mentioned in the discussion have method, which can be found 
in the experimental section (Chapter 4).  
As the thesis has already exceeded maximum capacity, compounds 211- 250 
have not been mentioned in the discussion and experimental, but have been 
isolated. If the experimental procedures are required, this information can be 
provided in the form of a CD-ROM disc. 
 
 
  
 
Grid 1: H-W reactions 
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Grid 2: H-W reactions (continuing from Grid 1) 
 
Grid 3 : H-W reactions 
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Grid 4 : H-W reactions 
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Grid 5 : H-W reactions (continuing from Grid 4) 
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Grid 6 : H-W grid using α-substituted aldehyde 
